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Eosinophilic Oesophagitis (EoE) is a chronic condition, characterised by oesophageal symptoms 
and eosinophil predominant inflammation ≥15 eosinophils/high powered field (HPF). Increased 
understanding of disease pathogenesis in the past decade has suggested that EoE is primarily 
non-IgE mediated. However, dietary management strategies remain focused on elimination of 
common IgE-mediated food allergens and exploration of other adverse food reactions such as 
food chemical intolerances in these patients is limited. In addition, current dietary elimination 
strategies are ad hoc in nature and focus on the initial elimination phase and forgo explanation 
of the critical challenge/reintroduction and long term management of these patients. Thus, 
application of optimal dietary management in the clinical setting is difficult for the patient, 
dietitian and multidisciplinary team.  
This thesis aimed to inform dietary management, from assessment through to monitoring and 
evaluation of EoE, by exploring patient experiences and characteristics, and examining the use 
of a low chemical elimination diet and challenge protocol to develop a personalised dietary 
management approach, as well as exploring dietitian proficiency in managing the condition. 
The Nutrition Care Process (NCP) model was used as a framework for identification of key 
considerations for dietetic management.  
A national survey of members of the Australian eosinophilic disease support group examined 
patient characteristics and current management practices. Australian patients with EoE were 
identified to have many similarities to other western cohorts including symptoms, atopic 
conditions and male to female ratio. Functional gastrointestinal symptoms, fatigue and 
behavioural problems were also identified. Dietary self-restriction and inconsistent food 
challenge/reintroduction strategies were common. This was reiterated in focus groups with 
the support group members, which explored patient experiences and opinions on improving 
their care pathway. Thematic analysis of four focus groups identified six major themes related 
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to the participants perceptions of the current management pathway and ten key themes 
comprising suggestions for improving the pathway. Participants desired a clear and direct 
treatment pathway with the role of the dietitian highlighted as important; including provision 
of individualised advice, support, information on meeting nutrition requirements and food 
reintroduction guidance.  
Patient characteristics and a potential dietary management protocol were explored in detail in 
a case study of patients attending the Royal Prince Alfred Hospital (RPAH) Allergy Unit. 
Patients with EoE (N=169) presenting between 1997 and 2017, were identified to experience 
oesophageal symptoms, atopic conditions (allergic rhinitis, asthma and eczema), as well as a 
variety of symptoms reflective of food chemical intolerance including reflux, abdominal pain, 
diarrhoea, constipation, headaches/migraines, behavioural changes and non-allergic rhinitis. 
Approximately three quarters of patients were sensitised to airborne allergens and half of 
patients were sensitised to foods on allergy tests, though less than a quarter had a diagnosed 
food allergy. Patients also reported a variety of foods to be symptom triggers including fruits, 
meats and vegetables.  
In a subset of this total group, patients with EoE achieved symptomatic and histological 
remission on a low chemical elimination diet (N=59, 43/HPF vs. 6/HPF, p<0.001), with dietary 
non-adherence and food allergen sensitisation associated with histological non-response (both 
p<0.001). Patients completing challenges (N=64) had a positive challenge response to a median 
of three challenges with milk (61%), amines (59%), salicylates (57%) and wheat (55%) the most 
common symptom triggers. Patients maintained symptomatic and histological remission on 
their personalised diet, identified from challenges.  
Within the case study, N=35 patients agreed to participate in a prospective study (2015-2017) 
completing quality of life (QOL), psychological and psychometric questionnaires and weighed 
food records over the dietary protocol. Depressive and anxiety symptoms were identified to be 
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elevated in these patients at baseline, whilst QOL was identified to be impacted at all stages, 
related to symptom frequency and dietary restriction. In addition, at baseline, patients with 
EoE were identified to have low calcium and fibre intakes. On the low chemical elimination 
diet calcium, vitamin A and fibre intake was inadequate, but improved to be adequate with 
supplementation. Overall dietary quality improved on the low chemical elimination diet from 
baseline, due to decreased consumption of discretionary food choices. 
The final study explored dietitian knowledge and proficiency in the dietary management of EoE 
using survey methodology. Dietitians reported their proficiency in the dietary management of 
EoE to be low, with a third reporting that they were not at all proficient in conducting food 
challenges/reintroduction in patients with EoE. Dietary management of EoE was identified to 
be a key area for further training. 
The dietary management of EoE is complex; but there are many opportunities for improving 
patient outcomes including increasing disease awareness, care coordination within the 
multidisciplinary team, thorough nutrition assessment, personalised dietary intervention and 
increasing dietetic training and resources.  The investigations in this thesis provide an outline 
of considerations for dietitians following the NCP, highlighting patient experiences and the 
need to advocate for patients as well as providing them with education to achieve the best 
overall health outcomes and QOL.
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CHAPTER 1: EOSINOPHILIC OESOPHAGITIS: IMPLICATIONS FOR 
THE NUTRITION CARE PROCESS 
1.1 INTRODUCTION 
Eosinophilic Oesophagitis (EoE) is a chronic gastrointestinal disorder that affects individuals of 
all ages. EoE is characterised clinically by symptoms of oesophageal dysfunction and 
histologically by eosinophil infiltration of the oesophageal mucosa. Whilst the exact 
mechanisms behind the pathophysiology are unknown, dietary elimination has been explored 
as a management option to assist patients to achieve disease remission.1 This thesis considers 
how dietitians may work with patients to achieve disease remission through a personalised 
approach to dietary management, by providing considerations on aspects of the Nutrition Care 
Process (NCP) model,2 including nutrition assessment, intervention and monitoring and 
evaluation, central to dietetic practice. This includes exploration of patient experiences and 
needs, characteristics, and investigation of the use of a low chemical elimination diet to 
develop an individualised dietary management approach, as well as examination of dietitian 
knowledge and skills. This chapter provides an overview of what dietitians may need to 
consider as part of their care of patients with EoE as well as highlighting areas of unmet need.  
1.2 EOSINOPHILIC GASTROINTESTINAL DISORDERS 
In healthy individuals, eosinophils (non-specific destructive and cytotoxic white blood cells)3 
are usually present in small numbers throughout the gastrointestinal tract, except for the 
oesophagus. Primary Eosinophilic Gastrointestinal Disorders (EGID) are conditions in which 
eosinophilic inflammation is present in the gastrointestinal tract in the absence of known 
causes of eosinophilia (for example parasitic infection). These disorders include EoE, 
eosinophilic gastritis, eosinophilic gastroenteritis, eosinophilic enteritis and eosinophilic colitis.  




EoE has been reported mainly in industrialised countries, including the United States (US), 
Canada, Europe and Australia.5 There is evidence to suggest that the incidence of EoE has 
dramatically increased over the past 20 years.6 However, a Canadian study showed that whilst 
incidence rates had increased over a four year period, this correlated with an increased 
number of endoscopies performed over the same time period.7 Therefore, it is likely that the 
incidence of EoE may be rising as well as becoming increasingly recognised as a distinct 
diagnosis. The most recent evidence suggests that the incidence of EoE has increased and 
currently varies from 1-20 new cases per 100 000 per year. Prevalence rates range from 13-49 
cases per 100 000,1 with a higher prevalence in adults (43 cases/100 000) than children (30 
cases/100 000).8  
1.4 CLINICAL AND HISTOLOGICAL MANIFESTATION 
EoE was first characterised in 1962 by Schreiber,9 but was not described as a distinct disease 
entity until 1978.10  Early case reports described an idiopathic disease, with distinct clinical and 
histological manifestations. EoE has been likened to ‘asthma of the oesophagus’ due to the 
similarities in patient characteristics and inflammatory infiltrate, with long standing disease 
resulting in structural changes and dysfunction.11 EoE can occur at any age and predominantly 
affects males (3:1 male/female ratio).5 Clinical indicators of EoE are known to vary with age 
(Table 1.1) and are often non-specific in young children; for example difficulty feeding, 
vomiting and abdominal pain. These symptoms generally progress to dysphagia and food 
impaction as adolescents and adults.6
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On endoscopy, evidence of tissue inflammation and remodelling can be seen, and can vary 
amongst patients and over time. Two main phenotypes have been used to describe these 
variants in macroscopic appearance; 1) fibrostenotic: circular, concentric rings which may be 
transient or fixed (Figure 1.1 A), oesophageal narrowing (Figure 1.1 B), and stricture, and 2) 
inflammatory: endoscopic features of linear furrowing (vertical lines in the oesophageal 
mucosa) (Figure 1.1 C), white exudates, specks, nodules or granularity (Figure 1.1 D), and 
oedema. These phenotypes can also occur together (mixed) (Figure 1.1 F).13 It has been 
reported that up to 30% of children can have an oesophagus of unremarkable appearance on 
endoscopy12 and that the risk for the fibrostenotic phenotype increases with age, suggesting 
that EoE can be a progressive disease.14 Therefore, it is recommended that biopsy specimens 
should be taken regardless of endoscopic appearance. Histological features suggestive of EoE 
include ≥15 eosinophils per high powered field (HPF), degranulation, eosinophilic 
microabcesses, superficial layering in the upper one third to half of the squamous epithelium, 
basal zone hyperplasia, dilated intercellular spaces, papillary elongation, lamina propria 
fibrosis and increased lymphocytes and mast cells.1,12 Overall, evidence suggests that the 
natural history of untreated EoE is associated with persistent symptoms and inflammation 
resulting in stricture formation that is not pre-malignant.14 Additionally, quality of life (QOL), 




Figure 1.1: Endoscopic features suggestive of eosinophilic oesophagitis. (A) oesophageal rings, 
(B) oesophageal narrowing, (C) linear or longitudinal furrowing, (D) white plaques or exudates, 
(E) crepe-paper mucosa, with tears from the passage of the endoscope, (F) a combination of 
rings, linear furrows, narrowing and white exudates. Adapted [reprinted] from “Diagnosis and 
management of eosinophilic esophagitis,” by Dellon, ES 2012, Clin Gastroenterol Hepatol., 
10:116.  Copyright 2012 by “PubMed.”15 
1.5 DEFINITION 
Despite being identified in the 1960’s and 1970’s, it was not until the early 1990’s that 
research into EoE began to progress.10 In 2006, a task force of 31 physicians performed a 
systematic literature review to provide guidelines for uniform diagnosis and treatment. The 
first consensus guidelines published in 2007 provided a key definition of EoE: 
“primary clinicopathologic disorder of the esophagus, characterized by esophageal 
and/or upper gastrointestinal tract symptoms in association with esophageal mucosal 
biopsy specimens containing ≥15 intraepithelial eosinophils/HPF in 1 or more biopsy 
specimens and absence of pathologic gastroesophageal reflux disease as evidenced by 
a normal pH monitoring study of the distal esophagus or lack of response to high-dose 
Proton Pump Inhibitor (PPI) medication”12 
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These guidelines, followed by the 2011 updated consensus guidelines,16  provided an overview 
of the epidemiology, clinical and histological picture and current treatment modalities for EoE. 
Additionally, they highlighted the need for research in all these areas. In January 2017, 
updated evidenced based statements and recommendations for diagnosis and management of 
EoE were released, with a key change to the definition and diagnostic criteria. More 
specifically, under these statements, EoE is defined as “a chronic, immune mediated 
oesophageal disease, characterised by oesophageal dysfunction and eosinophil predominant 
inflammation”1 in the absence of other pathological causes. An important distinction of the 
new guidelines is that patients achieving clinical and histological remission on PPI therapy are 
now considered part of the EoE continuum.1   
1.6 GASTROESOPHAGEAL REFLUX DISEASE AND EOSINOPHILIC OESOPHAGITIS 
Gastrointestinal Oesophageal Reflux Disease (GORD) is defined as “a condition which develops 
when the reflux of stomach contents causes troublesome symptoms and complications,”17 and 
is estimated to effect around 10% of the Australian population,18 and up to 20% of Western 
populations.17 Symptoms and complications of GORD are commonly treated through acid 
suppressive medications such as PPIs.19 EoE and GORD were first characterised as distinct 
entities by Attwood et al. in 1993,20 closely followed by Straumann et al. in 1994.21 They 
described patients with increased oesophageal intraepithelial eosinophils (>20 
eosinophils/HPF), and symptoms of dysphagia, but normal 24hr pH testing. However, the 
similarities in clinical symptoms and histological manifestation of EoE and GORD presented 
challenges in distinguishing between the two conditions.22,23 In 2006, Ngo and colleagues,24 
presented the concept of PPI responsive oesophageal eosinophilia (PPI-REE), describing a 
subgroup of patients with endoscopic, histological and clinical markers of EoE, but who 
completely respond to PPI therapy. This counteracted the 2007 consensus definition of EoE 
which described oesophageal eosinophilia that is non-responsive to PPI therapy,12 allowing the 
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two conditions to be differentiated. As such, controversy ensued as to whether EoE and GORD 
are mutually exclusive conditions, with three main theories provided to explain the 
relationship. 
The first hypothesis is that GORD and EoE may coexist but are not pathogenically related. Since 
GORD is a highly prevalent disease (up to 28%),25 the likelihood of clinical overlap is high. 
However, the prevalence of GORD in EoE populations is higher than expected (25-50%), when 
compared to the general population, suggesting an important interaction between the two 
conditions.22,23 
The second hypothesis is that EoE may contribute to GORD. The first two mechanisms 
suggested, are based on the premise that the primary cause of GORD is transient relaxation of 
the lower oesophageal sphincter, allowing stomach acid to enter the oesophagus. Eosinophils 
are known to secrete agents such as vasoactive intestinal peptide, which can affect 
oesophageal smooth muscle function. Secondly, impaired oesophageal function related to 
thickening and fibrosis of the oesophagus (a known histological component of EoE) may result 
in lower oesophageal sphincter dysfunction. Thirdly, inflammatory mediators from eosinophils 
may predispose the oesophagus to be more susceptible to injury from acid reflux. 22,23 Thus, in 
patients who respond to PPI therapy it is possible that PPI’s may have an anti-inflammatory 
effect, as they have been shown to decrease T helper type 2 (Th2) cell (immune response 
associated with EoE) secretion of eotaxin-3 (cytokine chemotactic for eosinophils).24 
The third and most current hypothesis describing the link between GORD and EoE suggests 
that GORD may contribute to EoE. It is well known that exposure of the oesophageal mucosa 
to acid can result in impaired mucosal integrity, by increasing intercellular oedema in the 
oesophageal epithelium. Oesophageal mucosal integrity has been shown to be markedly 
impaired in patients with EoE compared to healthy controls. This increased mucosal 
permeability theoretically allows increased penetration of swallowed allergens, resulting in 
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allergic sensitisation, in a similar model to allergen sensitisation in children with eczema,22,23 
though this hypothesis remains speculatative.1 Subsequently, acid suppression would allow 
repair of the mucosal epithelium explaining patient response to PPI therapy. However, 
considering that many patients do not respond completely to PPI therapy and the high 
prevalence of reflux in the general population who do not have eosinophilic inflammation, it is 
likely that other factors also contribute.  
The consensus statement from the latest guidelines succinctly summarises this relationship, 
stating that EoE and GORD are distinct entities and may co-exist in a single patient either 
unrelated or interacting bidirectionally.1  
1.7 ATOPIC CONDITIONS AND EOSINOPHILIC OESOPHAGITIS 
1.7.1 Historical background to atopic conditions and eosinophilic gastrointestinal 
disorders 
Atopy is defined by the American Academy of Allergy and Immunology (AAAAI) as the “genetic 
tendency to develop allergic diseases such as allergic rhinitis, asthma and atopic 
dermatitis (eczema), and is associated with heightened immune responses to inhaled allergens 
and food allergens.”26 Early case reports of EGIDs identified concomitant atopic conditions 
such as asthma, eczema, hayfever and food allergy, with approximately half of the cases 
having atopic histories. The association between atopic conditions and EoE has been 
recognised since the 1980’s. Case reports identified a strong allergic background (both food 
and airborne) in many patients, commonly recognised in other eosinophilic disorders of the 
gastrointestinal tract.27,28 
1.7.2 IgE-mediated allergy definition, diagnosis and testing  
Adverse food reactions have been broadly categorised into immune mediated and non-
immune mediated hypersensitivity (reproducible symptoms initiated by exposure to a defined 
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stimulus at doses tolerated by normal persons) reactions. An allergy is a hypersensitivity 
reaction initiated by specific immunological mechanisms and can be further defined by the 
immunological mechanism mediating the reaction (Figure 1.2).29,30  Immunoglobulin-E (IgE) 
mediated allergy is the most common, well defined and understood of these reactions.30  
 
Figure 1.2: Classification of types of adverse food reactions. Adapted [reprinted] from 
“Guidelines for the diagnosis and management of food allergy in the United States” by Boyce 
et al. 2010, Journal of American Dietetic Association, 126(6):1105-1118. Copyright 2010 by 
‘Elsevier’.30 
IgE-mediated allergy is characterised by two phases: primary immunological sensitisation from 
exposure to an antigen (allergen), and reaction on re-exposure to the same antigen. An 
individual becomes sensitised when T and B lymphocytes recognise otherwise harmless 
antigens from pollen or food proteins, which promotes the differentiation of naïve T cells into 
activated Th2 cells. These cells stimulate B lymphocytes to produce allergen-specific IgE 
antibodies, which attach to Fcε-receptors on tissue mast cells and blood basophils. When the 
sensitised individual is re-exposed to the allergen through the mucosa by skin penetration, 
inhalation or ingestion an adverse reaction can occur. The allergen binds to the IgE on the 
mast cell resulting in degranulation and release of mediators such as histamine, prostaglandins 
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and leukotrienes. These mediators stimulate sensory nerve fibres promoting immediate 
symptoms.30–33 Newly synthesised mediators contribute to delayed Th2 cell and eosinophil 
predominant inflammation and hyper-reactivity (late phase response).33 
Allergy diagnosis should be made by obtaining a thorough clinical history (including a detailed 
medical history; symptoms and potential causative food and physical examination) and 
appropriate allergy testing with relevant foods identified in the clinical history. The two main 
testing procedures used are Skin Prick Test (SPT) and allergen specific serum IgE (sIgE) in blood 
tests. SPTs have the benefit of producing a result within 10-20 minutes and have a high 
negative predictive value (NPV).34 Correlations can be made between SPT wheal diameter, sIgE 
level and the likelihood of an allergic response. A 95% Positive Predictive Value (PPV) of food 
allergy for SPT wheal size ≥ 6mm has been described for egg and peanut in children, however, 
specificity was low.35 As such, the tests cannot distinguish between sensitisation and a true 
allergy.32 Thus, allergy tests are recommended for identifying foods and/or aero-allergens that 
could potentially evoke an IgE-mediated allergic reaction, but alone are not diagnostic.30   
Another investigational test available is Atopy Patch Testing (APT). APT is designed to detect 
delayed (T-cell mediated) reactions by applying small pads soaked in the allergen to the skin 
for 48hrs. Currently insufficient evidence exists to support the use of APT, due to the poor 
sensitivity and specificity and there is no consensus on appropriate reagents, methods or 
interpretation of tests. Early studies reported that APT may be useful for identification of food 
triggers in EoE,30 however more recent evidence does not support their use in directing dietary 
therapy.36 Other investigational tests that have shown promise in the detection of food 




1.7.3 Relationship between IgE-mediated food allergy and eosinophilic oesophagitis 
IgE-mediated food allergy reactions are characterised by immediate and reproducible 
symptoms of urticaria, angioedema, breathing difficulty and in severe cases anaphylaxis to 
specific food proteins commonly: egg, milk, nuts, seafood, wheat and soy. In Australia, food 
allergy is estimated to affect around 5-10% of children and 2% of adults.40 Food avoidance and 
an emergency action plan are required for management of IgE-mediated food allergy. 
Additionally, avoidance of potential allergens that may be cross-sensitised, due to common 
epitopes, may be advised.32 
Prevalence of IgE-mediated food allergy in EoE populations has been reported at rates 
between 15-43%,1,41–43 though it should be noted that definitions used to estimate these 
prevalence statistics is highly variable. Patients with EoE who have a concomitant food allergy 
are younger and have other atopic conditions such as eczema,44 consistent with the natural 
history of food allergy.45 Evidence suggests that paediatric patients with EoE have higher rates 
of IgE-mediated food allergy than the general population.46 It has been reported that up to 
77% of children and 50% of adults with EoE have a positive SPT to foods.46 Peanut, egg, milk 
and soy have been reported as the most common positive SPT in other EoE populations.41,47 
However, these sensitisations rarely translate to a clinically diagnosed IgE-mediated food 
allergy.48  
It has been suggested that food sensitisations seen in patients with EoE may be a result of 
cross reactivity of food allergens after birch pollen sensitisation.49 Oral Allergy Syndrome (OAS) 
is a form of localised IgE-mediated allergy, usually to raw fruit or vegetables and most 
commonly affects patients who are allergic to pollens; especially birch pollen.30 OAS is caused 
by IgE cross reactivity between a prior aero-allergen sensitisation and similar plant-derived 
proteins.50 Symptoms are usually confined to the lips, mouth, tongue and throat and include 
itch, swelling and tingling, but anaphylaxis has also been reported. 30 A recent study in the US 
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found approximately 25% of an adult cohort of patients with EoE had OAS, commonly to more 
than one food including apple, carrot, peach and banana, associated with birch cross-
reactivity.51 
1.7.4 Relationship between allergic rhinitis and eosinophilic oesophagitis 
Rhinitis is characterised by inflammation of the mucous membrane lining of the nasal 
passage52 with symptoms of nasal congestion, itching, sneezing, rhinorrhoea and post nasal 
drip.33 Rhinitis can be classified as allergic: those who are sensitised to airborne allergens, and 
non-allergic: symptoms in the absence of identifiable allergen sensitisation. Allergic rhinitis can 
be further classified as seasonal (associated with pollens), and perennial (related to dust mites 
or domestic animals).33 In allergic rhinitis, airborne allergens bind to specific IgE antibodies on 
mast cells resulting in mast cell degranulation. Mediators, for example histamine, stimulate 
sensory nerve endings resulting in immediate symptoms such as itch and sneezing. 
Additionally, chronic rhinitis symptoms and nasal hyper-reactivity is promoted by the release 
of mast cell mediators such as leukotrienes, chemokines and cytokines resulting in eosinophil 
and Th2 cell predominant inflammation as well as release of neuropeptides including 
substance P (SP) and calcitonin gene-related peptide (CGRP), and neurokinins from sensory 
nerve endings.33,53 Common treatments of allergic rhinitis include antihistamines, intranasal 
sprays (glucocorticoid steroids or antihistamine) and leukotriene-receptor antagonists (e.g. 
Montelukast). Intranasal steroid sprays are currently thought to be the most effective and 
consistent treatment.33,53,54 Prevalence of allergic rhinitis in Australia is not well reported but is 
estimated to affect around 20% of the population (range 12-41%).55 Non-allergic rhinitis occurs 
when nerve endings in the nose are irritated by various triggers, for example drugs, gustatory 
rhinorrhoea and hormonally induced.56 Allergic and non-allergic rhinitis can co-exist.52 
The prevalence of allergic rhinitis in EoE patients is reported in the literature at 40-75%.16 A 
recent US study found that allergic rhinitis was present in 71% of EoE patients (combined 
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adults and children),57 and very similar rates have been reported in adults and children, 66% 
and 64% respectively.58 Non-allergic rhinitis has not been well reported in patients with EoE.  
In the early 2000’s, a hypothesis emerged that inhaled respiratory allergens may contribute to 
EoE.59 Mishra et al.59 showed that in a mouse model, exposure to intranasal allergens elicited 
oesophageal eosinophilia, where oral exposure did not. Consequently, consideration of 
treatment with intranasal steroids was suggested.59 In 2003, Fogg et al.60 presented a case, 
documenting a young woman diagnosed with EoE, with negative SPT and APT to a wide range 
of foods, but with positive tests to seasonal and environmental aero-allergens. Interestingly, 
the patient’s symptoms and eosinophilic inflammation worsened during summer and spring 
(pollen seasons) but were mild during the winter season. The author hypothesised that 
swallowing nasal secretions and deposition of pollen in the oesophagus may be responsible for 
the fluctuation in symptoms.60 Seasonal aero-allergen induced EoE has since been 
documented in a larger cohort of children.61 Furthermore, it was identified that the onset of 
allergic rhinitis occurred before the onset of EoE, suggesting a role in sensitisation.62  
1.7.5 Relationship between asthma, eczema and eosinophilic oesophagitis 
Asthma and eczema are strongly associated with allergy and EoE.12 Asthma is defined as 
“recurrent attacks of breathlessness and wheezing, which vary in severity and frequency from 
person to person,”63 and is associated with chronic airway inflammation, and bronchial 
hyperreactivity. Airway nerve endings are easily irritated by odours, pollutants, temperature 
and weather changes, which can result in contraction of bronchial smooth muscle with airflow 
limitation.63,64 The association between asthma and EoE was first recognised in the 1980’s in a 
case series of patients with EoE, of which two had asthma.27 More recently, in a cohort of 50 
children and 50 adults with EoE, 38% had a history of asthma.58 When compared separately, 
history of asthma was significantly higher in children (52%) compared to adults (24%). 
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Evidence suggests that the prevalence of asthma in patients with EoE can range anywhere 
between 14-70%.16  
Similarly, the literature suggests that the prevalence of eczema in patients with EoE can range 
from 4-60%.16 A recent study found, in a cohort of adults and children, 17% had eczema, with 
24% of children and 10% of adults reporting a history of eczema,58 consistent with the natural 
history of eczema.65 Eczema is usually characterised by dry skin, patchy lesions especially in the 
flexures, and itching related to chronic allergic inflammation, increased transepidermal water 
loss and epidermal barrier dysfunction.66 There is a strong genetic link in patients with eczema, 
as well as a strong association between eczema, food allergies66 and possibly non-
immunological food intolerance.67 
1.8 OTHER CONDITIONS ASSOCIATED WITH EOSINOPHILIC OESOPHAGITIS 
There are speculative studies and case reports that have identified possible associations 
between EoE and autoimmune diseases such as coeliac disease68 and Crohn’s disease,69 
connective tissue disorders such as joint hypermobility syndrome, Marfan syndrome, 
hypermobile Ehlers-Danlos syndrome70 and other diseases: atopic cataracts,71 erythema 
nodosum,72 oesophageal atresia and Barrett’s oesophagus.73,74 Overall, it is suggested that 
there is no causal or temporal relationship between these diseases and EoE. However, 
evidence is limited, and further prospective research is required to explore these 
relationships.1 
1.9 PATHOGENESIS 
Since their first recognition in the 1930’s EGIDs, remain uncommon and of unclear aetiology. 
To date the pathogenesis of EoE is not well understood. A variety of genetic and 
environmental factors have been linked with the disease pathogenesis, as well as disrupted 
17 
 
epithelial barrier function, alterations in sensory nerve function, immunological mechanisms 
and more recently alterations in the oesophageal microbiome.75  
1.9.1 Genetic and environmental factors influencing the pathophysiology of 
eosinophilic oesophagitis 
Evidence suggests that there is a strong familial link in patients with EoE, with a high estimated 
sibling risk ratio of 80.76 A family history of EoE or dysphagia is also commonly reported.77 
Genetic variants in the genes: CAPN14, TSLP, TSLPR, CCL26 (eotaxin-3 gene), WDR36 and FLG 
have been associated with EoE in a familial and genome wide association studies.77  A recent 
twin study reported that heritability accounts for approximately 14.5% of EoE cases, whilst a 
common environment accounts for 80% of the variation. The study also identified factors in 
early life such as birth season, breastfeeding, antibiotic exposure and penicillin allergy may 
influence the risk of developing EoE.78 
1.92 Oesophageal epithelial barrier dysfunction in the pathophysiology of 
eosinophilic oesophagitis 
There is increasing evidence that EoE is associated with dysfunction of the epithelial barrier.79 
Patients with EoE have been shown to have increased numbers of epithelial dilated 
intercellular spaces and decreased levels of proteins that comprise both adheren and tight 
junctions. These alterations in epithelial barrier integrity likely contribute to initiation and 
propagation of EoE, with suggestions that impaired barrier function may promote increased 
antigen exposure to elicit immune responses.75  However, the reasons for these alterations 
remain unclear. Gastric acid exposure is a likely factor contributing to oesophageal barrier 
dysfunction.80 Evidence suggests that luminal acid exposure can attack and damage epithelial 
tight junctions resulting in dilated intercellular spaces and impaired epithelial integrity.81 
Additionally, a variety of molecules important for epithelial integrity have also been shown to 
be dysregulated in animal models and oesophageal biopsies of patients with EoE. For example, 
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desmosomal cadherin desmoglein (DSG1) and keratin, intercellular adhesion molecules critical 
to epithelial integrity, have been shown to be reduced in oesophageal biopsies of patients with 
active EoE. Interleukin-13 (IL-13) has also been shown to downregulate DSG1.80 
1.9.3 Visceral hypersensitivity in the pathophysiology of the inflamed oesophagus 
Evidence of the role of the enteric nervous system (ENS) in pathophysiological disorders of the 
gut is growing.82  The ENS is an extensive neuronal network imbedded in the gut wall, including 
the oesophagus, which is responsible for intrinsic regulation of gastrointestinal function, 
independent of the CNS.83 In the colon, neuronal function has shown to be modulated by 
stress, the immune system, gut microbiota and inflammation. It is thought that inflammation 
causes sensory afferent nerve endings to become hypersensitive, activated at reduced 
stimulus intensities and enhance their mechanical responsiveness (visceral hypersensitivity). 
Long-lasting structural, synaptic or intrinsic changes that alter neuronal function have been 
termed neuroplasticity and contribute to abnormal secretion, motility and sensation in the 
gut, for example discomfort, pain and diarrhoea in Inflammatory Bowel Disease (IBD).82,84 
Neurogenic inflammation is mediated by release of two main neuropeptides: CGRP and SP 
from nociceptors. Human oesophageal mucosa nerve fibres have been shown to be 
immunoreactive to neuropeptides including CGRP and SP.85 These neuropeptides act directly 
on vascular endothelial and smooth muscle cells. It is therefore, possible that abnormal 
oesophageal motility recorded in patients with EoE is a result of the action of these 
neuropeptides.84 SP can also activate mast cells promoting release of nerve growth factor 
(NGF),86 and subsequently nerve ending growth, upregulation of neurotransmitters and 
neuromodulatory receptors and recruitment of immune cells.87 
Three main pathways to explain the mechanism of visceral hypersensitivity have been 
proposed: peripheral sensitisation; with sensitisation of local afferent nerves, central 
sensitisation; with sensitisation of spinal dorsal horn neurons, and viscero-visceral 
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hyperalgesia; sensitisation due to the convergence of afferent nerves from different organs 
with shared central afferent terminals.88  
In peripheral sensitisation, local oesophageal inflammation, for example by tissue damage due 
to acid reflux, results in sensitisation of afferent nerves due to the release of inflammatory 
mediators such as ions, prostaglandins and histamine.89 Oesophageal pain and heartburn 
symptoms occur when acid and/or other components of gastric refluxate reach sensory nerve 
endings through dilated intercellular spaces in GORD and non-erosive reflux disease.90 
Similarly, patients with EoE felt pain earlier and tolerated less oesophageal acid perfusion than 
healthy controls.91  
Transient receptor potential (TRP) ion channels are widely studied molecular mediators of 
neuromodulation92 and have been implicated in inducing neuroplasticity of the gut.93 Nerve 
fibres expressing TRP vanilloid one (TRPV1), an acid, heat and capsaicin sensitive receptor; are 
present in the human oesophagus. In the Guinea pig oesophagus, these nociceptive vagal 
afferents have been shown to respond to mechanical stimulation such as distension and 
chemical stimulation. For example capsaicin, a selective agonist of the TRPV1 receptor and the 
active ingredient in chilli peppers.94 It has been suggested that initial steps leading to the 
development of oesophageal inflammation may be mediated by TRPV1.95 Indeed, TRPV1 has 
been shown to be over-expressed in the inflamed human oesophagus93 and has been 
implicated in retrosternal pain and heartburn symptoms in patients with EoE.96 Thus, visceral 
hypersensitivity is consistent with current evidence for development of oesophageal 
inflammation in EoE79,80 and may explain symptom and histological improvement on PPI 
therapy in patients with EoE.1  
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1.9.4 Immune cells and mediators associated with the pathophysiology of 
eosinophilic oesophagitis 
The molecular mechanisms involved in EoE have only partially been elucidated. EoE was 
initially suspected to be IgE-mediated in nature, due to associations between atopy and IgE 
food allergy and EoE79 (Section 1.7). However, not all patients have elevated levels of total or 
specific IgE and animal models have identified that IgE is not necessary for oesophageal 
eosinophilia. Additionally, targeted food avoidance and trials testing the effect of monoclonal 
antibodies which bind to IgE rendering it inactive (omalizumab) show limited effects.80,96 Thus, 
the role of IgE in EoE is unclear and whilst often associated with IgE-mediated allergy, EoE is 
not simply IgE-mediated in nature.79  
It has been suggested that the oesophageal epithelium may have an important role in the 
development of EoE, by production of epithelium derived cytokines such as Thymic Stromal 
Lymphopoietin (TSLP) and Interleukin-33 (IL-33). These cytokines can be induced by proteases 
or mechanical damage and promote the Th2 inflammatory response,75 resulting in eosinophil 
activation. Epithelial cytokines target invariant natural killer T cells (iNKT); a subset of 
lymphocytes that produce Th2 cytokines (Figure 1.3a). Patients with EoE have been found to 
have increased oesophageal iNKTs compared to controls. Additionally, under experimental 




Figure 1.3a: Model of the initiation of inflammation in eosinophilic oesophagitis pathogenesis. Adapted [reprinted] from “Novel immunological mechanisms 




Figure 1.3b: Model of the perpetuation of inflammation in eosinophilic oesophagitis pathogenesis. Adapted [reprinted] from “Novel immunological 




The Th2 inflammatory response has been associated with EoE in animal models and in vitro, 
with increased numbers of B cells, T cells, eosinophils and Th2 associated cytokines. It is 
thought that the Th2 response leads to recruitment and activation of mast cells and 
eosinophils, which degranulate, releasing mediators (such as cytokines) that instigate tissue 
damage and repair.77 Eosinophilic inflammation characterises the disease and stimulates 
fibrosis.79 However, an initial antigen presenting cell interaction initiating the Th2 response has 
not been demonstrated.79,80  
Mast cells are long lived leukocytes that are found abundantly in body barriers, such as the 
gastrointestinal tract, ready for optimal interaction with the environment. Mast cells are 
involved in a number of physiological and immune responses such as vascular and epithelial 
permeability, ion secretion, peristalsis, fibrosis and tissue repair, chemotaxis and 
nociception.97 Mast cells have been shown to be upregulated in patients with EoE and may be 
modulated by dietary therapy.98 Mast cells have been most extensively studied in relation to 
their activation and degranulation in response to IgE antibodies. IgE bearing mast cells have 
been observed in mucosal biopsies of EoE patients. However, it has been reported that 90% of 
mast cells in the oesophagus of patients with EoE are classified as mast cells with tryptase and 
chymase which are responders to non-immunological mechanisms such as gastric acid or ENS 
action.99 Mast cells may contribute to fibrosis6 and express a factor which can induce smooth-
muscle cell contraction (Figure 1.3b).100 
Prostaglandin D2 (PGD2) is a prostanoid produced by mast cells. Prostaglandins have been 
shown to promote eosinophil infiltration into the oesophagus in animal models whilst 
prostaglandin antagonists may protect against inflammation.80  
Oesophageal biopsy samples of patients with active EoE have increased levels of cytokines 
(low molecular weight proteins which have specific effects on cell interactions)101 and 
chemokines (low molecular weight proteins that stimulate leukocyte recruitment)102 including 
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interleukin-4 (IL-4), interleukin-5 (IL-5), IL-13, interleukin-15 (IL-15), interleukin-18 (IL-18), 
tumour necrosis factor alpha (TNF-α), transforming growth factor beta (TGF-β) (Figure 1.3). IL-
4 can induce secretion of eotaxin-3 a chemoattractant for eosinophils but does not appear to 
be necessary for oesophageal inflammation development. IL-5 is known to promote eosinophil 
development, activation and recruitment, with reduced eosinophil accumulation and fibrosis 
shown in the absence of IL-5. Additionally, IL-5 expression in the oesophagus is down-
regulated by topical steroid treatment. IL-13 is believed to affect multiple genes in the 
oesophagus, particularly those important for oesophageal barrier integrity, for example, 
filaggrin, and has been implicated in up-regulation of eotaxin 3. IL-15 mediated signalling has 
been implicated in T cell proliferation, production of IL-5 and IL-13 and increased expression of 
eotaxin proteins. Additionally, IL-15 deficient mice are protected against the development of 
experimental EoE. IL-18 is produced by immune and non-immune cells and can influence IL-5 
and IL-13 production by iNKTs.80  
TNF-α is a cytokine expressed by oesophageal epithelium cells and is thought to promote 
fibrosis.80 TGF-β1 is another cytokine produced by eosinophils and mast cells. TGF-β1 is over-
expressed in the oesophageal epithelium of patients with EoE and is also believed to 
contribute to oesophageal fibrosis by inducing matrix metalloproteinases. Moreover, it 
induces expression of periostin which facilities recruitment of eosinophils from the blood 
stream to oesophageal tissue (Figure 1.3b).96  
In summary, the pathogenesis of EoE remains to be determined. Genetic and environmental 
factors likely predispose to the development of EoE alongside dysregulation of the 
oesophageal epithelial barrier. The development and perpetuation of oesophageal 
inflammation likely involves a complex interaction of the immune and nervous systems, with a 
variety of cell types and inflammatory mediators implicated.  
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1.10 DISEASE MANAGEMENT AND MONITORING 
It is currently recommended that PPIs, topical corticosteroids or dietary therapy can be offered 
as a first line treatment to patients with EoE (Figure 1.4).1 These treatment strategies have 
been developed from treatments of conditions commonly associated with EoE such as GORD 
and IgE-mediated food allergy. Resolution of clinical symptoms and histological remission are 
the two primary goals of management of EoE. More specifically, treatment aims to maintain 
remission to prevent potential complications such as strictures, correct and prevent nutritional 
deficiencies, prevent treatment related complications and maintain QOL.103 The choice of 
therapy should be discussed individually with the patient and efficacy assessed by a follow up 
endoscopy six to twelve weeks post therapy implementation. Symptoms do not always 
correlate with histological disease activity, hence endoscopy and oesophageal biopsy is 
currently necessary to monitor EoE.1 Due to the complexity of disease management and 
number of associated conditions, management of EoE is multidisciplinary including 
gastroenterologists, immunologists and dietitians.104 It has been suggested that the success of 
dietary therapy is dependent upon a multidisciplinary approach and that the input of a 
dietitian with understanding and expertise in food substitution is essential.105 Additionally, a 




Figure 1.4: Proposed therapeutic algorithm for management of eosinophilic oesophagitis in 
clinical practice. Adapted [reprinted] from “Guidelines on eosinophilic esophagitis: evidence-
based statements and recommendations for diagnosis and management in children and 
adults” by Lucendo et al. 2017, United European Gastroenterology, 0(0):1-24. Copyright 2017 
by ‘Sage’.1 
1.11 MEDICAL MANAGEMENT 
1.11.1 Proton pump inhibitors 
PPI’s reduce acid secretion, almost neutralising gastric acid and making the refluxate less 
irritating.107 A recent meta-analysis showed that PPI therapy led to histological remission in 
approximately 50% of patients with EoE and symptomatic improvement in 60%. Many patients 
with EoE experience symptom improvement with PPI therapy despite persistent oesophageal 
inflammation. Additionally, retrospective evidence suggests that histological remission is 
maintained on PPI therapy.1 However, long term PPI therapy has been associated with adverse 
events such as infections, changes to the gastric mucosa and acute kidney injury.108 Thus, 
alternative therapies may be desired.  
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1.11.2 Swallowed topical corticosteroids 
Topical corticosteroids (fluticasone or budesonide) are swallowed from puffs from inhalers or 
as a viscous slurry1 (mixed with sucralose or Neocate Spoon,109 aimed at increasing mucosal 
contact time). Swallowed topical corticosteroids are reportedly effective in 50-90% of patients, 
depending on the dose, type of steroid used and delivery method.1 Use of topical 
corticosteroids has been shown to reduce eosinophils and symptoms, however, when 
discontinued the disease recurs.16 Additionally, there is a doubtful effect on remodelling and 
fibrosis.110 Swallowed topical corticosteroids are considered to have a favourable safety 
profile, with minimal adverse effects reported in randomised control trials (RCTs) assessing 
efficacy.1 However, oesophageal candidiasis may occur in up to 10% of patients. Additionally, 
suppression of systemic cortisol levels has been described in children receiving high dose 
topical corticosteroid treatment.111  
1.11.3 Endoscopic dilatation 
Endoscopic dilatation (stretching of a narrowed area of the oesophagus) is an effective therapy 
for patients with EoE, providing symptomatic relief for prolonged periods112 but does not 
influence oesophageal inflammation. Recent studies have shown dilatation to be a safe 
procedure, however, the risk of complications such as mucosal tears, bleeding, post-
procedural discomfort and perforation is notable.113 The risk of complications is increased for 
patients with strictures.112 Therefore reduction of long term persistent inflammation and 
remodelling of the oesophagus is preferential.  
In summary, medical management of EoE can provide safe and effective relief of symptoms 
and oesophageal inflammation.1 However, long term side effects have been described, some 
therapies are not effective in all patients, and thus dietary management may be a more 
desirable long term management strategy. In the overall context of disease management, 
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medical management will need to be considered in conjunction with dietary management and 
the individual’s symptoms, circumstances, preferences, lifestyle and QOL.  
1.12 DIETARY MANAGEMENT 
1.12.1 Background to dietary approaches to treatment 
Free-living people eat a combination of foods containing a mix of nutrients (macro and 
micronutrients) and non-nutritive components (for example phytochemicals and food 
additives). Foods are commonly classified as core: nutrient-dense whole foods associated with 
health benefits, including grains/cereals, fruits, vegetables, lean meats, fish/seafood, nuts, 
eggs, legumes, dairy products such as milk, yoghurt and cheese and alternatives such as soy,114 
or non-core discretionary: foods that are not essential for providing nutrients, for example 
cakes, biscuits and soft drinks.115 These food combinations provide an individual’s diet and 
reflect food preferences influenced by social, cultural, health, environmental and economic 
determinants.116 In the past decade, populations in developed nations have experienced 
dramatic changes in their food supply systems with increased access to pre-prepared, 
processed and packaged foods, increased availability and access to foods, and new foods and 
additives.117  Parallels have been drawn between the evolving food supply, increases in 
discretionary food availability and consumption, subsequent decreases in core food intake and 
the increasing prevalence of chronic diseases, including atopic conditions.117  
From an evolutionary perspective, human beings have developed several behavioural, 
metabolic, immunological and non-immunological adaptations to allow choice of safe food, 
with some individuals more sensitive than others, and more likely to experience adverse 
effects. However, due to the multitude of components within food and the daily diet, it may 
not always be clear as to which component(s) the individual is reacting.118 
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Dietary interventions aim to increase or decrease particular foods or nutrients to produce 
positive health outcomes and/or reduce adverse effects. Increase in intake of some foods 
means that less of other foods are consumed to compensate for changes in other components 
of the diet. Subsequently, caution must be taken when interpreting results of studies focused 
on single dietary factors 116 and when dietary change is undertaken the impact on an 
individual’s nutritional status and broader aspects of health such as QOL must always be 
considered.  
1.12.2 Food chemical intolerance definition, investigation and management 
Food chemical intolerances are non-immunologically mediated reactions to foods or food 
components including gluten, dairy, soy, naturally occurring food chemicals and additives 
(Figure 1.2).119 The most commonly reported symptoms are gastrointestinal, such as 
abdominal pain and diarrhoea.120,121 However, symptoms can also manifest in other body 
systems: the skin (recurrent urticaria and/or angioedema), the Central Nervous System (CNS) 
(headaches, migraines, behavioural problems (e.g. hyperactivity and fatigue)), the respiratory 
and the genitourinary tract. Symptoms have been likened to drug-side effects with cumulative 
dose-dependence and withdrawal effects described.119,122 Following high-dose challenge, 
symptom onset can be acute or delayed (hours after consumption) and can last for several 
days.120,121 
Salicylates, biogenic amines and free glutamate are the best characterised naturally occurring 
food chemicals known to produce adverse food reactions.122,123 These chemicals provide 
flavour and aroma to food. Salicylic acid is synthesised by plants as a protective mechanism118 
and is widely distributed in plant foods such as fruits, vegetables, herbs and spices.122 Biogenic 
amines are produced by bacteria during food ripening, ageing, processing, fermentation, 
storage and decay. Biogenic amines and free glutamate are found predominantly in animal 
products such as processed meats and cheeses, but also plant products (e.g. tomato).122,123 
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Food additives are substances added to food, to preserve or improve the quality of the food, 
including flavour, colour and texture. Several additives have been implicated in food chemical 
intolerances: natural and artificial colours (tartrazine and annatto), sulphites, benzoic acid 
(benzoate), sorbates, monosodium glutamate (MSG), artificial antioxidants (butylated 
hydroxyanisole (BHA) and butylated hydroxytoluene (BHT)) and nitrites/nitrates.119,123  
Little is known about the mechanisms of food chemical intolerance. Neurogenic inflammation 
is one hypothesis that has been suggested with sensitisation of sensory nerve pathways 
occurring through chemical compounds binding to chemoreceptors on sensory nerve fibres 
and promoting the release of inflammatory mediators.124 Modulation of mast cells, 
intracellular cyclic nucleotide levels or elevated nitric oxide levels have also been suggested as 
possible mechanisms.124,125  
Investigation of food chemical intolerance involves dietary elimination and challenge testing. 
This involves exclusion of all possible culprit foods for a period of time, then if and when 
symptoms subside, suspected foods are reintroduced systematically. Objective testing of food 
intolerance requires double blind placebo controlled (DBPC) challenge testing.121,123 To date 
the role of food chemical intolerance has not been systematically explored in patients with 
EoE. 
1.12.3 Background to elimination diets in eosinophilic gastrointestinal disorders  
In the 1970’s and 1980’s, whilst there was no uniformity of atopic findings in patients with 
EGIDs or clear role in the pathogenesis, elimination diets were often trialled with varying 
success.126 These included food-specific elimination diets (based on patient reported symptom 
triggers), directed elimination diets (removal of foods based on allergen skin testing), 
oligoantigenic diets (a diet of meat (lamb or chicken), carbohydrate (potato or rice), one fruit 
(apple or banana), one vegetable, water and a dietary supplement),127 empirical diets 
(elimination of commonly offending foods),126 and elemental diets (use of amino acid 
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formulas).128 Currently, there are three main dietary interventions discussed in the literature 
which are used in the investigation and management of EoE, based on the assumption that 
EoE is triggered by food allergens, namely elemental, directed and empirical elimination diets. 
Overall, these diets aim to induce symptomatic and histological remission and identify food 
triggers through recurrence of oesophageal inflammation (and symptoms) on challenge or 
reintroduction of the food.103 Landmark studies as well as the results of a meta-analysis129 and 
recommendations from the consensus guidelines1 are summarised below for each of the three 
main dietary interventions (Tables 1.2, 1.3 and 1.4).  
1.12.4 Historical overview of dietary management in eosinophilic oesophagitis 
This first report of the role of diet in EoE was by Kelly et. al.130 The study involved children who 
had been diagnosed with GORD, but were unresponsive to medical treatment and had 
persistent oesophageal eosinophilic infiltrate. These children also had a history of failure to 
thrive, food refusal, abdominal pain and vomiting. Kelly et al.130 hypothesised that food 
hypersensitivity (to food proteins) could be contributing to the eosinophilic infiltration. Ten 
children were placed on an elemental (amino acid based) formula for a minimum of six weeks. 
Children who were old enough to tolerate solids were also allowed to consume corn and 
apple. After the dietary trial, eight children had complete and two had partial symptomatic 
improvement. There was a significant reduction in eosinophilic infiltrate in all ten children. 
Open food challenges were conducted by introducing protein foods (milk, soy, wheat, peanut 
and egg) one by one, twice daily for three consecutive days. Nine children experienced 
symptoms upon reintroduction of food, including gagging, irritability, abdominal pain and 
urticaria. Seven out of the nine children reacted to milk, four to soy and two to wheat. Three 
out of the ten children had demonstrated positive SPTs to food (so did not trial these foods), 
suggesting that symptoms elicited from milk, soy and wheat were due to non-IgE-mediated 
reactions.130 This study was closely followed in 1997 by Cardi et al.131 who reported on a case 
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of EoE in a nine year old boy. The patient was placed on the “Rezza-Cardi” diet (a formula 
comprised of lamb, rice and extra virgin olive oil with added vitamins and minerals) for eight 
weeks. On follow up he had no symptoms and histopathology was normal. 
1.12.5 Elemental formulas 
Following on from Kelly et al.130, Markowitz132 also examined the effect of an elemental 
formula on a larger cohort (N=51) of children and adolescents. These children were placed on 
an elemental formula for one month, with striking improvement in symptoms and histological 
outcomes.  A similar study placed 25 children on elemental formula and showed significant 
improvement in eosinophilic inflammation in 88% of cases.133 More recently, the efficacy of an 
elemental formula in adult EoE patients was trialled. Of the 18 patients that completed the 
study, histological improvement was identified in all patients except one, however, symptom 
improvement was not significant. Reintroduction of food caused eosinophil counts to increase. 
Interestingly, only 12 of the 17 patients tested had positive SPT. This study had a high dropout 
rate related to the poor acceptance of the unpalatable elemental formula by adult patients.134  
The overall efficacy of elemental diets is reported at 91%,129 however, it is suggested that they 
should only be considered after failure of other medical or dietary intervention (Table 1.2).1 
Subsequently, alternative dietary therapies have been developed and trialled.  
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Table 1.2: Summary of studies examining elemental diets in patients with eosinophilic oesophagitis. 








Kelly et al.130 1995 Prospective IV Neutral 10 Children Elemental diet 
and food 
reintroduction 
All patients had symptomatic and 
histological improvement.  
Markowitz et al.132 2003 Prospective IV Neutral 51 Children Elemental diet Significant decrease in symptoms 
and eosinophils. 
Peterson et al.134 2013 Prospective III-3 Neutral 29 Adults Elemental diet Significant decrease in eosinophils. 
No change in symptoms. High 
dropout rate (11/29) 
Warners et al.137  2017 Prospective III-3 Neutral 21 Adults Elemental diet Significant decrease in eosinophils. 
Arias et al.129 2014 Systematic review 
and meta-analysis 
III-2 Positive 13 studies of 
adults and 
children 
Elemental diet Overall effect: 90.8 (84.7-95.5) 
Lucendo et al.1 2017 Consensus 
recommendations 
III-2 Neutral Adults and 
Children 
Elemental diet Consider after failure of other 
medical or dietary treatment 
a  NHMRC: National Health and Medical Research Council
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1.12.6 Directed elimination diets 
The directed elimination diet approach uses allergy testing to try to identify possible triggers of 
symptoms and/or eosinophilic inflammation in patients with EoE (Table 1.3). This process was 
first described in 2002 by Spergel et al.138 who used SPT and APT to try and identify food 
allergens that could be contributing to a patient’s EoE. Foods identified as potential triggers 
were eliminated from the diet of 24 paediatric patients. On average five foods were eliminated 
and 75% of patients achieved histological remission. Further retrospective analysis assessed 
the efficacy of a directed elimination diet in a larger cohort of children47 with approximately 
77% of patients showing histological and symptomatic improvement. Results are less 
conclusive in adults. In a study examining 15 adult EoE patients who followed a directed 
elimination diet for six weeks, only four (24%) patients achieved complete histological 
remission, and one had partial remission.47 The overall efficacy reported in a recent meta-
analysis is approximately 45%.129 The low efficacy of the directed elimination diet highlights 
the lack of consistency between SPT and APT results and identification of triggers of symptoms 
and/or oesophageal inflammation in EoE. One study has examined the PPV, NPV, sensitivity 
and specificity of SPT and APT in a cohort of patients with EoE.139 The PPV values and 
sensitivity was found to be high for the common food allergens (milk, egg, soy, wheat, 
peanut). Interestingly, the NPV was also high for all foods except milk. This suggests that a 
negative SPT to milk does not exclude milk as a trigger of symptoms and/or inflammation in 
EoE, and that broader elimination of foods may be required to eliminate all triggers as 




Table 1.3: Summary of studies examining directed diets in patients with eosinophilic oesophagitis. 








Spergel et al.138 2002 Prospective IV Low Children Directed diet 
(SPT and APT) 
Histological remission in 13 (50%) patients. 
Symptom improvement in 18 (69%) patients. 
Spergel et al.41  2012 Retrospective IV Neutral Children Directed diet 
(SPT and APT) 
Symptomatic and histological improvement. 
Liacouras et al.140  2005 Retrospective III-3 Neutral Children Directed diet 
(SPT and APT) 
Significant improvement in eosinophils in 75 
(56%) patients. 
Syrigou et al.141 2015 Prospective III-3 Neutral Children Directed diet 
(sIgE, SPT and 
APT) 
Symptomatic and histological improvement. 
Arias et al.129 2014 Systematic review 
and meta-analysis 
III-2 Positive 14 studies of 
adults and 
children 
Directed diet Overall effect: 45.5 (35.4-55.7) 
Lucendo et al.1 2017 Consensus 
recommendations 
III-2 Neutral Adults and 
Children 
Directed diet The utility of allergy tests in identifying food 
triggers in EoE is consistently low. 
a  NHMRC: National Health and Medical Research Council
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Overall, allergy directed testing theoretically has the advantage of allowing the fewest foods to 
be removed from the diet, but its low efficacy when compared to elemental and non-directed 
diets makes it a less desirable choice. Furthermore, little consideration is given to patients who 
have negative allergen tests and how this affects their management.  Current consensus 
guidelines suggest that the diagnostic accuracy of skin allergy tests is insufficient to design or 
support diets in patients with EoE.1 
1.12.7 Empiric or non-directed elimination diet(s) 
An empiric or non-directed elimination diet removes foods that are commonly associated with 
food allergies and EoE mucosal injury.105,133 The most common empiric diet is the six food 
elimination diet (6-FED) which excludes cow’s milk, wheat, egg, soy, nuts and seafood 
regardless of SPT or APT results. In a study which treated 35 children with a 6-FED for six 
weeks, 74% of children achieved significant improvement in eosinophilic inflammation.133 This 
was compared to children who had used elemental formula exclusively and identified 
enhanced rates of acceptance, cost and adherence in the 6-FED cohort. In further work, a 
cohort of 46 children were identified to have complete clinical and histological remission with 
a 6-FED,142 whilst in a trial of 50 adult patients, after six weeks on the 6-FED, 74% had less than 
15 eosinophils/HPF. Significant decreases in dysphagia frequency, duration and intensity was 
also found.143 Of the initial 50 patients, 20 patients subsequently completed challenge testing 
to identify causative agents of oesophageal inflammation. This involved the introduction of a 
new food group every two weeks, with a biopsy completed every four weeks or if the patient 
became symptomatic. Wheat (60%) and milk (50%) were the most common food triggers of 
inflammation identified with 67% of patients identifying food triggers for which they had no 
positive SPT result. In a recent meta-analysis, a combined efficacy of 72% was established for 
the 6-FED in inducing histological remission129 and is supported by the consensus 
recommendations1 (Table 1.4). 
37 
 
Table 1.4: Summary of studies examining empirical diets in patients with eosinophilic oesophagitis. 








Kagalwalla et al.142 2011 Retrospective IV Neutral Children 6-FED Reports on 46 patients who achieved 
histological remission on a 6-FED. 
Gonsalves et al.143 2012 Prospective III-3 Neutral Adults 6-FED Histological remission reported in 36 
(72%) of patients. 
Lucendo et al.144  2013 Prospective III-3 Neutral Adults 6-FED  Histological remission reported in 49 
(73%) of patients. 
Molina-Infante et 
al.145 
2014 Prospective III-3 Neutral Adults 4-FED Histological remission reported in 28 
(54%) of patients. 
Philpott et al.146 2016 Prospective III-3 Neutral Adults 6-FED Histological remission reported in 29 
(52%) of patients. 
Arias et al.129 2014 Systematic review 
and meta-analysis 
III-2 Positive 7 studies of 
adults and 
children 







Overall effect: 72.1 (65.8-78.1) 
 
 
Overall effect: 53.4 (35.7-70.6) 
Lucendo et al.1 2017 Consensus 
recommendations 






Induces remission in around three 
quarters of adults and children with 
EoE. 
Induces remission in half of patients. 
a  NHMRC: National Health and Medical Research Council
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The most common foods causing oesophageal inflammation identified from response to a 6-
FED have been milk and wheat, followed by egg and soy, with a negligible role for nuts and 
seafood.147 Subsequently, other dietary approaches based on the theory of non-directed diets 
and these most common food triggers have been tested. A four food elimination diet (4-FED) 
(dairy, wheat, egg and soy/legumes) has been trialled, with 67% of patients achieving 
histological remission after six weeks. 145 Of those who responded, each food group was 
reintroduced systematically one by one for a six week period, followed by an endoscopy and 
biopsy. Similarly, to other studies milk, followed by wheat were the two most common food 
triggers of inflammation. A three food (milk, wheat and egg) and two food elimination diet 
(milk and gluten exclusion) have also been shown to achieve remission in 30% and 40% of 
patients respectively.41,147 Thus, it has recently been suggested that patients trial a “step-up” 
approach (exclusion of two foods, then four foods, then six foods) if symptomatic and 
histological remission is not achieved with initial two food exclusion.147  
Single food exclusions have also been examined. For example, a subgroup of patients (N=17) 
trialled a diet free from cow’s milk, for six weeks, after which 65% had complete or partial 
histological remission of their EoE and symptom improvement.148 Simon et al.149 placed six 
adult patients with EoE on a diet free from wheat, rye and barley (gluten free) for six weeks. 
Whilst a small improvement in symptom frequency was found, duration and intensity of 
symptoms was not found to improve in any patients. Patients were subsequently challenged, 
using a DBPC manner, with specially formulated drinks. Challenge testing did not induce 
dysphagia in any patients, even those sensitised to wheat and rye.149 Similarly, in studies in 
patients with coeliac disease and EoE, gluten free diets had limited efficacy in inducing 
histological remission.68 
Other empiric elimination diets have been trialled including milk, wheat, soy, egg and meat 
(chicken, beef, turkey and pork) elimination and a vegan diet (excluding milk, egg, seafood and 
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meat).41 Cultural variations in the empiric diet have been described. For example, Spanish 
cohorts describe exclusion of all legumes, not just soy. Empiric and directed elimination 
approaches have also been used in combination.147  
1.12.8 Food reintroduction 
Food reintroduction to identify food triggers of symptoms and/or inflammation in EoE lacks 
evidence, consistency and clear guidelines. Firstly, the frequency at which a new food should 
be introduced varies with a new food introduced every three days,130  every week, 105 every 
two weeks,149 and every six weeks.145 The order in which foods are introduced also varies. 
Reintroduction of foods has been directed by patient preference and skin test results, in the six 
and four food elimination diets respectively.123,143 For those on an elemental diet, foods have 
been reintroduced based on their allergenicity, such that the least allergenic foods are 
introduced first, and most allergenic are introduced last.105 Additionally, the amount of a 
particular food that should be introduced has not been clearly outlined in any studies to date. 
The use of a washout period (removal of the trigger food), is also inconsistently used. One 
study used a six week washout period and an endoscopy to confirm histological resolution 
before the next food was introduced.143 In contrast, in a more recent study a new food group 
was introduced regardless of whether the previous food group was identified as a trigger and 
eosinophils were elevated.145 Additionally, the frequency of follow-up biopsies varies. Biopsies 
have been conducted every four weeks after two new foods had been introduced,143 monthly 
after three to four foods are introduced105 and at six weeks after the introduction of each new 
food.145 The frequency of endoscopies also presents a concern in relation to cost, associated 
risks and invasiveness; especially in children. Overall, the current consensus recommendations 
highlight that the 6-FED may be most efficacious but the higher level of dietary restriction and 
large number of endoscopies may counteract its effectiveness and use in clinical practice.1 
40 
 
1.12.9 Complexity of dietary management in patients with eosinophilic oesophagitis 
A variety of dietary elimination strategies are currently available in the literature with variable 
efficacy, benefits and limitations. The main difficulty with all diets described is the choice of 
foods to include or exclude. As Groetch and colleagues103 explain: if modifying the elimination 
diet by one or two foods does not result in remission then it is uncertain if dietary elimination 
as a means of management was a failure or that one or more of the added foods was a trigger. 
Certainly, this is the basis of a “step-up” approach.147 
Furthermore, it is interesting to consider that broader elimination through a 6-FED has a higher 
efficacy than a 4-FED, despite nuts and fish not being common triggers of oesophageal 
inflammation. Additionally, reintroduction of all six foods without histological recurrence has 
been described in patients completing a 6-FED.142 This suggests that broader elimination using 
the 6-FED may have resulted in the unintentional exclusion of other food components 
contributing to oesophageal inflammation. Certainly, this could explain the efficacy of the 
elemental diet, where not only food proteins are removed but also a variety of other food 
components such as food chemicals or additives, to which the patient could be intolerant. 
Additionally, current allergy testing does not correctly identify EoE food triggers of symptoms 
and/or inflammation, supporting the role of non-IgE mediated mechanisms.79  
The lack of clear direction and consistency of guidelines for reintroduction of foods to identify 
triggers in EoE highlights a significant gap in the literature. It also suggests that food 
reintroduction may not regularly occur, and patients may remain on restricted diets long term. 
Additionally, the recommendation in the consensus guidelines1 for repeat endoscopies 
presents concerns in relation to invasiveness, risks, costs (to patients and the health care 
system) and feasibility.  
Overall, these factors highlight the complexities and difficulties of the dietary investigation and 
management of EoE for both the patient and the professional. It is clear that dietary 
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elimination can be an effective management option for patients with EoE, with suggestions 
that the success of dietary therapy is dependent upon a multidisciplinary approach and the 
input of a dietitian, as well as individualising the approach to the patient.105,150 However, 
application of an individualised approach in the clinical setting remains challenging. 
1.13 THEORETICAL CONSTRUCTS OF DIETARY MANAGEMENT 
1.13.1 Personalised medicine 
The concept of personalising medical treatment can be traced back to the teachings of 
Hippocrates. His treatment approach was based on the understanding that an individual’s 
unique characteristics determined their response to the disease and treatment.151 In recent 
years, personalised medicine has re-emerged as a conceptual framework for management of 
complex conditions.152 The term ‘personalised medicine’ was first discussed in the late 90’s and 
gained momentum with the Human Genome Project. In 2004, the Personalised Medicine 
Coalition was founded and defined personalised medicine as; 
“the management of a patient’s disease or disease predisposition, by using molecular 
analysis to achieve the optimal medical outcomes for the individual-thereby improving 
the quality of life and health, and potentially reducing overall healthcare costs,”153 
Since then, the concept of personalised medicine has evolved and adapted. Broad 
descriptions, for example use of knowledge about an individual to improve their health, and 
narrow descriptions, such as diagnostic tests to predict drug response, have resulted in some 
disagreement in the current definition. To add to the confusion, the concepts of personalised 
medicine and precision medicine are often used interchangeably due to the considerable 
overlap of the two terms. Whilst both refer to tailoring medical treatment to individual 
characteristics of the patients, precision medicine focuses on the clinical and molecular data 
(often with a genetic focus) to better explain the biological basis of disease and to develop 
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treatments. Personalised medicine focuses on individual aspects of a patient to determine 
treatment. This is exemplified by the current Personalised Medicine Coalition definition of 
personalised medicine: 
“an evolving field in which physicians use diagnostic tests to determine which medical 
treatments will work best for each patient. By combining data from those tests with an 
individual’s medical history, circumstances and values, health care providers can 
develop targeted treatment and prevention plans”153 
 
Personalised medicine is a multifaceted concept encompassing various approaches to tailoring 
healthcare, by adapting treatment to specific needs and preferences of a patient during all 
stages of care including prevention, diagnosis, treatment and follow up.154 Therefore, 
personalised medicine is applicable to both the research and clinical care contexts, and is 
essential to the effective translation of treatment from bench to bedside and back.155  
In the research context, personalised medicine involves moving from generating evidence on 
‘ideal’ interventions to generating evidence on how to best treat an individual. RCTs are 
considered the gold standard for evaluating treatment outcomes and providing information on 
treatment efficacy. However, well recognised limitations of RCTs are their ability to assess only 
one possible causal factor, in an ‘artificial’ environment and strict inclusion/exclusion criteria. 
As such, generalisability of these studies is low, and many patients treated in daily practice do 
not fulfil the criteria of these trials, so treatment applicability and individualisation of care is 
limited. Therefore, it has been suggested that greater acceptance of broader group evidence 
such as retrospective analyses, prospective and comparative studies may be required to better 
understand how to personalise care.155 ‘Real-life’ studies reflecting treatment in clinical 
practice are also rapidly expanding. These studies involve prospective or retrospective data 
collection examining interventions under routine clinical circumstances.156  
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In clinical practice, personalised medicine involves tailoring treatment to the individual patient 
considering factors such as co-morbidities, psychosocial characteristics and lifestyle.155  
Personalised medicine in clinical care focuses on producing local knowledge for individual 
patients about their condition or treatment response, facilitating shared decision making and 
incorporating patient preferences.157 To better understand how personalised medicine can be 
applied to the clinical care context we must also consider current best practice care models.  
1.13.2 Patient centred care  
Patient centred care as a concept is multifaceted, with broad heterogeneity in the definition 
and key components.158,159  The concept of patient centred care emerged in the early 1950’s 
and has increased in recognition over the past two decades.158 In the late 1980’s, the Picker 
Institute conducted extensive research into the patient care experience, laying the foundations 
for our understanding of patient centred care today.  In 2001, the Institute of Medicine listed 
patient centred care as one of the six aims for health care improvement and provided an 
important definition of patient centred care:  
 “healthcare that is respectful of, and responsive to, the preferences, needs and values 
of patients;”160 
More recently, as part of the National Safety and Quality framework in Australia, patient 
centred care has been promoted as an integral part of quality health care.160 Additionally, the 
patient centred health paradigm is recognised as the best model of care specifically within 
dietetics, as reflected in the Dietitians Association of Australia (DAA) Competency Standards 
2015.161  
Many definitions and models of patient centred care are available. Recently, Castro et al.159 
conducted a literature review and concept analysis of patient centred care models, combining 
aspects of the patient experience, physician-patient relationship and contextual elements of 
44 
 
care. The concept analysis identified specific characteristics including definitions, antecedents, 
attributes and consequences of patient centred care to establish empirical referents or 
defining characteristics of patient centred care and to provide a comprehensive definition. 
Under this model, patient centredness is a biopsychosocial approach and attitude that aims to 
deliver care that is respectful, individualised and empowering. It infers the individual 
participation of the patient and is built on a relationship of mutual trust, shared knowledge, 
sensitivity and empathy.159  Overall evidence suggests that patient centred care should be 
individualised based on the patient’s situation rather than focusing exclusively on the disease. 
This enforces a comprehensive approach in which the health professional visualizes the illness 
through the patient’s perspective and is responsive to their needs and preferences.158 More 
broadly, patient centred care may encompass elements of respect, emotional support, physical 
comfort, information, communication, stability and transition, care coordination, family and 
carers involvement and access to care.160  
Patient centred care has been highlighted as a key area of focus for dietitians. Certainly, 
dietitians can be involved in many aspects of the patients care pathway including dietary 
assessment and counselling and interdisciplinary coordination. Patient centred counselling has 
been shown to increase dietary adherence.162,163 Additionally, qualitative research suggests 
that patients desire a patient centred approach to dietary counselling which adapts to their 
individual needs. They also viewed good communication and rapport, information and 
resources and regular support to be an important part of their care consult.163 A four step 
process also referred to as the NCP is often used to describe patient centred dietary 
counselling. 
1.13.3 The Nutrition Care Process  
The NCP is a standardised, systematic framework designed to guide dietitians to provide high 
quality, individualised nutrition care. This framework encompasses aspects of patient centred 
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care but is specific to dietetic practice. At the centre of the NCP model (Figure 1.5) are the 
patients’ needs and values. This reflects patient centredness and the relationship between the 
dietitian and the patient. The second ring acknowledges the strengths of the dietitian including 
their knowledge, skills and abilities and the application of evidence based, ethical practice. 
Collaboration and communication with the interdisciplinary team is also key. The model 
recognises the influence of environmental factors affecting the patient such as social support 
and the broader health care system. 
 
Figure 1.5: The Nutrition Care Process model. © 2017 Academy of Nutrition and 
Dietetics (formerly American Dietetic Association) [Access to most current terminology 
for nutrition care. Subscribe to the eNCPT at http://ncpt.webauthor.com/]2
46 
 
In dietetic practice the patient centred NCP model provides a framework for approaching 
clinical management including nutrition assessment, diagnosis, intervention and monitoring 
and evaluation. Using this model can assist in identifying and considering factors that may 
influence individual patient care and thus allow clinicians to tailor treatment accordingly. As 
such, the patient centred care model is an interrelated aspect of personalised medicine and 
can facilitate the application of personalised medicine in clinical practice.  
1.14 GAPS IN THE LITERATURE 
Research into EoE pathophysiology and management has evolved greatly over the past 
decade. Increased knowledge and understanding of disease pathogenesis has suggested that 
EoE is primarily non-IgE mediated79 and acknowledged the role of GORD and rhinitis.1 
However, despite the paradigm shift in understanding of disease pathogenesis, dietary 
management strategies remain focused on the elimination of common IgE-mediated food 
allergens. The exploration of alternative dietary interventions including other adverse food 
reactions, such as food chemical intolerances, in these patients is limited.  
In addition, current dietary elimination strategies appear ad hoc in nature and reports in the 
literature mostly focus on the initial elimination phase and forgo explanation of the critical 
reintroduction and long term management of these patients. Subsequently, application of 
personalised dietary management in the clinical setting is difficult for both the patient and the 
multidisciplinary team. There is an increasing recognition that treatment must go beyond 
resolution of clinical symptoms and histological remission and consider dietary factors, reflux, 
rhinitis, prevention of potential complications such as strictures, and treatment related 
complications such as nutritional deficiencies, all while maintaining QOL.103 Recently, clinical 
management of EoE has focused on an individualised, multidisciplinary approach, with 
dietitians considered key to the implementation and success of dietary therapy,103,105,150 by 
ensuring proper patient education, nutritional assessment and planning.164 However, a specific 
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framework for dietitians on nutrition assessment, dietary management and monitoring of 
patients with EoE, in the clinical setting is lacking, meaning optimal dietary management is 
difficult to achieve in patients with EoE.  
1.15 HYPOTHESES 
EoE is a complex and multifaceted disease, with symptoms and pathology dependent on a 
variety of interwoven variables. These may include but are not limited to acid reflux, rhinitis 
and food allergy, with food chemical intolerances yet to be explored. As such the management 
of these patients is also complex, with individualised assessment and treatment required. This 
thesis therefore hypothesises that an individual approach accounting for all these factors will 
allow patients and health professionals to determine a personalised management approach in 
EoE.  
1.16 AIMS OF THIS RESEARCH 
In the context of the Australian health care system this thesis aimed to inform the dietary 
management of EoE, from assessment through to monitoring and evaluation, within the 
patient centred framework of the NCP by: 
1) exploring patient characteristics and current management; 
2) exploring patient experiences and needs; 
3) examining the use of a low chemical elimination diet to develop a personalised dietary 
management approach; and 
4) exploring dietitian knowledge.  
The aims of this research were addressed through four main studies: 
Study 1: A national survey of patients and parents of children with EoE to identify key 
characteristics and current management practices (Aim 1). 
48 
 
Study 2: A qualitative investigation of patients and parents of children with EoE perspectives in 
optimising the management of EoE (Aim 2). 
Study 3:  A case study of patient management at the Royal Prince Alfred Hospital (RPAH) 
Allergy Unit to identify key patient characteristics for nutrition assessment and examine the 
use of a low chemical elimination diet and challenges in determining a personalised dietary 
management approach (Aims 1 and 3). 
Study 4: A national survey of dietitians to explore current knowledge and competency of 
dietitians in the management of EoE as well as resource and training needs (Aim 4).  
1.17 SIGNIFICANCE OF THE RESEARCH 
This thesis sets out to investigate the multifactorial issues influencing dietary investigation and 
management of patients with EoE in the context of the Australian health care system and 
answer the research question: How can we improve the dietary investigation and management 
of EoE? The investigations within this thesis form an initial important step in establishing a 




CHAPTER 2: THESIS RESEARCH DESIGN AND METHODOLOGY 
2.1 INTRODUCTION 
This thesis explored a variety of factors influencing the dietary investigation and management 
of patients with EoE. The background and theoretical framework of the principals of dietary 
investigation and management underlying the research were discussed in detail in Chapter 1. 
This chapter continues to provide the foundations of this research in terms of context, 
methodologies and methods used. The broad approach to answering the research question 
within the framework of the NCP is described first, followed by a detailed overview of the 
research approach and methods.  
2.2 SUMMARY OF THE RESEARCH PROBLEM 
EoE is a multifactorial disease and assessment and treatment of all possible contributing 
factors is required for management. The concept of ‘personalised medicine’ recognises that 
most disorders are complex, multifactorial processes and understands that each person may 
be fundamentally different from the average population. As such, personalised medicine aims 
to move beyond evaluating and treating disease as if there was only one underlying cause, but 
instead to consider multiple factors, including how the individual may respond to a particular 
treatment.152 Therefore, the broad theoretical framework of personalised medicine inclusive of 
the NCP was deemed appropriate for examining the complexities of the dietary management 
of EoE in this thesis. 
If we consider EoE in the context of the NCP and more broadly patient centred care and 
personalised medicine, at the centre, is the patient and their experiences with the disease and 
within the health care system. This includes their interaction with the multidisciplinary team 
and investigation and management of the disease. More specifically, the dietitian is part of the 




to answer the research question: How can we improve the dietary investigation and 
management of EoE? we must firstly consider the experience of patients’ with EoE and their 
current management. Secondly, we must examine the dietary investigation and management, 
from assessment to monitoring/evaluation, in the context of the multidisciplinary team and 
current health care system; as well as considering a patient’s individual characteristics and 
biopsychosocial factors. Furthermore, we need to address the knowledge and skills of 
dietitians providing care to patients as they ultimately must manage the NCP. 
2.3 RESEARCH APPROACH: MIXED METHODS RESEARCH 
The following sections describe the broad methodologies of this research informed by the 
theoretical construct of personalised medicine, the NCP framework, context and methods. 
When designing a research project Creswell165 suggests that there are three important 
elements of inquiry that the researcher must consider: the researcher’s knowledge claims, 
strategies of inquiry to inform the procedures, and the methods of data collection and 
analysis. These aspects inform the research approach, acknowledging the broad assumptions 
bought to the project by the researcher and the practical aspects of data collection and 
analysis. The broad approach chosen for this research project will be outlined first, followed by 










2.3.1 Study design for this thesis 
Mixed methods research has emerged over the past four decades. Certainly, there is a growing 
acceptance that research practice is not quantitative versus qualitative but lies somewhere on 
a continuum between the two.165 To include only quantitative or qualitative methods falls 
short of the major approaches used in human research today. Additionally, it has been 
suggested that the use of multiple methods may help neutralise the biases associated with a 
single method. The current research involved developing an understanding of patient 
experiences and management, to inform clinical care. Hence, a combination of quantitative 
and qualitative methods was required to investigate the multitude of factors influencing 
dietary management of patients with EoE (Figure 2.1). Each of the different methods described 
were used to explore various aspects of patient care, specific to dietary investigation and 
management of EoE to provide a more comprehensive understanding. 
2.3.2 Knowledge claims in this research 
The assumptions of a researcher involved in mixed methods research are often described as 
pragmatic,165,166 with the problem and a solution to the problem most important to 
pragmatists: How can we improve the dietary investigation and management of EoE? 
Knowledge claims rise from previous actions and situations, as in the case of this research; 
clinical practice. Thus, the scope of this thesis reflects both my own experience working as a 
dietitian and the guidance of an experienced immunologist and dietitians. Whilst these 
experiences should be considered when reviewing this research, maintaining objectivity was 
considered important throughout all the studies.  
This research was primarily undertaken in an interdisciplinary, outpatient public hospital clinic. 
The experiences of the researcher as a dietitian working with patients with EoE are reflective 
of the setting of this research. Firstly, the context of the allergy clinic, provided an 




public hospital setting highlighted the benefits of liaising with the multidisciplinary team. It 
also provided an awareness of budgetary and resource constraints, particularly around 
medical procedures such as SPT and endoscopies. The experience as a dietitian working with 
patients with EoE has also highlighted the psychological and QOL impacts of this disease and 
dietary restriction on the individual and their relationships with partners, family and friends. 
This reinforced the necessity of adapting management strategies to the individual patients’ 
preferences and circumstances. Fundamentally, as a dietitian working with patients on 
restricted diets, consideration of nutritional adequacy and dietary quality was also paramount.  
As a major teaching hospital, the clinic where this research was undertaken also supports and 
trains dietitians in adverse food reaction management. Discussion with visiting dietitians 
regarding their experiences and difficulties in managing patients with EoE in private practice 
increased awareness of the paucity of support available.  
Thus, from these clinical experiences, it became clear that the research hypothesis could not 
be explored in isolation, but that consideration of the patient experience was vital. 
Additionally, from examining patients’ experiences and discussions with dietitians it became 
apparent that exploring dietitians’ knowledge and areas for improved support was also 
important.  
2.3.3 Strategies of inquiry in this research 
Mixed methods researchers look to many approaches to provide the best understanding of a 
research problem. How these quantitative and qualitative methods are combined is important 
for supporting the intended outcomes. Strategies of inquiry provide specific directions for 
procedures in research. In mixed methods research, methods may be combined in a variety of 
ways depending on the purpose of the research. In general, there are three main strategies of 
inquiry in mixed methods research, with many variations within each.  Sequential procedures, 




findings of one method with the other. Concurrent procedures involve collecting data from 
multiple studies at the same time, after which the data is combined to provide a 
comprehensive analysis of the research question. Transformative approaches involve an 
overarching theoretical framework in which the methods and outcomes are anticipated. 
Within each of these strategies of inquiry, methods associated with quantitative and 
qualitative research may also be used.165,166  
For this research, two different contextual areas were examined: a national focus exploring 
patients and practitioners experiences with the management of EoE, and a case study of 
patient management at RPAH Allergy Unit exploring management experience in situ. The 
national focus involved a combination of sequential and concurrent strategies of inquiry 
(Figure 2.1). A national survey was conducted to explore patient characteristics and current 
management in the broader EoE community (Chapter 3) and a qualitative study was designed 
to explore patient management experiences and needs (Chapter 4). Subsequently, from the 
qualitative study, another survey was developed for health professionals to address gaps and 
enhance the data collected from the qualitative study (Chapter 6). A combination of sequential 
and concurrent strategies of inquiry were also chosen for the case study of patient 
management at RPAH Allergy Unit including concurrent analysis of a case series and 
sequentially completed questionnaires, nutritional analysis and a follow up survey (Chapter 5). 
Each of these studies are considered individually and then together to more completely 
understand the complexity of the dietary investigation and management of EoE. 
2.3.4 Case study methodology 
Case study methodology allows in-depth exploration of an individual, group, organisation, 
event or problem within its environmental context.167 Case studies can be exploratory: a form 
of pilot study to inform future research, descriptive: in-depth and contextual description of the 




for its unique interest, and the contextual conditions of the research are part of the 
investigation. Case studies are advantageous in their use of a variety of data collection 
methods allowing a detailed description and analysis of the case.167 Case studies are also 
useful for identification of patterns and relationships,167 development and evaluation of 
assessment and treatment techniques,169 and can assist in explaining complexities of real-life 
situations which may not be captured in experimental research.170 Caution should be taken as 
to the extent which findings are generalisable to other settings.168 
In this thesis, case study methodology was utilised to provide in-depth and contextual 
description of clinical management of patients with EoE, in a ‘real life’ clinical setting. The 
Allergy Unit at RPAH is a multidisciplinary outpatient clinical service for assessment and 
management of allergic disorders with a speciality in adverse food reactions, located within a 
major metropolitan city. Since the early 1980’s the Allergy Unit at RPAH had become known 
for its interest in food related conditions and thus received a wide variety of referrals of 
patients with varying clinical symptoms thought to be attributed to dietary factors. This 
included patients with EGIDs, firstly those with eosinophilic gastroenteritis and later EoE. EGID 
patients presented with abdominal pain, nausea, vomiting and diarrhoea, symptoms similar to 
functional gastrointestinal disorders (FGID). Additionally, many of these patients were non-
atopic and implicated a variety of foods to be related to their symptoms. Previous success with 
FGID symptom management with a diet low in gluten, dairy, soy and food chemicals (RPAH 
elimination diet)67 led to a trial of the elimination diet and challenge testing in the 
management of patients with EGIDs, with success. Thus, the RPAH Allergy Unit provides a 
unique clinical setting to investigate food chemical intolerances and dietary management in 
patients with EoE. Within the case study, three main studies were conducted (case series 
analysis, prospective study and a follow up study). These studies used a variety of methods to 




study were considered together with the broader national studies in this thesis, and evidence 
from the literature, to increase the generalisability of the results.  
2.4 RESEARCH METHODS USED IN THIS RESEARCH 
The choice of research methods for data collection is governed by the intent of the research 
and the type of data to be collected, each with their own advantages and disadvantages.165 
Qualitative methods used in this thesis included focus groups. Focus groups attempted to 
explore the overall patient experience, patient care needs and new research areas. 
Quantitative methods included questionnaires, case series and nutritional analysis of dietary 
intake records. A survey was used to explore patient characteristics and current patient 
management in an Australian context. Within the case study, case series analysis allowed in-
depth exploration of patient characteristics and results from an individualised dietary 
management approach in patients with EoE, in a clinical setting. QOL, and psychosocial 
questionnaires were used to explore patient QOL, psychological characteristics and factors 
related to dietary adherence. Weighed food records (WFR) were used to assess nutritional 
adequacy and dietary quality. Lastly, dietitians knowledge and skills were also explored 
through survey methodology. Descriptions of focus groups, questionnaires, case series and 
nutritional analysis follow in this section, with consideration of the advantages, disadvantages 
and quality. Detailed methods are included in the methods section of corresponding chapters.  
2.5 QUALITATIVE RESEARCH 
In qualitative research, the researcher collects open-ended data exploring the views others 
have about a subject, with the primary intent of developing themes from the data. 
Traditionally, the effectiveness of treatment is derived from quantitative trials. However, they 
fail to explore some aspects of the clinical feasibility of the approach and the impact of the 
treatment on the individual. Qualitative research can help maximise the value of the 




and identifying factors that impact on the intervention, thus directing the development of 
guidelines for clinical practice.165,166,171 Therefore, qualitative research was chosen to explore 
patient experiences and areas for care improvement (Chapter 4).  
2.5.1 Philosophical assumptions in qualitative research 
To understand qualitative research, one must first understand the philosophical assumptions 
that underpin it. Awareness of these assumptions is imperative to the choice and justification 
of methods for data collection and analysis. The five main philosophical assumptions include: 
1) Ontological: relates to a person’s view on reality and the world 
2) Epistemological: the theory of knowledge; encompassing objectivity and subjectivity 
3) Methodology: the process of research, including deductive and inductive reasoning, 
and if the research is contextual 
4) Axiological: acknowledgement of the values and bias present in the research  
5) Rhetorical: the language style of the research, first or third person171 
The study outlined in Chapter 4 accepted the following assumptions. A relativist ontological 
position: reality is socially constructed; thus, a person’s thoughts and perceptions are 
influenced by social factors. A subjective epistemic position: acknowledging that the 
professional background of the researcher adds an important contextual element and that 
different individuals experience the same environment differently. The methodology chosen 
was that of inductive reasoning: data collection and analysis were guided by one or more open 
ended research questions. They direct the study rather than trying to predict (hypothesise) the 
findings. The axiological and rhetoric positions were typical of constructivism: acknowledging 




2.5.2 Strategies of inquiry in qualitative research 
Strategies of inquiry in qualitative research provide researchers with a strategy to formulate, 
analyse and evaluate their methods. There is a vast array of strategies available. Common 
examples available in health research include Ethnography, Phenomenology and Grounded 
theory.171  
Grounded Theory is an approach for developing theory that is "grounded in data systematically 
gathered and analysed". The process begins with the researcher asking a question or series of 
questions designed to lead to the development or generation of a theory concerning some 
aspect of life.172 Grounded theory was deemed appropriate for this research.  
2.5.3 Quality considerations in qualitative studies 
The rigour of qualitative research can be enhanced by using evaluative criteria. Suggested 
criteria are similar to those used across all research streams but require additional 
considerations due to the unique open-ended nature of the data collected. These criteria 
include validity, through triangulation or respondent validation, reliability, method clarity, 
reflexivity, dealing with deviant cases, fair dealing, worth and generalisability.173 
Validity, the concept of measurement accuracy is usually explained through replication. 
However, in qualitative research, studies cannot be replicated as it is impossible to recreate 
identical social circumstances. Thus, alternative techniques have been suggested: triangulation 
and respondent validation. Triangulation is an attempt to replicate research within the same 
setting, as opposed to across settings, by using a variety of methods of data collection. 
However, results are likely to be different across different methods, thus the weight that 
should be placed on each of these results is unclear. Respondent validation is a comparison of 
the researcher’s account with the participant’s accounts. This usually involves asking research 
participants to comment on the researcher’s description. However, items of importance are 




comparing data sources and revisiting inconsistences is likely to ensure that data is more 
representative of the participant’s truth.173 In the current research, triangulation, with focus 
groups and questionnaires was used to ensure validity.  
Reliability, is the consistency of a measure. Internal reliability, consistency of data collection 
and analysis amongst researchers can be assessed through inter-rater reliability checks. 
Different researcher’s applications are compared, and adjustments made accordingly.173 In this 
research (Chapter 4) a primary and secondary coder similarly coded the data and compared 
and reviewed codes to reach consensus. External reliability, the extent to which a measure 
varies from one time to another is more difficult. It is possible for researchers to provide clear 
definitions of concepts and explicit research methods for the reproducibility of the research 
however, it is likely less relevant as identical social circumstances cannot be created.173 
Clarity of methods is essential in assessing whether the research methods used were 
appropriate to answer the research question. This includes sufficient information on the 
theoretical underpinnings, data collection and analysis and why these methods were chosen, 
described here and also in Chapter 4.173 
Reflexivity involves two main components. The first is recognition of the impact of the 
researcher on the research setting, this might include acknowledgment of the potential 
professional, intellectual and personal biases, in addition to potential changes in responses 
from participants due to a desire to please or engage in a particular way with the researcher. 
The ‘distance’ between the researcher and the participants could also be explored. Secondly, 
reflexivity requires recognition of the active involvement and purposeful engagement of 
research participants. Specifically, their behaviour in the context of the research setting.173 In 
the focus groups described here, an observer was present to document participant-researcher 




Acknowledgment of deviant cases is important to ensure the representativeness of the data. 
That is ensuring that all participant views are presented, not just the ideas that align with the 
researcher’s views. Similarly, fair dealings of participants’ responses are important to ensure 
one group, or one participants responses are not favoured over another.173 The use of 
exemplary quotes in the focus groups in Chapter 4 helped to ensure fair dealing and to reflect 
on deviant cases.  
Worth or value is the addition to existing knowledge that the research provides. This includes 
acknowledgment of how the research provides new knowledge, builds on existing knowledge 
or expands the knowledge to other settings.173 Certainly, the exploration of patient 
perceptions and needs in the management of EoE in this research is unique, as is the 
Australian healthcare context.  
Generalisability, applicability of the research findings to a broader population. Due to the small 
sample sizes used in qualitative research, results are not empirically generalisable. However, 
they can be theoretically generalisable. Consideration of sampling techniques, to obtain a 
representative sample should be deliberated.173,174  
2.5.4 Sampling in qualitative research 
A variety of sampling techniques can be used in qualitative research. Due to the smaller 
numbers used in qualitative research, purposive sampling is commonly used as it involves 
deliberate selection of participants to address the research aim.174  In the focus group study, 
purposive sampling was used to select participants based on the characteristic of EoE. This was 
conducted within the sampling frame of the ausEE organisation (Australian EGID support 
group). Additionally, theoretical sampling, originating from Grounded theory was employed. 
Theoretical sampling involves exploring theoretical constructs within the data, and to continue 




2.5.5 Data collection techniques: focus groups and in-depth interviews 
Observation, interviews and focus groups are the most well-known data collection techniques 
in qualitative research. Observations are used to capture individual behaviour in a specific 
social setting. Alternatively, interviews and focus groups are used to capture individual 
thoughts, experiences and opinions. Focus groups have the added purpose of the utilisation of 
group dynamics to explore group norms, knowledge and concerns. Interview and focus group 
structure can vary from structured: predetermined questions and order, semi-structured: 
predetermined structure with variable question structure, phrasing and order, and 
unstructured: no predetermined questions, only ideas. Unstructured interviews or focus 
groups allow in-depth discussion of values and priorities, but are not ideal for answering 
research questions, whilst structured questions may miss important unanticipated 
responses.174 Thus, semi-structured focus groups were chosen for this research (Chapter 4) to 
allow in-depth exploration of patient thoughts and experiences with EoE.   
2.6 QUANTITATIVE RESEARCH 
A quantitative approach employs experiments and surveys to collect quantifiable facts to 
produce descriptive and statistical data to explore relationships. As with qualitative research, 
careful consideration of the study design, sampling technique and data collection tools are 
required to minimise bias and maximise the research quality. In particular, three main criteria 
must be considered when examining the quality of quantitative research. Internal validity is 
the extent to which causality can be inferred and consideration of confounding factors. 
External validity evaluates the generalisability of the results, and reliability is the extent to 
which the same results would be obtained if repeated elsewhere. 172,175 These quality criteria 




2.6.1 Sampling in quantitative research 
The primary aim of sampling in quantitative research is to obtain a representative sample of 
the target population so that results may be empirically generalisable. Data is drawn from the 
population with the aim of being statistically representative and with a large enough sample to 
minimise error.174 Two main sampling techniques are commonly used in quantitative research. 
Probability sampling: random sampling from the target population. This technique is most 
likely to produce a representative sample and sampling error can be calculated. Non-
probability sampling involves non-random selection of a target population such as 
convenience, purposive or snow ball sampling. These samples are often not representative of 
the total population but are useful for obtaining data on difficult to reach or specific 
populations.176 Due to the specific disease (EoE) and health professional population (dietitians) 
examined in this research, non-probability sampling was chosen for the national survey 
(Chapter 3) and dietitians survey (Chapter 6). It is recognised that this may affect the 
generalisability of this research.  
2.6.2 Survey methodology 
Surveys are descriptive in nature and are useful for facilitating the collection of data and 
subsequent description of larger populations. Surveys are also beneficial in providing 
information for planning or examining the relationship between a disease and other variables 
of interest, although not determining causation. Whilst surveys are simple to conduct, they 
require consideration of several disadvantages and maximisation of the validity.177 
Surveys permit data collection in a standardised format. Firstly, consideration should be given 
to the type of questions which best suit the needs of the researcher. Close ended questions 
assume that the list of responses will cover the needs of all participants. Alternatively, open 
ended questions allow participants to express their answers personally and can be viewed as 




to be constructed so that all participants can interpret a question in the same way and answer 
willingly and accurately. Hence, pilot testing survey questions is useful to ensure clarity of 
meaning, avoid possible misinterpretation and elicit variance in response. The issue presented 
in each question also needs to be neutral, to reduce the risk of leading questions that can 
threaten the reliability and validity of the data. Question order is also important if 
consideration of question/response may influence subsequent questions.177  
Successful questionnaires depend on adequate representation from the entire group being 
studied. The response rate provides information on the representativeness of the sample. The 
lower the response rate the greater the chance that responders may differ from non-
responders, affecting the reliability and external validity.178 Thus, optimising response rates is 
essential to the accuracy of the results. Controllable methods for optimising survey response 
rates include effective survey delivery, mode of administration, use of incentives, length of 
survey, personalisation, multiple attempts to engage potential respondents and survey timing. 
Additionally, researchers should be aware of uncontrollable factors such as gender and 
relevance to an individual.177  
Similarly, the characteristics of non-respondents can impact on the accuracy of the survey. 
Non-response bias occurs when the response from non-responders differ from those who did 
complete the survey. Thus, the survey results do not accurately reflect the entire group. 
Acquiesce bias is the perception that it is easier to agree than to disagree. Additionally, it can 
also refer of the ease of answering questions, such as always choosing the response closest to 
the question (on a scale).  Acquiesce bias can be reduced by switching the order of responses 
periodically. Similarly, Response-choice order bias can be reduced in this manner.177  
Recall bias can affect the accuracy of survey responses. Sensitive information bias is the 
participant’s willingness to disclose personal information about themselves, such as in health 




Questionnaires were used in multiple aspects of this research. A web based survey was used 
with members of ausEE to gather information on characteristics of a larger Australian EoE 
population (Chapter 3). Additionally, questionnaires were used to gather information on 
patients in the case study (prospective and follow up studies) in a standardised format and 
were important to follow up these patients (Chapter 5). A second web based survey was used 
to explore the knowledge and proficiency of Australian dietitians in the dietary management 
of patients with EoE (Chapter 6). This method was useful in allowing national participation 
with many participants. All questionnaires used in this thesis were pilot tested to assist with 
clarity of responses. Questionnaires were also self-administered and anonymous (ausEE and 
dietitians survey) to encourage honest responses. Multiple attempts were made to engage 
participants through email reminders for all surveys. The use of incentives (no cost for initial 
appointment) and email personalisation were also incorporated into the prospective study to 
encourage participation.   
2.6.3 Case series methodology 
A case series is an observational study used to report data on a subject group, without a 
comparison population. Whilst reported as the lowest level of evidence on the National Health 
and Medical Research Council (NHMRC) level of hierarchy (level IV), case series are common 
clinical studies in the medical literature, as a true control may involve withholding a treatment 
in some circumstances. Understanding the advantages and acknowledging the disadvantages 
is crucial to producing a high quality case series study.179 
Case series studies are often used to describe outcomes of new or novel treatments. Case 
series studies are not designed to provide cause and effect, but rather to generate hypotheses, 
refine new techniques or treatment protocols before conducting more focussed or advanced 




prevalent diseases. As well as requiring less time and financial resources to conduct than case-
control, cohort and RCTs.179  
Case series are prone to bias due to the lack of control group. Selection bias is common due to 
the lack of randomisation. It is suggested that selection bias can be limited by: clear and well 
defined objectives and a study protocol derived from clear deductive reasoning. Furthermore, 
consecutive patient enrolment, explicit inclusion and exclusion criteria and the time-frame for 
participant selection and follow up should be clearly stated. Outcomes measures should be 
relevant to the clinical context and ideally collected prospectively. It is suggested that health 
related QOL measures can help strengthen case series. A high follow up rate will support the 
study validity. For those patients who do not complete the study, explanation of the reasons 
for loss to follow up is imperative.179 
In this thesis, a case series (Chapter 5) was examined to identify and explore patient 
symptoms, patterns of allergen sensitisation, patient-reported symptom triggers and 
outcomes of a dietary management protocol. This method was chosen as it allowed 
hypothesis generation and exploration into the role of food intolerance in patients with EoE. It 
was also considered feasible for the disease prevalence and time frame of the study. Specific 
inclusion criteria and a dietary protocol were provided, and an attempt was made to follow up 
all patients. QOL measures were also incorporated to strengthen understanding and 
individualisation of dietary management.   
The case series analysis involved a number of components to best provide an in depth 
exploration of patient management. Firstly, cross sectional analysis of patients baseline 
characteristics. Secondly, evaluation of a clinical dietary management approach in case series 
patients with histological and symptom outcomes examined. Thirdly, a prospective study 
involving QOL, psychosocial assessment and dietary data collection in a subset of the case 




combined use of case series, questionnaire and dietary data constituted the methods used in 
the case study (Chapter 5), thereby providing information specific to the NCP including 
nutrition assessment, dietetic diagnosis and intervention and monitoring/evaluation to guide 
future advice to dietitians.  
2.6.4 Elimination diet methodology 
Today, elimination diets remain the basis for the management of a variety of adverse food 
reactions including food intolerances, food allergy, coeliac disease and EGIDs. Typical 
management involves food exclusion for a period of time with assessment of symptom and/or 
pathological response. Reintroduction of excluded food(s) may then occur depending on the 
individual and the condition. Reintroduction through DBPC challenges are considered the gold 
standard.31  
Studies examining the role of natural food chemicals and additives using elimination diets have 
populated the literature since the 1940’s. However, these chemicals and additives are usually 
looked at in isolation.123 The elimination diet described here (RPAH elimination diet and 
challenge protocol) is unique in its exclusion and challenge of all possible whole food, natural 
food chemical and additives to identify food chemical sensitivities. However, due to the unique 
presentations of individuals with EoE adaptations to the standard protocol used in practice 
were required. The background to the RPAH elimination diet, and overview of the diet and 
adaptations can be found in Appendix A. In brief, patients eliminate gluten, dairy and soy, 
foods containing natural salicylates, biogenic amines and glutamate, as well as additives: 
preservatives including propionates, artificial antioxidants, benzoates, sorbates, sulphites and 
nitrates, and colourings (Figure 2.2). Challenges are commenced after at least two weeks on 





Figure 2.2: Flow diagram of the Royal Prince Alfred Hospital low chemical elimination 




Challenge testing is DBPC, using capsules containing the purified food chemicals and/or with 
foods containing gluten, dairy and soy or the specific food chemical/additive. Once patients 
have completed all challenge testing, their diets are modified (‘personalised diet’), based on 
their results. Food chemicals and additives that did not provoke symptoms are reintroduced 
and symptoms monitored. Once stable on their personalised diet for at least three to four 
weeks, patients are then encouraged to slowly liberalise whole foods and food chemicals they 
reacted to, one by one, to find their threshold; the point at which symptoms reoccur (Figure 
2.2). 
2.6.5 Quality of life assessment 
Improving QOL is a key goal of personalised medicine.153 QOL is a broad and multidimensional 
concept, encompassing all aspects of one’s life, including the social, cultural, emotional and 
spiritual values of the individual. QOL is defined as an “individual’s perception of their position 
in life in the context of the culture and values systems in which they live and in relation to their 
goals, expectations, standards and concerns.”180 Consequently, measuring QOL can assist in 
determining the burden of diseases, such as EoE. Additionally, it can also give an indication of 
treatment progression, particularly in conditions such as EoE where treatment may impact on 
QOL.181 
QOL is commonly assessed through validated questionnaires. These questionnaires aim to 
provide a subjective evaluation of the various domains of an individual’s QOL. For example, 
the 36-item Short Form Health Survey (SF-36)182 questionnaire is designed to address generic 
aspects of QOL commonly seen in the wider population. Disease specific QOL instruments are 
increasingly being recognised as fundamental tools to assist in understanding QOL issues that 
are specific to patient groups. This is because disease specific questionnaires are likely to have 
a greater sensitivity in detecting changes in QOL over time.183  For example, use of both a 




and after treatment of patients with EoE, with steroids, identified significant improvements in 
symptoms and eating with the specific tool, and improvements in social functioning and 
mental health domains with the generic questionnaire.184 This highlights the benefits and 
limitations of both tools. A generic tool can provide a broad overview of an individual’s QOL 
(physical, emotional and social) such as bodily pain, however; is limited as it does not provide 
detail on which specific aspects improved. A specific tool, focused on a single condition, can 
provide greater detail, for example, pain can be specified to a particular area, such as pain on 
swallowing in EoE. Still, a specific tool may not capture all aspects of an individual’s QOL or 
place a lesser emphasis on that QOL facet in perspective of overall wellbeing. Hence, specific 
and generic QOL instruments may be particularly beneficial when used in a complimentary 
manner.185 A review of the literature identified ten QOL tools (both specific and generic) that 
had previously been used to assess QOL in patients with EoE (Appendix B). Thus, for the study 
outlined in Chapter 5 (Part C) both specific (Adult Eosinophilic Oesophagitis Quality of Life 
Questionnaire (EoO-A-QOL)186) and generic (World Health Organisation Quality of Life Bref 
Questionnaire (WHO-QOL-bref)187 and SF-36 version 2188) QOL tools were chosen (Table 2.1). 
These tools have been previously shown to have good validity and reliability.  
In addition, the Food Related Quality of Life questionnaire (FRQOL) (Appendix C): a 
questionnaire adapted by the clinicians at the Allergy Unit from the validated Food Allergy 
Quality of Life Questionnaire-Adult Form (FAQLQ-AF),189 was used to explore the broader 
impact of food reactions on patient QOL. The FAQLQ-AF is a disease specific questionnaire 
designed to assess the impact of food allergy on food allergic adults including dietary 
restriction, emotional impact, risk of accidental exposure and food allergy related health. 
Modification of this tool included adjustment of question phrasing and scoring (from a six to a 




Table 2.1: Quality of life assessment tools used in this thesis. 
Tool Description Number of items Subscales 
World Health Organisation Quality of Life Bref 
Questionnaire (WHO-QOL-Bref)187 
 
Generic questionnaire provides an overall 
measure of a patient’s QOL, their perception of 
health and measures in four QOL domains 
26 Physical health, psychological, 
social relationships and 
environmental 
RAND 36-item Short Form Health Survey (SF-
36) Version 2182 
 
A multipurpose, short form general health 
survey. Subscale scores can be summarised 
using two widely accepted constructs: Physical 
Component Summary (PCS) and Mental 
Component Summary (MCS) scores. 
36 Physical health, role limitations due 
to physical functioning, bodily pain, 
general health, vitality, social 
functioning, role limitations due to 
emotional functioning and mental 
health 
Food Related Quality of Life (FRQOL) 
 
A disease specific questionnaire designed to 
assess the impact of food on QOL (Appendix D) 
23 Food avoidance and dietary 
restriction, risk of accidental food 
exposure, food related health, and 
emotional impact 




A self-reported questionnaire designed to 
assess QOL issues specific to adult patients 
with EoE 
24 
(an additional six 
items are 
answered for 
those following a 
restricted diet) 
Social impact, emotional impact, 
eating/diet impact, disease anxiety 




2.6.6 Psychological and psychometric characteristics, coping styles and dietary 
adherence 
Increased psychological symptoms of depression and anxiety have been described in children 
and adolescents with EoE and EGIDs.190–192 Increased symptoms of depression and anxiety 
have also been reported in other gastrointestinal conditions such as Irritable Bowel Syndrome 
(IBS), IBD and food allergy.193 Prevalence of eating disorders has not been explored in patients 
with EoE and there is minimal research available on the psychological symptoms or impact of 
EoE on adult patients. Understanding if these psychological characteristics relate to individuals 
with EoE is consistent with the personalised medicine aims of improving health151 and could 
help to minimise symptoms and maximise QOL.194 It also provides another potential arm in the 
assessment of individuals with EoE, within the NCP, which may consider the impact of 
psychological symptoms on food choice or readiness for dietary change.  
Adherence to diet prescription is amongst the lowest of all medical treatments.195 Non-
adherence to prescribed dietary treatments has been reported in paediatric patients with 
EGIDs196,197 and is common in individuals suffering from other chronic gastrointestinal diseases 
such as coeliac disease and IBD.196,198 Adherence to management strategies is critical to the 
overall health of patients and prevention of disease progression; including narrowing and 
hardening of the oesophagus, and to avoid subsequent complications such as stricture 
formation.148,196,198,199 It has also been identified as a key outcome of a patient centred 
approach to care.159 Understanding factors which predict adherence may assist health 
professionals in choosing appropriate care plans and intervening before patients are unable to 
adhere to suggested dietary modifications.199  
Psychological symptoms of depression, anxiety and eating disorder risk have been shown to be 
related to poor adherence. In fact, patients suffering from depression may be three times 




behavioural symptoms, particularly depression has been significantly associated with dietary 
non-adherence.196 Higher depression and anxiety symptoms have also been correlated with 
poorer dietary adherence in patients with coeliac disease.198 Furthermore, adolescents with 
co-morbid eating disorders and coeliac disease had poorer gluten free diet adherence.198  
Coping behaviour has also been explored in relation to adherence. Task-oriented coping: 
purposeful efforts aimed at solving the problem, and emotion-oriented coping: self-oriented 
emotional reactions with the aim to reduce stress, correlated with gluten free diet adherence 
in patients with coeliac disease.198 In kidney transplant patients, a palliative coping pattern 
(focus on emotion, religion or fantasy) was associated with medication non-adherence.200 
Alternatively, a problem-focused coping strategy were associated with medication adherence 
in patients with Human Immunodeficiency Virus (HIV).201 Coping strategies and treatment 
adherence have not been explored in any EoE population.  
Personality traits have also been identified as predictors of medication and dietary adherence. 
Five main personality traits (Five Factor Model) have been described to account for the 
variances in human personality including conscientiousness: the tendency to be organised and 
disciplined, neuroticism: the tendency to experience negative emotions, extraversion: the 
tendency to be sociable, openness: the tendency to be creative and open-minded, and 
agreeableness: the tendency to be trusting and compassionate.202 The relationship between 
traits of conscientiousness and neuroticism, and adherence are the most well described. For 
example, conscientiousness has been positively associated with dietary adherence in 
adolescents with type-1 diabetes199 and weight-loss programs in obese adults.203 Whilst 
neuroticism has been shown to be inversely associated with medication adherence in 
adolescents with type-1 diabetes.199 Personality traits and treatment adherence have not been 




Attitudes towards foods have also been shown to influence eating behaviour, and thus may 
also need to be considered when prescribing dietary treatment.204 Personal belief in diet-
health connections have been shown to influence dietary consumption patterns.205 
Convenience orientation, taste, food pleasure, cost and health are also known to influence 
purchasing and eating behaviour.206,207 Food pleasure seeking has been previously associated 
with poor dietary adherence in children with EGIDs. Older age, nutrition education and school 
support were also identified to influence dietary adherence in the same study.197  Thus, 
examining food attitudes may be useful in predicting dietary adherence in patients with EoE. 
Psychological symptoms, psychometric characteristics and coping styles are commonly 
assessed through validated scales or interviews.208  These questionnaires aim to provide 
descriptive information such as symptoms, that can be used to assist with making a diagnosis 
or classification.209 A variety of scales exist for examining depressive, anxiety, eating disorder 
and coping symptoms and can be generic or specific. The psychological symptom and coping 
questionnaires chosen for inclusion in this thesis were: State and Trait Anxiety Inventory 
(STAI),210,211 Beck Depression Index (BDI-II),212 Eating Disorder Examination Questionnaire (EDE-
Q)213 and Coping Inventory for Stressful situations (CISS).214 These questionnaires were chosen 




Table 2.2: Psychological, psychometric and coping questionnaires used in this thesis. 
Tool Description Items Subscales 
Beck Depression Index (BDI-II)212 
 
Self-reported screening tool that is used to assess the clinical status and 
severity of depression in patients 
21 NA 
State and Trait Anxiety Inventory-
Y (STAI-Y)210,211 
 
A self-reported tool to assess state and trait anxiety. State anxiety 
refers to feelings of apprehension, tension, nervousness and worry, 
that increase in response to physical danger and psychological stress. 
Trait anxiety refers to differences between people in the tendency for 
anxiety and their propensity to perceive dangerous or stressful 
situations and respond with elevations in their state anxiety. Trait 
anxiety is used to assess clinical anxiety in medical patients 
20 State and trait anxiety 
Eating Disorder Examination 
Questionnaire (EDE-Q)213 
 
A self-reported measure of eating disorder psychopathology, that 
generates two types of data: the frequency of key behavioural features 
of eating disorders such as binge eating, and attitudinal features 
reflecting the severity of the behaviour 
36 Restraint, eating concern, 
shape concern and weight 
concern 
Coping Inventory for Stressful 
Situations (CISS)214 
 
Designed to assess coping strategies in a variety of contexts and is 
useful for assisting with assessment and decision making for medical 
patients 
48 Task, emotion and avoidance  
Food-Life Questionnaire Short 
Form (FLQ-SF)204 
 
Designed to assess food attitudes 21 Weight concern, diet-health 
orientation, belief in diet-
health linkage, food and 





Designed to assess the degree to which a consumer is inclined to save 
time and energy in regards to meal preparation 
6 Time and energy and variety 
seeking 
Big Five Inventory-10 (BFI-10)215 
 
Designed to assess individual differences in personality based on the 
‘Five Factor Model’ 
10 Conscientiousness, 
neuroticism, extraversion, 




The psychometric questionnaires chosen for inclusion in this thesis were: Food-life 
Questionnaire Short Form (FLQ-SF),204 Big Five Inventory-10 (BFI-10)215 and Construct of 
Convenience-Orientation (CONVOR).207 These questionnaires were chosen as they have 
previously been validated and provide information on behavioural and personality 
characteristics that have been previously associated with adherence (Table 2.2).199,204,216  
Adherence has been defined by the World Health Organisation (WHO) as the extent to which a 
person’s behaviour such as following a diet, corresponds with the recommendations from the 
health care provider.217 Measurement for dietary adherence is not well described. Dietary 
adherence measures have been described broadly as structured: a measured scale or 
categories, for example never, occasionally, frequently and always, and unstructured: general 
descriptive information on adherence (for example “good compliance”).218 Structured 
measures, allow examination of rates and predictors of adherence, thus structured adherence 
categories were chosen for this thesis (Chapter 5).  
2.6.7 Nutritional adequacy 
Any research exploring an intervention must consider the basic tenant of healthcare ‘do no 
harm,’ with nutritional adequacy considered one of the basic tenants of nutrition intervention. 
A well-recognised potential shortcoming of elimination diets excluding foods or food groups is 
the increased likelihood of reduced nutrient intake, resulting in nutrient deficiency.219 The 
RPAH EoE dietary protocol limits multiple foods and food groups in the initial diagnostic phase 
and patients may continue to limit their diet long term depending on their challenge results. 
Thus, examining nutrient intake over the course of the RPAH EoE dietary protocol was 
considered imperative in consideration of the protocol as an option for nutritional care.   
Nutritional adequacy is when all essential macro and micro nutrients are consumed in 
adequate amounts to meet the individual’s everyday needs to prevent disease from 




for each nutrient, specific to an individual’s age and gender. Although elimination diets focus 
on the exclusion of foods or food groups, they also limit nutrients through both absolute 
exclusion of specific food groups and limited selection of foods within a group. In the context 
of nutrition research; application of the correct NRVs appropriate for use in the individual 
and/or group setting is important (Table 2.3). 








Daily nutrient level 
estimated to meet the 
requirements of half 
the healthy individuals 
of a particular life stage 
or gender 
Examine probability 





within a group 
Recommended 
Dietary Intake (RDI) 
Average daily dietary 
intake level sufficient to 
meet the nutrient 
requirements of nearly 
all healthy individuals 
of a particular life stage 
or gender 
Usual intake at or 
above this level has a 
low probability of 
inadequacy 
Do not use 
Adequate intake (AI) Average daily dietary 
intake based on 
estimated of nutrient 
intake by a group of 
apparently healthy 
people that are 
assumed to be 
adequate 
Usual intake at or 
above this level has a 
low probability of 
inadequacy 
Average intake at or 
above this level 
implies a low 
prevalence of 
inadequate intakes 
Upper Level of 
Intake (UL) 
Highest average daily 
nutrient intake level 
likely to pose no 
adverse health effects 
to almost all individuals 
in the general 
population 
Usual intake above 
this level may place 
the individual at risk 
of adverse effects 
Estimate the 
percentage of the 
population at risk of 
adverse effects from 
excessive intake  
 
Estimated Average Requirements (EAR) and Adequate Intake (AI) values were used to assess 
nutritional adequacy of patients with EoE over the course of the RPAH EoE dietary protocol 




used for estimation of prevalence of inadequate intake in individuals and groups.220 Upper 
Level (UL) of intake was also examined in those taking vitamin and mineral supplements to 
identify excessive intake.220  
2.6.8 Dietary patterns 
Free-living people eat combinations of foods reflecting cultural, social, health, economic, 
environmental and lifestyle factors. Thus, examining the relationship of the overall diet with 
health has advantages.116 Recently there has been a shift towards dietary patterns research, 
with researchers embracing the concept of food synergy and whole-diet in relation to disease, 
moving away from traditional nutrition research, focused on individual nutrients or nutritional 
deficiencies and their relationship to chronic disease. It is interesting to consider that this 
paradigm shift is likely due to the focus on chronic diseases such as obesity, type-2 diabetes 
and heart disease that are becoming increasingly prevalent within the community. Thus, there 
is little research into diet quality for those on restricted diets, therefore the exploration of 
nutritional adequacy must also include review of dietary quality over the course of the RPAH 
EoE dietary protocol.  
There are two main approaches to dietary patterns research: empirically defined dietary 
patterns, and theoretically derived dietary patterns. Empirically defined dietary patterns are 
derived from food consumption data. Factor or cluster analysis is used to identify groups of 
dietary components, for example a western diet pattern. The derived patterns of dietary 
exposure can then be used to examine diet and disease associations.116  
Theoretically defined dietary patterns are based on existing nutrition knowledge and foods 
that are known to be important for health. Diets are assessed for the presence or absence of 
certain foods or nutrients. As such theoretical dietary patterns are often based on national 
food guidelines, such as the Australian Dietary Guidelines (ADG), which are designed to 




be based on cultural eating patterns such as the Mediterranean diet. This research method has 
been termed diet quality.116 
A diet quality tool is a predefined measure usually based on food groups, nutrients or dietary 
guidelines and may be general, for example the Healthy Eating Index, the Alternate Healthy 
Eating Index221 and the Healthy Eating Index for Australian adults 2013 (HEIFA-2013),222 or 
specific, for example the Adolescent Micronutrient Quality Index for lacto-ovo vegetarians.223 
The tool creates a score by subject. Consideration should be given to how the tool was 
designed, the score applied and the population it was validated in.224 For this research, the 
HEIFA-2013 was chosen as it is based on the most recent dietary guidelines for Australian 
adults, and was validated in population of young adults appropriate to this population.222  
2.6.9 Dietary data collection and analysis 
A variety of methods have been designed to measure food intake. These strategies vary in 
their purpose, detail, errors and practical applications and difficulties.225 The following table 
(Table 2.4) summarises the advantages and disadvantages of the three main methods 
available. It is important to note that there are variations within each method that are not 
detailed here. WFRs were utilised in this research due to the greater precision of dietary data 
obtained than 24hr recall methodology. The WFR allowed detailed dietary analysis, providing 
insight into dietary adherence and nutritional adequacy and diet quality at each dietary 
stage.225 Traditionally, WFR have been completed for seven consecutive days to allow 
collection of information about foods eaten less often. However, due to participant fatigue, 
recording periods of more than four days have been associated with reduced validity in the 
later days.  It has been suggested that a minimum of three days is required to capture reliable 
information on usual food consumption. The unit where this research took place typically 
collects 4-day WFRs, therefore to ensure consistency of data, a four day time period was 




Table 2.4: Advantages and disadvantages of dietary data collection methods.225 
Method Data Collection Advantages Disadvantages 
Weighed food record Individual/investigator weighs every food or drink item 
consumed over a set time period (3-7 days) 
Gold standard 
Widely used 
Precision of portion sizes 
High respondent burden 
Miss-reporting 
Expensive 
Limited by food composition 
data 
24 Hour recall Interview asking respondent to detail food and drink eaten 
in last 24hrs 
Low respondent burden 
Suitable for large studies 
Telephone administration 
Estimation of portions 
Single observation is a poor 
measure of individual intake 
Recording bias 
Memory bias 
Food frequency questionnaire Self-administered questionnaire. Respondent selects 
frequency of consumption of individual food items 
  
Low respondent burden 
Suitable for large studies 
Self-completed 
Estimation of portions 






Food composition databases are essential tools for dietary analysis. However, there are several 
considerations that need to be accounted for when choosing a database as well as 
acknowledging the inherent limitations of the data available.227 The main consideration for 
choosing a food composition database is the applicability of the foods to the population 
including country, age, gender and ethnicity. Other considerations may include food 
components of interest, currency of data and data derivation methods. It is also important to 
acknowledge the limitations of food composition data. Firstly, due to the ever evolving food 
supply, food composition data is unlikely to ever be complete. Food composition data is also 
inherently variable, reflecting the influences of genetics, the environment and processing in 
food production and consumption.228  The AUSNUT 2011-2013 Australian food composition 
database was chosen for the dietary analysis study outlined in Chapter 5 (Part D), as it contains 
the most up to date Australian food composition data and provides a comprehensive range of 
products.229  
2.7 CONCLUSION 
A variety of methods were required for this research to allow comprehensive investigation of 
patient perceptions, current dietary management and considerations for an individualised care 
pathway for patients with EoE. Qualitative and quantitative methods were employed to 
provide complementary data, a broad understanding of the patient experience and a detailed 
exploration of patient characteristics and dietary management respectively.  
Chapter 3 outlines the characteristics and current management of the broader EoE population 
in Australia. Chapter 4 involved exploring the views of patients and parents of children with 
EoE utilising focus groups. Chapter 5 describes the results of a case study, exploring the 
characteristics of the study population and outlines the response to a low chemical elimination 
diet and challenges, as well as long term follow up. In addition, Chapter 5 explores QOL, 




adequacy and quality over the course of the RPAH EoE dietary protocol. Lastly, Chapter 6 
described the implementation of a national survey of dietitians, to quantify self-reported 
knowledge and proficiency in the dietary management of EoE.  
To enhance understanding of factors influencing the NCP the findings of the case series and 
patient surveys are compared. Additionally, to enhance methodological rigour and 
understanding of the interplay of stakeholders in the patient care pathway the findings of the 
focus groups were triangulated with the results of the national survey (Chapters 3 and 4) and 
the dietitians survey (Chapter 6).  
The NCP provides an ideal framework for exploring the dietary investigation and management 
of EoE by dietitians within the broader construct of personalised medicine. The methodology 
used to explore the question ‘How can we improve the dietary investigation and management 
of EoE?’ in this thesis were chosen to maximise the opportunities to collect data from key 
stakeholders in the dietetic care pathway. Hence, the NCP framework and mixed methods 
provides a broad and complementary data to inform clinical management of EoE, particularly 





CHAPTER 3: CHARACTERISTICS AND CLINICAL MANAGEMENT 
OF EOSINOPHILIC OESOPHAGITIS IN AUSTRALIA: A NATIONAL 
SURVEY 
3.1 INTRODUCTION 
Present knowledge and understanding of characteristics and current treatment of patients 
with EoE stems from research previously describing European and American cohorts, with data 
on the characteristics of children and adult patients with EoE in Australia currently limited. 
Additionally, knowledge of current clinical practice treatment for patients with EoE, in 
Australia, has not been previously documented. A greater understanding of characteristics of 
Australian patients with EoE and their management could assist identification of important 
areas for improving assessment, intervention and monitoring/evaluation of these patients. 
Therefore, this study aimed to explore characteristics of Australian patients with EoE and their 
current management.  
The objectives of this study were: 
1) To examine and characterise demographic, symptoms, associated conditions, atopic 
conditions, family history and maternal influences in an Australian EoE population 
collected from a national support group. 
2) To examine and describe medical and dietary testing and management in an 





3.2.1 Overview of study participants and design 
The national eosinophilic disease support network (ausEE) is a not-for-profit organisation and 
support group for Australians and their families living with EGID’s. They provide resources, 
host support groups/forums, and raise awareness of EGID’s. Member data from 2012 (N=246), 
reported that most members were female (86%) (Unpublished data). At the time of this study 
there were approximately 800 members, of whom two-thirds were children/parents of 
children with EoE.  
Members of the ausEE organisation were invited via email to complete a questionnaire and 
participate in a focus group (Chapter 4). An initial email and two follow up emails were 
distributed to all ausEE members, in December 2015, January 2016 and February 2016, 
respectively. Inclusion criteria were adults (≥ 16 years) or parents of children (<16 years) 
diagnosed with EoE. This study was approved by the Sydney Local Health District Human 
Research Ethics Committee (#X15-0169 & LNR/15/RPAH/229).   
3.2.2 Questionnaire design and analysis 
Two questionnaires were designed, one for adults (≥ 16 years) and one for parents of children 
(< 16 years) with EoE, to explore symptoms, diagnosis and management of Australian adults 
and children with EoE. Each version of the questionnaire had the same core questions; 
however, some additional age specific and maternal questions were incorporated into the 
children’s survey (Appendix E). Multiple choice and open-ended questions were included with 
participants required to complete a question before moving onto the next question. 
Participants could provide more than one response to each question.  
The initial versions of the surveys were pilot tested by ten volunteers, including four adults and 




Feedback was collated and used to aid in refining the surveys, including some grammatical 
changes and changes to response options. Preliminary information about the time taken to 
complete the questionnaire was also obtained.  
The final questionnaires were constructed and distributed using the online survey tool 'Survey 
Monkey' (Survey Monkey Inc. California, USA).230 A link to the final questionnaires was 
included in the email invitation sent to all ausEE members (approximately 800). The 
questionnaire was open for three months, with reminders sent each month to increase 
participation rates. Consent was implied by the completion of the questionnaire. Results were 
de-identified and collated in Survey Monkey. Basic demographic data was tabulated and 
further analysis, using descriptive statistics was conducted using SPSS statistical analysis 
software (IBM Australia Ltd., Sydney, Australia).231 Percentage responses were calculated 
based on the number of participants completing the question. Data was tested for normality 
using Shapiro Wilks test and identified to be non-parametric. Mann Whitney U tests were used 
to identify differences between age, age of diagnosis and age of symptom onset, and 
symptoms and atopic conditions. Pearson’s Chi square test was used to examine relationships 
between gender and symptoms and atopic conditions. A P value less than 0.05 was considered 
statistically significant.  
3.3 RESULTS 
3.3.1 Characteristics of the questionnaire participants 
A total of N=46 adults and N=75 parents of children attempted the questionnaire, providing an 
approximate response rate of 15% of members. Participants were more likely to be adult 
females with EoE or mothers of male children with EoE, Caucasian and highly educated (Table 
3.1). The demographic results are reflective of member data collected by ausEE in 2012. Most 
individuals with EoE (self-reported or reported by a parent) were male (2:1 ratio), diagnosed in 




five years (N=73, 66%). Individuals reported experiencing symptoms for an average of four 
years prior to diagnosis. No trend according to month of diagnosis was identified.  
Table 3.1: Demographic characteristics of all survey participants (N=121). 






Male N (%) 74 (61) 12 (26) 62 (83) 
Age mean (SD) [range] 18 (16) [1-68] 36 (12) [16-68] 7 (4) [1-15] 
Caucasian N (%) 114 (94) 45 (98) 69 (93) 








































































Age of symptom onset* years 
mean (SD) 
11 (15) 27 (13) 1 (3) 
Age of diagnosis* years mean (SD) 14 (16) 31 (13) 3 (4) 
































*N=110, ^N=103, Abbreviations: ACT: Australian Capital Territory, NSW: New South Wales, QLD: 
Queensland, VIC: Victoria, TAS: Tasmania, SA: South Australia, WA: Western Australia, NT: Northern 
Territory. 
3.3.2 Symptoms 
Almost half (48%) of parents of children with EoE reported persistent vomiting as the reason 




reflux (14%). A third of adult respondents reported food impaction as the reason for their first 
endoscopy, followed by dysphagia (26%), and choking (21%). Other reasons for endoscopy, 
reported by both adults and children, included distress, reflux, chest pain, abdominal pain and 
IBS type symptoms.  
Participants reported experiencing similar symptoms to those previously reported in the 
literature16,232,233 with children primarily describing daily abdominal pain (24%) and reflux 
(23%) and occasionally experiencing dysphagia (44%) and diarrhoea (38%). In adults, the 
sensation of food sticking (43%) and dysphagia (35%) were more likely to occur daily to 
weekly, whilst pain with swallowing (39%), regurgitation (39%) and diarrhoea (46%) occurred 
occasionally. Other commonly occurring (daily to weekly) gastrointestinal symptoms included 
nausea (30%), bloating (29%), wind (52%) and constipation (30%) in children, and reflux (27%), 
abdominal pain (27%), bloating (30%) and wind (39%) in adults.  
Participants who reported experiencing abdominal pain had a significantly younger age of 
symptom onset than those that did not experience abdominal pain (p=0.024). Participants 
who reported experiencing bloating where older, had an older age of symptom onset and age 
of diagnosis than those that did not experience bloating (p=0.003, p=0.007, p=0.003 
respectively).  Participants who reported currently experiencing wind were also significantly 
older (p=0.019). Females were more likely to report food impaction, migraine, heartburn, 
bloating and constipation than males (p=0.024, p<0.001, p=0.008, p=0.009, p=0.016 
respectively).  
Non-gastrointestinal symptoms of interest reported in the survey included behavioural 
changes (29%), sleep disturbance (24%) and fatigue (23%) in children. Daily fatigue (24%) and 




Other associated or concomitant conditions were also explored in the survey participants. 
Coeliac screening was reported by 64% of survey participants with four participants (one adult) 
identified to be diagnosed with coeliac disease. Anxiety/depression was reported in 13% of 
children. Connective tissue syndromes such as Ehlers–Danlos syndrome were also reported in 
four children and mast cell activation disorder was reported in three children.  
3.3.3 Atopic conditions 
Atopic conditions and allergy testing were examined in the survey population. A history of 
eczema and asthma was frequently reported in children (65%, 48% respectively) and adults 
(51%, 57% respectively). Seasonal hayfever was also commonly reported in children (35%) and 
adults (46%).  
Completion of allergy testing was reported by 90% of survey respondents. SPT (96%) was the 
most commonly reported allergy test used, followed by radioallergoabsorbent testing (RAST) 
(54%) and APT (29%). Nuts were the most commonly reported food allergen to be identified 
on testing in adults (37%) and children (56%). Sensitisation to egg was also reported in 
approximately half the children (53%). In children and adults, 68% reported an environmental 
inhalant allergy. Dust mite was the most predominantly reported inhalant allergen 
sensitisation (56%) followed by grasses (51%), pollens (41%) and animals (28%). No 
associations were identified between age, gender, age of diagnosis or age of symptom onset 
and atopic conditions.  
3.3.4 Participant reported food triggers 
Participants were asked to report on up to five perceived food triggers and the symptoms 
elicited (Table 3.2). Commonly reported triggers by adult respondents included gluten 
containing foods (69%), dairy (51%) and vegetables (31%), whilst dairy (45%), nuts (40%) and 




Gluten containing foods were commonly reported to elicit lower gastrointestinal (GIT) 
symptoms (nausea, abdominal pain, bloating and diarrhoea) in adults (58%) and children 
(53%). Dairy was also commonly reported to trigger lower GIT symptoms in adults and children 
(72%, 33% respectively) and rhinitis symptoms (33%) in adults. Nuts and seeds were most 
commonly reported to be related to the symptom of anaphylaxis in children (52%). 
Table 3.2: Participant reported food triggers.  




Dairy  18 (51) 28 (45) 
Gluten  24 (69) 17 (27) 
Egg  3 (9) 21 (34) 
Fish/shellfish  4 (11) 8 (13) 
Nuts/Seeds  8 (23) 25 (40) 
Fruits  6 (17) 18 (29) 
Vegetables  11 (31) 13 (21) 
Meat  6 (17) 8 (13) 
Soy/legumes  5 (14) 12 (19) 
Alcohol  3 (9) 0 
 
3.3.5 Texture and temperature as reported triggers 
Survey respondents who reported difficulty swallowing (75%) were asked to report on which 
foods were most difficult to swallow. Meat (67%) was the most commonly reported food 
amongst adults and children to be difficult to swallow. When individual foods were 
categorised into groups: fruits (27%) such as apple (N=11), and vegetables (26%) such as carrot 
(N=7) and potato (N=5), were often reported as triggers of dysphagia. Respondents also 
reported specific food textures, rather than foods that were difficult to swallow including dry 
foods (15%) and crispy/crunchy foods (9%). When asked specifically about food textures 73% 
reported that the texture of the food and 15% reported temperature influenced their ability to 





3.3.6 Strategies for symptom relief 
Drinking water, followed by regurgitating or self-induced vomiting were the most common 
strategies, reported by both adults and children (Table 3.3), used to relieve symptoms when 
foods were difficult to swallow. Many participants described using more than one strategy. 
Antacids and paracetamol were the medications reported to be used by adults.   
Table 3.3: Top strategies used to relieve symptoms when food is difficult to swallow. 




Drink water 21 (57) 44 (85) 
Regurgitate/self-induced vomiting 16 (43) 13 (25) 
Wait for food to go down 9 (24) 3 (6) 
Drink carbonated beverages e.g. soda 
water 
6 (16) 2 (4) 
Hospital 5 (14) 2 (4) 
Movement (e.g. walk or jump) 5 (14) 1 (2) 
Medication e.g. antacid 4 (11) 0 
Food refusal 0 5 (10) 
Throat clearing/cough 0 4 (8) 
Texture modification e.g. soft foods 1 (3) 3 (6) 
Keep calm/deep breaths 2 (5) 2 (4) 
*Participants could report more than one strategy. 
 
3.3.7 Medical management 
Approximately half (49%) of the respondents reported current treatment with swallowed 
corticosteroids. Fluticasone was the most commonly used steroid among adults (61%), whilst 
Budesonide was more commonly used in children (40%). The average duration of swallowed 
corticosteroid use was 1.7 years in adults and 2.4 years in children. Three quarters of 
participants reported an improvement in symptoms when using swallowed steroids. 
Approximately half of those using swallowed corticosteroids reported having an endoscopy to 
assess histological improvement, with the majority reporting improvement (75%).  
In addition to the above therapies many patients also reported daily PPI use and medical 




44% of participants. The average duration of PPI use was 2.4 years in adults and 2.3 years in 
children. Symptomatic improvement with PPI therapy was reported by nearly half of the 
participants (43%).  
3.3.8 Dietary management 
Just over half of the participants reported they were currently following a restricted diet. A 6-
FED was the most common dietary therapy (54%). Interestingly, a ‘self-selected’ diet, based on 
foods patients believed to trigger symptoms was also common (30%) (Figure 3.1). 
Symptomatic improvement was reported by the majority following a restricted diet. However, 
most participants did not specify or were unsure of histological changes with dietary 
modification. The average reported diet duration in children was 16 months, with the mean 
duration of exclusive elemental formula use being 12 months. Gastroenterologists (74%), 
followed by immunologist (59%) were most likely to recommend dietary intervention in both 
adults and children. Dietitians (76%), followed by medical specialists (52%) were the most 


































































Figure 3.1: Current dietary treatment strategies reported by patients with eosinophilic 
oesophagitis (N=82). Abbreviations: 6-FED: Six food elimination diet. Other category 
included: paleolithic diet, two food elimination diet, combination of approaches, low 
Fermentable Oligosaccharides, Disaccharides, Monosaccharides and Polyols 
(FODMAPs) and Gut and Psychology Syndrome (GAPs) diets.  
 
Of the N=82 participants following a restricted diet, 61% reported completing a challenge or 
reintroducing food, with symptoms (48%) being the most commonly used method to identify a 
food trigger. Methods and results of food reintroduction were not well reported. This is 
possibly due to unclear reintroduction instructions being provided to participants, with many 
participants listing the number of serves required to consume per day as “a regular serving 
size” or “eat twice per day” or “normal diet”. Food categories reported to be introduced 
included dairy, gluten, soy, nuts, eggs, fish/seafood, meat, fruit and vegetables. The average 
amount and time period for food reintroduction for adults and children are compared to the 




type of food, for example; milk, cheese or yoghurt, amount of food (1 tsp - 3 cups) and time-
frame for food reintroduction (1 day – 16 weeks). One week was the most common time 
frame used for food reintroduction in adults (N=18) and children (N=10). However, on average 
children completed longer food reintroduction trials than adults. Dairy was the most common 
food group reported to be re-introduced in adults, whilst gluten was the most common among 
children. Two participants reported attending the emergency department after the first 
reintroduction of fish due to severe reactions. Owing to a limited number of participants 
reporting on reintroduction of vegetables, egg and fish in adults and fish, nuts, fruit, 
vegetables and meat in children, these could not be further explored. 
Table 3.4: Adult participant reported food challenges.  








Dairy  8 3 1.40 (0.02-3.00) 1.20 (0.14-6.00) 
Gluten  5 6 2.25 (1.00-4.00) 1.47 (0.43-4.00) 
Nuts^  4 3 1.00 (1.00-1.00) 0.81 (0.43-1.00) 
Soy/legumes  5 3 0.47 (0.08-1.00) 0.75 (0.43-1.00) 
Fruit+ 5 2 1.11 (0.14-3.00) 1 (1.00-1.00) 
^Type not specified, +apple: N=1, banana: N=2, strawberry N=1, watermelon: N=1. 
Abbreviations: ADG: Australian Dietary Guidelines. 
 
Table 3.5: Child participant reported food challenges. 








Dairy  8 1-3.5 0.67 (0.08-1.00) 6.79 (0.57-16.00) 
Gluten  11 4-7 1.67 (1.00-5.00) 4.51 (0.43-16.00) 
Soy/legumes  5 1-3.5 0.56 (0.08-1.00) 5.50 (1.00-16.00) 
Egg  7 1-2.5 0.14 (0.083-0.25) 2.28 (0.43-6.00) 
Abbreviations: ADG: Australian Dietary Guidelines. 
3.3.9 Family history 
Family history of allergic and associated disease was also explored in this cohort (Table 3.6). 
Allergic rhinitis was the most prevalent condition amongst mothers (50%) and fathers (37%) of 




EGID (3%).  Headaches or migraines, reflux and asthma were also common maternal 
complaints. Reflux and asthma were common amongst fathers.  





Asthma 22 (24) 26 (29) 
Eczema 13 (14) 20 (22) 
Food allergy 11 (12) 17 (19) 
Allergic rhinitis 33 (37) 45 (50) 
Eosinophilic oesophagitis 3 (3) 2 (2) 
Eosinophilic gastrointestinal disorder (other) 1 (1) 2 (2) 
Reflux 23 (26) 26 (29) 
Irritable bowel syndrome 6 (7) 21 (23) 
Coeliac disease 0 0 
Headaches or migraines 8 (9) 34 (38) 
 
3.3.10 Early life exposures 
In this cohort, mothers reported that children with EoE were commonly born full term (88%), 
and born via vaginal delivery (58%). A history of breastfeeding was reported in 92% of 
respondents. Average age to wean from the breast or bottle was reported at 10 months. Poor 
weight gain (28%), unsettled behaviour (23%) and refusal (23%) were common reasons for 
breastfeeding cessation. However, most mothers did not cease breastfeeding for symptomatic 
reasons, rather the child was weaned as the duration was considered sufficient (44%). 
Introduction of solids most commonly occurred between five to eight months (61%), 
consistent with the Australian infant feeding guidelines at the time of the survey.234  
3.4 DISCUSSION 
This survey was unique in its characterisation of an Australian EoE support group population 
and highlighted several areas that may be important for consideration in the NCP. Australian 
patients with EoE were identified to have many similarities to other western cohorts including 
symptoms, atopic conditions and male to female ratio.16,140,232 They also describe FGID type 




strategies as a means of management appeared to be equally common, with dietary self-
restriction and inconsistent food reintroduction strategies notable. Dietitians were also 
identified to be key providers of dietary advice. 
3.4.1 Prevalence 
Responses from the survey population suggests that two-thirds of respondents were 
diagnosed in the last five years. An increasing prevalence of EoE in Australian children has 
previously been reported in which diagnostic shift and increased awareness could only 
partially account,235 thus our data may reflect an increase in prevalence. However, more 
recently, another Australian study reported that the increase in prevalence has reached a 
plateau,236,237 hence other factors may have contributed to these findings. Firstly, it is possible 
that engagement in the ausEE support group is more common for those with more recent 
diagnoses. Additionally, EoE has become progressively better recognised over the past 20 
years and thus oesophageal biopsies are performed more routinely.238 This matches data 
showing an increased number of endoscopies performed in children239 and an overall increase 
in endoscopies performed in Australia each year.7,240 National studies are required to estimate 
the current incidence and prevalence of EoE in Australia.  
3.4.2 Symptoms and atopic conditions 
EoE has been described as a progressive disease, with children typically experiencing 
symptoms of abdominal pain and vomiting, and adults experiencing dysphagia and food 
impaction. Additionally, patients with childhood onset EoE present with significantly more 
abdominal pain, vomiting, failure to thrive and less dysphagia than those with adult onset 
EoE.13 Symptoms reported by the ausEE survey population is consistent with these 
observations, with participants reporting abdominal pain significantly more likely to have a 
younger age of disease onset. However, additional symptoms of nausea, bloating, wind and 




described by this cohort. Evidence suggests that 5-30% of the general population experience 
IBS symptoms, which may account for this finding. However, the prevalence of reflux 
symptoms (which are commonly described in EoE) has also been reported to be increased 
four-fold in individuals with IBS compared to those without, highlighting a significant overlap 
between conditions.241 Bloating has also been associated with constipation predominant IBS242 
and heartburn.243 Furthermore, a relationship between heartburn and dysphagia has been 
described.243 It has been suggested that the clinical overlap between reflux and IBS is due to a 
similar underlying mechanism of visceral hypersensitivity. Thus, it is possible that this clinical 
overlap may also include EoE.  
A unique finding of this study was the number of patients reporting fatigue, headaches, 
behavioural issues and sleeping disturbances. Interestingly, these symptoms have been 
previously linked to other gastrointestinal conditions such as IBS244 as well as food chemical 
intolerances.123,245 Apart from sleeping disturbances (25-33% of children with EoE),246 these 
symptoms have not been previously well reported in an EoE population. Behavioural feeding 
problems have been reported in children with EGIDs247 and improvements in disruptive 
behaviour and attention deficit hyperactivity disorder (ADHD) have been described in one case 
of a child with EGID, treated with an elimination diet.248 Further investigation is required to 
establish if these symptoms commonly occur in other EoE populations and their relationship to 
the disease. Further investigation of these symptoms in patients with EoE and food chemical 
intolerances is described in Chapter 5.  
The prevalence of coeliac disease in the questionnaire cohort was low at 3%. Previous reports 
have suggested a prevalence of coeliac disease in patients with EoE ranging from 0.16-57.1%, 
though it should be noted that the large variability is due to the information available being 
prone to publication bias.249 Current evidence suggests that coeliac disease and EoE are 




two diseases can be ruled out.249 Connective tissue disorders were also reported in four 
children in the questionnaire. A link between the prevalence of EoE and connective tissue 
disorders such as Marfan Syndrome, Ehlers-Danlos syndrome and joint hypermobility 
syndrome has been reported previously, including an eight-fold risk of EoE in patients with 
these disorders.250 Thus, consideration may need to be given to concomitant conditions as part 
of management of patients with EoE.  
Symptoms of anxiety and depression may also be an important consideration in assessment of 
patients with EoE. Internalising symptomatology such as anxiety and depression has been 
reported in almost half of children with EGIDs and EoE.246 In the current study, only a small 
proportion of children were reported to have anxiety/depression, however, due to the self-
reported nature of the survey it is unclear if this is an accurate representation. Further 
research into the QOL and psychological impact in children and adults with EoE is required and 
is explored in Chapter 5 (Part C).  
Asthma, eczema and allergic rhinitis were reported to occur in participants in this survey at 
similar rates to the literature.16  Sensitisation to airborne allergens was identified in two thirds 
(68%) of the survey group, consistent with prevalence statistics suggesting between 40-70% of 
patients with EoE have allergic rhinitis.16 Nuts and eggs were the most commonly reported 
food allergens, as well as common food triggers related to symptoms of anaphylaxis, urticaria 
and angioedema, in children in this study. Similarly, in other cohorts, children with EoE most 
commonly reported IgE-mediated food allergy to peanut, egg, soy and milk,41,47 whilst peanut, 
soy, wheat, and milk allergy have been more commonly reported in adults.48,146 These results 
suggest that considering atopic conditions as part of assessment and management is 
important to holistic care of patients with EoE, due to the impact of these conditions on QOL251 
and the possibility of contribution to underlying inflammation.1 Additionally, it highlights the 




3.4.3 Texture and temperature as participant reported triggers 
This study identified that specific food textures may influence swallowing difficulty. Foods 
reported by survey participants to be difficult to swallow included meat, fruits and vegetables, 
as well as dry and rough food consistency, similar to those reported previously in the 
literature.41,252 The reason why certain textured foods are reported to be difficult to swallow is 
likely to be multifactorial. Firstly, dysphagia in patients with EoE could be caused by physical 
obstruction of the oesophagus, for example rings, narrowing or stricture,253 making large or 
highly textured foods more problematic. Alternatively, motility disorders such as abnormal 
peristalsis have been reported in patients with EoE, with approximately 10% experiencing non-
specific motor disorders.254 Additionally, Korsapati et al.255 identified diminished longitudinal 
muscle function in patients with EoE. However, the clinical significance of dysmotility and its 
relationship to symptoms in patients with EoE is currently unclear.256 
Similar to other studies, participants in the ausEE support group reported avoiding meat, 
lumpy foods such as bread, and specific food textures, eating slowly, drinking after each bite, 
taking small bites, lubricating foods with liquids or butter, extensive chewing of food and 
texture modification as compensatory strategies.16,253,257 Other strategies for symptom relief 
such as use of carbonated beverages and medications identified in this study, have not 
specifically been reported in the EoE literature to date. However, the use of carbonated 
beverages or effervescent agents has been described in the management of food impaction in 
emergency departments.258,259 A review of the use of effervescent agents identified low level 
evidence suggesting that these agents may be effective, but not without risk of 
complications.260 Appreciation of strategies used for symptom relief by patients may be useful 
in disease recognition and emergency management. Additionally, these results suggest that 




assessment of patients with EoE and that patients may require education on food texture 
modification. 
A small number of respondents reported temperature, particularly heat, to affect swallowing 
ability. To the best of the researcher’s knowledge this is the first time this has been reported in 
patients with EoE. Temperature has been reported as an important sensory function in normal 
swallowing and swallowing dysfunction.261 Temperature has also been reported to influence 
swallowing in patients with oesophageal motility disorders, with cold fluids inducing pain.262 In 
a recent study the effects of hot and cold water on oesophageal motility was observed in 
healthy adults. Cold water was found to prolong peristalsis and oesophageal body contraction, 
whilst hot water was found to shorten the duration of oesophageal body contraction and 
decrease lower oesophageal sphincter pressure. Thus, in contrast to our study, hot water was 
found to pass more easily into the stomach262 and high temperature food has been reported to 
be easier to swallow.263 Krarup et al.91 also identified that patients with EoE were 
hypersensitive to acid but not heat. Further studies are required in EoE patients to determine 
the effect of temperature on dysphagia. 
3.4.4 Medical management 
In the survey, the use of swallowed corticosteroids and dietary therapy were equally used as 
forms of therapy. The average duration of corticosteroid use was greater than six months. A 
recent study in children with EoE identified 10% of patients had developed adrenal 
insufficiency after treatment with swallowed glucocorticoids for greater than six months.111 It 
is therefore recommended that the lowest effective dose for maintenance of histological 
remission should be used, alongside screening for adrenal insufficiency in patients on long 




3.4.5 Dietary management 
Many participants in this study reported following a self-selected diet, with a fifth of 
participants undergoing dietary investigation obtaining dietary advice through their own 
research. Self-imposed dietary restrictions raise concerns about nutritional adequacy due to 
the impact on intake of essential micronutrients.265 Evidence suggests that children on 
restricted diets have lower intakes of essential nutrients, with a greater number of food 
restrictions increasing the number of deficient nutrients.266 Thus, whilst the types of foods 
patients were self-restricting was not well reported in this survey, limiting conclusions about 
potential nutrients that may be at risk, the necessity of growth/weight monitoring by all health 
professionals involved in the care of patients with EoE is highlighted. Additionally, health 
professionals should be aware that these patients may be following self-imposed dietary 
restrictions, and therefore referral to a dietitian for nutrition assessment, education for 
replacement foods and monitoring of nutrient intake is important. Self-imposed dietary 
restrictions and the impact on nutrient intake is explored in further detail in Chapter 5. 
Interestingly, participants reported symptom improvement on their self-selected diet, and this 
has also been reported elsewhere.41 The relevance of patient reported symptom triggers in 
symptom management is also explored in further detail in Chapter 5.  
Food reintroduction/challenge advice reported by participants was variable in relation to the 
type, amount and frequency. Food reintroduction processes in the literature are also variable, 
for example the frequency at which a new food should be introduced varies from a new food 
introduced every three days,130 up to every six weeks,143  likely accounting for the variation 
reported by survey participants.  Looking more broadly at food reintroduction protocols for 
non-IgE mediated food reactions further exemplifies that oral challenges for non-IgE mediated 
food reactions are not well defined.267,268 Protocols are available for oral challenges for IgE-




amounts, and build up incremental doses every 15-30mins until an age-appropriate serve size 
is met.269 However, as these challenges are used to identify acute IgE-mediated reactions this 
protocol is unlikely to be useful for identifying EoE specific food triggers due to the delayed 
(non-IgE mediated) reactions experienced by these patients.79  Currently there is a lack of 
knowledge about the amount of food necessary to elicit a reaction in EoE,164 with two studies 
suggesting consumption of one serve, twice daily.130,146 The average serve size reported to be 
reintroduced to children, in this study, was less than one standard food serve for all 
foods/food groups except gluten containing foods. Indeed, on average all participants 
reported that the average amount of each food group introduced was well below the 
recommended daily serves specified in the dietary guidelines. Thus, food reintroduction to 
identify tolerance of a minimum of one serve size (age appropriate) is an important 
consideration when conducting food reintroduction. More than one serve is likely required to 
ensure tolerance of usual dietary intakes. Further research is required to establish dose related 
responses in EoE.  
The majority of participants reported that they used symptoms to identify food triggers when 
reintroducing food, despite current guidelines recommending a repeat oesophageal biopsy.1 
The use of symptoms to identify food triggers is clinically practical and feasible for patients, 
reducing time, costs and associated endoscopy risks. However, a disassociation between 
symptoms and histological activity has been identified,270–272 though the relationship between 
symptoms and histological activity on reintroduction of a specific food has not been evaluated. 
Subsequently, it is suggested that a lack of symptoms cannot assume a lack of histological 
activity 272 and a repeat biopsy is indicated147 after the reintroduction of a single or two foods 
for six to eight weeks.122,123,143 Although, this may be shortened in the context of symptom 




food because of the symptoms experienced? Furthermore, what is the relevance of foods 
triggering symptoms but not inflammation and should these be excluded?  
Two participants reported severe adverse reactions on reintroduction of fish in this study. Loss 
of tolerance after a period of food avoidance in sensitised subjects has been reported 
previously.46 This emphasises the importance of allergy testing and monitoring in these 
patients, especially in relation the food removal and reintroduction. Overall, the lack of clear 
food reintroduction guidelines, specific to clinical practice is evident.  
3.4.6 Family history and early life exposures 
There is good evidence to suggest that there is a strong familial association and an increased 
heritability risk for first degree relatives of patients with EoE,78,273 whilst parental allergy has 
been reported as a risk factor for occurrence of EoE.274 In this survey study, a small proportion 
of respondents reported a family history of EoE. Maternal and paternal allergic rhinitis, asthma 
and eczema were also commonly reported in this study, consistent with rates reported in 
recent studies of children with EoE.274,275 A novel finding of the survey was the reports of 
maternal and paternal history of reflux. A family history of GORD has been previously 
associated with reflux symptoms276 and increased severity of oesophagitis277 in patients with 
GORD. Further research is required to confirm the relationship between a family history of 
reflux and EoE.  
A recent twin and family study reported environment, particularly early life environment was 
thought to have a greater influence than genetics on the development of EoE.78  Breastfeeding 
has previously been reported to be possibly protective in the development of EoE.78 However, 
other studies have shown no association between breastfeeding and EoE.278,279 A trend 
towards increased odds of EoE and caesarean birth and preterm delivery was also 
described.279  In this survey, the majority of mothers of children with EoE reported having their 




of breastfeeding was not well quantified. Average weaning age was higher than expected, with 
the Australian infant feeding survey in 2010 reporting that only 42% children were continued 
to be breastfed between seven and twelve months. This likely reflects the high education 
levels observed in our surveyed population, as tertiary education and higher income have 
been associated with breastfeeding previously.280 Additionally, mothers who are members of a 
support group may be more health oriented.281 Further larger scale studies are required to 
explore early life exposures as risk factors for EoE. 
3.4.7 Strengths and limitations of the survey 
The use of survey techniques in this study were useful in providing descriptive information on 
symptoms, associated conditions, allergen testing results and family history. The low response 
rate (15%) and self-reported nature of the survey presents a limitation and may have 
introduced recall bias. Additionally, it must be acknowledged that individuals that join a 
support group may be different to the broader Australian EoE population. For example, the 
high adult female response rate and high education levels of the survey population suggests 
that the survey results may not be reflective of Australian adult males and/or patients with 
lower education levels.  
3.5 CONCLUSION 
In summary, Australian children and adults with EoE are characteristically similar to other 
Western populations describing symptoms of reflux, vomiting, dysphagia and food impaction 
as well as concomitant asthma, eczema and allergic rhinitis. They also describe FGID type 
symptoms and unique symptoms of fatigue and behavioural problems, which are explored in 
more detail in the case study in Chapter 5. Reports of anxiety and depression amongst children 
with EoE also warrants further investigation into the psychological impact of the disease. 
Chapter 5 (Part C) explores this issue in adult patients with EoE. Self-imposed dietary 




Overall, this study provided a broad and descriptive overview of Australian patients with EoE 
symptoms, associated conditions and current management strategies. Numerous factors that 
may impact the management of EoE (requiring further exploration in this thesis) were 
highlighted as well as the idiosyncratic presentation of these patients and inconsistencies in 
current management. Thus, Chapter 4 explores these patients with EoE experiences with the 




CHAPTER 4: PATIENTS AND PARENTS PERSPECTIVES IN 
OPTIMISING THE MANAGEMENT OF EOSINOPHILIC 
OESOPHAGITIS: FOCUS GROUP RESULTS 
4.1 INTRODUCTION 
The practice of patient centred care rests on two main principles, the patient’s subjective 
experience of the disease and collaboration between the patient and health professionals to 
define goals, make decisions and carry out a treatment plan.282 It has been suggested that the 
importance of the various dimensions of patient centred care may differ amongst patient 
groups. Additionally, the preference and effectiveness of different care delivery and treatment 
strategies may differ among patients.283 Treatment of EoE is complicated by the variability in 
efficacy and applicability of each treatment between individuals105 as well as the need for 
repeated endoscopies to evaluate treatment effectiveness.284 Additionally, multiple health 
professionals may be required to manage different aspects of EoE and associated conditions.13 
Given the complexities of diagnosis, treatment and ongoing coordination of care, a broader 
understanding of patient treatment preferences and what aspects of patient centred care are 
important to patients with EoE could help to improve care provision and subsequently patient 
outcomes. Therefore, this study aimed to explore patient views on the process of diagnosis, 
management and treatment of EoE, including how this process could be optimised to 
maximise a patient centred and personalised approach to care.  
 
The objectives of this study were: 
1) To explore patients with EoE and parents of children with EoE experiences and views 




2) To explore patients with EoE and parents of children with EoE opinions on improving 
and optimising the care pathway.  
4.2 METHODS 
This chapter reports results relating to patients’ perceptions of the management pathway of 
EoE through the use of a questionnaire and focus groups. The focus groups were conducted 
concurrently with the national survey of members of the ausEE support group outlined in 
Chapter 3. 
4.2.1 Questionnaire design and analysis 
The following chapter discusses further results of the questionnaires (Appendix E) completed 
by the ausEE cohort described in Chapter 3. The ethical requirements, study design and 
methods were outlined in Chapter 3. Questions specific to the research aim (improvement of 
the management pathway) were identified. Percentage responses were calculated based on 
the number of participants completing the question.  
4.2.2 Focus group design and analysis 
Members of the ausEE organisation who expressed interest in participating in a focus group 
were assessed for eligibility and availability. Focus groups were mixed face to face and online, 
to allow intercity and interstate participation. Synchronous online teleconferencing was 
conducted using ZOOM (Zoom Video Communications, Inc., San Jose, CA),285 with online 
participants displayed on a large screen. Participants consented to recording and transcription 
of the focus group.  
Groups of 4-10 participants ran for approximately 1.5 hours, with separate focus groups for 
adults and for parents of children with EoE. Focus groups were conducted by experienced 
moderators and an observer, with additional technical support, as outlined by Krueger and 
Casey.286 The moderator followed a semi-structured format, with questions designed 




group prior to use in the focus groups. Questions covered the patient journey (diagnosis, 
endoscopy, medical management and dietary management) as well as issues related to QOL, 
patient/carer needs, areas for improvement and further research (Table 4.1). The moderator 
focused on clarifying opinions, probing and exploring themes and encouraging contribution of 
less vocal participants. The observer’s written record included verbal and non-verbal cues, 
capturing group dynamics and interactions to enhance the final analysis. Focus groups were 
conducted until theoretical saturation was reached. Participants demographic and descriptive 
data was obtained from the questionnaire. 
Table 4.1: Semi-structured focus group questions. 
1. a) Can you describe your experience(s) leading up to and being diagnosed with EoE and 
reflect on the positive and negative aspects?  
b) What do you think could have been improved OR would be useful/helpful? What 
might have made things easier for you? 
2. a) Can you describe your experience with medical management of EoE such as hospital 
visits, endoscopies or medications and reflect on the positive or negative aspects? 
b) Where you would like to see improvements? What would be useful/helpful? 
3. Do you have any experience with dietary management of EoE?  
Can you describe your positive and negatives experience with dietary management? 
Where would you like to see improvement? What would be useful/helpful? 
4. Reflecting on the different areas of your lives such as home, work/school. How does 
EoE affect your day to day life? 
5. What do you think would be useful or is needed for you and others (newly diagnosed) 
with EoE that could have improved your experience? 
6.  Thinking of each of the steps we have discussed – from diagnosis to treatment – what 




Focus groups were digitally recorded, transcribed verbatim and de-identified. Transcripts were 
reviewed against recordings to ensure accuracy. Data coding and analysis was guided by 
Grounded Theory,165 involving identification and interpretation of common themes within the 
data. Initial content and thematic analysis was carried out by the primary coder (PhD 
candidate) to identify dominant themes. Sub-categories were documented within themes to 
differentiate responses. A secondary coder similarly coded the data and differences were 
identified and deliberated to reach consensus. All themes were reviewed using QSR NVivo 11.0 
qualitative software (QSR International Pty Ltd, Melbourne, Australia).288 Further thematic 
analysis was completed following an iterative approach. Exemplar quotes illustrating each 
theme were also identified. 
As the purpose of the present study was optimisation of the management pathway (diagnosis 
to treatment) of EoE, schematic analysis was applied to dominant themes to identify major 
themes related to the management pathway and suggestions for its improvement.  
4.3 RESULTS 
4.3.1 Questionnaire results specific to care improvement 
Three questions were identified to be related to the management pathway and improving 
patient care. These included questions in relation to accessing specialist care and advice, 
diagnostic and treatment tools such as endoscopy and blood tests, and important factors that 
respondents felt had most assisted their management of EoE. 
Questionnaire participants were more likely to be mothers of male children with EoE or adult 
females with EoE, Caucasian and highly educated (Chapter 3). Difficulty accessing specialist 
care was reported by 54% of participants. Adults (61%) were slightly more likely to report 
difficulties accessing specialist care than parents seeking care for their children (51%). 




commonly reported difficulties. Lack of understanding, support and knowledge about EoE, by 
health professionals, was also reported by 24% of participants. Parents of children with EoE 
(30%) were more likely to report lack of specialist knowledge and support than adults with EoE 
(18%). 
Most participants (81%) reported that they would prefer a blood test for diagnosis and 
monitoring over an endoscopy. This desire was slightly higher in parents of children (84%), 
than adults (76%). Reasons for desiring a blood test included convenience, lack of need for 
anesthetic, and reduced risk compared to surgery. Reasons for not preferring a blood test 
were only reported by parents of children (9%) and included needle phobia, easier for young 
child to be sedated than have blood test whilst awake, inability to obtain macroscopic 
appearance of the esophagus and concern about accuracy.  
Participants were asked to report what they felt had most helped the management of EoE 
(Figure 4.1). The most common factors included swallowed corticosteroids (35%) and dietary 
management (31%). Adults (31%) were more likely to report trigger avoidance as helpful for 
management than parents of children (11%). Parents of children were more likely to report the 
use of swallowed steroids (38%) and understanding specialists (9%) to be more helpful than 
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Figure 4.1: The five most common factors survey participants reported to help the 
management of their eosinophilic oesophagitis the most (N=88). Participants could 
report more than one factor.  
 
4.3.2 Characteristics of the focus group participants 
Four focus groups were conducted with a total of N=27 individuals from N=67 who originally 
expressed interest in participating (39%). Reasons for participant drop out included time, day 
and length of focus groups. Two focus groups were held with adults with EoE: N=9 (1 male) 
and N=4 (3 male). The remaining two focus groups were conducted with mothers of children 
with EoE or children with EoE: N=7 (6 mothers and 1 female child, aged 14) and N=7 mothers.  
Demographic data (Table 4.2) identified participants were more likely to be female, middle 




Table 4.2: Demographic characteristics of focus group participants. 
Characteristics Adults 
(N=13) 
Parents of Children 
(N=13) 
Male N (%) 4 (31) 0 
Age mean (SD) [range] 39 (12) [20-68] 40 (7) [28-49] 
Caucasian N (%) 13 (100) 11 (85) 




























*Patients seen by authors in the past 2 years. Abbreviations: NSW: New South Wales, QLD: Queensland, 
WA: Western Australia, VIC: Victoria. 
 
4.3.3 Themes 
Thematic analysis of 87 pages of transcribed data identified 34 dominant themes (Appendix G). 
Schematic analysis identified 16 major themes related to the management pathway (six 
themes) and suggestions for its improvement (ten themes). These, and the 18 related sub-
themes are discussed in detail in this chapter. 
Patient perceived management pathway 
Six major themes related to the participants’ perceptions of the management pathway (Table 
4.3), through each phase of the disease from diagnosis to longer term management, were 
identified. These included time and emotion associated with diagnosis, endoscopy 
experiences, treatment, diet therapy, medication therapy, and long term outcomes and 
consequences. These themes clearly highlight that there are difficulties for both patients and 
health professionals at each step of the management pathway, with concerns specific to the 




Table 4.3: Summary of the major themes and subthemes related to participant perception of the management pathway of eosinophilic oesophagitis. 
Major themes (definition) Major subthemes 
(definition)* 
Exemplar quote 
Time and emotion associated with diagnosis  
(The diagnostic journey including time to diagnosis 
and emotional aspects) 
Referral pathway  
(Pathway of specialists, tests and 
alternative diagnoses taken by patients to 
prior to diagnosis) 
“I went to my GP in 2011, I had a burning pain in my chest 
that I couldn’t explain …. I saw neurologists, ENTs, and lots 
of specialists… then I got into the allergy clinic … and then 
my GP at the time had tried me on various medication to 
help me with my pain so he wanted an endoscope that was 
in January 2014”  
Participant 8, Focus group 3 
Length to diagnosis 
(Time from symptom onset to diagnosis is 
delayed) 
“I’ve only just been recently diagnosed in September last 
year but prior to that symptoms pretty much my whole life”  
Participant 9, Focus group 3, 
Relief at diagnosis  
(Identification of cause is a relief) 
“He did a scope and the eosinophils were off the scale and, 
it was a huge relief to go, ‘At last I've got something.’"  
Participant 2, Focus group 4 
Endoscopy experiences (Experiences with 
endoscopy including positive and negative 
experiences) 
 “My little one has his tonsil ruptured on the way out and he 
was in hospital for five days”  
Participant 1, Focus group 1 
Treatment  
(Broadly describes the treatment of EoE including 
the time taken to commence treatment, treatment 
effectiveness and treatment choice) 
Treatment effectiveness (Response to 
treatment including positive or negative 
responses and monitoring effectiveness) 
“We did flixotide, and that worked for a long time. Then it 
stopped working. They increased the dose. It worked for a 
little while and then it stopped working”  




Treatment options or choice (Patients 
desire treatment choice) 
“The gastroenterologist didn’t really give us a choice with 
treatment, she just said, “He needs to go on medication. He 
needs to go on it now”  
Participant 1, focus group 2 
Diet therapy  
(Aspects of dietary management including type, 
positive and negative facets)  
Length of time on restricted diet (Length of 
the dietary elimination and reintroduction 
process) 
“We’re 18 months into the diet” Participant 2, Focus group 1 
 
Self-directed  
(Patient or parent directs dietary changes 
with limited professional input) 
“You’re sailing the ship on your own when it comes to diet 
and eliminating foods with your child”  
Participant 6, Focus group 2 
 
Difficulty of food reintroduction and trigger 
identification  
(Trigger identification through food 
reintroduction is difficult) 
“I felt that every time I tried to introduce food it would be 
that much worse”  
Participant 8, Focus group 2 
Medication therapy (Aspects of medical 
management including adverse reactions, 
administration and desire for alternatives) 
Adverse reactions to medications 
(Symptoms experienced from medications) 
“[the] effect [of] being on Nexium, especially because I take 
40mg …. it trashes my B12”  
Participant 8, Focus group 2 
Long term outcomes and consequences (Future 
implications of the chronic disease and disease 
treatment) 
Long term effects of medication and 
compounding effects of polypharmacy  
(Future implications of medication use) 
“I worry about the long term effects of things like 
medication”  
Participant 1, Focus group 2 






Figure 4.2: Schematic diagram of the management pathway as perceived by patients and suggested areas for improvement. The patient perceived 
management pathway is displayed in bold text. Areas of improvement are displayed in un-bolded text. The relationship between the patient perceived 




The six themes related to the participants’ perceptions of the management pathway can be 
schematically represented as care pathways with key stakeholders engaged with patients 
throughout their journey (Figure 4.2). For example, the family (general) practitioner who may 
have been accessed as the first point of medical care, followed by various medical 
professionals including gastroenterologists, immunologists and dietitians. These interactions 
are described in the themes (italicized in the text) and sub-themes below.  
Time and emotion associated with diagnosis, explores the diagnostic journey including the 
referral pathway. Participants described the lead up to their diagnosis of EoE to be a 
“rollercoaster” of different specialists and tests.  A sense of relief was commonly described 
upon obtaining a diagnosis.  
“[Getting] a diagnosis of EoE ... it was like a big load off my shoulder” Participant 5, 
Focus group 2 
Participants also described diagnosis as a positive step towards treating the disease. 
Conversely, the time taken to obtain a diagnosis was described as a negative and frustrating 
aspect of the diagnostic experience.  
Endoscopy experience was reported in association with diagnosis, but also frequently as part of 
ongoing follow up to assess treatment effectiveness. Experiences were both positive and 
negative. Many participants, particularly mothers, expressed concern surrounding the risks 
associated with their child undergoing sedation, and the need for frequent endoscopies, 
especially in relation to food reintroduction to identify dietary triggers.  
Treatment experiences and effectiveness of diet and medication were key discussion points 
amongst participants. Through this discussion it became clear that most participants had not 




“We were never given the option of medication. We were only given the option of diet. 
When I did say to the gastro, ‘well, what about some medicine?’ he kind of just shook his 
head.” Participant 7, Focus group 2 
Medication therapy was another important discussion point linking with the theme of 
treatment, within the focus groups. The use of swallowed corticosteroids, PPIs, inhaled 
corticosteroids for asthma and corticosteroid creams for eczema were common. Many 
mothers reported adverse reactions to medications, particularly swallowed corticosteroid. 
“The steroids actually made the (his) behavior that much worse. It was like living with 
a two-year-old on ‘roid rage” Participant 8, Focus group 2 
Diet therapy, encompasses all aspects of dietary management. Varying degrees of dietary 
restriction were reported by participants, many being on a restricted diet such as the 6-FED for 
an extended period (for example 18 months) beyond the usually recommended two to three 
months.289 Additionally, dietary restrictions prior to diagnosis of EoE, due to food allergies and 
avoidance of known symptom triggers also contributed to the length of time spent on a 
restricted diet. Difficulties with food reintroduction and food trigger identification also 
contributed to a prolonged period on a restricted diet. Reasons surrounding the difficulty of 
trigger identification included worsening of symptoms when challenged and lack of guidance 
from health professionals. A self-directed approach in relation to diet was also commonly 
described.  
Participants were also largely concerned with the long term consequences of prolonged 
medication use, including steroids, mixers of artificial sweetener such as sucralose (usually 
SPLENDA® (Heartlands Consumer Food Products Group, Amsterdam, The Netherlands)) and 




participants. This included the concept of treating symptoms, versus treating the underlying 
inflammation.  
Patient suggestions for improving the management pathway 
Ten key themes comprising participant suggestions for improving each step of the 
management pathway were identified including professional awareness, knowledge and 
understanding of EoE, alternative method to endoscopy, clear and direct treatment pathway, 
specialists should provide information and support, role of the dietitian, nutrition and growth, 
easy, quick and reliable dietary testing method, improved medication and administration 
options, holistic management, and potential disease trajectory (Table 4.4). The major themes 
(italicized in the text) found to be related to the improvement of the management pathway 
were identified to have a strong link with each of the steps in the management pathway such 
as diagnosis, represented schematically in Figure 4.1. Secondly, these themes were identified 
to align with the concepts of patient centred practice and aspects that could be improved.  
These included areas for improvement specific to dietitians and application of the NCP.  
Professional awareness, knowledge and understanding of EOE, explores the knowledge or lack 
of knowledge amongst health care professionals. Most participants firmly believed that 
increased knowledge and awareness amongst health care professionals would assist with an 
earlier diagnosis, especially primary health care professionals (family or general practitioners 
(GP) and pediatricians), as well as physicians who patients were commonly referred to, such as 
Ear, Nose and Throat Surgeons (ENTs). Additionally, participants felt that increased support 
and validation of their symptoms was an important factor in achieving an appropriate referral 
and subsequent diagnosis.  
There was also strong consensus for the need for Alternatives to endoscopy, consistent with 










Professional awareness, knowledge and 
understanding of EoE (Knowledge or lack of 
knowledge of all health professionals 
surrounding EoE) 
Awareness in primary care setting (greater 
disease recognition is desired by patients 
among primary care physicians e.g. GPs) 
“We were under a general paediatrician, a GP, the allergy 
clinic and no one at any time mentioned EoE until we saw 
the sleep specialist. He referred us to a paediatric gastro” 
Participant 2, Focus group 2 
Lack of belief or support from professionals 
(Lack of validation of symptoms by health care 
professionals and appropriate 
referral/management) 
“I had a really hard time finding a doctor who believed me 
until they actually saw it. I actually called my doctor and 
said, ‘My son’s reacting now I’m coming to bring him in’” 
Participant 9, Focus group 2 
Alternative method to endoscopy (Method to 
test disease activity other than an endoscopy) 
 “it would be great if we had another method for testing for 
EoE rather than an endoscopy”  
Participant 6, Focus group 2 
Clear and direct treatment pathway (A 
protocol of the treatment procedure to allow 
progress) 
 “All these things need to be compiled into something that 
can be proceduralised. That if somebody has someone who 
suspects that problem (EoE) or may be in the beginning 
stages; what’s my next step; what do I do next; how do I 
proceed?”  
Participant 3, Focus group 4 
Specialists should provide information and 
support (Participants desire provision of 
information, support, and regular follow up 
and are contactable) 
 “It’s very overwhelming, so somebody that could actually 
explain it to you, this is what it is, this person had 
recommended this plan of attack”  
Participant 6, Focus group 1 
Role of the dietitian  
(What do patients view as the most important 
aspects of nutrition assessment and 
management by a dietitian) 
Individualised dietary advice and support is 
lacking (Tailored dietary advice and support is 
desired) 
“We didn’t get much guidance from the dietitian. We got 
handed some paper that said everything that milk and soy 
was in and that was it”  
Participant 6, Focus group 2 
Food reintroduction guidance (Instructions on 
how to introduce food) 
“This year I’m going to try and introduce some more foods. 




that I wouldn’t be able to figure out on my own” Participant 
1, Focus group 4 
Information on how to meet nutrient 
requirements and increase intake on restricted 
diet (Specific strategies to meet macro and 
micronutrient requirements on a restricted 
diet) 
“I think the toughest thing has been working out how to get 
enough nutrition with such a narrow number of foods…I 
think that really specialist advice, nutritional advice around 
how you get enough calcium, how you get enough protein” 
Participant 2, Focus group 2 
Recipes and food product knowledge  
(Provision of reliable recipes, foods and 
products) 
“the recipe book, that was a really big help to me” 
Participant 3, Focus group 2 
Nutrition and growth (Difficulty of 
maintaining nutrition and growth in children 
and adults with EoE) 
 “He was literally fading away in front of our eyes, there’s not 
much [of] him as I think with all EoE kids, they’re really 
skinny because they’re not getting any nutrients from what 
they do eat”  
Participant 1, Focus group 1 
Easy, quick and reliable dietary testing 
method 
(Test used to identify dietary triggers) 
 “Something that allows you to be less blunt with diet…so 
that we can move quickly”  
Participant 3, Focus group 1 
Improved medication and administration 
options (Alternatives to corticosteroids and 
enhanced administration options) 
 “Non-steroidal medications to treat EoE would be my top 
two”  
Participant 8, Focus group 2 
Holistic management (Treatment of patient as 
whole not per each condition) 
Communication of multidisciplinary team 
(Communication between multiple medical 
specialists is important and desired) 
“My sons got a respiratory specialist, a dietitian, a 
gastroenterologist, an immunologist, a paediatrician and a 
GP. And they all want to sort of focus on one particular thing 
not him as a whole”  
Participant 2, Focus group 1 
Case manager (Medical advocate to assist 
professional communication and treatment 
plan) 
“I felt that there needed to be a case manager, someone 
that was in charge of what was going on”  




Potential disease trajectory (Knowledge of 
disease path and possible barriers and 
conditions) 
 “When you get told about you're going to have a baby they 
say, ‘Don't go in having too much of a plan about your birth 
plan because it could change’ … I guess EoE is a bit like that; 
you need to go in with an open mind.  I guess the more we 
know about the path ahead…  It's not going to be the same 
or it can go up, it can go down."  
Participant 1, Focus group 2 




Specialists should provide information and support was an emergent theme reflecting 
participant views that information and support was lacking from health care professionals. The 
ability to contact their specialist was also considered important.  Furthermore, participants 
expressed a desire for information on a Clear and direct treatment pathway, a step-by-step 
protocol of the treatment procedure, to allow them to progress forward.  
“All these things need to be compiled into something that can be proceduralised. That if 
somebody has someone who suspects that problem (EoE) or may be in the beginning 
stages; what’s my next step; what do I do next; how do I proceed? Participant 3, Focus 
group 4 
Furthermore, this treatment plan needed to be part of Holistic management, the idea that the 
individual should be treated, not per each condition. This included the desire for better 
communication amongst the multidisciplinary team. Some mothers of children with EoE 
thought that a “case manager” would be beneficial to assist this communication.   
Alternatives to medications and alternative steroid administration techniques, to enhance the 
effectiveness were discussed in the theme of Improved medication and administration options. 
Role of the dietitian, explored patient’s expectations of dietitians surrounding dietary 
management. Individualised dietary advice and support, including reliable recipes, food and 
food product ideas. Instructions and support for food reintroduction were also considered 
important. Concern from mothers surrounding Nutrition and growth in their children was also 
evident.  Reports of children losing weight and being on restricted diets without adequate 
nutritional substitutions, such as elemental formula were common.  
“We were told to take milk and soy out of my son’s diet, which was horrendous 




this or this at least we knew he was getting fats and solids from milk and cream and 
custards” Participant 6, Focus group 2 
The theme of Easy, quick and reliable diet testing method, highlights the desire for a test that 
can immediately identify food triggers. Furthermore, participants, particularly mothers 
expressed a desire for more knowledge of the Potential disease trajectory of EoE. This involved 
greater knowledge of the natural history of EoE, treatment benefits and consequences, 
possible barriers to disease management and associated conditions. 
“Something like a potential trajectory and within that trajectory there's lots of little 
branches of … what would happen this way and the other” Participant 5, Focus group 
2 
In summary, patients and carers identified in both their questionnaire and focus group 
responses concerns relating to diagnosis and treatment and could provide suggestions for 
strategies which may improve their quality of care, including dietary management.  
4.4 DISCUSSION 
Mixed, face-to-face and online focus groups provided an effective way to explore participants’ 
thoughts and experiences surrounding their disease management. Participants acknowledged 
that the management process was neither optimised nor patient centred. The areas of 
improvement identified from qualitative analysis are greater awareness, communication and 
support from health care professionals, greater direction surrounding treatment, as well as 
improved treatment methods and tools. This was further supported by the questionnaire 
results.  It is apparent that despite increased research in EoE in the past 20 years,16 consensus 
on diagnosis and the increasing prevalence of EoE6 that day-to-day clinical management of 





Relief upon diagnosis and frustration at the length of diagnosis was reported in this study by 
both adults and parents of children. These issues have been raised by other patients with 
EoE,290 as well as by individuals with other gastrointestinal diseases, such as coeliac disease.291 
The survey results emphasise the delay to diagnosis with an average of 3.9 years between 
patient reported symptom onset and diagnosis in adults and children. Delay in diagnosis in 
patients with EoE has also been reported in the literature.291,292 
It has been suggested that where EoE symptoms are primarily assessed by general 
practitioners, that raising awareness is vital to avoid missed diagnoses.293 It is also interesting 
to note that despite the common referral and role of the otorhinolarynologist in general 
dysphagia management, there is limited information about EoE in ENT journals.  Whilst, this 
may account for lack of awareness amongst ENTs, it also highlights an unexplored research 
area.294  
Participants felt that increased support and understanding of their symptoms was an 
important factor in obtaining a referral and subsequent diagnosis. However, one participant 
did acknowledge the difficulty of suspecting EoE from symptoms, due to the large variability in 
symptoms experienced by patients with EoE. The non-specific nature of many symptoms 
experienced by patients with EoE such as reflux also adds to this difficulty. Interestingly, even 
when disease awareness is high, such as in coeliac disease, the time to diagnosis can still be 
prolonged. This could be due to lack of awareness of symptom variability between patients, by 
health professionals, however, the inability of patients to identify or describe their symptoms 
could also contribute to difficulties with diagnosis.291 Nevertheless, whilst no symptom in 
isolation is specific for the diagnosis of EoE, if a patient develops reflux-like symptoms and 
does not respond to treatment, EoE should be suspected.295 Based on these patient 




presumably reduce symptom regression whilst empowering the patients through provision of 
diagnosis.  
4.4.2 Endoscopy experiences 
It is unsurprising that there was a strong consensus for the need for an alternative diagnosis 
and monitoring method to an endoscopy. This was supported by the broader survey group, 
with 81% reporting a desire for an alternative to endoscopy. In this study, both the survey and 
focus group results suggested that adults were less likely to be concerned about undergoing 
endoscopies than parents of children with EoE, perceiving endoscopies as a conventional part 
of treatment. Conversely, mothers expressed anxiety surrounding sedation and the need for 
multiple endoscopies, especially in very young children. The use of mild sedation and the 
endoscopist’s skill have been shown to have a major impact on a patient’s opinion and 
preference for endoscopy.252 Additionally, a preference for capsule endoscopy over endoscopy 
via tube insertion has been recorded in other gastrointestinal disorders.296,297 However, this 
does not reflect the mothers or parent’s opinions in this research.  
Menard-Katcher and Furuta298 discuss how the repeated endoscopy approach is suboptimal, 
not only for the risk to patients but also the high costs associated with multiple endoscopies. 
Interestingly the expense of endoscopies and time off school/work was not reported as an 
important factor for participants. This is likely to be due to government subsidised health 
services which reimburse the cost of patient endoscopies in Australia. However, these costs 
are still a burden on the healthcare system. Procedures of the digestive system were reported 
as the second highest proportion of procedures in Australian private hospitals in 2013-2014, 
with an average per patient expenditure of $542.299 
Research exploring alternatives to endoscopies for EoE is underway.297,298 Preliminary research 
examining serum inflammatory markers associated with EoE pathogenesis has thus far been 




reduced cost, time and lack of need for sedation.284 Alternatively, non-endoscopic methods for 
obtaining esophageal biopsies, such as a semi-invasive esophageal string test300 and 
Cytosponge, an ingestible gelatin capsule containing compressed mesh, also attached to a 
string301 have also shown potential. Ongoing research and subsequent introduction of these 
techniques will likely improve experiences of patients with EoE in the future.  
4.4.3 Treatment experiences 
Through focus group discussion desire for treatment choice was notable. Interestingly, in focus 
group participants who desired an alternative treatment to the one prescribed, a change in 
treatment (usually from medication to diet) was self-directed. This “experimentation” with 
treatment modalities has been described in other diseases. Information seeking was also 
noted as an early part of this experimentation process.302 A desire for more information and 
support, particularly from specialists, usually gastroenterologists was also expressed in this 
study. This was further exemplified in the survey where a quarter (24%) of participants 
described difficulty accessing services often related to lack of understanding, support and 
knowledge of health professionals.  
Many focus group participants also felt that they were not given a choice of treatment. The 
doctor’s knowledge, personal prejudices, access to resources such as allergy testing or the 
interdisciplinary team, such as dietitians, and complexity of optimal management are 
possible.303 Additionally, evidence suggests that doctors may not involve patients in treatment 
decisions due to the extra time required, difficulties eliciting patient preferences, and patient 
preferences may differ from the doctors.304 Involving patients in the decision making process is 
vital to providing personalised care in the outpatient setting305 and improving adherence to 
the treatment plan.282 Additionally, in this study participants identified supportive and 
understanding specialists as helpful in the management of EoE. However, training and support 




The specific information desired by participants was a clear and direct treatment pathway. 
This treatment plan needed to be holistic, involving consideration of all associated conditions 
and communication between disciplines. In outpatient care, there are limited guidelines 
around care delegation. Subsequently, patient suffering can occur because of these cross-
organisational inconsistencies. It is suggested that all interdisciplinary groups involved in the 
patient’s care must be able to understand each other’s approaches, as well as decide on a 
shared treatment approach.305 It is possible that EoE specific outpatient clinics may increase 
multidisciplinary care coordination and improve patient outcomes, however, there is currently 
no available research to support this.  
Four mothers believed that a medical advocate or case manager would help assist professional 
communication and treatment planning. Evidence suggests that case management may reduce 
caregiver burden283 and improve health outcomes.306 However, there is an unmet need for 
case management even in highly prevalent chronic health conditions such as mental health.307 
Thus case management is often left to family or general practitioners, who are already under a 
high level of demand and require training and support to do so.308 Additionally, doctors in 
family practice are unlikely to have the expertise to manage complex conditions like EoE. 
Therefore, this suggests that case management should be the responsibility of the primary 
specialist, usually the gastroenterologist.  Additionally, for patients following an elimination 
diet, the dietitian is also well placed to act as a care coordinator. All health professionals 
involved in the management of EoE should be encouraged to provide information on 
treatment options to patients. As well as make treatment decisions and plans in conjunction 
with patients, families and the multidisciplinary team to provide holistic patient care.  
4.4.4 Drug therapy 
Many mothers reported adverse reactions to medications, particularly swallowed 




consequences of prolonged medication use, including steroids, mixers of SPLENDA® and PPIs. 
Concern about being on long term medication and fear of medication side effects has been 
reported previously.290 Recent studies have shown adrenal suppression in some children who 
used high dose (>440µg/day) swallowed gluco-corticosteroids for more than six months.111 PPI 
use has also been associated with vitamin B12309 and iron deficiency.310 
Therefore, it is unsurprising that alternatives to the above medications were desired by many 
participants who answered the questionnaires and attended the focus groups. Alternative 
steroid administration techniques, to enhance the effectiveness were also discussed. Novel 
drug therapies have been explored with varying levels of effectiveness. Immunosuppressant’s, 
PGD2 receptor antagonists and anti-IL-13 monoclonal antibody treatments have shown 
promise, however, further studies with larger patient numbers are required to establish 
effectiveness and safety. Currently, PPI’s and swallowed corticosteroids remain the primary 
medication for EoE. It has been suggested that an initial high dose (1000µg/day) of swallowed 
corticosteroids, be used for up to four weeks to induce remission. After which a lower dose 
should be used for maintenance to reduce the risk of long term consequences.264 Monitoring 
nutritional blood biomarkers for those on long term PPI therapy should also be considered. 
Ongoing research into alternative drug therapies and introduction of the above techniques will 
likely improve experiences with drug therapy and outcomes of patients with EoE now and in 
the future.  
4.4.5 Dietary therapy 
Individualised dietary advice, support surrounding food, and food product ideas, as well as 
instructions and support for food reintroduction were considered important to participants 
following a restricted diet.  A recent survey of Australian dietitians in self-reported confidence 
in managing food allergy showed a low to moderate competency in educating patients on food 




Therefore, there is a need to increase dietitians’ knowledge and skill in managing food 
allergies, and related disorders such as EoE (Chapter 6). 
Concern from mothers surrounding nutrition and growth in their children was unmistakable. 
Subsequently, advice on meeting nutrient requirements on a restricted diet was highly desired 
among mothers. Wechsler et al.105 supports nutrition assessment as an important part of 
dietary advice for patients with EoE. They highlight the role of the dietitian as an expert in food 
substitution to ensure a nutritionally adequate diet (Chapter 5, Part D), especially in growing 
children.  
The idea of a quick, easy and accurate diet test was also mentioned by many participants, in 
relation to food trigger identification. However, as Simon et al.79 concludes, elucidating the 
exact mechanism of the role of food in EoE is needed before the development of novel 
diagnostic tests for food-specific markers will be possible. Hence, improving the knowledge 
and capacity of dietitians in providing individualised advice on current dietary regimens and 
food challenge/reintroduction is paramount (Chapter 6). Furthermore, increased awareness of 
the importance of nutritional assessment in the management of EoE is needed amongst all 
health professionals.  
4.4.6 Long term outcomes and consequences 
In this study, participants, particularly mothers expressed a desire for more knowledge of the 
potential disease trajectory of EoE, including greater knowledge of the disease path, treatment 
benefits and consequences, possible barriers, and common co-morbidities. Unfortunately, 
research and knowledge of the natural history of EoE is limited to retrospective studies. A 
recent, unique natural history study showed EoE to be fibrostenotic in nature and although 
persistent, to be a benign disease not associated with cancer or need for surgery.14 This 




However, further exploration of the role of dietary restriction and long term swallowed 
corticosteroids in reducing long term fibrotic changes is required.14   
Allergic rhinitis is known to be concomitant and may contribute to EoE.312 Additionally, atopic 
conditions such as asthma and eczema are common comorbidities with EoE.12 Other co-
morbidities may include reflux,1 connective tissue disorders,70 coeliac disease68 and Crohn’s 
disease.69 Further research into the relationship of these conditions with EoE is required to 
establish if their management may impact on EoE. It is also important for the physician to be 
aware of these conditions and make appropriate referrals as required.  
4.4.7 Strengths and limitations of the focus groups 
Strengths of this study include the purposeful sampling technique to identify adults or parents 
of children with EoE. Additionally, focus groups continued until data saturation was achieved. 
Internal reliability was achieved through the use of a secondary coder to compare and contrast 
codes and categories until consensus was reached. Triangulation with questionnaire results 
also helped to increase validity. The use of mixed face-to-face and online focus groups was 
beneficial in its ability to allow national participation. However, it is acknowledged that most 
participants were from metropolitan areas and thus difficulties in rural areas may not have 
been well captured. Additionally, the small number of adult male focus group participants also 
means that the results presented are unlikely to be truly representative of an adult EoE 
population, which would typically have a male majority.1 Online focus groups may have also 
decreased the ability to obtain non-verbal cues, such as  hand gestures, which are key to face-
to face-groups. Additionally, health professional’s experiences in managing patients with EoE 
were not obtained in this study. Further research is needed to understand the perceptions and 





Currently, care management of EoE is generally not optimised or patient centred. Improving 
primary care physician’s awareness of EoE may assist in reducing diagnostic delays. 
Additionally, health care professionals providing patients with support, information and 
greater direction surrounding treatment, in conjunction with the multidisciplinary team, would 
help to improve patient centred practice. Building the knowledge and capacity of dietitians 
working in this area would also benefit patients following restricted diets to manage their EoE. 
Chapters 5 and 6 address this issue by examining patient characteristics, a dietary investigation 
and management protocol and knowledge and proficiency of Australian dietitians to provide 
clinical practice recommendations in line with the NCP. Further research into endoscopy and 
medication alternatives, improved diet testing methods, as well as documentation of long 





SUMMARY AND INSIGHTS FROM THE AUSEE COHORT 
Chapters 3 and 4 explored the characteristics and experiences of patients with EoE, who are 
members of an Australian support group. A national survey provided broad, descriptive data 
on patient characteristics and current management practices in Australia. Concurrently, a 
qualitative approach was used to gather in-depth information on the experiences and 
perspective of patients with EoE on the optimisation of the management process. Evidence 
from these studies suggested that patients with EoE may present with a variety of symptoms, 
atopic conditions and patient reported triggers and have trialled a variety of management 
options, all of which will need to be considered as part of nutrition assessment and 
management of these patients. It was also highlighted that many patients see a variety of 
health care professionals because of the diversity of their symptoms and conditions and that 
consideration of the relationship between these conditions and improved multidisciplinary 
care coordination would support a more holistic approach to assessment and management. 
Additionally, to further support a patient centred approach to care, provision of general 
disease education, an overview of treatment options, information on the benefits and 
limitations of these options and long term outcomes and consequences is important to 
patients. More broadly, these studies emphasised the impact of diagnosis, symptoms and 
management strategies on QOL, psychosocial and physical health and the importance of these 
in the NCP. These findings are explored and expanded further in Chapter 7 as part of the 






CHAPTER 5: CASE STUDY OF DIETARY INVESTIGATION AND 
MANAGEMENT AT THE ROYAL PRINCE ALFRED HOSPITAL 
ALLERGY UNIT 
5.1 INTRODUCTION 
The previous two chapters have explored patient characteristics and experiences with EoE in 
the context of the Australian health care system. Patient experiences described in Chapter 4 
identified that current management of EoE is neither optimised nor patient centred. This was 
particularly notable for dietary management, with difficulties identified at all stages of the 
NCP, particularly food challenge/reintroduction (nutrition intervention), reiterating gaps 
identified in the literature (Chapter 1). Additionally, patients with EoE in the ausEE cohort 
(Chapters 3 and 4) reported a variety of symptoms and concomitant conditions, not commonly 
reported in the literature. In particular, non-oesophageal symptoms including FGID type 
symptoms, fatigue and behavioural issues. From clinical experience, evidence from the 
literature (Chapter 1) and evidence from Chapters 3 and 4, it seemed that food chemical 
intolerances (alongside acid reflux, rhinitis and food allergy) may play a role in symptoms and 
pathophysiology of EoE. Therefore, the aim of this study was to inform dietary management of 
EoE, by firstly documenting characteristics of patients with EoE. Secondly, examine the use and 
subsequent outcomes of a low chemical elimination diet and challenge testing to develop a 
personalised dietary management approach. To address this aim, a case study of dietary 
investigation and management at the RPAH Allergy Unit was conducted.  
5.2  CASE STUDY DESIGN AND METHODS 
5.2.1 Overview of case study design  
The RPAH Allergy Unit provides a valuable setting in which to conduct a case study of patient 




clinical assessment and treatment from gastroenterologists, specialist immunologists and/or 
paediatricians, and dietitians, with the majority also having undergone investigation with the 
RPAH low chemical elimination diet and challenge protocol (Appendix A). This case study 
describes these patients (any age, with a diagnosis of EoE), who presented to the RPAH Allergy 
Unit between August 1997 and February 2017.  
This case study enabled three main studies for this thesis (Figure 5.1), each involving a variety 
of methods of data collection and analysis that addressed the defined aim. Firstly, a case series 
of patients with EoE seen between 1997 and February 2017 was analysed. This included cross 
sectional analysis of baseline characteristics of these patients, and evaluation of data on those 
who completed the low chemical elimination diet and challenge protocol, including the 
outcomes from following personalised diets. Questionnaires including details of symptoms and 
diet, completed as part of standard clinical practice were also examined. 
Secondly, a prospective cohort study was initiated in July 2015 involving adult patients (≥ 16 
years) who were part of the case series described above. This enabled a detailed examination 
of specific factors (such as QOL and nutritional adequacy) at various time points across the 
management process. Patients in the prospective study followed the RPAH EoE dietary 
protocol (Appendix A.3), which included implementation of the low chemical elimination diet 
and challenges, systematic recording of data and endoscopies at standard timepoints. The 
prospective study cohort completed additional questionnaires (relating to QOL and 
psychosocial characteristics), WFRs and blood tests (Section 5.2.2).  
Finally, a follow up survey was reviewed. This involved all patients from 1997, including the 
prospective cohort. The follow up questionnaire was distributed in July 2017 to all patients 






Figure 5.1: Case study of Royal Prince Alfred Hospital Allergy Unit comprising three 
studies: case series analysis, a prospective cohort study and a follow up survey study. 
Abbreviations: RPAH: Royal Prince Alfred Hospital, EoE: eosinophilic oesophagitis, Aug: 
August, and Feb: February. 
The results of the three studies are presented in this chapter to address assessment issues 
emerging from presenting characteristics (Part A), dietary treatment protocols (Part B), 
psychosocial and QOL issues (Part C) and concerns for nutritional adequacy (Part D). The 
breakdown for each part are as follows:  
• Part A: Baseline characteristics of patients with EoE attending the RPAH Allergy Unit. 




o Prospective cohort study baseline symptom/diet questionnaire analysis 
• Part B: Evaluation of a low chemical elimination diet, dietary challenges, personalised 
diets and long term outcomes in patients with EoE.  
o Case series analysis: outcomes of the low chemical elimination diet, challenges 
and personalised diets; 
o Prospective cohort study ‘on-elimination diet’ and ‘personalised diet’ 
symptom/diet questionnaire analysis; and 
o Follow up survey symptom/diet questionnaire analysis. 
• Part C: Quality of life, psychological factors and personality traits in adult patients with 
EoE. 
o Case series quality of life and psychosocial questionnaire analysis;  
o Prospective cohort study QOL and psychosocial questionnaire analysis; and 
o Follow up survey QOL and psychosocial questionnaire analysis. 
• Part D: Nutritional adequacy and dietary quality of patients with EoE following the 
RPAH EoE dietary elimination and challenge protocol.  
o Prospective cohort study weighed food record analysis; and 
o Follow up survey weighed food record analysis. 
Access to health and medical records and all aspects of the prospective and follow up studies 
were approved by the Sydney Local Health District Human Research Ethics Committee 
(HREC/15/RPAH/49/X15-0030).  
5.2.2 Overview of case study methods 
The case series included all patients who presented to the RPAH Allergy Unit prior to February 
2017, with a known diagnosis of EoE. The case series provided in depth information on 
characteristics of patients with EoE to inform nutrition assessment (Part A) and outcomes of 




Inclusion/exclusion criteria, clinical management, data collection, classification and statistical 
analysis are described in the respective parts of this chapter.  
The prospective study explored the patient experience over the course of the RPAH EoE dietary 
protocol and began in July 2015, with data collection for this thesis ceasing in August 2017. 
The prospective study was designed and conducted to gather in-depth information on a subset 
of the case series at baseline, on the elimination diet and on their personalised diet. Inclusion 
criteria: Patients were eligible to participate in the prospective study if they were 16 years or 
older, had been diagnosed with EoE and were prescribed the RPAH EoE dietary protocol 
between July 2015 and February 2017. Exclusion criteria: were patients with suspected EoE or 
EGIDs other than EoE, patients less than 16 years of age, and patients who were not 
prescribed dietary management.  
Recruitment: To enhance recruitment, letters and emails were sent to gastroenterologists 
located locally or who had previously referred patients to the Allergy Unit advising them of the 
study, including the study aim, design and study information form. All referrals to the Allergy 
Unit regarding patients with EoE were directed to the PhD candidate for screening and to 
make an appointment. Eligible patients were provided with information about the prospective 
study when making their appointment, with further information sent via email if they 
expressed interest. Interested participants were then approached at their initial appointment, 
the study discussed, and written consent was obtained from all patients who agreed to 
participate. Participation was voluntary and patients who chose to join the study were not 
charged for their appointment.  
Data collection: Prospective study patients were asked to complete the study documents and 
procedures listed below at three main time points in their clinical management: 1) at their 
initial appointment, 2) on the strict elimination diet, and 3) on their personalised diet, as 




• Symptom-Diet Questionnaires: The Symptom/Diet Questionnaire (SDQ) is a clinical 
tool designed by the investigators to capture information from patients regarding 
symptoms and their current diet at specific time points. Questionnaires (Appendix I) 
included questions regarding frequency and severity of symptoms, with patients asked 
to record symptom frequency (‘not at all’ to ‘daily’) and severity (mild to severe) on a 
five point Likert scale. Additionally, the questionnaires asked about other medical 
conditions, medications and supplements, foods perceived to trigger symptoms and 
self-reported QOL. The baseline SDQ included additional questions on current and past 
dietary modifications, cooking and shopping habits and skills. The ‘on-elimination diet’ 
SDQ included additional questions regarding starting the diet, withdrawal symptoms 
and changes in symptoms on the elimination diet. The ‘personalised diet’ SDQ 
included additional questions on changes in symptoms on the elimination diet and 
personalised diet, current dietary modifications and food reaction frequency. 
Symptom data from these forms is presented in Parts A and B and self-reported QOL 









• Quality of life questionnaires: Patients completed three QOL assessment tools, the SF-
36 QOL, the FRQOL and the Adult-EOE-QOL tool at each time point (Part C).  
• Psychological questionnaires: At their initial appointment participants were asked to 
complete four validated psychosocial questionnaires: BDI-II, STAI Y-2, CISS and EDE-Q, 
and three psychometric questionnaires (FLQ-SF, CONVOR, BFI-10) (Part C).  
• Four day weighed food records: Participants were invited to complete a four day WFR 
(three week days and one weekend day) at each time point (Part D).   
• Blood collection: The collection and analysis of blood samples was a parallel arm of 
this study and is not included as part of this thesis. Patients were also asked to provide 
a blood sample at baseline, after six to eight weeks on the elimination diet and after 
six to eight weeks on their personalised diet. Blood samples were collected by an 
honours student (MA) to provide allergen specific serum IgE testing, coeliac serology 
and human leukocyte antigen (HLA) genotype, and immune biomarkers such as 
eotaxin -1, 2 and 3, eosinophil cationic protein (ECP) and eosinophil-derived 
neurotoxin (EDN), with the view to identify common biomarkers to be used as a 
screening and monitoring tool for patients with EoE.  
Paper questionnaires were provided at the initial and follow up appointments. For participants 
that did not complete the questionnaires at their clinic visit, a reply-paid envelope was 
provided to the patient to allow them to complete and return the questionnaires from home. 
A reminder to complete the questionnaires and WFRs was sent via email two weeks before 
and one week after the ‘on elimination diet’ and ‘personalised diet’ appointments. Participants 
in the prospective study who did not return after three months (from their initial appointment 
date) were sent the ‘on elimination diet’ questionnaires at three months via post and did not 
receive the personalised diet questionnaires. Further detailed methods are provided in the 




This follow up survey study examined long term outcomes and reasons for loss to follow up in 
case series patients. Inclusion criteria: Patients were sent a follow up questionnaire (Appendix 
J) if they had presented to the Allergy Unit between August 1997 and February 2017, had been 
diagnosed with EoE and were 16 years or older at July 2017. The questionnaire was designed 
to gather information about: whether they started and continued with the elimination diet, 
whether they experienced withdrawal symptoms, their current symptoms (including frequency 
and severity), current dietary modifications or restrictions, medications, supplements, and 
other medical conditions. The follow up questionnaire followed the same structure, format 
and style as the SDQs from the prospective study, thus it was deemed appropriate to combine 
results from these questionnaires (Part B). Patients were also asked to complete the QOL 
questionnaires (SF-36, FR-QOL, EOE-A-QOL), psychological questionnaires (BDI-II, STAI, EDE-Q, 
CISS) (Part C) and invited to complete a four day WFR (Part D). 
The follow up SDQ, QOL questionnaires and psychological questionnaires were inputted into 
Survey Monkey. A link to the questionnaires was sent via email to EoE patients in July 2017. A 
reminder email was sent to any patients who had not completed or partially completed the 




PART A: BASELINE CHARACTERISTICS OF PATIENTS WITH 
EOSINOPHILIC OESOPHAGITIS ATTENDING THE ROYAL PRINCE 
ALFRED HOSPITAL ALLERGY UNIT (1997-2017) 
5.3  BASELINE CHARACTERISTICS OF PATIENTS WITH EOSINOPHILIC 
OESOPHAGITIS 
Oesophageal symptoms and an atopic background are considered hallmark characteristics of 
patients with EoE.1 However, from clinical experience and evidence from the ausEE cohort 
described in Chapters 3 and 4, patients often present with a broader array of symptoms 
including other non-oesophageal GIT symptoms and non-GIT symptoms, which have not been 
well reported in the literature. Additionally, patients attributed many of these symptom to a 
variety of foods. Increased knowledge and understanding of the variety of symptoms, 
concomitant conditions and patient-reported symptom triggers experienced by patients with 
EoE will assist health professionals in conducting comprehensive assessments and devise an 
individualised management approach. Additionally, a broader exploration of these 
characteristics may provide insights into disease pathophysiology.  
The objectives of Part A of this case study report were: 
• To characterise and report on potential relationships between demographic, 
symptomatic, atopic and endoscopic characteristics of EoE in children and adults 
attending RPAH Allergy Unit. 
• To report on symptom triggers recognised by patients with EoE and any relationships 




5.4  METHODS: BASELINE CHARACTERISTICS OF PATIENTS WITH EOSINOPHILIC 
OESOPHAGITIS 
5.4.1 Case series baseline cross sectional analysis 
Sample: The case series includes all patients who presented to RPAH Allergy Unit prior to 
February 2017, with a known diagnosis of EoE. Inclusion criteria were patients of any age, with 
a confirmed diagnosis of EoE.1 Exclusion criteria were patients with suspected EoE or EGIDs 
other than EoE.   
Setting: At their initial appointment, patients in the case series were assessed by an 
immunologist or paediatrician, completed allergen SPT and had a consultation with a dietitian. 
Symptoms and patient-reported symptom triggers were recorded prior to explanation of the 
low chemical elimination diet and challenge protocol. Patients who presented on reflux and 
rhinitis treatment were initially maintained on that medication.  
SPT was conducted by trained nursing staff with a standard panel of inhalant and food 
allergens, in accordance with accepted guidelines at the time of the patients’ presentation. A 
wheal diameter of ≥ 3mm compared to the control was considered positive. It should be noted 
that standard panels used at the Allergy Unit for adults and children are different and have had 
minor updates over time (Appendix H). Additionally, occasional omissions in SPT for foods and 
airborne allergens may have occurred depending on individual patient circumstances or at 
their physician’s discretion.  
Endoscopies and oesophageal biopsies were conducted by the patients’ referring 
gastroenterologist or a RPAH gastroenterologist. An endoscopy was conducted before 
commencing the elimination diet or the most recent endoscopy results were used. It should be 
noted that due to differing gastroenterologists and pathologists between patients there were 




location of oesophageal biopsies taken. Within the prospective study cohort, efforts were 
made to standardise the number and location of oesophageal biopsies.  
In addition, as part of standard clinical practice introduced to the Allergy Unit in 2013, adult 
patients were asked to complete questionnaires to assess symptoms, QOL and psychometric 
measures. These included the baseline SDQ, WHOQOL-Bref or SF-36, FRQOL, FLQ-SF, CONVOR 
and BFI-10. Further explanation of these tools and the results obtained are detailed below and 
in Part C.  
Data collection: Patient files were systematically examined for symptoms, patient reported 
symptom triggers, SPT results, endoscopy and histopathology reports. Data was extracted 
from patient clinical notes, electronic medical records, endoscopy and pathology reports. 
Specific data including demographics, symptoms, coexisting conditions, SPT results, 
endoscopic and histological findings obtained from patient files was entered onto the patient 
database, or entered into a spreadsheet specifically designed for this study. All data was 
reviewed and entered initially by the PhD candidate. Files were examined a second time to 
ensure accuracy and completeness. The final review was conducted in conjunction with 
physicians/dietitians to clarify written notes and ensure data was entered accurately.  
Due to the retrospective nature of the data collected in much of the case series group, it is 
important to acknowledge how variables were defined (Table 5.1) and missing data treated. 
Adults were classified as ≥ 16 years of age as this aligned with the prospective study and the 









Age of disease onset 
Age of diagnosis 
Disease duration 
Delay to diagnosis 
 
Age at initial appointment date 
≥16years 
The age at which symptoms first occurred 
Age of first diagnosis of EoE 
Initial appointment date – age of disease onset^ 






Dysphagia, sensation of food sticking, food impaction and oesophageal pain 
Reflux, heartburn, mouth ulcers, nausea, vomiting, abdominal pain, indigestion, bloating, constipation, diarrhoea 
Neurological: headache/migraine, behavioural changes or disturbances (such as hyperactivity), fatigue and sleep 
disturbance 
Cutaneous: urticaria, angioedema and eczema 
Respiratory: rhinitis and asthma 
Anaphylaxis 






Presence of furrows, white plaques or normal oesophagus and no evidence of fibrostenotic changes 
Presence of oesophageal rings, narrowing or stricture and no evidence of inflammatory changes 
A combination of inflammatory and fibrostenotic changes 
Histological  
Peak eosinophil count 
 
The greatest number of eosinophils in a high-powered field76  
Atopy 
Atopic 
Inhalant sensitisation (positive) 
Food sensitisation (positive) 
 
At least one SPT to food or airborne allergen ≥ 3mm 
At least one inhalant sensitisation ≥ 3mm 
At least one food sensitisation ≥ 3mm 
Patient-reported triggers A food, food component, environmental or psychological aspect reported to elicit symptom/s 




Due to the large number and variety of symptoms recorded, symptoms were categorised into 
groups for ease of description, presentation and analysis (Table 5.1). If a symptom was not 
recorded by the attending physician or dietitian this was assumed as not having the symptom, 
and thus there were no missing symptom values. All symptoms reported were defined as 
current symptoms (having occurred in the two years prior to presentation) unless otherwise 
specified. Past symptoms were defined as having occurred greater than two years prior to the 
initial presentation at the Allergy Unit and are specified in the results.  
Atopy was defined per the joint World Allergy Organisation and European Academy of Allergy 
and Clinical Immunology guidelines as at least one SPT to food or airborne allergen wheal size 
≥ 3mm313 and was obtained from the baseline SPT results. To allow comparison of SPT results 
to patient-reported symptom triggers, SPT results for nuts and seafood were combined 
(Appendix K) such that if a patient had one or more SPT ≥ 3mm to any nut or seafood, this was 
considered positive. A large SPT (wheal ≥ 6mm): sensitisation with a 95% PPV of eliciting a 
clinical reaction,35  was considered likely to be reflective of a “primary” food sensitisation.  
Endoscopic phenotypes of EoE were categorised according to the definition previously 
described by Dellon et al.13 reflecting the degree of oesophageal inflammation and/or 
remodelling (fibrostenotic, inflammatory and mixed). For patients where data was available on 
at least one endoscopic feature, this was recorded, and all other features were recorded as 
absent. For patients who did not have any endoscopy data available this was classified as 
missing. It is acknowledged that this data is limited by lack of standardised reporting criteria, 
differing gastroenterologists performing the procedure and differing pathologists reporting the 
histopathology between patients.  
Patient-reported triggers were commonly foods (Table 5.1). Thus, for analysis foods reported 
by patients to trigger symptoms were classified in three ways: food groups; triggers 




with SPT panels e.g. nuts, and food chemical groups; foods containing one type of food 
chemical e.g. salicylates (Appendix K). If a patient did not report a food trigger this was 
assumed as not having a trigger, thus there were no missing values for triggers.  
Statistical analysis: Preliminary data management and analysis was conducted using Microsoft 
Excel (Microsoft Office 2016, Sydney, Australia). Further analysis, was conducted using SPSS 
statistical analysis software (IBM Australia Ltd., Sydney, Australia).231 Figures were produced in 
GraphPad Prism (GraphPad Software, La Jolla California, USA).314 Normal distribution of the 
data was assessed using the Shapiro-Wilk test and statistical significance was determined using 
a P value less than 0.05, unless otherwise specified. Basic demographic data was tabulated 
from the patient database. Continuous demographic variables were reported as the median 
and interquartile range (IQR) due to the non-parametric distribution of the data. The 
proportion of patients reporting symptoms, symptom triggers and with positive SPT was 
calculated. The association between baseline categorical variables (age, gender, atopy, 
triggers, symptoms and SPT) was calculated using Pearson’s Chi-Square crosstabulations. Due 
to the small number of patients reporting specific symptoms or triggers or having a positive 
specific food or aeroallergen SPT, the relationship between many of these variables could not 
be calculated and are specified in the results.  
5.4.2 Prospective study baseline symptom/diet questionnaire analysis 
Part A also discusses baseline data from the prospective study, obtained from the baseline 
SDQ, including symptom frequency and severity, and concomitant conditions. The study 
population, design, inclusion/exclusion criteria, ethics requirements, data collection and 
analysis were described in Section 5.2.2. As the baseline SDQ was also used as a clinical tool, 
patients who declined participation in the prospective study may have also completed this 




Completed questionnaires were entered into a Microsoft Excel spreadsheet specifically 
created for this study. All data was reviewed and entered by the PhD candidate, and then 
examined a second time to ensure accuracy. Basic demographic and characterising data was 
tabulated. Further analysis using descriptive statistics was conducted using SPSS statistical 
analysis software.231 All continuous variables were tested for normality using the Shapiro-Wilks 
test and statistical significance was determined using a P value less than 0.05.  
5.5 RESULTS: BASELINE CHARACTERISTICS OF PATIENTS WITH EOSINOPHILIC 
OESOPHAGITIS 
5.5.1 Baseline characteristics of patients in the case series 
The case series sample comprised N=169 patients (August 1997-Feburary 2017) with EoE, the 
majority of which were male and adults (77%) (Table 5.2). The median reported age of 
symptom onset in the cohort was 20yrs, with a median age at diagnosis of 27yrs, five year 
delay to diagnosis and seven year disease duration. An increase in the number of 
presentations to the Allergy Unit for EoE was noted over time (Appendix L).  
Table 5.2: Characteristics of eosinophilic oesophagitis patients presenting to a metropolitan 
allergy unit (N=169). 






Male N (%) 108 (64) 81 (62) 27 (69) 
M:F 2:1 2:1 3:1 
Age years median (IQR) 30 (22) 35 (42) 4(13) 
 
A total of N=46 patients were identified to be eligible for participation in the prospective study, 
of which 76% (N=35) consented to participate (Figure 5.3). Half the participants were male 
(N=16, 46%) with a median age of 33yrs. A further N=24 patients were identified to have 





Figure 5.3: Flow diagram of prospective study participants and patients completing the 
baseline Symptom/Diet Questionnaire. Abbreviations: SDQ: Symptom/Diet 
Questionnaire. *Symptom/Diet Questionnaire was introduced as a clinical tool in 2013. 
 
5.5.2 Symptoms 
Overall there was a large variability in the number and type of symptoms reported by patients 
with EoE at their initial appointment. On average patients reported 10±4 different symptoms. 
Non-oesophageal GIT symptoms (94%) were the most commonly reported symptoms, 
followed by oesophageal symptoms (83%) and rhinitis symptoms (76%).  
Oesophageal symptoms 
The sensation of food sticking (43%), dysphagia (difficulty swallowing) (40%), oesophageal pain 
(34%) and food impaction (33%) were the most common types of oesophageal symptoms 
reported. Oesophageal symptoms were more likely to be experienced by adults and a greater 
proportion of males experienced dysphagia (p=0.033).  
Non-oesophageal gastrointestinal symptoms 
A large proportion of patients with EoE experienced non-oesophageal GIT symptoms (94%), 
with reflux (62%) and abdominal pain (53%), reported in more than half of patients. Vomiting 




experiencing vomiting and constipation, whilst adults were more likely to experience mouth 
ulcers, nausea and abdominal pain (Figure 5.4). Additionally, a greater proportion of females 
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Figure 5.4: Differences in non-oesophageal gastrointestinal symptoms experienced by 
adults and children with eosinophilic oesophagitis (N=169).  Abbreviations: *: p<0.05. 
Chi square analysis identified a significant association between age and mouth ulcers 
(X2:9.013, df=1, p=0.003), nausea (X2:5.306, df=1, p=0.021), vomiting (X2:9.181, df=1, 
p=0.002), abdominal pain (X2: 4.457, df=1, p=0.035) and constipation (X2: 4.07, df=1, 
p=0.044).  
 
The majority of patients with EoE experienced a combination of oesophageal and non-
oesophageal GIT symptoms (78%). Only a small number of patients experienced either 





Figure 5.5: Oesophageal and non-oesophageal gastrointestinal symptoms in patients 
with eosinophilic oesophagitis (N=169). 
 
Non-gastrointestinal symptoms 
A variety of non-GIT symptoms were identified in approximately three quarters (71%) of 
patients with EoE. All patients reporting non-GIT symptoms also reported oesophageal and/or 
non-oesophageal GIT symptoms (Figure 5.6). Headaches/migraines were the most common 
non-GIT symptom (44%), and were more often experienced by adults and females (p=0.001, 
p<0.001 respectively). Symptoms of fatigue (15%), behavioural changes (11%) and sleep 
disturbance (10%) were also identified. Chronic urticaria (8%) and angioedema (6%) were 
reported in a small proportion of this population. Genitourinary symptoms (any) were 





Figure 5.6: Eosinophilic oesophagitis patients experiencing oesophageal, non-
oesophageal gastrointestinal symptoms and non-gastrointestinal symptoms (N=169). 
 
Symptom frequency and severity at baseline 
Patients who attempted the baseline SDQ were asked to rate their symptom frequency and 
severity on a five point Likert scale (N=37). Overall most patients experienced ‘weekly-daily’ 
dysphagia and ‘sensation of food sticking.’ Oesophageal symptoms were perceived as more 
severe, particularly food impaction. Reflux, heartburn, indigestion and headaches/migraines 
were commonly reported to be experienced weekly. Most patients reported ‘Never’ having 
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Figure 5.7: Self-reported symptom frequency and severity at baseline (N=37). Darker 





Other concomitant conditions 
A diagnosis of coeliac disease was reported in six patients (4%). One patient was identified to 
have an eating disorder diagnosis of anorexia nervosa. No patients were identified to have IBD.  
Patients who had attempted the baseline SDQ also reported a variety of other medical 
conditions including psoriasis, arthritis (unspecified), rheumatoid arthritis, anaemia, 
endometriosis, hypercholesterolemia, Asperger syndrome, Attention Deficit Disorder (ADD), 
hypothyroidism, Polycystic Ovarian Syndrome (PCOS), lupus and schizophrenia (all N=1).  
5.5.3 Atopic features 
Atopy 
Baseline SPT data was available for N=166 (98%) of patients. The majority of patients were 
classified as atopic (N=141, 83%) and these patients were more likely to be male (57%) and 
adults (67%) (p=0.009, p=0.006 respectively).  
Atopic conditions 
At baseline, 20% of patients had a known food allergy diagnosis, and a greater proportion of 
these were children (N=20 children, p<0.001). Reports of anaphylaxis (5%), acute urticaria (4%) 
and acute angioedema (3%) were uncommon. A diagnosis of OAS was reported in three 
patients.  
Current associated atopic conditions of asthma (39%) and eczema (23%) were identified, as 
was a past history of asthma (38%) and eczema (24%). A greater proportion of children 
experienced current eczema, whilst adults were more likely to report a history of asthma 
(p<0.001, p=0.011 respectively). Three quarters (76%) of patients with EoE experienced 
symptoms of rhinitis including sneezing (50%), nasal congestion (46%), rhinorrhoea (35%) and 




Inhalant allergen sensitisation patterns at baseline and associations with symptoms 
Baseline airborne allergen SPT results was available for N=164 (97%) of patients. 
Approximately three quarters (73%) of patients were sensitised to airborne allergens with 
dustmite (Dermatophagoides Pteronyssinus: 63%; Dermatophagoides Farinae: 67%) and rye 
grass (47%) being the predominant sensitisations (Figure 5.8). Patients were sensitised to a 
median of five (IQR: 9) inhalant allergens. Patients with inhalant sensitisation were more likely 
to be male (N=86, 52%) and adults (N=105, 63%) (p=0.006, p<0.001 respectively).  
Most patients with airborne allergen sensitisation had rhinitis symptoms (N=105, 64%), with a 
significant association identified between these two variables (p <0.001). Interestingly, 13% 
(N=21) of patients reported symptoms of rhinitis but had a negative SPT, suggesting possible 
non-allergic rhinitis. A greater proportion of those with airborne allergen sensitisation 
experienced oesophageal symptoms (p=0.004). Those with negative SPT to inhalants were 
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Figure 5.8: Baseline inhalant allergen skin prick test results in patients with eosinophilic oesophagitis (N=164). Abbreviations: D. Pter: Dermatophagoides 
Pteronyssinus, D. Farinae: Dermatophagoides Farinae, H. Cladosporium: Herbarum Cladosporium. The dark grey indicates the proportion of patients who 
had a positive skin prick test (wheal size ≥ 3mm). Figure a) Baseline skin prick test results for dust, mould and animals, Figure b) Baseline skin prick tests 




Sensitisation to pollen with food cross-reactivity 
Birch pollen, Timothy grass, Orchard grass, Ragweed and Mugwort have all been implicated in 
oral cross-reactivity with foods.315 Birch pollen sensitisation was uncommon in this EoE patient 
cohort, as in the general Australian population.316 Approximately half of patients tested had 
sensitisation to Timothy grass and Orchard grass, whilst a quarter of patients had sensitisation 
to Ragweed (Figure 5.9). Mugwort was not tested in this population. It is interesting to note 
that whilst only three patients had an OAS diagnosis, symptoms of mouth and throat itch was 
reported by N=20 patients. Twelve of these patients had a positive SPT to one or more of these 



















































Figure 5.9: Baseline skin prick test results to pollens which can cross-react with foods 
in patients with eosinophilic oesophagitis. The dark grey indicates the proportion of 






Food allergen sensitisation patterns at baseline 
Baseline food allergen SPT results was available for N=164 (97%) of patients. Approximately 
half (53%) of patients were sensitised to food. Patients were sensitised to a median of one 
(IQR:4) food allergen. Peanut, almond, egg white, corn and soy were the most common food 
sensitisations (Figure 5.10). Twenty-three percent of patients (N=37) had large “primary” food 
sensitisations (≥ 6mm). No differences in food allergen sensitisation by age, gender or 
symptoms were identified. Overall, food allergen sensitisation was identified to be individual 
and heterogenous in nature. However, trends of food allergen sensitisation in relation to SPT 
size were identified at baseline and are illustrated by SPT results for egg white, cow’s milk, 
nuts, soy and wheat (Appendix M). Firstly, a group of patients with no food sensitisations 
(N=39) were identified. Secondly, N=35 patients was identified to have only minor 
sensitisations (< 3mm). A third group of EoE patients were identified to have positive food 
sensitisations (≥ 3mm). Within this group, three distinct sub groups were identified: patients 
with a single positive SPT (≥ 3mm) and no other sensitisations (N=9), patients with more than 
one (median 4, IQR:3) positive SPT (≥ 3mm) (N=17) and patients with a combination of SPT 
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Figure 5.10: Baseline food allergen skin prick test in patients with eosinophilic oesophagitis. The dark grey indicates the proportion of patients who 
had a positive skin prick test (wheal size ≥ 3mm). Figure a) Baseline skin prick test results for egg white, milk, soy and meat, Figure b) Baseline skin 
prick tests results for nuts and seeds, Figure c) Baseline skin prick test results for seafood, Figure d) Baseline skin prick tests for grains, Figure e) 





5.5.4 Endoscopic and histological features 
Information on endoscopic features was available for N=108 (64%) of patients at baseline 
(Table 5.3). Most patients were classified as the inflammatory phenotype (N=48, 44%), with a 
greater proportion of children having the inflammatory phenotype and a greater proportion of 
adults having the fibrostenotic phenotype (p=0.001, p=0.034 respectively). There was no 
association between gender, delay to diagnosis or disease duration and endoscopic 
phenotypes. The median peak eosinophil count at baseline was elevated (N=110, 45/HPF). 
There were no differences in eosinophil counts by phenotypic or atopic groups.  
Table 5.3: Baseline endoscopic and histological features of patients with eosinophilic 
oesophagitis.  
Characteristics N Eosinophilic oesophagitis patients 













Associations between endoscopic phenotypes and baseline symptoms were examined. Those 
with the inflammatory phenotype were more likely to report eczema and behavioural changes 
(p=0.006, p=0.001 respectively). A greater proportion of those with the fibrostenotic 
phenotype had dysphagia and those with the mixed phenotype were more likely to have 
rhinitis symptoms (p=0.014, p=0.022 respectively). 
The relationship between atopy, airborne allergen sensitisation and food allergen sensitisation 
and endoscopic characteristics was examined, however, due to small cell counts not all the 
relationships could be fully explored. Patients with negative inhalant SPT were more likely to 
have the inflammatory phenotype (p=0.020). There were no associations between food 
allergen sensitisation and inflammatory, fibrostenotic or mixed phenotypes, nor were there 





5.5.5 Patient-reported symptom triggers 
The majority of patients reported at least one symptom trigger at baseline (N=147, 87%). 
Foods (85%) were the most commonly reported symptom triggers, followed by environmental 
factors (28%) and medications/supplements (9%). Thirteen percent of patients did not report 
any symptom triggers. 
Types of foods reported as symptom triggers 
Fruit (39%): banana (12%), apple (8%) and kiwifruit (7%), meat (37%), and vegetables (32%): 
tomato (9%) and onion (5%) were the most common patient-reported symptom triggers 
reported at baseline. Adults were more likely to report symptom triggers of meat and bread, 
whilst children were more likely to report symptom triggers of milk (p<0.001, p=0.001, p=0.013 
respectively). A greater proportion of those with the mixed phenotype reported bread as a 
symptom trigger (p=0.001).  No associations were identified between atopy and any trigger 
categories. 
 
Types of symptoms reported to be elicited from patient-reported food triggers 
Oesophageal symptoms were most commonly reported with meat, bread and rice (Figure 
5.11). Non-oesophageal GIT symptoms were frequently reported with fruit, milk, other dairy, 
vegetables and grains and cereals. More specifically, symptoms of reflux, abdominal pain and 
diarrhoea were commonly attributed to these foods (Table 5.4). Non-GIT symptoms were 
commonly attributed to sweets, other dairy, fruit, and vegetables (Figure 5.11), with small 
numbers of patients (< 5) reporting symptoms of angioedema, urticaria, headache/migraine, 
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Figure 5.11: Patient-reported food triggers and symptoms (N=169). Patients could 
















Fruit 46 9 9 4 
Vegetables 32 3 10 6 
Milk 24 2 9 6 
Other dairy 29 3 11 9 
Grains and cereals 20 2 16 5 
 
Triggers of food bolus impaction 
Of the N=62 (37%) patients who reported experiencing a food bolus impaction (current and 
past), N=20 (32%) had the food causing that impaction recorded. Meat was the most 
commonly reported trigger of impaction (N=16), followed by rice (N=5) and bread (N=2).  
Patient-reported symptom triggers and common IgE-mediated food allergens 
Patients with EoE reported symptoms to all six common IgE food allergens: milk, wheat, 
seafood, egg, nuts/seeds and soy (Figure 5.11). As reported above, milk/other dairy and wheat 
products were most commonly reported to elicit non-oesophageal GIT symptoms such as 
abdominal pain and diarrhoea, which are not usually associated with an IgE-mediated food 
reaction. For seafood, eggs, nuts/seeds and soy, similar non-oesophageal GIT symptoms were 
reported including nausea, reflux and abdominal pain by small numbers of patients (all < 5). 
Additionally, symptoms that may be attributed to an IgE-mediated reaction to these foods 
including vomiting, urticaria and angioedema were reported by a small number of patients (<5, 
<5, <10 respectively).  
Relationship between patient-reported triggers and skin prick tests 
The relationship between patient-reported symptom triggers and SPT were examined for 
specific foods (Appendix N).  Due to small numbers of patients reporting specific food triggers, 




those with a positive SPT to any nut reported nuts as a symptom trigger (p=0.039 
respectively), and approached significance for any seafood (p=0.050). There was no 
association between a positive SPT to wheat and reporting wheat as a symptom trigger. A 
trend towards having a positive SPT to kiwifruit and reporting kiwifruit as a symptom trigger 
was identified. No trends for milk, egg, soy, chicken, pork, tomato, rice or potato were found.  
An attempt was made to examine the relationship between pollens and grasses (that are 
known to cross-react with specific foods315) and patient-reported symptom triggers (Appendix 
N). However, due to small numbers of patients reporting specific food triggers conclusive 
results could not be drawn. A trend towards a positive SPT for ragweed and reported symptom 
triggers of watermelon and rockmelon was identified. No relationship trends were found for 
birch pollen, timothy grass or orchard grass.  
Relationship between patient-reported triggers and food chemicals 
Forty percent (N=67) of patients with EoE reported symptoms to a variety of salicylate 
containing foods including apple, onion and coffee. Amine containing foods (N=47, 28%): 
chocolate, banana and tuna were also reported to elicit symptoms. Symptoms reported to 
both salicylate and amine containing foods were most commonly non-oesophageal GIT (54%, 
66% respectively), specifically abdominal pain (N=14, N=6 respectively) and reflux (N=8, N=5 
respectively).  
5.6 DISCUSSION: BASELINE CHARACTERISTICS OF PATIENTS WITH 
EOSINOPHILIC OESOPHAGITIS 
This analysis of baseline characteristics of the case series identified a variety of factors that 
may need to be considered in clinical assessment, nutritional intervention and monitoring and 
evaluation. Many similarities to previously described clinical samples were identified including 




identified that patients with EoE experience a variety of non-oesophageal GIT and non-GIT 
symptoms and report a variety of fruits, meats and vegetables to be oesophageal, non-
oesophageal GIT and non-GIT symptom triggers.  
5.6.1 Patient characteristics 
Consistent with studies in other EoE populations, patients in this case series were more likely 
to be middle aged males.1 Certainly, male sex has been reported as a risk factor for EoE, along 
with rising incidence of EoE with age, peaking at 30-50years.1 A five year delay to diagnosis 
was also identified in this study and has been reported in other cohorts.14,293,319,320 However, 
the reason for the delay in diagnosis remains unclear. Access to endoscopies and under-
recognition of EoE have been suggested237 and were factors discussed by participants in the 
surveys and focus groups in Chapters 3 and 4.  
The number of new referrals presenting to the RPAH Allergy Unit has doubled in the last ten 
years. A number of factors have likely contributed including increased clinical and research 
interest over the past 20 years resulting in EoE becoming progressively better recognised, an 
increase in endoscopies performed in Australia each year7,239,240 with oesophageal biopsies 
being performed more routinely,238 an increase in the referral population due to local 
population growth over this time321,322 and recruitment for the prospective study in 2015 and 
2016. Internationally, data from a recent meta-analysis suggests that incidence and prevalence 
of EoE is rising,8 thus the data presented here may reflect a genuine increase in prevalence. 







All studies, including the present study, reported oesophageal symptoms including dysphagia 
and food impaction16,41,42,47,317,318 and that these symptoms occur more commonly in older 
children and adults with EoE.1 An additional interesting finding was that patients were likely to 
experience other gastrointestinal symptoms in combination with oesophageal symptoms. 
The study reported here is consistent with other studies in patients with EoE, which reported 
symptoms of reflux and abdominal pain. 8,10,11,13,23 Nausea, vomiting, food refusal, and failure to 
thrive have been reported previously1 with reflux, vomiting and abdominal pain recognised as 
common clinical manifestations of EoE in children.1,16 In this case series, vomiting was 
associated with younger age. However, abdominal pain was more likely to be experienced by 
adults and reflux was equally common among both age groups. Abdominal pain and reflux has 
been reported in adults with EoE, though perhaps less frequently than in children.16 This 
emphasises the individuality of the patient and that consideration of a broader array of 
symptoms when assessing patients with EoE is required. Furthermore, ‘extra-oesophageal’ 
symptoms of diarrhoea and constipation have been reported in paediatric EoE populations at 
rates similar to this study. Hopp323 suggests that these symptoms are likely under-reported, co-
morbidities “as a result of a downstream effect of EoE on gastrointestinal function,”323 with 
many of these symptoms (reflux, nausea, abdominal pain, diarrhoea and constipation) noted 
to be clinically similar to other gastrointestinal conditions such as, IBS324 and IBD.325 Similarly, 
an overlap between GORD and IBS has been described and is thought to be related to a 
common underlying pathophysiology of visceral hypersensitivity.326 For example, oesophageal 
acid perfusion has been shown to increase the sensitivity of the rectum and result in a reduced 
pain threshold in the duodenum.88 This presents another interesting explanation for symptoms 




considering the connection between food intolerances and IBS and GORD .324 Thus, viewing 
EoE as part of a broader clinical spectrum of interrelated, or a continuum of, conditions 
provides a framework for holistic assessment and management of patients, as well as a novel 
hypothesis for mechanistic exploration. Overall, exploration of all GIT symptoms appears 
relevant in dietetic assessment of EoE. Moreover, as with IBS cohorts244 non-GIT symptoms 
occurred in conjunction with GIT symptoms in all patients in this case series. 
Non-gastrointestinal symptoms 
A unique finding of this study was the number of patients reporting headaches/migraines, 
fatigue, behavioural issues and sleeping disturbances. Migraines have been described in one 
EoE case,327 whilst headaches and fatigue have not been described. Similar findings have been 
reported in patients with IBS, for example, Whitehead et al.244 reported IBS patients to have 
more than double the likelihood of experiencing headaches and fatigue than controls. More 
broadly, patients in this cohort experienced headaches/migraines at a greater rate compared 
to the general population (44% vs. 14% of the US population). Consistent with the general 
population, females were more likely to report headaches/migraines.328  
In the study reported here, a slightly higher proportion of patients (11%, 9% children) reported 
behavioural difficulties compared to the general population, where disruptive behaviour 
problems are estimated to affect 5-10% of children and adolescents.329–332 Intellectual focusing 
difficulties, learning difficulties,333 hyperactivity/inattention, conduct problems,334 disruptive 
behaviour and ADHD248 have been described in paediatric EoE and EGID patients. Additionally, 
it has been reported that 25-33% of children with EoE experience sleeping difficulties246 such 
as nocturnal awakening,292,335 higher than reported in our cohort. The reasons for sleeping 





Cross sectional analysis of this case series identified symptoms of headache/migraine, fatigue, 
behavioural and sleeping disturbances occurring at rates higher than the general population. 
These symptoms were also reported in the broader Australian EoE population described in 
Chapter 3 and have been previously linked with food chemical intolerances123,245 and other 
gastrointestinal conditions such as IBS.244 This suggests that EoE may be part of a more global 
body-systems disruption due to visceral hypersensitivity. Further investigation is required to 
establish if these symptoms commonly occur in other EoE populations and their relationship to 
the disease. Overall, consideration of these symptoms (oesophageal, non-oesophageal GIT and 
non-GIT) and concomitant conditions in the assessment and management of patients with EoE 
may support dietitians and other health professionals to provide greater patient centred and 
personalised care.  
5.6.3 Atopic features 
Atopy and atopic conditions 
From initial descriptions of the disease, EoE has been repeatedly recognised as an atopy 
associated disorder, with prevalence rates reported between 24-84%.13,41,42,49,336 Certainly, in 
this study most patients (83%) were classified as atopic. Atopic conditions of asthma and 
eczema were also identified in this cohort at rates similar to those reported in the literature.16  
Consistent with the literature, 20% of patients in this case series had a clinically diagnosed IgE 
mediated food allergy and were more likely to be children. Prevalence of IgE food allergy in 
EoE populations has been reported at rates between 15-43%1,13,41,42 with evidence suggesting 
that paediatric EoE patients have higher rates of IgE food allergy than the general population.37 
Moreover, patients with EoE who have a concomitant food allergy are younger and have other 
atopic conditions,44 consistent with the natural history of food allergy45 and our study. 
Symptoms of IgE mediated food allergy are not well reported in the EoE literature. Rates of 




considerably higher than our population (5%). Symptoms of anaphylaxis and urticaria related 
to IgE mediated food allergy have been described in two other paediatric studies,41,44 
predominantly to peanut and egg.41  
OAS was reported in three patients in this case series, though up to 12% of patients had 
symptoms of mouth and throat itch, suggestive of OAS. Schoepfer et al.293 reported 5% of 
Swiss EoE patients had OAS, whilst symptoms suggestive of OAS were reported in 37% of 
patients with EoE in a Dutch study.49 Prevalence of OAS is influenced by geographical pollen 
distribution, dietary influences and atopic disease, with OAS estimated to affect 47-70% of 
pollen allergic European patients compared to 8% of American patients and 1-15% of 
Australian patients.338,339 Consideration of OAS when conducting dietary assessment, planning 
and providing advice may be important for patients with EoE,103 particularly in populations 
were OAS is more prevalent. It has been suggested that food sensitisations seen in patients 
with EoE may be a result of cross reactivity of food allergens after birch sensitisation.49 
However, in our population and other cohorts146 birch pollen sensitisation was not common, 
consistent with Australian sensitisation patterns,316 countering this hypothesis. Additional 
research into the role of aero-allergen and food allergen cross-sensitisation in EoE is required 
to further elucidate genuine associations between pollen sensitisations, pollen cross-reactive 
foods and oesophageal inflammation in EoE.103  
Overall, this case series and other reports of similar clinical samples identified that patients 
with EoE may have concomitant atopic conditions of asthma, eczema, IgE-mediated food 
allergy and OAS, possibly at rates higher than the general population. Thus, consideration of 
these conditions when assessing and managing these patients is vital to ensure a holistic and 
individualised approach to care. Further research is still required to determine if these 




patients are non-atopic is important to ensure that these patients also receive personalised 
care.  
Rhinitis and inhalant allergen sensitisation 
Allergic rhinitis was identified in two thirds of patients in this case series. Similarly, allergic 
rhinitis has been reported in patients with EoE with estimated prevalence between 40-75%16 
and is thought to be more common in EoE populations than the general population.1 
Sensitisation to airborne allergens was identified in a large proportion of the case series 
cohort, predominantly to dust mite and rye grass, which is consistent with inhalant allergen 
sensitisation patterns in the general population where the study took place.316 Similarly, a 
recent study in another Australian group identified rye grass and house dust mite predominant 
sensitisation in adult EoE patients and low rates of sensitisation to birch pollen.146 Likewise, 
geographical influences in aero-allergen sensitisation have been observed in American (dust 
mite, tree and pet sensitisations predominant)48 and Dutch cohorts (grass pollen, tree pollen, 
house dust mite).49 
In this case series, airborne allergen sensitisation was associated with oesophageal symptoms, 
whilst rhinitis symptoms were associated with the mixed phenotype. Similarly, strictures have 
been associated with aeroallergen sensitivity in one study.48 Aero-allergen sensitisation has 
previously been reported to be a possible contributing factor to EoE pathophysiology, via 
intranasal exposure and swallowing of nasal mucus containing the allergen,312 evidenced by 
animal models and reports of seasonal variations in oesophageal symptoms and eosinophil 
counts.61,312 The IgE allergic response is known to promote acute (overt activation of nerves 
from a specific stimulus) and longer lasting changes in sensory nerve function (neuroplasticity), 
thought to be due to the close relationship between mast cells and nerve fibres. Allergen 
challenge and associated mast cell mediator release has been shown to increase neural 




contribute to peripheral sensitisation of the oesophagus, and subsequently symptoms in an 
allergic individual. Central sensitisation has been used to explain the sensation of the 
persistent urge to cough or sneeze despite lack of a physical stimulus, with activation of airway 
nerve fibres, by mast cells, resulting in to stimulation of tracheal nerve fibres and coughing at 
stimulus intensities below the normal threshold.340 In animal models, allergen challenge in the 
nose can also induce oesophageal inflammation,341 thus, it is possible that aero-allergen 
stimulation in the nose of aero-allergen sensitised EoE patients could result in central 
sensitisation of oesophageal nerves, and subsequently symptoms and inflammation. 
Therefore, it has been suggested that identifying and treating allergic rhinitis in patients with 
EoE could alleviate symptoms, however it remains unknown if this would affect the underlying 
pathology. Overall, allergic rhinitis may contribute to symptoms and oesophageal 
inflammation in patients with EoE and can adversely affect QOL, thus should be considered as 
part of a patients management plan.53  
In the study reported here, a small subset of patients (13%) was identified to have possible 
non-allergic rhinitis. One other study described two patients with EoE with seasonal variation 
in eosinophil counts, corresponding rhinitis symptoms but no positive SPT.61 It is possible given 
the potential role of allergic rhinitis in EoE, that non-allergic rhinitis may also contribute to the 
aetiology.  A recent study by De Corso and colleagues342 identified that the nasal cytology of 
approximately 55% of patients with non-allergic rhinitis contained inflammatory cells.342 This 
group could be further subdivided into non-allergic rhinitis with eosinophils, neutrophils, mast 
cells or mixed (containing both eosinophils and mast cells). The presence of eosinophilic 
and/or mast cell infiltrate was significantly associated with other comorbidities, such as 
asthma and aspirin (salicylate) intolerance.  Additionally, these patients were more likely to 
experience severe symptoms from their rhinitis and have a family history of rhinitis. 




been linked with tissue damage and inflammation. Activated inflammatory cells, for example 
mast cells, monocytes and macrophages can release inflammatory mediators such as 
cytokines, chemokines and proteases which could potentially contribute to the pathogenesis 
of EoE.343 The prevalence and role of non-allergic rhinitis, and swallowing nasal secretions 
containing inflammatory cells and mediators (e.g. examining nasal cytology) should be further 
explored in patients with EoE.  
Food allergen sensitisation 
Sensitisation to food allergens occurred in just over half of the patients in this case series, 
predominantly to nuts, egg, corn and soy. Similarly, Olson et al.48 identified 54% of their adult 
patients with EoE to be sensitised to food, with peanut and soy the most prevalent. It has been 
reported that up to 77% of children and 50% of adults with EoE have a positive SPT to foods46 
with peanut, egg, milk and soy reported as the most common positive SPT in other EoE 
populations.41,47  
In this case series, trends in food sensitisation patterns were identified in relation to SPT size. 
Firstly, a group of patients (24%) were identified that had no sensitisation to any food on SPT, 
which has been described in other cohorts.35,36, 143,325,326 Twenty-three percent of patients with 
large primary food sensitisations were also identified, similar to a Dutch cohort, where 22% of 
patients were identified to have a primary sensitisation capable of causing systemic 
reactions.49 Interestingly, in this case series, many patients were identified to have an array of 
food sensitisations, where wheal size would often be deemed clinically insignificant.35,345 In a 
study in paediatric EoE patients comparing SPT and specific IgE to food in patients with and 
without concomitant clinically diagnosed IgE food allergy, patients with a clinical IgE food 
allergy were more likely to demonstrate positive SPT responses and higher specific IgE to a 
variety of common food allergens regardless of whether the food tested was confirmed as a 




different subtypes of EoE, possibly due to mechanistic influences of IgE mediated food allergy, 
especially as they also identified differences in symptom presentation between the two 
groups.44 Consistent with these findings, Mulder et al.346 identified that atopic EoE patients 
had increased expression of oesophageal IgE bearing mast cells than non-atopic patients.346 
Whilst we did not see any symptom differences between our food sensitised and non-
sensitised groups (similar to Olson et al.48), this is interesting to consider in relation to the 
difference in dietary response seen in these groups (Part B, Section 5.9.2).  
Overall, the data reported here supports other reports in the literature that approximately half 
of patients with EoE have food allergen sensitisation, though, these sensitisations rarely 
correspond to a clinically diagnosed IgE-mediated food allergy.48 Thus, the clinical relevance 
and emphasis that should be placed on these individual food sensitisations remains unclear 
and requires further exploration. However, food allergen sensitisation patterns in patients 
with EoE may be useful in exploring disease mechanisms. This could then assist with 
individualising treatment in the future. 
5.6.4 Endoscopic and histological features 
In this case series, children were more likely to have the inflammatory phenotype, whilst 
adults were more likely to have the fibrostenotic phenotype. Dellon et al.13 also identified an 
association between younger age and the inflammatory phenotype. In contrast, Lipka et al.319 
did not find any differences in age between phenotypic groups. However, both studies and our 
study identified dysphagia and food impaction were more likely to be associated with the 
mixed or fibrostenotic phenotype. This is consistent with evidence that oesophageal 
remodelling and fibrosis results in decreased oesophageal compliance affecting bolus flow.261 
Additionally, it may link with growing evidence that EoE is a progressive disease, moving from 
an inflammatory to a fibrostenotic phenotype over time,14 resulting in a change in symptom 




Increased duration of diagnostic delay has been associated with increased risk of stricture 
prevalence.293 Lipka et al.319 identified a significantly longer delay to diagnosis in patients with 
the fibrostenotic phenotype compared to the inflammatory phenotype. This trend was not 
found in this case series, perhaps due to the slightly younger age and shorter delay to 
diagnosis compared to Lipka’s cohort. Additionally, in this case series, eczema and behavioural 
changes were associated with the inflammatory phenotype. Dellon et al.13 reported that the 
inflammatory phenotype was associated with atopic conditions (inclusive of allergic dermatitis 
and rhinitis). Overall further research is required to explore these relationships and should also 
evaluate whether these endoscopic phenotypes differ in how they respond to treatment. 
5.6.5 Patient-reported symptom triggers 
Oesophageal symptoms were commonly reported to meat, bread and rice and this has been 
reported in patients with EoE elsewhere.16,253 Meat and bread were also more commonly 
reported as symptom triggers by adults, particularly of oesophageal symptoms. In addition, 
the mixed phenotype was associated with bread as a patient-reported symptom trigger likely 
attributed to the progression of symptoms (dysphagia) and pathology (fibrostenotic) in 
adulthood.14 More specifically, these foods were identified to be common foods resulting in 
food impaction. Two main factors have been identified to contribute to food bolus impaction: 
the nature of the food, and the presence of pathology of the oesophagus.347 The texture of 
bread and meat is a likely contributing factor,347 with meat reported as one of the most 
common causes of food bolus impaction in western countries.348 Poor chewing habits, 
particularly poor chewing of meat, have also been associated with food bolus impaction.347 
Interestingly, many patients with EoE report compensatory strategies, such as prolonged 





Oesophageal rings and stricture and/or abnormal oesophageal motility may contribute to food 
bolus impactions in patients with EoE.350 Decreased oesophageal luminal width,351 impaired 
oesophageal motility including distensibility, abnormal peristalsis and hypotonicity of the 
lower oesophageal sphincter have been described in patients with EoE and been associated 
with higher rates of food impaction in some studies.256 Reasons for changes in oesophageal 
motility in patients with EoE are unclear, however, interactions between eosinophils and mast 
cells352 and the neuronal plexus have been suggested.99  
In this case series, it was identified that patients reporting symptoms from nuts (N=21) were 
more likely to have IgE sensitisation to that food (57% vs. 43%). Considering that IgE food 
allergy and food sensitisations are commonly associated with EoE312 and that peanut and tree 
nut allergy are some of the most common food allergens in older children and adults in 
Australia, this is perhaps unsurprising.353 Interestingly, there was no association between 
patients reporting symptoms to wheat containing foods and sensitisation to wheat on SPT. 
Similarly, Simon et al.149 completed double blind challenges with wheat, in wheat sensitised 
patients with EoE and identified no relationships, but patients did experience symptoms of 
dysphagia related to the consistency of the bread. This suggests that unlike nuts, wheat was 
unlikely to be a IgE-mediated food trigger in patients with EoE in our cohort and possibly 
others.149 However, patients may report wheat as a symptom trigger due to the texture (such 
as bread being difficult to swallow) of wheat based foods or by associating them with IBS type 
symptoms as with other IBS populations.265  
Fruit, vegetables, grains and cereals, milk and other dairy have also been recorded as foods 
perceived by IBS patients to trigger IBS symptoms265 and were also commonly reported by 
patients in this case series to trigger non-oesophageal GIT symptoms. Spergel et al.41 also 
describes patients with EoE having symptoms and histological changes to fruits and 




further specified. Other factors in these foods that may contribute to symptoms could include 
food chemicals or fermentable carbohydrates such as lactose.31 More broadly, when patients 
perceive diet to play a role in their symptoms, dietary investigation may be warranted. At the 
very least dietitians should assess whether patients are restricting perceived food triggers in 
their diet and the impact on their nutrient intake.265  
Overall, these findings emphasise the importance of allergy testing in this population, 
especially if symptoms suggestive of an IgE mediated food allergy are identified or foods are 
being excluded and reintroduced as part of dietary management.354 However, additional 
assessment, exploration and discussion with patients about other types of adverse food 
reactions and consideration of compensatory strategies related to food texture may also be 
required.  
5.6.6 Conclusion  
In this characterisation of RPAH Allergy Unit patients with EoE (N=169) it was found that 
patients experienced oesophageal symptoms, atopic conditions such as allergic rhinitis, 
asthma and eczema, as well as a variety of symptoms including reflux, abdominal pain, 
diarrhoea, constipation, headaches/migraines, behavioural changes and non-allergic rhinitis, 
and these rarely occurred exclusively. Approximately three quarters of patients were 
sensitised to airborne allergens and half of patients were sensitised to foods on SPT. However, 
less than a quarter had a diagnosed IgE food allergy. Patients with EoE also report a variety of 
foods to be symptom triggers including fruits, meats and vegetables and these were identified 
to be related to food texture and SPT results. Overall, symptoms, atopic conditions, 
endoscopic feature and patient-reported symptom triggers varied within the individual as well 
as by age and gender, thus dietitians should consider all of these factors when implementing 
the NCP to ensure a holistic approach to patient care. The variability in symptoms, food 




consideration of alternative strategies, to traditional elimination of common allergens, in the 




PART B: EVALUATION OF A LOW CHEMICAL ELIMINATION DIET, 
DIETARY CHALLENGES, PERSONALISED DIETS AND LONG TERM 
OUTCOMES IN PATIENTS WITH EOSINOPHILIC OESOPHAGITIS 
5.7 DIETARY PROTOCOL 
Dietary elimination is a common strategy used in the management of patients with EoE, with 
histological remission alongside symptom resolution considered the primary goal. Current 
dietary strategies focus on food allergen elimination and include elemental, directed and 
empirical approaches.1,103 However, current allergy testing does not accurately identify EoE 
food triggers suggesting a non-IgE mediated mechanism79 and broader elimination beyond 
empirical approaches is often required to achieve symptomatic and histological remission.103  
Food challenge/reintroduction: to identify dietary triggers (of symptoms and/or oesophageal 
inflammation), post dietary elimination, is a key step in the dietary investigation of patients 
with EoE. However, currently food challenge/reintroduction protocols in the literature are 
unclear and inconsistent, and are reflected in current management practices (Chapter 3) 
impacting patient care (Chapter 4). Patients are also required to undergo an endoscopy after 
challenge with each food which presents concerns in relation to invasiveness, risks, costs and 
feasibility. A diet excluding dietary triggers is then prescribed, with the goal of maintenance of 
symptom and histological resolution. However, this phase is poorly described in the literature.  
Symptoms and patient-reported food triggers (such as fruits and vegetables) described in 
patients with EoE in Part A and in the ausEE cohort (Chapter 3) could be suggestive of potential 
food chemical intolerances. Dietary investigation for food chemical intolerances at the RPAH 
Allergy Unit can be broadly classified into two main phases: an initial diagnostic elimination 




can be liberalised long term. Therefore, Part B documents an exploration of the use of a low 
chemical elimination diet and challenges in patients with EoE, to investigate the potential role 
of food chemical intolerances, and as an alternative dietary investigation strategy to identify a 
personalised diet. 
The objectives of Part B of this case study report were: 
• To report on the outcomes of initiating a low chemical elimination diet in patients with 
EoE including symptomatic and histological changes. 
• To report on challenge results and the long-term outcomes of personalised diets and 
liberalisation in patients with EoE who have completed a low chemical elimination diet 
and challenge protocol. 
5.8 METHODS: DIETARY PROTOCOL 
5.8.1 Analysis of clinical cases undergoing the low chemical elimination diet and 
challenge protocol 
Sample: Part B describes data from patients in the case series sample undergoing trial of a low 
chemical elimination diet (strict, moderate or simple), as well as challenge results, 
personalised diet and liberalisation. Inclusion criteria: were patients of any age, with a 
confirmed diagnosis of EoE1 who returned for dietary review on the low chemical elimination 
diet. Exclusion criteria were patients with suspected EoE or EGIDs other than EoE.   
Setting: At their initial appointment patients were provided with standard dietary education 
by the attending dietitian on starting the low chemical elimination diet. The standard dietary 
intervention excluded foods containing natural salicylates, biogenic amines and glutamate, as 
well as additives (preservatives, colourings), gluten, dairy and soy (Appendices A.2). Food 
allergens were also excluded. The level of dietary restriction was based on symptoms, patient 




1) Strict: Includes low chemical foods and unflavoured or vanilla flavoured elemental 
formula. Excludes foods with moderate, high and very high levels of food chemicals 
and food additives from the diet. 
2) Moderate: Includes low and moderate chemical foods. Excludes foods with high and 
very high levels of food chemicals and food additives.  
3) Simple: Includes low, moderate and high chemical foods. Excludes foods with very 
high levels of food chemicals and food additives.355   
In infants who were breastfeeding, the mother’s diet was restricted, or infants and young 
children were prescribed an elemental formula. Depending on the child’s age, symptoms and 
nutritional requirements; breastfeeding or elemental formula was exclusive or with 
complementary low chemical foods. Adults may also have been prescribed elemental formula 
if their symptoms, current dietary intake and circumstances indicated this was necessary.  
All patients were reviewed regularly by their dietitian to ensure adherence, nutritional 
adequacy and dietary quality. At subsequent follow up appointments the physician and/or 
dietitian recorded withdrawal symptoms (temporary flare up in symptoms during initial stages 
of the elimination diet), symptom response to the diet and dietary adherence. An endoscopy 
was conducted on the elimination diet after 4-8 weeks. If indicated, appropriate rhinitis and 
reflux medications were prescribed by the attending physician, during the dietary testing, 
according to patient symptoms and circumstances.  
To be eligible to start challenges, patients must have completed the strict elimination diet for 
four to eight weeks and exhibited improvement in symptoms. Standard challenge instructions 
and education material356 was provided by the dietitian. Challenge testing was conducted as 
described in Appendices A.2 and A.3. A challenge was considered to be ‘positive’ if any 
symptom (oesophageal, non-oesophageal-GIT and/or non-GIT) was elicited. The assumption 




any sensitised organ system, and that there is a mechanistic connection between these FGID 
and non-GIT type symptoms and EoE (discussed in Sections 5.6.2). Thus, any of these 
symptoms can guide dietary modification with the purpose of achieving a personalised diet on 
which an individual has symptomatic and histological remission of their EoE. The number and 
type of challenges completed by patients depended on their individual circumstances and 
preferences. For example, open food chemical challenges (not capsules) were often deemed 
more appropriate for children. Food challenges were not conducted in patients who were SPT 
positive to those foods. Once patients completed all challenge testing, their DBPC capsule 
results were decoded, and they were prescribed a personalised diet based on their challenge 
results, continuing to exclude foods/food chemicals they had a positive challenge response to, 
and reintroducing foods they did not react to. Patients were advised to follow this diet for four 
to eight weeks, with dietary review, to confirm their challenge results. Patients were then 
encouraged to slowly liberalise their personalised diets, systematically adding in small 
amounts of foods/food groups containing the chemicals they reacted to, in order to identify 
their reaction threshold: the point at which symptoms reoccurred. An endoscopy was 
conducted whilst on the personalised diet and/or after liberalisation of their personalised diet 
Data collection: Patient files were systematically examined for dietary and challenge 
interventions, withdrawals, symptom response (patient and/or health professional reported), 
endoscopy and histopathology reports. Data was entered and reviewed as described in Part A, 
Section 5.4.1. Dietary response was examined separately for patients prescribed the strict 
elimination diet, and those prescribed simple, moderate or exclusive elemental diets. 
Reported variables are defined in Table 5.5. All other variables were defined previously in Part 
A, Section 5.4.1. 
Symptomatic response to the diet was assessed by the attending physician and/or dietitian. 




Dietary non-adherence was assessed using the dietitians’ clinical notes. The final challenge 
outcome was determined from the combined DBPC capsule and food challenge results. 
Preservative (sorbates, benzoates and sulphites) challenge results were grouped due to the 
standard capsule challenge set having a combined challenge for these compounds (as they 
often occur in similar foods). One or more positive challenge outcomes to the single or 
combined preservative challenges was considered indicative of preservative intolerance. It 
should be noted that two changes were made to the DBPC capsule challenge sets used at the 
RPAH Allergy Unit during the time period of this case series (Appendix O). These changes were 
not deemed to alter the likelihood of reactivity and hence were not analysed separately.  









Patient reported complete resolution of symptoms (> 80%) 
Patient reported partial resolution of symptoms (20-80%) 
Patient reported an improvement in symptoms (% 
improvement not recorded) 
Patient reported no change in their symptoms 
Histological remission Peak eosinophil count ≤ 15 eosinophils/HPF 
Non-adherence Regular consumption of foods not allowed on the strict low 
chemical elimination diet 





Any symptom on challenge 
No symptoms on challenge or indeterminate challenge 
response 
 
Statistical analysis: A Wilcoxon signed rank test was used to assess for differences in 
eosinophil count before and on the strict elimination diet. A Kruskal Wallis H test was used to 
examine differences in median eosinophil count and median diet duration between the 
different symptom response groups, followed by post hoc analysis with Dunn’s non-parametric 
comparisons within groups. Spearman’s Rho correlations was used to assess the relationship 
between diet duration and histology. The relationship between symptom response, 




square crosstabulations. Differences in characteristics of patients returning on the strict 
elimination diet and patients that did not return for further dietary counselling were examined 
using Mann Whitney U test and Pearson’s Chi square crosstabulations for continuous and 
discrete variables, respectively.  
The proportion of patients reacting to each challenge compound and the 95% confidence 
intervals were tabulated. An exact McNemars test was used to assess whether the frequency 
of positive or negative reactions differed from the placebo. Bon-Ferroni adjustments were 
used to account for multiple comparisons. As there were 11 active challenges the significance 
level was set at P < 0.0045. The relationship between challenge results, demographics, 
baseline triggers and SPT was also assessed using Pearson’s Chi square crosstabulations. 
Personalised diets were based on each individual patient’s challenge results and the dietitians 
notes. A Friedmans test was used to assess for differences in the median eosinophil count 
before, on the strict elimination diet and on a patients personalised diet or after dietary 
liberalisation, followed by post hoc analysis using a Wilcoxon Signed rank test to identify 
differences between groups.  
5.8.2 Prospective and follow up study symptom/diet questionnaire analysis 
Part B also discusses data from the prospective and follow up studies, obtained from the ‘on-
elimination diet’, ‘personalised diet’ and follow up SDQs, including withdrawal symptoms, 
changes in symptoms, reasons for loss to follow up and current dietary modifications. Specific 
questions (reasons for starting/not starting the elimination diet and withdrawal data) from the 
prospective study ‘on-elimination diet’ SDQ and (changes in symptoms, current dietary 
restrictions and food reaction frequency) from the prospective study ‘personalised diet’ SDQ 
were repeated in the follow up study SDQ, hence, were combined for descriptive analysis. 
Data entry and descriptive statistics was conducted as described in Part A, Section 5.4.2. Self-




(Never/Occasionally vs. Monthly/Weekly/Daily). McNemar’s test was used to assess for 
differences in self-reported symptom frequency at baseline and on the strict elimination diet 
in the ‘on-elimination diet’ SDQ. McNemar’s test was also used to assess for differences in self-
reported symptom frequency at baseline, on the elimination diet and on their personalised 
diet, including liberalisation in the ‘personalised diet’ SDQ and follow up questionnaire. 
Pearson’s Chi square test was used to assess for associations between symptom frequency and 
current dietary modifications. 
5.9 RESULTS: DIETARY PROTOCOL 
5.9.1 Characteristics of patients undergoing the low chemical elimination diet and 
challenge protocol 
Of the patients with EoE in this case series (N=169), 92% were provided with education on the 
low chemical elimination diet (Figure 5.12). Reasons for not being provided dietary education 
included trial of swallowed corticosteroids, trial of removal of SPT positive foods (directed 
elimination diet), previous completion of the low chemical elimination diet and challenges and 
no dietitian referral. A total of N=98 (58%) patients returned for further dietary review. Of 
these, N=88 (90%) were identified to be following the strict elimination diet, with N=10 
patients identified to be non-adherent. The remaining patients were following an elemental 





Figure 5.12: Overview of patients with eosinophilic oesophagitis completing the low 
chemical elimination diet and challenge protocol 1997-2017. Abbreviations: Aug: 
August, Feb: February. 
 
In the follow up study N=140 patients were identified to be eligible for inclusion, with 12% 
(N=17) completing the survey (Figure 5.13). Of the patients who had attempted the ‘on-
elimination diet’ (N=24) or follow up SDQ (N=15), most (N=33) reported starting the low 





Figure 5.13: Flow diagram of prospective and follow up study participants completing Symptom/Diet questionnaires. Abbreviations: SDQ: 




5.9.2 Histological response to the strict elimination diet 
Of the N=88 (52%) case series patients who returned on the strict elimination diet, histological 
data on the elimination diet was available for N=64 patients after a median of eight weeks 
(IQR:4 weeks). Of these, N=40 (63%) achieved histological remission. Paired histological data 
before and on the strict elimination diet was available for N=59 patients. There was a 
statistically significant decrease in the median peak eosinophil count in individuals with EoE, 
following the strict elimination diet, from 43/HPF to 6/HPF (Figure 5.14).  
















Figure 5.14: Peak eosinophil count before and on the strict elimination diet in patients 
with eosinophilic oesophagitis (N=59). Abbreviations: **: p<0.001. The dotted line 
represents clinical remission (≤15 eosinophils/HPF). A Wilcoxon signed rank test 
identified a statistically significant change in the median peak eosinophil count before 
and on the strict elimination diet (Z=-5.124, p < 0.001). Ranks identified that N=47 
patients had a lower eosinophil count on the diet, N=9 had a higher count and N=3 
had no change. 
 
Factors affecting histological response to the strict elimination diet were examined. A 
significant difference in histological response between patients with and without food allergen 
sensitisation was identified, with complete histological remission more likely in patients 




duration and eosinophil count on the strict elimination diet.  Due to the small cell counts the 
relationship between histological response and age, gender and atopy could not be fully 
examined. No trends by age and gender were identified; however, there was a trend towards 
association of atopy and histological non-response. Multiple binomial logistic regression 
analysis was performed to identify predictors of histological response, however, was unable to 
be calculated due to small numbers for some variables.  
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Figure 5.15: Peak eosinophil count on the strict elimination diet of eosinophilic 
oesophagitis patients with (N=36) and without food sensitisation (N=26). 
Abbreviations: **: p<0.001. The dotted line represents histological remission (≤15 
eosinophils/HPF). A Mann-Whitney U test identified a significant difference in the 
median peak eosinophil count on the strict elimination diet between eosinophilic 
oesophagitis patients with and without food sensitisation (17/HPF vs. 1/HPF, U=219.5, 
p<0.001).  
 
5.9.3 Symptom response to the strict elimination diet 
Withdrawal symptoms 
Dietary restriction of food chemicals, followed by withdrawal symptoms: a temporary flare up 
in symptoms during the first one to two weeks of the elimination diet, after which symptoms 




with EoE that returned on the strict elimination diet, approximately half had withdrawal data 
recorded (Table 5.6). Of those patients, 71% reported experiencing withdrawal symptoms, 
with a median onset time of seven days and seven-day duration. Headache/migraine, fatigue, 
oesophageal symptoms, diarrhoea and abdominal pain were the most commonly reported 
withdrawal symptoms.  
Table 5.6: Withdrawal symptoms experienced by case series patients with eosinophilic 
oesophagitis who commenced on the strict elimination diet (N=88). 
Withdrawal Symptoms N Eosinophilic oesophagitis patients 

























Similar results were reported by prospective and follow up patients in the ‘on-elimination diet’ 
and follow up SDQs (N=32). Exactly half of these patients reported experiencing withdrawal 
symptoms, with a median three (IQR:12) day onset and five (IQR:7) day duration. Headaches 
were the most commonly reported withdrawal symptom (N=10).  
Symptomatic response to the strict elimination diet 
Of the N=88 (52%) patients who returned on the strict elimination diet, 94% had symptomatic 
improvement and 6% were non-responders. Of the symptom responders, 31% reported 
complete symptomatic improvement, 27% reported partial-symptom response and 42% were 
symptom responders with an unspecified level of improvement (Table 5.7). There was no 
difference in diet duration between any symptom response groups, with a median eight weeks 




weeks for symptom non-responders. Due to the small number of symptom non-responders 
the relationship between symptom response and age, gender and atopy could not be fully 
examined. No trends towards relationships between any of these variables was identified.  
Table 5.7: Symptom response in patients with eosinophilic oesophagitis to the strict 
elimination diet (N=88). 
Symptom response type Total number of patients 
(N) 
Number of responders 
(N) 








Oesophageal responder  43 40 

































 Abbreviations: GIT: gastrointestinal 
Specific symptom response was also examined. Oesophageal symptom response was reported 
in half of patients following the strict elimination diet, with 93% reporting symptom 
improvement. Improvements in non-oesophageal GIT symptoms and Non-GIT symptom 
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Figure 5.16: Self-reported symptom frequency at baseline and on the elimination diet 
(N=22). Darker colour indicates more patients reported that symptom monthly-daily. 
Abbreviations: ED: Elimination diet.  
 
In patients who had completed the ‘on-elimination diet’ or follow up SDQ and reported 
starting the elimination diet (N=33), most (N=27) reported symptom improvement after a 




returning to their baseline diet and the remaining four continuing to maintain a partially 
modified diet. 
Prospective study patients following the RPAH EoE dietary protocol reported symptom 
frequency before and on the strict elimination diet in the ‘on-elimination diet’ SDQ (N=22). 
There was a decrease in reported frequency of symptoms on the elimination diet, particularly 
oesophageal and non-oesophageal GIT symptoms (Figure 5.16). Notably, there was a 
significant decrease in the proportion of patients experiencing pain on swallowing, indigestion, 
chest pain and reflux on the strict elimination diet (p=0.031, p=0.031, p=0.016, p=0.031 
respectively).  
5.9.4 Relationship between symptomatic and histological response to the strict 
elimination diet 
The median peak eosinophil count on the strict elimination diet for symptom responders was 
7/HPF (IQR: 30/HPF). Interestingly, the two symptom non-responders with histological data 
available both achieved histological remission. As such, there was no difference in median 
peak eosinophil counts between symptom responders and non-responders on the strict 
elimination diet. However, there was a significant difference in the median peak eosinophil 
count between the different symptom response groups on the strict elimination diet, 
specifically between unspecified responders and partial responders, and complete responders 
and partial responders (Figure 5.17). In general, patients who reported symptom improvement 
also had histological response, although in the two patients histological improvement was not 










































Figure 5.17: Differences in median peak eosinophil counts on the strict elimination 
diet between symptom response groups (N=64). Abbreviations: *: p<0.05.  Complete 
responder (N=26), unspecified responder (N=18), partial responder (N=18), non-
responder (N=2). The dotted line represents histological remission (≤15 
eosinophils/HPF). There was a significant difference in eosinophil counts between the 
different symptom response groups on the strict elimination diet (X2=18.909, p < 
0.001), with a mean rank of 28.7 for complete responders, 25.5 for unspecified 
responders, 47.6 for partial responders and 9.5 for non-responders. Post Hoc analysis 
identified significant differences in the median peak eosinophil counts on the strict 
elimination diet between: unspecified responders and partial responders (1/HPF vs. 
50/HPF, X2=-22.056, p=0.002) and complete responders and partial responders (6/HPF 
vs. 50/HPF, X2=-18.863, p=0.005). 
 
5.9.5 Relationship between dietary adherence and histological and symptomatic 
response 
Most patients (N=78, 89%) reported adhering to the strict elimination diet. A statistically 
significant difference in median peak eosinophil count on the strict elimination diet between 
patients who adhered to the elimination diet and patients that did not adhere was identified 
(Figure 5.18). However, it is recognised that conclusions are limited by the small number of 




dietary adherence and symptom response could not be fully examined due to the small 
number of patients who were non-adherent or did not respond symptomatically. No 
relationship trends between these two variables could be seen.  

















Figure 5.18: Difference in median peak eosinophil count on the strict elimination diet 
between dietary adherers (N=55) and non-adherers (N=9). Abbreviations: **: p<0.001. 
The dotted line represents histological remission (≤15 eosinophils/HPF). A Mann 
Whitney U test identified a statistically significant difference in the median peak 
eosinophil count on the strict elimination diet between ‘adherent’ and ‘non-adherent’ 
patients (3/HPF vs. 50/HPF, U=57.5, p<0.001). 
 
5.9.6 Changes in food allergen sensitisation on the strict elimination diet 
In Part A of this case study it was reported that many patients had positive food sensitisations 
(≥ 3mm) at baseline as well as minor sensitisations (1-3mm) (Appendix M). Therefore, an 
attempt was made to examine changes in these food allergen sensitisations from baseline and 
on the strict elimination diet. Due to the heterogeneity of patient SPT results only observations 
could be made. No patterns were identified in relation to the type and number of food 
sensitisations. Trends in relation to changes in SPT size were identified and are exemplified by 
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Figure 5.19: Changes in food allergen sensitisation before and on the strict elimination diet. Black lines indicate changes in skin prick test size of individual 
foods. The dotted lines indicate the cut off for positive skin prick test (≥ 3mm) and primary food sensitisations (≥ 6mm). The shaded area indicates the 
change in peak eosinophil count. Figure a) Skin prick test results before and on the strict elimination diet for a female adult (26yrs) with a peanut allergy. 
Figure b) Skin prick test results before and on the strict elimination diet for an adult male (46yrs). Figure c) Skin prick test results before and on the strict 





In patients with large “primary” food sensitisations (≥ 6mm), these persisted regardless of 
dietary changes and changes in other smaller sensitisations (Figure 5.19 a and c). In contrast, 
there was a trend for reduction of positive SPT (≥ 3mm) to small (1-3mm) or no sensitisation. 
This was often seen alongside histological improvement suggesting that the sensitisation may 
be a consequence of the inflammation (Figure 5.19 a and c). In some cases, small sensitisations 
(1-3mm) to food appeared or persisted (Figure 5.19 b and d). 
5.9.7 Characteristics of patients lost to follow up 
Characteristics of case series patients who returned on the strict elimination diet were 
compared to patients that did not return for further dietary evaluation (N=58). Patients who 
returned on the strict elimination diet were more likely to be children and experience eczema, 
constipation and fatigue (p=0.019, p=0.009, p=0.036, p=0.025 respectively). No differences by 
gender, disease duration or atopy were identified.  
Of the patients (N=39) who had attempted the ‘on-elimination diet’ or follow up SDQ, four had 
not started the diet and two did not provide a response. In those that did not start the 
elimination diet, one patient reported modifying their diet based on the information provided 
at the Allergy Unit and reported symptom improvement. Reasons for not starting the 
elimination diet included holidays, already having completed the dietary protocol, not being 
prescribed the diet and difficulty due to concomitant food allergy.  
5.9.8 Response to moderate and simple elimination diets 
Two patients trialled a moderate elimination diet, of which one patient reported symptom 
response and showed histological improvement with a reduction in the peak eosinophil count 
from 30/HPF to 20/HPF. Three patients trialled a simple elimination diet with one reporting 
symptom response, one reporting partial symptom response and one non-responder. No 
patients undergoing a simple elimination diet had an endoscopy and oesophageal biopsy on 




5.9.9 Response to an exclusive elemental diet 
All patients, four children and one adult, following an elemental diet reported symptomatic 
improvement and achieved histological remission.  
5.9.10 Challenge results 
A total of N=64 (38%) of patients were identified to have completed at least one challenge 
(Figure 5.12). Three patients had completed the full challenge battery of gluten, dairy, soy, 
natural chemicals and additives. A further N=20 patients had completed all but one challenge, 
usually soy (N=19), due to soy not being a regular part of patients diets and/or an unpopular 
drink. At least one symptom trigger was identified in most patients (N=59, 92%). Five patients 
did not identify a symptom trigger on challenge, however, they did not complete the full 
challenge battery and/or had indeterminate challenge results.  
Common food chemical symptom triggers 
Overall challenge outcomes of patients with EoE were highly variable, particularly in relation to 
the number and type of food chemicals evoking symptoms on challenge (Table 5.8). Patients 
had a positive challenge response to a median of three (IQR:3) challenges. Milk (61%), amines 
(59%), salicylates (57%) and wheat (55%) were the most common symptom triggers identified 
by challenge (Table 5.9). Children were more likely to have a positive salicylate and a positive 
preservative final challenge outcome (p=0.018, p=0.013 respectively). No other associations 




Table 5.8: Example of idiosyncratic nature of challenge results in patients with eosinophilic 
oesophagitis (N=30). 













































































1 39 M - - nt - - - - - + - - - - 
2 19 F - + nt - - + - - - - - - nt 
3 56 M - - nt + - + + + - + - - - 
4 3 M - + nt + + - + - - - + - nt 
5 29 F - + nt - - + + - - - - - - 
6 32 M + + nt + + - - + - - - - - 
7 36 M + + nt - + + - - - - - - - 
8 46 M nt + nt + + - - - - nt - - + 
9 26 F - nt nt - - - + - - - - - nt 
10 18 M + - nt + - - + - - + + + nt 
11 8 M - + + + + nt + + + - nt nt nt 
12 48 F + - nt - + - - - - + + - - 
13 53 M + - nt - - + - + + - + - - 
14 10 F - + nt - + - - - - - + + - 
15 1 M - + nt - - - - + - + + nt - 
16 29 F + + + + + - + - - nt - - - 
17 36 M - + nt - + - + - - - - - - 
18 23 F + nt nt - + - - - - - - - - 
19 35 M - - + - + - - + - + - - - 
20 38 F + + + + + + + + + nt nt - - 
21 30 F + + nt + + - + - - - - - nt 
22 42 M - + nt - + - - - - + + - - 
23 46 M + + nt + + - - - + - + - - 
24 12 F + nt nt + + + - - - + - nt + 
25 22 M + + - - - - + - - - - - - 
26 42 F + + nt + + + - - - - - - - 
27 8 M - - nt + - - - - - - + nt nt 
28 7 M + - nt + + + + + + nt + - - 
29 51 M + - nt - + - + - - + + - - 
30 45 M - - - - - - - - - - - - nt 
+: Positive challenge response (any symptom), -: Negative challenge response (no symptom provoked), 







Table 5.9: Whole food, natural food chemical, food additives and placebo challenge response 
rates in patients with eosinophilic oesophagitis (N=64). 


































































































A positive placebo response to sucrose was low (Table 5.9). The proportion of patients reacting 
to each of the active challenge compounds compared with placebo was compared using an 
exact McNemars test, with an adjusted P value (p < 0.0045) allowing for multiple comparisons. 
A significant difference in the proportion of patients with a positive challenge outcome to 
amines and placebo (p < 0.001), wheat and placebo (p=0.002) and milk and placebo (p=0.001) 
was identified. There was no significant difference between reactions to antioxidants, colours, 
glutamate, nitrate, propionate, salicylates, soy and preservatives and placebo.  
Response rates to capsule and food challenges 
Differences in response rates to DBPC capsule and food challenges of the same natural food 
chemical or additive was also explored to assess concordance of capsule and food challenge 
results. However, conclusions were limited due to the small number of patients completing 
both DBPC capsule and food challenges for each compound. Relationship trends suggested no 




amine (N=22) challenges, whilst there was good concordance between a negative capsule 
challenge and negative food challenge results (N=14, N=10 respectively), there were also a 
trend towards patients having a negative capsule challenge response, but a positive food 
challenge (N=5, N=7 respectively). Small numbers for positive capsule/positive food and 
positive capsule/negative food, limited further conclusions.  
Cross-reactivity between challenge compounds 
Cross-reactivity between compounds has been previously reported in other food intolerant 
populations.357  Reactivity to amines was associated with reactivity to milk and salicylates 
(p=0.038, p=0.009 respectively). Reactivity to salicylates was also associated with reactivity to 
antioxidants (p=0.002). Small cell numbers limited examination of other challenge compounds 
and analysis of possible clustering of reactions to challenge compounds.  
Symptoms elicited by challenges 
Overall, symptoms elicited on challenges were highly variable and individual. Non-oesophageal 
GIT symptoms, particularly abdominal pain, were the most commonly reported symptoms to 
all challenges (Figure 5.20). Non-GIT symptoms were also reported. Neurological symptoms 
were notable, whilst cutaneous symptoms were uncommon.  
Provocation of oesophageal symptoms on challenge was generally uncommon. Across the 
challenge compounds, oesophageal symptoms were most commonly reported for wheat, 
amines, antioxidants, and glutamate (Figure 5.20). Abdominal pain was the most commonly 
reported symptom to milk, wheat, salicylates, artificial antioxidants and amines. Other notable 
non-oesophageal GIT symptoms to these foods/food chemicals included reflux, nausea and 
diarrhoea (Figure 5.20). Neurological symptoms were also notable with headache/migraine, 
fatigue and behavioural changes (irritability, oppositional, aggressive, hyperactivity) reported 
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Figure 5.20: Symptoms provoked on challenges in patients with eosinophilic 
oesophagitis.  
 
Relationship between baseline symptoms and symptoms elicited on challenge 
Due to the variety and variability in baseline and challenge symptoms, the large overlap 
between baseline symptoms and the limited numbers of challenge results, the relationship 
between baseline symptoms and challenge symptoms could not be fully examined. Overall, 
non-oesophageal GIT symptoms were the most common challenge symptom regardless of 






Relationship between baseline reported symptom triggers, allergen tests and challenge 
outcomes 
No associations were identified between baseline patient-reported symptom triggers of 
wheat, milk, salicylates or amines and final challenge outcomes. Small numbers limited the 
examination of baseline reported triggers of antioxidants or soy and their respective final 
challenge outcomes. Similarly, the relationship between baseline SPT and final challenge 
outcomes could not be fully examined.  
5.9.11 Personalised diet and liberalisation 
Of the patients in the case series who had completed challenges, N=41 (64%) had data 
available on their personalised diet, and N=28 had information on liberalisation of their diet 
(Figure 5.12).  
Types of personalised diets 
Personalised diets of patients with EoE were highly variable and individual, reflective of their 
challenge results. Personalised diets were recognised to vary based on the number and types 
of challenges completed, SPT food sensitisations and other conditions, for example coeliac 
disease and individual dietary preferences. Table 5.10 highlights the heterogeneity of 
personalised diets. Patients were identified to be excluding a median of 6 (IQR:7) whole foods, 
food chemicals and/or additives on their personalised diets. Six patients were identified to 
have a personalised diet equivalent to the strict elimination diet. Soy was the most commonly 
excluded food on patients with EoE prescribed diets (N=36), though this was due to a limited 
number of patients challenging with soy. Dairy, gluten and amines were the next most 
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16 o ✔ o ✔ ✔ o ✔ o o ✔ o o ✔ 
17 o ✔ o ✔ ✔ o o o o o o o o 
18 ✔ o o ✔ o ✔ ✔ ✔ ✔ ✔ ✔ ✔ ✔ 
19 ✔ o o ✔ ✔ ✔ ✔ ✔ ✔ o o o o 
20 o o o o o ✔ o ✔ ✔ o ✔ ✔ o 
21 o ✔ o o o o o o o o o o o 
22 o o o ✔ o ✔ o ✔ o o o o o 
23 ✔ o o ✔ o ✔ o ✔ ✔ ✔ ✔ ✔ ✔ 
24 o o o ✔ o ✔ ✔ ✔ ✔ ✔ ✔ ✔ ✔ 
25 ✔ ✔ o ✔ o ✔ ✔ o ✔ o ✔ ✔ ✔ 
26 o o o o o o o o o o o o o 
27 o o o o o ✔ o ✔ ✔ ✔ ✔ ✔ ✔ 
28 o o o ✔ ✔ o o o o o o o o 
29 ✔ o o ✔ o o ✔ ✔ ✔ o o o o 
30 ✔ o o o o o o o o o o o o 
31 o o o ✔ o o ✔ ✔ o ✔ ✔ ✔ ✔ 
32 o o o o o o ✔ ✔ ✔ o ✔ ✔ ✔ 
33 o ✔ o o ✔ ✔ ✔ ✔ ✔ ✔ o o o 
34 o o o o o o o o o o o o o 
35 o o ✔ ✔ ✔ ✔ o ✔ ✔ ✔ ✔ ✔ ✔ 
36 o o o o o o ✔ ✔ ✔ ✔ o ✔ ✔ 
37 ✔ ✔ o o ✔ ✔ ✔ ✔ ✔ ✔ o o ✔ 
38 o o o o o o o o o o o o o 
39 o o o o o o o o o o o o o 
40 ✔ ✔ ✔ ✔ ✔ ✔ o ✔ ✔ ✔ ✔ ✔ ✔ 
41 ✔ ✔ ✔ ✔ ✔ ✔ o ✔ ✔ o o o o 
Total 
excluding 
26 31 36 20 27 22 21 17 15 22 22 21 19 





Histological response to personalised diets 
Histological data was available for N=19 patients on their personalised diets, of which 53% 
were identified to be in histological remission with a median peak eosinophil count of 12/HPF. 
Paired data was available for N=18 patients. A statistically significant difference in the median 
peak eosinophil count before, on the strict elimination diet and on a patient’s personalised 
diet was identified. More specifically, there was a significant difference between the median 
peak eosinophil count at baseline and on the personalised diet (41/HPF vs. 16/HPF) but no 
difference in eosinophil count between the strict elimination diet and the personalised diet 
(Figure 5.21).  This suggests that histological improvement is maintained on a patient’s 
personalised diet, however, it is recognised that the conclusions are limited by small numbers. 










Figure 5.21: Median peak eosinophil count before, on the strict elimination diet and 
on a patients personalised diet in patients with eosinophilic oesophagitis (N=18). 
Abbreviations: *: p<0.05, ED: Elimination diet. The dotted line represents histological 
remission (≤15 eosinophils/HPF). A Friedman’s test identified a statistically significant 
difference between the median eosinophil count at different dietary stages (X2(2): 
13.522, p=0.001). Post Hoc analysis with a Wilcoxon signed rank test identified a 
statistically significant difference in the median peak eosinophil count before and on 
the elimination diet (41/HPF vs. 6/HPF, Z=-3.432, p=0.001) and baseline and on the 




Histological response after dietary liberalisation 
Histological data was also available for N=18 patients on liberalisation of their personalised 
diets, with a median peak eosinophil count of 27/HPF and 39% were identified to be in 
histological remission. Paired data was available for N=16 patients. A statistically significant 
difference in the median eosinophil count before, on the strict elimination diet and after 
dietary liberalisation was identified. Post hoc analysis showed a significant difference between 
the median peak eosinophil count before and on the elimination diet (38/HPF vs. 6/HPF) and 
on the elimination diet and on liberalisation (6/HPF vs. 34/HPF) but not between baseline and 
liberalisation (Figure 5.22). This suggests that histological improvement is not maintained 















Figure 5.22: Median peak eosinophil count before, on the strict elimination diet and 
on a patients liberalised diet in patients with eosinophilic oesophagitis (N=16). 
Abbreviations: *: p<0.05, ED: Elimination diet. The dotted line represents histological 
remission (≤15 eosinophils/HPF). A Friedman’s test identified a statistically significant 
difference between the median eosinophil count at different dietary stages (X2(2): 
15.613, p<0.001). Post Hoc analysis with a Wilcoxon signed rank test identified a 
statistically significant difference in the median peak eosinophil count before and on 
the elimination diet (38/HPF vs.6/HPF, Z=-3.517, p<0.001) and on the elimination diet 
and liberalisation (38/HPF vs. 28/HPF, Z=-2.379, p=0.017).  
 
Due to limited numbers of patients with histological data on both their personalised diet and 
after liberalisation (N=6), statistical analyses examining differences between the two could not 
be performed. Two patients were identified to be in histological remission on their 
personalised diets and have an increase in eosinophil counts after liberalising one food 
chemical in their diets. The dietary changes and subsequent changes in peak eosinophil counts 
of these patients are described in Table 5.11, suggesting identification of causal foods. 
Notably, both cases were identified to have ‘over’ liberalised with symptom recurrence. 
Interestingly, Case B subsequently resumed his personalised diet, with symptomatic and 




histological re-occurrence, suggesting a dose related response and that complete avoidance of 
glutamate may not be required. 
Table 5.11: Examples of patients with eosinophilic oesophagitis personalised diets and 
liberalisation with changes in peak eosinophil count. 
Case Personalised diet Liberalised diet 
Food(s) excluding Peak eosinophil 
count (HPF) 
Food(s) liberalising Peak eosinophil 
count (HPF) 
A Gluten, dairy, 
amines, glutamates 
0 Amines 


































5.9.12 Long term outcomes 
Participants completing the follow up SDQ (N=15) were identified to have had their initial 
appointment at the Allergy Unit a median of three (IQR:6) years prior. Of the N=25 patients 
completing the personalised and follow up SDQ, just over half reported ‘never/occasionally’ 
experiencing food reactions ‘accidentally’ or ‘knowingly’ (56%, 64% respectively). Participants 
reporting that they were currently following a modified diet (N=14) reported that gluten, dairy 
and glutamates were highly restricted (N=8, N=6 and N=7 respectively). Salicylates and amines 
were reported to be ‘not at all’ restricted in half of patients (N=6, N=7 respectively). Due to 
small cell counts the association between current diet restrictions and food reactions could not 




Patients completing the personalised and follow up SDQ were asked to rate their symptom 
frequency before, on the elimination diet and at follow up. A decrease in oesophageal and 
gastrointestinal symptom frequency on the elimination diet is notable and appears to be 
maintained long term (Appendix P). A significant difference in the proportion of patients 
experiencing dysphagia, the sensation of food sticking, reflux and heartburn before and on the 
elimination diet was identified (p<0.001, p<0.001, p=0.004, p=0.031 respectively). Similarly, a 
significant difference in the proportion of patients experiencing dysphagia, the sensation of 
food sticking, reflux and heartburn at their initial appointment and at follow up was identified 
(p=0.001, p<0.001, p=0.002, p=0.016 respectively). There was no difference in symptoms 
experienced on the elimination diet and at follow up, suggesting that patients maintain 
symptom improvement long term. Due to small cell counts the relationship between 
symptoms and current dietary modifications could not be examined.  
 
5.10 DISCUSSION: DIETARY PROTOCOL 
In Part B of this case study, the response of case series patients with EoE to a low chemical 
elimination diet was reported. Responses to DPBC and food challenges with whole food, 
natural food chemical and additives were also noted, and both used to determine a 
personalised diet. To the best of the researchers’ knowledge this is the first in depth report of 
patients with EoE responses to a low chemical elimination diet in which they achieved 
symptomatic and histological remission, as well as the first in depth report of food chemical 
and additive challenge outcomes in patients with EoE. Furthermore, these challenges allowed 
patients to identify symptom triggers and to determine a personalised diet on which they 




5.10.1 Response to a low chemical elimination diet  
In this study, 63% of patients with EoE, who completed the strict low chemical elimination diet 
and had an oesophageal biopsy, achieved histological remission. This is similar to rates of 
remission described to a 6-FED (66-78%),105 and higher than directed diets and 4-FEDs (46%, 
53% respectively).105,129  
Most patients (93%), in this case series, reported symptom improvement on the strict low 
chemical elimination diet. Whilst this is likely an over-representation, as patients may be more 
likely to persist with the diet if they experienced symptom improvement (as seen in the 
prospective and follow up study results), it is an overall positive outcome of the study. In the 
prospective study significant decreases in symptom frequency of pain on swallowing, 
indigestion, chest pain and reflux were identified. Similarly, 94% of patients with EoE following 
a 6-FED,143 and 67% following a 4-FED had a decrease in dysphagia score on the diet.145 One 
paediatric study also reported improvements in digestive, respiratory and cutaneous 
symptoms on dietary therapy (6-FED and allergen avoidance).358  
Overall, a strict low chemical elimination diet can assist patients with EoE in achieving the two 
clinical goals of symptomatic and histological remission,1 though further prospectively planned 
studies are required to confirm these results. Additionally, it must be recognised that the strict 
elimination diet is not a long term diet but the initial diagnostic phase of dietary investigation 
and further challenge testing to identify symptom triggers and develop a personalised diet 
approach is required. Furthermore, when symptomatic and/or histological remission is not 
achieved, consideration of a variety of factors, such as those described below is required and 
emphasises the multifactorial nature of the disease.  
5.10.2 Factors affecting histological and symptom response 
The present study identified a significant difference in histological response to the strict low 




vs. 1/HPF). IgE is known to be produced locally in the oesophageal mucosa of patients with 
EoE.359 B lymphocytes have been shown to be increased in the oesophageal mucosa of patients 
with EoE and it has been suggested that B cell recruitment into the oesophageal mucosa is an 
active part of the disease process.359 Th2 cytokines such as IL-4 promote B cell class switching 
to be IgE producing.360 B cells may be locally challenged by an allergen, forming specific IgE 
plasmablasts (short lived), with only a small proportion forming IgE memory B cells 
(persistence of IgE memory).359,361 Thus, it is possible that the small food IgE sensitisations seen 
in this study may reflect local oesophageal mucosal IgE production as a consequence of 
oesophageal inflammation. Subsequently, when oesophageal inflammation is treated, local IgE 
production may be reduced and/or short lived IgE declines, which could explain decreases in 
sensitisation when histology improves. Alternately, these IgE sensitisations could perpetuate 
oesophageal inflammation, as the IgE response, once initiated can be further amplified by 
basophils, mast cells and eosinophils.360 This may explain why patients with IgE food 
sensitisations differed in their histological response to the strict low chemical elimination diet. 
Further research is required to confirm these results and determine if this is specific to a low 
chemical elimination diet as no differences have been identified in other EoE cohorts, between 
histological responders and non-responders, by food sensitisation results in patients following 
a 6-FED144 or directed elimination diet.47  
The relationship between symptoms and histology and their use in assessing treatment 
response is a controversial area in the literature. In the present study, a significant difference 
in eosinophil count between patients reporting complete symptom improvement and those 
reporting partial symptom improvement was identified. This suggests that symptoms may be 
associated with histological response, though we did identify two patients with no symptom 
improvement but histological remission. Similarly, in patients with EoE following a 4-FED, 




significant.145 Aceves et al.362 identified that symptoms of dysphagia and anorexia/early satiety 
correlated with histological findings of eosinophilia. Conversely, Safroneeva et al.272 and 
Pentiuk et al.270 identified that overall symptom score was not predictive of the degree of 
eosinophilia on histology. It is interesting to consider that these studies focus on oesophageal 
symptoms, whilst our study also documented other GIT and non-GIT symptoms, as did Aceves 
et al.362 which may account for these differences. Further exploration of the relationship 
between oesophageal and non-oesophageal symptoms and eosinophilic inflammation may 
allow clinicians and patients to make informed decisions about the frequency of endoscopies 
in the future.  
Dietary adherence was identified to be an important factor affecting histological remission in 
this study. Dietary adherence is discussed as an important factor for patients with EoE in the 
literature.103 However, to the best of the researcher’s knowledge this is the first time the 
relationship between dietary adherence and histological response has been specifically 
examined in dietary management in EoE, though loss of histological response due to poor 
adherence has been described in one study.363 This is likely due to knowledge that dietary 
adherence is important in achieving symptomatic and pathological improvements in other 
gastrointestinal conditions such as coeliac disease,364 and possibly also because it is difficult to 
measure.218 Adherence to elemental diets, particularly in adults has been noted to be poor.134 
Conversely, directed and 4-FEDs are often promoted as being easier to adhere to due to the 
reduced number of foods excluded, but are less efficacious.365 This is a potential disadvantage 
of the strict low chemical elimination diet as it is initially more restrictive in the diagnostic 
phase than 4-FED and 6-FEDs. However, overall adherence rates, in those returning to the 
Allergy Unit, to the low chemical elimination diet in this study were high. Food reintroduction 
to reduce dietary restriction and subsequently improve adherence has been suggested.129 




understanding factors that influence dietary adherence will be able to assist clinicians and 
dietitians in providing appropriate dietary advice, and is further explored in Part C.  
Duration of the strict low chemical elimination diet was not identified to influence histological 
response in this study. To the best of the researcher’s knowledge this is the first time the 
relationship between diagnostic diet duration and histological response has been examined in 
dietary management of EoE. Further research examining the time taken to achieve histological 
remission and/or evoke inflammation could allow for a shorter dietary elimination and 
challenge protocol. Currently, diagnostic diet duration is highly variable in diet therapies for 
EoE and predominantly based on spacing out endoscopies.147 Certainly, in this study clinical 
feasibility and patient preference were determining factors related to timing of the follow up 
endoscopy on the strict low chemical elimination diet. Repeat endoscopies increases the 
length of time on the restricted diet, potentially impacting adherence, QOL (Part C) and 
nutritional adequacy (Part D). Improved diagnostic tests and monitoring procedures (discussed 
in Chapter 4) will likely assist this process.  
Other factors that may have affected symptomatic and histological response include reflux, 
rhinitis and biopsy sampling errors. Seasonal variation in eosinophil counts and symptoms 
have been described in patients with EoE and allergic rhinitis.61 This was not controlled for in 
this study. It is also possible that, as EoE has a patchy distribution, normal biopsies could 
represent a sampling error. However, multiple biopsy samples were taken reducing this 
likelihood.142  
5.10.3 Challenge, personalised diet and liberalisation outcomes 
Food and DBPC capsule challenges were used to identify symptom triggers and provide a 
personalised diet in this study. Wheat and milk were identified as triggers at a rate comparable 
to the literature.113,123,143,326,349 This raises the question, “is the symptomatic and histological 




most common trigger foods of milk and wheat?” Certainly, that is the basis of the 4-FED and 
newer ‘step down’ approaches described in the literature.147 However, as described below, 
additional evidence from liberalisation suggests that removal of food chemicals, in addition to 
wheat and milk were important. 
Amines, salicylates and artificial antioxidants were identified as frequent symptom triggers via 
challenge. To the best of the researcher’s knowledge this is the first time naturally occurring 
food chemicals, artificial colours and preservatives have been reported as triggers of 
symptoms in patients with EoE. In a cohort of patients with IBS, glutamates, salicylates, 
nitrates and preservatives were identified as symptom triggers in almost two-thirds of 
patients,67 whilst in a cohort of patients with treated coeliac disease but persistent symptoms, 
amines, salicylates, milk, glutamates and propionates were identified as symptom triggers in 
approximately half of patients.367  Additionally, in a paediatric cohort of patients with EoE, 13% 
had symptoms and/or histological changes in response to fruits or vegetables.41 Similarly, 
Henderson et al.318 identified salicylate containing foods including strawberries, carrot and 
sweet potatoes and amine containing foods: cocoa, pork and banana to be triggers of 
oesophageal eosinophilic inflammation in paediatric patients with EoE.  Furthermore, in a 
recent case study, aspirin (a salicylate analogue) therapy for aspirin-exacerbated respiratory 
disease was identified as a possible contributing factor to the development of EoE and has also 
been implicated as a risk factor for stricture development.368 The presence of food intolerances 
in these different patient cohorts, with comparable gastrointestinal symptom profiles supports 
the hypothesis that a similar mechanism of visceral hypersensitivity may contribute to these 
symptoms and food chemical intolerances. It has been suggested that food chemicals may also 
act on chemoreceptors on sensory nerve fibres122,124 or act directly on mast cells120 resulting in 
the release of inflammatory mediators. Alternatively, food chemicals may promote peripheral 




decrease lower oesophageal pressure in healthy individuals369,370 and have been associated 
with reflux. In the case series, milk and amines were common symptom triggers identified on 
challenge by patients with EoE, with reflux frequently reported as a symptom. Hence, food 
chemicals may promote acid reflux and subsequently induce sensitisation of oesophageal 
mucosal nerves. Food chemicals could also promote central sensitisation by luminal exposure 
of food chemicals in the lower gastrointestinal system, resulting in local sensitisation of 
afferent nerves, followed by changes in the spinal neuron excitability, with a flow on affect to 
afferent nerves in the oesophagus. Conceptually, this heightened sensitivity throughout 
connected body systems could explains the variety of non-oesophageal symptoms experienced 
by patients with EoE89 in this case study and the ausEE cohort in Chapter 3. Additionally, 
heightened sensitivity within the oesophagus may also explain difficulties swallowing highly 
textured foods described by these patients. Alongside our findings of patients maintaining 
histological improvement on a personalised diet, excluding these food chemicals and induction 
of eosinophilic inflammation and recurrence of symptoms when liberalising with these foods, 
it is plausible that food chemicals may play a role in the pathogenesis of EoE. However, it is 
also recognised that symptom and histological changes to salicylate and amine containing 
foods such as fruit and vegetables could also be due to other adverse food reactions such as 
OAS, lipid transfer protein allergy or fermentable carbohydrates.31 Further research is required 
to establish the role of food chemicals in EoE pathogenesis. 
To the best of the researcher’s knowledge this is the first study examining DBPC capsule 
challenge results in patients with EoE. Overall, food chemical capsule challenges were useful in 
identifying triggers of any symptoms with a low positive placebo response and, determine that 
symptom response to amines, wheat and milk challenges occurred more frequently than 
expected by chance. This was not seen for the remaining challenges. However, analysis was 




traditionally suggested for small sample sizes, has the disadvantage of being conservative, 
producing larger P values and poor power,371 thus further research with a larger sample size is 
required. There was also generally good concordance between negative capsule and negative 
food challenge results for food chemicals. However, a trend towards negative capsule 
challenges and positive food challenges was identified, possibly due to food texture or a dose 
related response or direct contact response.  
Food texture may have confounded open food challenge results. As described in Part A, 
Section 5.6.5 and Chapter 3, food texture can play a role in oesophageal symptoms, thus it is 
possible that oesophageal symptoms on food challenges could have been due to food texture. 
However, clarification through comparison to background symptoms, other symptoms 
reported on challenge, use of DBPC capsule challenges and repeat challenges were important 
in reducing this confounding.  
Alternatively, food chemical doses in capsules may be insufficient to provoke oesophageal 
symptoms in patients with EoE. This highlights a potential disadvantage of the DBPC capsule 
challenges and an important and unexplored area in the EoE literature. Lucendo et al.144 
reported that two patients following a long term milk-free diet could occasionally consume 
milk/milk products with no symptoms, but when consuming milk daily for six weeks (on 
challenge) had histological recurrence, similar to Case B described in Section 5.9.11. 
Conversely, Kagalwalla et al.372 reported one case that had no histological improvement on a 6-
FED but achieved histological remission after subsequently excluding processed foods with 
milk-cross-contamination (though this is likely confounded by the overall broader dietary 
elimination such as food additives). Further research into dose related symptom and 
histological response in patients with EoE is essential to provide improved recommendations 
for doses required for capsule/food challenges and level of avoidance required for long term 




The differences in responses to capsule and food challenge responses also raises the question: 
is direct contact with the oesophageal mucosa important? One patient was asked to complete 
the capsule challenges twice, once with closed capsules and once with open capsules, mixing 
the powdered chemical with golden syrup. Whilst the same compounds provoked symptoms, 
slight variations in the symptom response type were identified. Thus, it appears that mucosal 
contact is not important, however, further research is required to establish this. 
The idiosyncratic nature and variety (oesophageal, non-oesophageal GIT and non-GIT) of 
symptoms reported on challenge is also a unique finding of this study, as symptoms recurring 
on challenge are not well reported in the literature and focus mainly on oesophageal 
symptoms. Though, Kelly et al.130 reported a variety of symptoms including emesis, gagging, 
retching, irritability, abdominal pain and urticaria on open food challenges in paediatric 
patients. Additionally, in our study, using symptoms to identify positive challenge responses 
and prescription of a personalised diet was identified to be successful in identifying a diet on 
which histological improvement was maintained. Further exploration, in a larger sample of 
patients, of oesophageal and non-oesophageal symptoms experienced on challenge, and post 
challenge histological findings would be beneficial to determine whether symptoms can be 
used as a predictor of histological response, thereby reducing the need for repeat 
endoscopies.  
Patient-reported triggers were not found to be related to final challenge results in this study. 
This is possibly due to delayed symptom onset, dose-response threshold and subsequent 
incorrect associations between foods and symptoms. Comparison of patient-reported food 
triggers and any symptom triggers identified by challenge are not otherwise reported in the 
literature. Overall, it emphasises the need for dietary elimination and challenge to correctly 




Personalised diets were found to be highly idiosyncratic. In the literature, final diets 
determined by challenge results are also noted to be highly variable and individual.145 In the 
present study, patients excluded a median of six foods/food chemicals/food additives on their 
personalised diet. In contrast, final diets described in the literature generally exclude only one 
to three foods.142,145 However, it should be noted that these diets focus on exclusion of EoE 
triggers only and do not report other foods patients may be excluding due to symptoms or 
concomitant conditions. Interestingly, this is similar to the number of foods identified to 
trigger symptoms on challenge in this study. This difference between challenge results and 
final personalised diets was due to many patients not completing the full challenge battery. 
For example, many patients did not challenge with soy as they did not consume soy products 
regularly in their usual diet. Similarly, Kagalwalla et al.142 reported that children following a 6-
FED did not challenge with seafood or nuts as these foods were not part of their initial diet. 
This emphasises the importance of personalising the dietary approach to the patient, though 
may have the disadvantage of further restricting the diet.  
Furthermore, many patients do not complete challenges due to the number of repeat 
endoscopies required,142 as endoscopies are suggested after each challenge due to the 
dissociation between symptoms and histology.147 Due to the clinical, observational, ethical and 
retrospective data collection in this study, assessment of the return of eosinophilic 
inflammation after each food chemical challenge was not carried out. This reiterates the need 
for a non-invasive monitoring options such as oesophageal string biopsy300 (Chapter 4) or 
scoring matrix373 and also presents a significant limitation of this study. However, in this study, 
histological and symptomatic improvement appears to be maintained on the personalised diet, 
as determined by symptomatic response to challenges. This highlights an advantage of the 
RPAH EoE dietary investigation protocol used in this study, with an endoscopy conducted after 




check the challenge results. Further research in a larger group of patients is required to 
confirm these results.  
Length of time to complete the entire RPAH EoE dietary protocol was not specifically examined 
as part of this study, but is still an important consideration. The estimated minimal amount of 
time required from starting the elimination diet to having an endoscopy on the personalised 
diet is six months. Though, clinically this is acknowledged to vary greatly from patient to 
patient. Length of time to complete dietary elimination and food reintroduction in other EoE 
dietary therapies appears to be much longer. One study reported patients following an 
elemental diet for an average of 4.5 months and took two years to complete food 
reintroductions. Patients following a 6-FED also spent an average of four months on the diet 
and took nine318 to 17 months142 to complete food reintroduction. Furthermore, patients 
underwent an average of six endoscopies in this time.142 The reduced amount of time and 
number of endoscopies represents a significant advantage of the RPAH EoE dietary protocol. 
However, considering that many patients did not complete the full challenge battery and the 
loss to follow up, a shorter protocol may be desirable.  
5.10.4 Long term outcomes 
Results from the prospective and follow up studies suggested that symptom improvement was 
reportedly maintained long term in patients who had completed the strict low chemical 
elimination diet and challenge protocol. However, histological remission was not maintained 
on liberalisation of the patients personalised diets. This suggests that patients with EoE may 
need to remain on their personalised diets and/or liberalise less freely to maintain histological 
remission, as in Case B (Section 5.9.11). However, further long term research with larger 
numbers is required to elucidate this. Additionally, this may provide key information related to 




In the literature, minimal data on long term dietary outcomes is available. One study followed 
up patients who completed a 6-FED and challenges and identified that patients maintained 
histological remission and reduced symptom scores for up to three years by avoiding trigger 
foods.144 Though it should be noted that the number of patients continuing to comply with the 
dietary restrictions decreased with each year of follow up. Furthermore, patients re-challenged 
with trigger foods four years post completing a 4-FED and challenges continued to react to 
their trigger food.142 Further research into long term dietary outcomes including adherence is 
required.  
5.10.5 Conclusion 
In Part B of this case study it was found that patients with EoE could achieve symptomatic and 
histological remission on a strict low chemical elimination diet. However, further prospective 
research is needed to confirm these results. Furthermore, important factors for monitoring 
and evaluation were identified including dietary adherence, symptoms, histology and allergen 
test results. Future research should more closely examine the relationship between symptoms 
(oesophageal and non-oesophageal), allergen test results and histological response.  
Patients with EoE completing whole food, natural food chemical and additive challenges could 
identify symptom triggers and a personalised diet on which they maintained symptomatic and 
histological improvement. Furthermore, the challenge protocol was beneficial in allowing a 
personalised dietary approach to managing symptoms and histological outcomes in a shorter 
timeframe and without multiple repeat endoscopies (compared to other dietary 
interventions). Long term, on liberalisation of their personalised diet, patients appeared to 
maintain symptom improvement but not histological improvement. It is therefore plausible 





PART C: QUALITY OF LIFE, PSYCHOLOGICAL FACTORS AND 
PERSONALITY TRAITS IN ADULT PATIENTS WITH EOSINOPHILIC 
OESOPHAGITIS 
5.11 QUALITY OF LIFE AND PYSCHOSOCIAL CHARACTERISTICS 
The previous parts of this RPAH Allergy Unit case study explored aspects of the NCP including 
assessment, diagnosis, intervention and monitoring/evaluation in a context of the Australian 
health care system. Patients with EoE in the ausEE cohort, described in Chapters 3 and 4, and 
in the case series described in this case study (Part A) were reported to experience a diverse 
range of symptoms and concomitant conditions. Additionally, patients in the case series 
completing a strict low chemical elimination diet and challenges experienced symptomatic and 
histological remission and identified symptom triggers (Part B). Outside the case study, patient 
experiences explored in Chapter 3 and 4 identified an impact on patients and family QOL in 
relation to symptoms, diagnosis and management, with depressive and anxiety symptoms 
reported. Thus, a broader understanding of biopsychosocial factors affecting patients with 
EoE, especially in relation to the dietary management protocol described in Part B of the case 
study was required. QOL, psychological characteristics and personality traits are often 
measured by validated questionnaires (see Chapter 2). In Part C of the RPAH Allery Unit case 
study characteristics and experiences of patients, including their QOL, psychological 
characteristics and personality traits, and the relationship of these to dietary adherence are 
explored.  
5.11.1 Quality of life in patients with eosinophilic oesophagitis 
By the time patients present with a diagnosis of EoE their QOL is often impaired.320,374–376 





mental health domain scores, vitality scores and perceived lower general health.320 Disease 
duration may also negatively impact the QOL of patients with EoE and has been significantly 
associated with lower mental health domain scores.320 For example, in an adult cohort of EoE 
patients who were diagnosed in childhood, total QOL scores were significantly lower for 
patients than controls.376  In contrast, Menard-Katcher et al.377 also examined an adult cohort 
diagnosed with EoE in childhood and found that total QOL was not significantly impaired; 
despite an average disease duration of seven years. The only impact appeared to be with 
dietary restriction, where overall QOL scores were significantly lower for patients on restricted 
diets than those without restriction.377 More specifically, emotional impact was shown to be 
higher amongst those following a restricted diet, whilst role limitations due to emotional 
problems, social functioning and specific components of the mental health score decreased on 
a 6-FED. 143,358 However, overall, both physical and mental health domain scores improved 
after dietary intervention.143   
Klinnert et al.375 identified that parent reported QOL scores and family impact scores improved 
after six months of individualised multidisciplinary treatment: dietary restriction, 
pharmacotherapy with steroids or a combination of the two. Total QOL scores also improved 
after two months of aerosolised corticosteroid treatment with Mometasone Furoate.374 More 
specifically, significant improvements were seen in symptoms (dysphagia), eating, social 
functioning and mental health scores. Correspondingly, decreased QOL has been found to be 
related to symptoms,290,375,379 especially symptom severity.186,375  Furthermore, psychological 
functioning and internalising symptoms have been shown to negatively impact QOL and thus 
should also be considered.246 
5.11.2 Psychological characteristics of patients with eosinophilic oesophagitis 
Symptoms of depression have been reported in 46% of children and adolescents with EoE, 





adolescents with EGIDs have also been reported to have significantly greater overall 
depressive symptoms than controls, particularly negative mood and negative self-esteem. 
Symptoms of physical anxiety were also significantly greater in this population compared to 
controls, whilst QOL was lower.191 Similarly, Harris et al.190 identified symptoms of anxiety in 
half of their paediatric cohort, with 33% experiencing severe anxiety. Jose et al.192 also 
reported similar rates of anxiety in a small group of children with EoE. There is evidence that 
children with EGIDs may also experience higher rates of somatisation380 and problems with 
social functioning,190 but appropriate symptom and pain management could produce positive 
trends in psychological symptoms.246 Prevalence of eating disorders have not been explored in 
patients with EoE. However, it has been suggested that clinicians should consider it as part of 
their assessment due to the association between other gastrointestinal disorders and eating 
disorders, and the use of diet restriction as a treatment of EoE.381 Currently, there is no 
research available on the psychological symptoms or impact of EoE on adult patients. 
Understanding psychological symptoms and coping styles of patients with EoE could help to 
minimise symptoms and maximise QOL.198  
5.11.3 Dietary adherence 
It has been reported that up to 33-37% of paediatric patients with EGIDs are non-adherent to 
dietary treatment.197,380 Psychological symptoms including depression, anxiety and disordered 
eating have been associated with dietary non-adherence in other gastrointestinal 
disorders.198,380  Additionally, psychological symptoms, in particular depression, have been 
associated with lower QOL and maladaptive coping.198 Psychometric characteristics such as 
personality and symptom severity have been associated with adherence to dietary 
prescription in other conditions.199,205 Understanding factors which predict adherence may 
assist health professionals in choosing appropriate care plans and intervening before patients 





individuals with EoE, who are advised to follow a diagnostic elimination diet and challenge 
protocol, will allow dietary interventions to be tailored to the individual.  
In summary, ongoing symptoms, repeated endoscopies, dietary and medical treatment can 
have a profound impact on QOL and psychological functioning. Understanding the impact of 
symptoms and treatments on patients with EoE, as well as factors that influence dietary 
adherence is important in assisting clinicians to direct, optimise and individualise patient 
care.106  
The objectives of Part C of this case study report were: 
• To assess the QOL of adult patients with EoE over the course of the RPAH EoE dietary 
protocol.  
• To examine psychological symptoms, coping strategies and psychometric 
characteristics of adult patients with EoE and examine potential relationships with 
dietary adherence.  
5.12 METHODS: QUALITY OF LIFE AND PYSCHOSOCIAL CHARACTERISTICS 
5.12.1 Overview of study participants and design 
Part C describes the QOL, psychological and psychometric characteristics of adult EoE patients 
who presented to the RPAH Allergy Unit. The study sample comprises patients described as 
part of the case series presented in Part A. The results presented here were collected in three 
stages: 1) as part of standard clinical practice (see Part A, Section 5.4.1), 2) as part of the 
prospective study (see Part A, Section 5.2.2), and 3) as part of the follow up study (see Part A, 
Section 5.2.2). Inclusion criteria: were patients aged 16 years or over, diagnosed with EoE and 
who had completed one or more of the QOL, psychological or psychometric questionnaires 
described below. Exclusion criteria were patients with suspected EoE or EGIDs other than EoE 





5.12.2 Assessment tools and data collection measures 
Symptom/Diet Questionnaires: In all the SDQs used in the prospective and follow up studies 
(see Appendices I and J) (baseline, on elimination diet, personalised diet and follow up), 
patients were asked to record symptom frequency (‘not at all’ to ‘daily’) and severity (mild to 
severe) on a five point Likert scale. Additionally, patients were asked to rate the impact of 
their symptoms on their QOL on a four point Likert scale (‘not at all’ to ‘very much’). 
Furthermore, in the baseline SDQ, participants were asked to report if they suffered from 
depression, anxiety or an eating disorder (current, past or never) and record the highest level 
of education obtained. 
Quality of Life questionnaires: The following QOL tools were used to assess general QOL and 
specific aspects of QOL related to diet and EoE over the course of the RPAH EoE dietary 
protocol.  
• WHO-QOL-Bref: provides an overall measure of a patient’s QOL, with patients asked 
to rate their QOL in the ‘last 2 weeks’ on a five point Likert scale. Domain scores were 
summed and converted into a score out of 100. A higher score indicates a better QOL. 
This questionnaire was only completed by clinical patients prior to July 2015.187  
• SF-36: includes eight subscales: physical health, role limitations due to physical 
functioning, bodily pain, general health, vitality, social functioning, role limitations due 
to emotional functioning and mental health. A higher score indicates an excellent 
health state.182,382 
• FRQOL: provides an overall food related impairment score, and four subscale scores: 
food avoidance and dietary restriction, risk of accidental food exposure, food related 
health, and emotional impact. A higher score indicates a reduced QOL (Appendix D). 
• EoO-QOL-A: assesses QOL issues specific to adult patients with EoE including: social 





An additional six items are answered for those following a restricted diet. Respondents 
rate the impact of EoE on their QOL, on a five point Likert scale, with a higher score 
indicating a poorer QOL.186 This questionnaire was introduced to the prospective study 
in February 2016.  
Psychological questionnaires: The following psychological questionnaires were used to 
examine psychological characteristics of patients with EoE at baseline and follow up, and to 
correlate to dietary adherence.  
• BDI-II: assesses the clinical status and severity of depression in patients with a higher 
score indicating greater severity of depression. A score of 0-13 is considered to 
indicate minimal risk of depression.212 
• STAI-Y: examines state and trait anxiety with respondents asked to rate the intensity 
and frequency of feelings of anxiety on a four point Likert scale. A higher score 
indicates a greater level of anxiety.211 
• EDE-Q: examines the frequency and severity of behavioural features of eating 
disorders. A total score of four or more is considered to reflect clinically significant 
eating disorder tendency. This can be further divided into four subscale scores: 
restraint, eating concern, shape concern and weight concern, with higher scores 
indicating a greater level of disturbance.383 
• CISS: assesses coping strategies with respondents asked to indicate “how much you 
engage in these types of activities when you are in a difficult, stressful or upsetting 
situation” on a five point Likert scale. T-scores are calculated, with t-scores of 45-55 
considered the ‘average’ classification range.214 
Psychometric questionnaires: The following psychometric questionnaires were examined at 






• FLQ-SF: For this study the diet-health orientation, food and pleasure and natural food 
preferences subscales were examined. A higher score indicates more of the food 
attitude for the subscale name.204 
• CONVOR: examines tendency to save time and energy in regards to meal preparation. 
Respondents are asked to agree with food related behaviours on a four point Likert 
scale with a higher score indicating a greater propensity for time and energy saving.207 
• BFI-10: assesses individual differences in personality based on the ‘Five Factor Model’.  
Respondents are asked to agree with personality traits on a four point Likert scale 
with a higher score indicating more of the personality trait. The addition of a third 
agreeableness item to increase the validity of the scale was used in this study as 
suggested by Rammstedt et al. 215 
Dietary adherence: Dietary adherence was assessed in two ways. Firstly, patients were 
classified as ‘diet-returners’: those that returned on the strict elimination diet, and ‘lost to 
follow-up’: those who did not return for diet follow up. Follow up study participants were 
categorised according to their response on the SDQ regarding starting the elimination diet 
(‘starter’ and ‘non-starter’).  
Secondly, for those that returned, dietary adherence was assessed by the PhD candidate at 
four and eight weeks on the elimination diet. For patients who had completed any of the 
questionnaires as part of standard clinical practice, dietary adherence was assessed from the 
attending dietitian’s clinical notes and clinical diet histories. Participants in the prospective 
study were asked to provide a self-evaluation of dietary adherence and this was cross checked 
against their diet history and/or four day WFR on the elimination diet.  
Patients were categorised as ‘adherent’ and ‘non-adherent’, according to the subcategories of 





Shepherd and Gibson,384 but were adjusted to reflect the shorter time frame of this study. 
Patients ‘lost to follow-up’ were assumed to be non-adherent. 
Table 5.12: Categories and definitions of dietary adherence. 
Major category Sub-category Definition 
Non-adherent Never Never followed the diet 
Occasionally Followed the diet less than 
50% of the time 
Adherent Frequently Followed the diet more than 
50% of the time OR 
Followed the diet at all times 
except on some occasions 
Always Followed the diet totally 
 
Anthropometry: Anthropometric measures were taken by trained staff at the initial 
appointments. Height was measured to the nearest 0.5cm using a stadiometer. Weight was 
measured to the nearest 0.1kg using digital scales. Follow up study participants were asked to 
provide self-reported height and weight. Body Mass Index (BMI) was calculated (kg/m2) and 
patients categorised according to their BMI class.114  
5.12.3 Data analysis 
Completed questionnaires were entered in a Microsoft Excel spreadsheet and scored, with any 
missing data adjusted according to the suggested scoring criteria for each questionnaire. Basic 
demographic data was tabulated from the patient database. Further analysis using descriptive 
statistics was conducted using SPSS statistical analysis software (IBM Australia Ltd., Sydney, 
Australia).231 Figures were produced using GraphPad PRISM software (GraphPad Software, La 
Jolla California, USA).314  All continuous variables were tested for normality using the Shapiro-
Wilk test. T-scores for the EoE population were calculated to allow for comparison against 
population norms where required. Independent t-tests were conducted to assess for 
differences between QOL, psychological and psychometric mean scores and Australian 





Independent t-tests and Mann Whitney U tests were used to assess for differences in QOL, 
psychological and psychometric scores by age, gender, education and BMI class at baseline.  
Spearman’s correlations were used to examine relationships between QOL, psychological 
scores and age of disease onset, age of diagnosis, delay to diagnosis and disease duration at 
baseline. Symptom frequency and severity were recoded into dichotomous variables (‘not at 
all/occasionally’ and ‘monthly-daily’, ‘mild-moderate’ and ‘moderate-severe’ respectively). The 
relationship between symptom frequency, symptom severity, dietary adherence and QOL, 
psychological and psychometric scores was also examined using independent t-tests and Mann 
Whitney U tests at baseline and at long term follow up. Pearson’s chi-square crosstabulations 
were used to examine associations between dietary adherence, symptom frequency and 
symptom severity. Self-reported QOL was recoded into dichotomous variables (‘not at all/just 
a little’ and ‘pretty much-very much’ affected). The relationship between self-reported QOL 
and SF-36 subscale scores were examined using a Mann Whitney U test.  
Dependent t-tests and Wilcoxon signed rank tests determined the difference between QOL 
scores and subscale scores at baseline and on the strict elimination diet. A Friedman’s test 
assessed differences in QOL scores at baseline, on the strict elimination and on the 
personalised diet. A McNemars test was used to assess for differences in self-reported QOL on 
the elimination diet and at follow up.  Questionnaires completed by patients not following the 
strict elimination diet at the ‘on elimination diet’ time point were examined separately to 
ensure scores reflected the impact of dietary change. Statistical significance was set at P < 
0.05.   
5.13 RESULTS: QUALITY OF LIFE AND PYSCHOSOCIAL CHARACTERISTICS 
5.13.1 Characteristics of patients completing QOL and psychosocial questionnaires 
Sixty-seven patients were identified as having completed at least one questionnaire at any 






Figure 5.23: Flow diagram of patients with eosinophilic oesophagitis completing 
quality of life, psychological and psychometric questionnaires. Abbreviations: SDQ: 
Symptom/Diet Questionnaire, SF-36: Short Form 36 item, WHO-QOL bref: World 
Health Organisation Quality of Life Bref Questionnaire, FRQOL: Food Related Quality of 
Life, EoO-A-QOL: Adult Eosinophilic Oesophagitis Quality of Life Questionnaire, BDI-II: 
Beck Depression Index, STAI-Y: State and Trait Anxiety Inventory-Y, EDE-Q: Eating 
Disorder Examination Questionnaire, CISS: Coping Inventory for Stressful Situations, 
FLQ-SF: Food-Life Questionnaire Short Form, CONVOR: Construct of Convivence 
Orientation, BFI-10: Big Five Inventory-10. *: Questionnaire introduced as a clinical tool 
in 2013. ^: Questionnaire introduced as a clinical tool in 2013 and removed in 2015. +: 






Approximately half the patients were male (57%) with an average age of 32.7±9.8 years. No 
specific differences were identified in demographic characteristics in patients completing the 
questionnaires at different dietary stages. Three patients who did not return for further 
dietary counselling and one patient on an elemental diet also completed the QOL 
questionnaires. Due to the small numbers, these patients’ questionnaires were not analysed.   
5.13.2 Baseline quality of life of patients with eosinophilic oesophagitis 
Overall results indicate the QOL in patients with EoE is affected at baseline compared to 
Australian population norms.385 The SF-36 mean subscale scores for role limitations due to 
emotional problems, vitality, social functioning and general health were identified to be 
significantly lower in the EoE population than the general population (Figure 5.24). In patients 
(N=19, 79% Male) who had completed the WHO-QOL-bref, the mean physical domain score for 
EoE patients was found to be one standard deviation below the population norm, 386 though 




































Figure 5.24: Baseline SF-36 mean subscale score for patients with Eosinophilic Oesophagitis 
compared to the Asutralian population norms387 (N=37). Abbreviations: *: p<0.05, **: p<0.001, 
PF: Physical functioning, RLP: Role limitations due to physical functioning, RLE: Role limitations 
due to emotional problems, V: Vitality, MH: Mental health, SF: Social functioning, BP: Bodily 
pain, GH: General health. A higher score indicates a better quality of life. Independent t-tests 
identified significantly lower mean subscale scores for; role limitations due to emotional 
problems (t=-2.15, df=35.6, p=0.038), vitality (t=-2.91, df=35.6, p=0.006), social functioning (t=-
3.04, df=35.6, p=0.004) and general health (t=-6.38, df=35.7, p<0.001) scores in the EoE 




Symptoms were identified to impact QOL at baseline. This was exemplified in the SF-36 data 
with significantly lower median Physical Component Summary (PCS) and Mental Component 
Summary (MCS) scores identified in those reporting more frequent symptoms (Table 5.13). 
Additionally, in patients completing the baseline SDQ (N=54) approximately half (57%) 
reported that symptoms impacted their QOL ‘pretty much’ or ‘very much’ and only three 
participants reported that their QOL was ‘not at all’ impacted by their symptoms. 





significantly higher on the general health SF-36 subscale than those reporting ‘pretty much - 





Table 5.13: Relationship between baseline SF-36 physical and mental component summary scores and symptom frequency.  












αMann Whitney U test. Abbreviations: CNS: Central Nervous System
Symptom frequency Physical Component Summary 
(median) 
Mental Component Summary 
(median) 
Never- Occasionally Monthly-daily P valueα Never- Occasionally Monthly-daily P value α 
Gastrointestinal 
Nausea 53.3 49.9 0.149 48.6 42.0 0.009 
Reflux 52.2 53.6 0.869 48.0 46.0 0.817 
Heartburn 53.2 41.1 0.017 48.4 44.6 0.407 
Indigestion 52.8 52.5 0.753 48.5 44.9 0.294 
Abdominal pain 53.2 51.7 0.181 50.1 44.1 0.030 
Diarrhoea 53.2 51.7 0.065 48.6 44.1 0.019 
Constipation 54.0 49.9 0.012 49.8 44.1 0.001 
CNS 
Headache 53.3 49.9 0.030 49.8 44.1 0.111 
Fatigue 53.3 51.7 0.011 50.1 44.1 0.043 





Additionally, in patients that had completed the EoO-QOL-A at baseline (N=14, 57% Male), the 
swallowing anxiety subscale was identified to be impacted (1.3±0.9 out of 4, where 4 is very 
poor QOL). Relationships between QOL and symptom severity could not be calculated due to 
small numbers. No relationships were identified between QOL and age of onset, age of 
diagnosis, delay to diagnosis or disease duration. 
Disease anxiety and dietary restriction were also identified to impact QOL of patients with EoE 
at baseline. The eating/diet impact (1.9±1.3) and disease anxiety (1.7±1.1) subscales of the 
EoO-QOL-A were identified to have the highest mean scores at baseline indicating a higher 
impact on QOL due to concern about eating, diet and health.  
Females were identified to have poorer QOL than males at baseline. In patients completing the 
SF-36, males with EoE were identified to score significantly higher than females on role 
limitations due to emotional problems, social functioning and bodily pain (p=0.015, p=0.025, 
p=0.009 respectively). Additionally, females were identified to have a significantly higher total 
(p=0.003) and subscale (food restriction p=0.002) and emotional impact (p=0.042) FRQOL 
scores than males at baseline, indicating poorer food related QOL in women. 
5.13.3 Baseline psychological characteristics of patients with eosinophilic 
oesophagitis 
Overall results indicate that patients with EoE exhibit greater depressive and anxiety 
symptoms, but not eating disorder tendency, compared to the Australian general population. 
More specifically, the mean BDI-II score was significantly higher in the EoE population than the 
Australian population (p=0.031), with a score twice that of the population norm.388 However 
both were considered minimal risk (scoring less than 13).  State anxiety was also identified to 
be significantly higher in the EoE population than the Australian population388 (p=0.033). In 
contrast, mean total EDE-Q score (0.9±1.0) at baseline was below the clinical cut-off of four, 





significant differences were identified between the EoE female population EDE-Q total and 
subscale scores and the Australian population norms (derived from females).383 However, 
females with EoE were identified to exhibit more psychological symptoms than males at 
baseline with significantly higher median BDI-II, state and trait anxiety and total and subscale 
EDE-Q scores than males (Appendix R). Self-reported depression, anxiety and disordered 
eating aligned with results from the respective assessment tools. Of the SDQ respondents 
completing this question (N=56), almost half (44%) reported current anxiety, whilst 13% 
reported current depression and no patients reported a current eating disorder. A history of 
anxiety (14%) and depression (27%) was also notable and three patients reported a history of 
disordered eating. 
 
Gastrointestinal symptoms and fatigue were identified to impact psychological characteristics 
at baseline. Significantly higher BDI-II scores were identified in patients experiencing ‘monthly-
daily’ symptoms of heartburn, abdominal pain, diarrhoea, constipation or fatigue compared to 
those experiencing symptoms ‘never/occasionally’ (Appendix S). Patients reporting more 
frequent symptoms of the sensation of food sticking, heartburn, indigestion, abdominal pain, 
diarrhoea, constipation and fatigue had significantly higher state and trait anxiety scores 
(Appendix S). Interestingly, significantly higher EDE-Q total scores were identified in patients 
experiencing ‘monthly-daily’ symptoms of diarrhoea and fatigue compared to those 
experiencing symptoms ‘never/occasionally’ (p=0.022, p=0.003 respectively). No relationships 
were identified between BDI-II, STAI-Y or EDE-Q total and sub scale scores and age, age of 
onset, age of diagnosis, delay to diagnosis or disease duration. 
 
At baseline, patients with EoE were identified to be emotion and avoidance oriented copers. 
Overall, all mean CISS t-scores for EoE patients were identified to be within the ‘average’ 





than the population norms for task-oriented coping (p=0.001, p<0.001 respectively), and 
higher for emotion-oriented coping (p<0.001, p=0.024 respectively), reflecting a maladaptive 
coping style. Males also had a significantly higher mean score for avoidance-oriented coping 
than the male population norms (p=0.002).  
5.13.4 Baseline psychometric characteristics of patients with eosinophilic 
oesophagitis 
Patients with EoE who attended the Allergy Unit, were identified to be diet-health oriented, 
food-pleasure oriented and to prefer natural food (Table 5.14). Patients were also found to 
have low (38 out of 100) time and energy saving scores indicating that they are not 
convenience oriented and were moderately (48 out of 100) variety-seeking. In relation to 
personality, patients with EoE were identified to score highly for conscientiousness and 
agreeableness (both 73 out of 100) and scored significantly higher for conscientiousness than 
the general Australian population (p=0.004). Interestingly, females with EoE scored 
significantly higher for extraversion and agreeableness than males (p=0.012, p=0.011 
respectively). No significant differences in FLQ-SF and CONVOR scores by age, gender, 
education or BMI class were identified.  
Table 5.14: Psychometric characteristics of patients with eosinophilic oesophagitis at baseline.  
Psychometric Variable Score^ 
Mean (SD) 
Food-life beliefs (N=54) 
Diet-health orientation 
Food pleasure 





Convenience Orientation (N=52) 






















5.13.5 Dietary adherence 
Patients who had completed at least one question in the baseline SDQ (N=58) were 
categorised into ‘diet-returners’ (N=37), ‘lost to follow-up’ (N=19) and ‘not for diet’ (N=2).  
There were no significant relationships between returning on the strict elimination diet and 
age, gender, education, BMI class, QOL, psychological or psychometric scores or symptom 
frequency. Patients were further categorised into ‘dietary adherers’ (N=35) and ‘non-adherers’ 
(N=23). Patients identified to adhere to the elimination diet were more likely to report 
‘monthly-daily’ indigestion at baseline than those that did not adhere to the strict elimination 
diet (p=0.022). No other significant relationships were identified. The relationship between 
adherence and symptom severity could not be examined due to small numbers.  
5.13.6 Quality of life of patients with eosinophilic oesophagitis over the dietary 
protocol 
Improvements in QOL in relation to symptoms were identified on the strict elimination diet 
and on the personalised diet. This was evident from SF-36 data with patients with EoE 
identified to score positively for physical functioning (88.8±20.4) on the elimination diet. There 
was also a trend towards improvement in mean bodily pain subscale score on the strict 
elimination diet, though this was not significant. Additionally, swallowing anxiety (0.6±0.6) in 
the EoO-QOL-A decreased (improved QOL) and was the least affected QOL subscale domain on 
the personalised diet. Furthermore, participants completing the ‘on-elimination diet’ and 
‘personalised diet’ SDQs were asked to rate the impact of their symptoms on their QOL at 
baseline, on the strict elimination diet and on the personalised diet. There was a significant 
increase in the proportion of patients reporting their QOL to be “not at all – just a little” 
impacted by symptoms on the elimination diet (p=0.008).  No differences in self-reported QOL 





Unsurprisingly, QOL was identified to be impacted by dietary restriction on the strict 
elimination diet and on the personalised diet. This was exemplified in the results from patients 
completing the FRQOL, with a significant increase in food restriction subscale score from 
baseline (p=0.022) indicating reduced QOL related to dietary restriction (Figure 5.25). Similarly, 
the eating/diet subscale in the EoE-QOL-A was identified to be most impacted (2.1±0.9) and 
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Figure 5.25: FRQOL mean total and subscale scores for EoE patients before and on the 
elimination diet (N=20). Abbreviations: *: p<0.05. A higher score indicates a poorer 
quality of life. A Wilcoxon Signed Rank test identified a significant increase in median 
food restriction subscale score on the elimination diet (Z=-2.299, p=0.022).  
 
Although, small numbers make interpretation difficult, results from the FRQOL (N=8) identified 





(3.3±0.5 out of 4). Similarly, the diet/eating subscale (2.1±1.3) for the EoO-QOL-A remained 
elevated on the personalised diet. Changes in QOL between baseline, on the elimination diet 
and on the personalised diet could not be calculated due to small numbers.  
The impact of dietary changes on social and emotional QOL appeared to be minimal. In 
patients completing the SF-36 questionnaire, there was a trend towards an improvement in 
role limitations due to emotional problems and social functioning on the elimination diet, but 
this was not significant. In contrast, no changes were seen in the FRQOL emotional impact 
subscale score on the elimination diet from baseline (Figure 5.25), whilst EoO-QOL-A subscale 
social and emotional impact scores increased, though this was not significant.  
5.13.7 Long term quality of life and psychological characteristics of patients with 
eosinophilic oesophagitis 
Overall results indicate that QOL is impacted at follow up compared to the Australian 
population norms.385 This was evident when examining the mean SF-36 sub-scale scores for 
EoE patients compared to the Australian population norms385 (Figure 5.26), with patients with 
EoE identified to score significantly lower than the Australian population for role limitations 
due to emotional problems, bodily pain and general health.  
QOL was identified to be impacted at follow up in relation to dietary restriction and concern 
about symptoms. This was evident from the FRQOL, where patients scored highly for diet 
restriction (2.6±0.7) and emotional impact (2.6±0.8) subscales indicating greater impact on 
QOL from dietary restriction and concern about food reactions. Furthermore, patients scored 
highest on the EoE-QOL-A swallowing anxiety subscale (1.7±1.3), indicating an impact on QOL 
due to concern about symptoms. Additionally, a trend towards poorer QOL scores (SF-36, 
FRQOL and EoE-QOL-A) with increasing symptom frequency was identified, however, due to 





the strict elimination diet could not be calculated. No difference in self-reported QOL at 

































Figure 5.26: Mean SF-36 subscale scores for patients with eosinophilic oesophagitis at 
long term follow up compared to Australian population norms385 (N=15). 
Abbreviations: *:p <0.05, **: p<0.001. PF: Physcial functioning, RLP: Role limitations 
due to physical functioning, RLE: Role limitations due to emotional problems, V: 
Vitality, MH: Mental health, SF: Social functioning, BP: Bodily pain, GH: General health. 
A higher score indicates a better quality of life. Independent t-tests identified 
significantly lower subscale scores for role limitations due to emotional problems 
(t=3.02, df=18633, p=0.003), bodily pain (t=3.33, df=18712, p<0.001) and general 
health (t=3.11, df=18728, p=0.002) in patients with EoE compared to the Australian 
population.  
 
Psychological symptoms of depression and anxiety in EoE patients at follow up were similar to 
Australian population norms.388 More specifically, mean BDI-II score for EoE patients was 
within the minimal risk range (9.3±7.9) and not significantly different from the Australian 





towards higher state and strait anxiety scores with increasing symptom frequency was 
identified. Due to small numbers relationships between BDI-II and STAI-Y scores and symptom 
frequency or starting the strict elimination diet could not be calculated. 
At follow up, patients did not exhibit eating disorder symptomatology. More specifically, mean 
total EDE-Q score was below the clinical cut off of four (0.8±1.0). Due to small numbers of 
females with EoE completing the follow up questionnaire, female only comparisons to the 
Australian population norms were not performed.  
Overall, patients at follow up were identified to be task oriented copers. All subscale scores 
were identified to be within the ‘average’ classification range. Males with EoE were identified 
to score significantly lower for task oriented coping and higher for emotion oriented coping 
than the Australian norms389 (p=0.048, p=0.039 respectively). Due to small numbers of females 
with EoE completing the follow up questionnaire, comparisons to the Australian female 
population norms were not performed.  
5.14 DISCUSSION: QUALITY OF LIFE AND PYSCHOSOCIAL CHARACTERISTICS 
This study identified that adult patients with EoE have reduced QOL at baseline, all stages of 
the RPAH EoE dietary protocol and at follow up. QOL was identified to be related to symptoms 
and dietary restriction. Furthermore, at baseline, patients with EoE experienced increased 
depressive and anxiety symptoms compared to the general population. Patients presenting the 
Allergy Unit were also more likely to be diet-health oriented and conscientious. Higher 
frequency of baseline indigestion was the only factor identified to be positively related to 
dietary adherence to the strict elimination diet.  
5.14.1 Quality of life of patients with eosinophilic oesophagitis  
Overall, this study identified that QOL is reduced in patients with EoE at baseline compared to 





vitality, social functioning and general health SF-36 subscales scores were all significantly lower 
than population norms. Similarly, in cohorts in the UK, Netherlands and US, vitality,320,390 
general health,320,390 mental health and MCS143 scores were lower in EoE patients than 
population norms.  
Females were identified to have poorer QOL than males in this study, particularly in relation to 
food restriction and emotional impact. Similarly, Molina-Infante et al.391 identified female 
gender to be a determinant of eating/diet related QOL in patients with EoE. Female gender has 
also been associated with reduced QOL in patients with coeliac disease392 and IBS,393 suggested 
to be due to greater concern about dietary restrictions than males392 or differences in 
symptom severity.393 Furthermore, in most western countries, in the general population, 
females report lower QOL than males,394  which could also explain this difference.  
This study was similar to other studies in identifying symptoms to impact QOL at baseline.391,395 
However, it differed in identifying lower gastrointestinal symptoms and fatigue, but not 
oesophageal symptoms to impact QOL.390,391 This is surprising as recurrent food impaction and 
regurgitation has been identified to significantly impact QOL in patients with EoE.395 The 
severity of symptoms has also been shown to be a major determinant of QOL in patients with 
EoE395,396 and IBS.397 In a conceptual model of factors influencing QOL in children with EoE, 
Lynch et al.246 suggest that targeting symptoms, particularly pain and sleep disturbances could 
help produce positive trends in QOL outcomes.  
The use of disease specific QOL tools (FRQOL and EoO-A-QOL) was useful in identifying more 
specific aspects of QOL impacted in patients with EoE. For example, disease anxiety was 
identified to contribute to poor QOL at baseline in this study. Increased disease anxiety related 
QOL in patients with EoE has also been described in other cohorts378,391 and has been related 
to symptoms, particularly food impaction.391 Our study identified food/diet related QOL was 





likely due to many patients with EoE already recognising dietary triggers (Part A) and 
restricting their diets prior to attending their initial appointment (Part D) due to symptoms, 
and concomitant conditions such as food allergy and coeliac disease. This highlights that 
assessment and consideration of baseline dietary restriction prior to prescribing any dietary 
elimination for management is also important in relation to impact on QOL.  
The aim of the RPAH EoE dietary protocol is to identify foods contributing to symptoms and 
oesophageal inflammation and subsequently provide a personalised diet to manage symptoms 
and QOL. However, understandably QOL was further impacted by dietary restriction on the 
strict low chemical elimination diet, with a significant increase in diet restriction related QOL 
score identified using the FRQOL tool. Whilst our small sample showed only a trend in an 
increase in the EoO-QOL-A diet/eating score, in a Spanish cohort, patients following a diet 
restriction were identified to have significantly poorer QOL in relation to food/eating and 
emotional impact compared to non-diet restrictors.378 Overall, our findings, consistent with the 
literature, suggest that QOL of patients with EoE is impacted by dietary restriction. This is an 
important consideration when prescribing any dietary management, particularly as QOL may 
already be impacted at baseline. However, QOL may improve with dietary restriction in 
relation to symptom improvement as seen in this study and others.1,143 This highlights the 
importance of discussing the benefits and limitations of dietary management plans with 
patients to allow them to make informed treatment choices.  
QOL in the follow up study group was also found to be impacted in this study in relation to 
symptoms and eating/diet restriction, similar to the prospective study cohort at baseline. 
Minimal data is available on long term QOL outcomes in patients with EoE, but in one cohort 
treated with swallowed corticosteroids for two months and followed up at one year, no 
changes were seen in any general QOL scores between baseline and one year.398 Chapter 4 





did not identify disease duration or diagnostic delay to be related to QOL scores, described in 
other populations.320,391  
Overall, QOL of adult patients with EoE is impacted at baseline due to symptoms, food/diet 
restriction and concern about health. QOL impacts continue with dietary restriction on a strict 
low chemical elimination diet, despite improvements in symptom-related QOL. Thus, within 
the NCP, QOL is an important consideration for assessment and planning of nutrition 
interventions in patients with EoE. In monitoring and evaluation, QOL can be used as an 
indicator to monitor change over the course of the RPAH EoE dietary protocol. Further studies 
with larger numbers are needed to explore patients with EoE QOL on their personalised diets 
and long term after dietary liberalisation. 
5.14.2 Psychological characteristics of patients with eosinophilic oesophagitis 
Adult patients with EoE were identified to score significantly higher for depressive symptoms 
than the Australian population norms at baseline in this study, however, overall were below 
the clinical cut-off score. Adult patients with EoE also scored significantly higher than the 
population norms for state but not trait anxiety. This suggests patients with EoE have an 
increased ‘current’ or ‘transitory’ level of anxiety, but not a greater disposition for anxiety as a 
personality trait than the general population. Increased state anxiety has been described in 
patients with other gastrointestinal conditions such as IBD and food allergies due to 
symptoms, concern about health, dietary restrictions and medical management,193 which are 
also likely to contribute to the increased state anxiety seen in our EoE population.  
To the best of our knowledge this is the first time depressive and anxiety symptoms have been 
specifically examined in adults with EoE. One Spanish study did report that approximately 10% 
of patients in their cohort showed ‘probable or certain depression’, whilst a third were 
reported to have ‘probable or certain anxiety’ on the Hospital Anxiety and Depression Scale.378 





depressive symptoms and elevated physical anxiety symptoms, but not total anxiety symptoms 
compared to controls.191 Additionally, in children with EoE, depression symptoms were 
reported in 46% of children, with half experiencing severe symptoms requiring clinical 
intervention.190 Symptoms of anxiety were also reported in half of patients, with a third 
experiencing severe anxiety.190 Furthermore, parent reported depression and anxiety symptom 
scores were elevated but not above the clinical cut-off.380 This may not be unique to EoE with 
symptoms of depression and elevated state anxiety described in other conditions including 
food allergy, asthma,193,399 IBS193,397 and coeliac disease.193  
One of the notable findings in our study is the increased depressive and anxiety symptoms in 
females compared to male patients with EoE, similar to a cohort of patients with other 
gastrointestinal conditions.193 Gender differences in these symptoms have also been described 
previously in the general population400,401 so the impact of symptoms and disease are likely to 
be similar in males and females. Clinicians should consider recommending referral to 
psychological support if patients with EoE are experiencing persistent or major depressive and 
anxiety symptoms.  
Frequency and severity of symptoms may be a key indicator of psychological symptoms. This 
work was consistent with studies showing increased anxiety in patients with food allergies with 
a history of anaphylaxis402 and in patients with more severe IBS symptoms.393,397 Anxiety 
symptoms to swallowing food have also been reported in children with EoE who have 
experienced food impactions.106 Additionally, patients with IBD and depression report greater 
gastrointestinal symptoms than those without depression.198 Thus, it is possible that 
depressive and anxiety symptoms may be heightened by symptoms, particularly oesophageal 
and gastrointestinal symptoms or food reactions in patients with EoE. Furthermore, 
management of these symptoms may assist in reducing or managing depressive or anxiety 





up cohort in this study with depressive and anxiety symptoms below the clinical cut off and 
similar to Australian population norms. 
This study was unique in its assessment of eating disorder symptomatology and identified that 
patients with EoE do not have a clinically significant eating disorder tendency and were similar 
to the Australian population both at baseline and long term follow up. Increased prevalence of 
disordered eating in other gastrointestinal disorders including coeliac disease, IBD, achalasia 
and FGID has been described, however, evidence remains conflicting.381 Interestingly, in this 
study greater frequency of diarrhoea and fatigue were associated with higher EDE-Q score. 
This could reflect some of the parallels in symptomatology described in gastrointestinal 
conditions and eating disorders. However, despite these similarities in symptoms, proper 
assessment will differentiate between EoE related symptoms and eating disorder tendency.  
This study identified both males and females with EoE, who attended the Allergy Unit, to score 
significantly lower on task-oriented coping and higher for emotion oriented coping compared 
to the population norm, at baseline and at long term follow up. Increased emotion oriented 
coping combined with decreased task oriented coping scores is generally considered to 
constitute a maladaptive coping style.198 Maladaptive coping is the use of coping methods that 
are not productive to the stressor experienced,201 for example, self-distraction, self-blame, 
denial, suppression or rumination.198,403  Maladaptive coping has been associated with 
depression and anxiety in the general population403 and in patients with coeliac disease,198 
IBD404 and HIV.201 Thus, it is possible that the use of maladaptive coping strategies could also 
conceivably contribute to the increased depressive and anxiety symptoms seen in our EoE 
population. It has been suggested that using appropriate coping strategies in stressful events 
may lessen psychological symptoms. Thus, identifying coping strategies used by patients, and 
educating patients on helpful, adaptive strategies and decreasing reliance on maladaptive 





QOL.198,201,402 To the best of the researchers’ knowledge this is the first time coping styles have 
been examined in patients with EoE, thus further research is required to better understand 
coping styles in patients with EoE and the impact on psychological symptoms and disease 
management.  
Overall, it seems that a multidisciplinary team, skilled not only in dietary management to assist 
patients in achieving symptom relief, but also in the provision of counselling strategies to deal 
with illness, may provide the best care for this patient group. Psychological issues may be 
outside the scope of practice of dietitians, but detection, recognition and appropriate referral 
of these problems is relevant to holistic care of patients with EoE, emphasising the importance 
of the multidisciplinary team.  
5.14.3 Psychometric characteristics of patients with eosinophilic oesophagitis 
Patients with EoE in this study were identified to be more conscientious than the general 
Australian population. This is likely a reflection of the referral population, that is, patients who 
are more conscientious would be more likely to seek treatment advice, participate in a study 
and complete questionnaires. Similarly, the low time and energy saving scores in this 
population may also have been a factor influencing participation in the prospective study and 
completing questionnaires. Additionally, patients with EoE in this study were identified to be 
diet-health oriented. This is likely also bias by the referral population as patients who are more 
diet-health oriented may be more likely to seek dietary advice, such as at the Allergy Unit. 
Overall, to the best of the researcher’s knowledge this is the first time psychometric 
characteristics have been described in an EoE population. Further research is required to 
identify if similar characteristics are seen in other populations as understanding personality 
and behavioural characteristics, and food and eating behaviours, may be useful to inform 





5.14.4 Dietary adherence 
Dietary non-adherence rates in this study were similar to those reported previously in children 
with EGIDs.197 Except for indigestion frequency, dietary adherence was not associated with any 
other factors measured. Lack of immediate symptoms has been identified to contribute to 
dietary non-adherence in children with EGIDs197 and non-adherence to a gluten free diet in 
patients with coeliac disease.405 Similarly, Part B identified that patient reported symptom 
triggers rarely correlated to dietary triggers identified by challenges due to food texture and 
the delayed nature of symptom onset. In individuals with coeliac disease, greater symptom 
severity has been associated with greater intention and adherence to a gluten free diet. 
Therefore, the lack of immediate symptoms may explain why many symptoms were not 
associated with dietary adherence in this study.  
Another factor associated with dietary adherence may be depression. In a cohort of children 
with EGIDs, clinical depression was significantly associated with medication non-adherence 
(although anxiety and somatisation were not).196 Depression has also been associated with 
dietary non-adherence in coeliac disease.198 In this study, no differences in depressive 
symptoms were identified between patients who adhered to the strict elimination diet and 
those who did not adhere. However, it should be noted that median BDI-II score was under the 
clinical threshold for both groups. Therefore, it is possible that depressive symptoms could 
contribute to dietary non-adherence in patients with EoE and clinical depression, but was not 
seen in this cohort due to the low rates of severe depressive symptoms.   
Other barriers to dietary adherence that have been suggested in relation to other restrictive 
diets include length of follow up, cost,103,406 access and availability of speciality food,197 social 
factors such as eating out and family/friend/school support,103,197,405 taste405 and ease of 
following the diet or incorporating the diet into lifestyle.197,218 Certainly, ease of following the 





with EGIDs identified membership in a support group tended to correlate with dietary 
adherence, with 85% of participants seeking online diet support.197 One study has examined 
the economic burden of a 6-FED, and did identify it to be more expensive and required 
shopping at an additional grocery store compared to an unrestricted diet.406 However, the 
impact on dietary adherence was not examined. Further research looking at symptoms, 
economic burden, access, availability, support and incorporation of dietary restriction into 
lifestyle and dietary adherence in patients with EoE is required. This should include the initial 
diagnostic phase of dietary management and long term maintenance diets. Qualitative 
research may be beneficial to assist with identifying specific factors influencing dietary 
adherence407 in patients with EoE. 
5.14.5 Conclusion 
In adult patients, attending the RPAH Allergy Unit, QOL appeared to be affected at 
presentation to the clinic, on the strict low chemical elimination diet, personalised diet and 
long term. Depressive and anxiety symptoms were also elevated in these patients at 
presentation to the clinic, but not in the long term. Additionally, this clinical sample did not 
have an eating disorder tendency. Dietary adherence was not related to age, gender, 
psychological functioning or psychometric characteristics, but may be related to symptoms of 
indigestion. Further research into the role of symptoms and other behavioural and social 
factors, such as cost, would be beneficial to identify factors related to dietary adherence. 
Overall this study emphasises the need for individualised care based on the patient’s situation 
rather than focusing exclusively on the disease, involving thorough assessment, nutrition 






PART D: NUTRITIONAL ADEQUACY AND DIET QUALITY OF 
PATIENTS WITH EOSINOPHILIC OESOPHAGITIS FOLLOWING THE 
ROYAL PRINCE ALFRED HOSPITAL EOE DIETARY ELIMINATION 
AND CHALLENGE PROTOCOL  
5.15 NUTRITIONAL ADEQUACY AND DIETARY QUALITY 
The previous parts of this chapter provided an in depth exploration into patient experiences 
with a dietary investigation protocol. This final section, Part D, continues with the in depth 
exploration, focusing on a concern identified outside the case study and reported in Chapters 3 
and 4: the impact of restricted diets used in the management of EoE on nutritional status. 
Determining dietary intake to examine the impact of dietary restriction on the nutritional 
status of patients with EoE was necessary to recommend and develop improvement strategies. 
Thus, dietary intake assessment was incorporated into the prospective and follow up studies 
described previously. 
A potential shortcoming of any diet that involves exclusion of multiple foods or food groups is 
the risk of inadequate nutrient intake, potentially resulting in nutritional deficiency. For 
example, a gluten free diet has been shown to lead to a reduction in carbohydrate, fibre and 
iron intake compared to pre-diagnosis diets, in patients with coeliac disease.219 The 6-FED, 
commonly used in the dietary management of EoE could also pose a risk of inadequate 
nutrient intake if appropriate substitutions are not made, as many food groups (dairy, grains, 
meat/meat alternatives) are restricted.103 The RPAH EoE dietary protocol (see Appendices A.2 
and A.3) requires elimination and substitution of foods across several food groups including 
dairy, grains, fruits and vegetables. Therefore, there is potential for inadequate intake of 





continues to be highly restricted. Generally, minimal data is available on the nutritional 
adequacy and dietary quality of restricted diets in adults. Despite the existence of practical 
guidelines to ensure patients are being supplemented or appropriate foods are being 
substituted correctly,103 no data currently exists to provide information on the nutritional 
adequacy or dietary quality of elimination diets used for dietary management of EoE. 
A key skill of dietary management is assessment and monitoring of patients nutrient intake, 
and providing appropriate advice for improving intake, including substitution. Understanding 
how nutrient intake and dietary quality is impacted by dietary modification is essential to 
providing high quality and tailored dietary education and prescription.  
The objectives of Part D of this case study were to: 
• Examine the nutrient intake and dietary quality of the diets of adult patients with EoE 
over the course of the RPAH EoE dietary protocol. 
• Report on the nutritional adequacy of a case with an adult patient with EoE on 
exclusive elemental formula.  
5.16 METHODS: NUTRITIONAL ADEQUACY AND DIETARY QUALITY 
5.16.1 Overview of study sample 
This study reports on nutritional data collected from the two studies (prospective and follow 
up) described in Part A, Section 5.2.2. Inclusion criteria: were patients aged 16 years or over 
with a confirmed diagnosis of EoE and who had completed a WFR. Exclusion criteria: were 
patients with suspected EoE or EGIDs other than EoE and patients less than 16 years of age.   
5.16.2 Dietary data collection: Prospective study 
Patients who agreed to participate in the prospective study were provided with instructions on 





three options to record their WFR: hard copy (printable Microsoft Word file), electronic copy 
(Microsoft Word file) or 'Easy Diet Diary' mobile application (iPhone/iPad).408 
Participants were asked to weigh or measure their food and drink intake over a four day 
period, including one weekend day. This included recording cooking methods, product names 
and recipes. Participants were also asked to record any supplements taken and physical 
activity completed over the four day period. A trained investigator reviewed each WFR with 
the patient and asked the patient to clarify any missing or unclear information.  
Participants were also asked to complete a WFR on the strict elimination diet and on their 
personalised diet (once they had identified dietary triggers through challenges). Patients were 
sent an email reminder two weeks prior to their appointment asking them to complete the 
WFR and a reminder email was sent one week after their appointment. Patients who did not 
return for a follow up appointment were invited to complete a WFR at three months. 
All patients were reviewed by an Accredited Practising Dietitian prior to commencing the strict 
elimination diet and over the course of the RPAH EoE dietary protocol. Patients were provided 
with information on ensuring nutritional adequacy and quality on the strict elimination diet. A 
list of vitamin and mineral supplements, suitable within the restrictions of the strict 
elimination diet was also provided to all patients. Anthropometric measures were taken by 
trained staff at the initial and follow up appointments. Height was measured to the nearest 
0.5cm using a stadiometer. Weight was measured to the nearest 0.1kg using digital scales.  
5.16.3 Dietary data collection: Follow up study 
Eligible patients were invited to complete a four day WFR at the time of the follow up study. 
Participants were sent instructions via email in July 2017, with a reminder sent two weeks 
post. Instructions on how to complete the WFR were the same as those provided in the 





WFR and asked the patient to clarify any missing or unclear information via email. 
Anthropometric measures were self-reported by the participants. 
5.16.4 Dietary data analysis  
Completed records were entered and analysed using FoodWorks (Version 8) dietary analysis 
software (Xyris Software, Pty Ltd, Australia),409 drawing upon the AUSNUT 2011-2013 
database.229 Any foods that were not present in this dataset were entered from nutrient 
information panels and patient recipes where necessary. When recipes were not provided by 
the patient an appropriate standard recipe was chosen from the AUSNUT database.229  
Basal Metabolic Rates (BMR) were calculated using the Schofield equations for weight, height 
and age, with an appropriate physical activity factor used to calculate Estimated Energy 
Requirements (EER).410 Under and over-reporters were identified by applying the Goldberg cut 
offs based on mean physical activity level and compared with the ratio for reported energy 
intake to BMR, with the purpose of identifying and excluding reported dietary data that is 
unlikely to represent valid data.411 However, patients identified as under-reporters were also 
identified to have reported reduced intake due to illness/symptoms or self-restricting their 
diet. Thus, these diaries were not removed from analysis as this was deemed to be clinically 
relevant.  
Macronutrient and micronutrient intake was assessed against the Australian NRVs including 
EAR or AI and UL for the patient’s age and gender. Patient diets were also assessed against the 
Acceptable Macronutrient Distribution Ranges (AMDR) for the proportion of energy 
recommended to be consumed from macronutrients including protein (15-25%), fat (20-35%) 
and carbohydrates (45-65%).412   
Diet quality analysis was conducted by assessment of dietary compliance to the 2013 ADG 





score out of 100, with a higher number indicating better diet quality. The scoring criteria 
consists of 11 components (fruits, vegetables, dairy/dairy alternatives, grains/cereals of which 
wholegrains is a sub component, meat/meat alternatives, fluids, unsaturated fat, non-core 
foods of which alcohol is a sub component, added salt, added sugar and saturated fat) and 
assesses the degree to which an individual’s diet conforms with the recommendations for each 
food group or nutrient for their age and gender. Each food was manually coded in FoodWorks 
according to the criteria established by Roy et al.222 The Australian Health Survey (AHS) 
discretionary food list was used to assist classification of foods into each component.413  
All diaries were reviewed for accuracy before being exported into a Microsoft Excel 
spreadsheet specifically designed for analysis. The spreadsheet compared the intake of 
participants to the NRVs and ADG for their age and gender. Statistical analysis was conducted 
using SPSS statistical analysis software (IBM Australia Ltd., Sydney, Australia)231 including 
descriptive statistics to assess changes in macronutrient and micronutrient intake and overall 
and component diet quality over the course of the dietary protocol. All continuous variables 
were tested for normality using a Shapiro-Wilks test. 
Individual intake of macro and micronutrients was converted into a percentage of the EAR/AI 
specific to that patient, with and without supplementation. The proportion of patients meeting 
(intake at 100% or more of the EAR/AI) their NRVs for each macronutrient and micronutrient 
was calculated at each dietary stage. Independent t-tests and Mann Whitney U tests were 
used to assess for differences in nutrient intake by gender, BMI Class and dietary restriction at 
baseline. Dependent t-tests and Wilcoxon Signed rank tests were used to examine differences 
in nutrient intake before and on the elimination diet. McNemars test was used to test if the 
proportion of patients meeting the NRVs changed between baseline and on the elimination 
diet. Dependent t-tests and Wilcoxon Signed rank tests were also used to assess for 





Additionally, differences in the proportion of patients meeting their NRVs with and without 
supplements was calculated using McNemars test.  
Mean and standard deviation for HEIFA-2013 total score and sub scores was calculated at each 
dietary stage. The proportion of patients meeting the recommended number of serves for 
each food group was calculated at each dietary stage. Independent t-tests and Mann Whitney 
U tests were used to assess differences in HEIFA-2013 scores by gender, BMI Class and dietary 
restriction at baseline. Dependent t-tests and Wilcoxon Signed rank tests were used to 
examine differences in HEIFA-2013 scores before and on the elimination diet. McNemars Exact 
test was used to examine if the proportion of patients meeting the recommended number of 
serves for each food group changed before and on the elimination diet. Statistical significance 
was considered P < 0.05.  
5.17 RESULTS: NUTRITIONAL ADEQUACY AND DIETARY QUALITY 
5.17.1 Characteristics of patients completing a weighed food record 
Of the N=35 patients who agreed to participate in the prospective study, N=25 completed a 
baseline WFR (Figure 5.27). Nineteen patients completed an ‘on-elimination diet’ WFR, of 
which one patient was identified to be on an exclusive elemental diet and thus was analysed 
separately (Case C). Only five patients completed a WFR on their personalised diets, limiting 
comparisons for this phase of the dietary management protocol. No WFRs were completed by 












Of the participants who completed the follow up study, N=2 provided a WFR. One patient was 
identified to be on their personalised diet, and thus was analysed with the personalised diet 
prospective study participants. Therefore, there are six patients (N=5 prospective and N=1 
follow up) within this personalised diet group. The other participant was identified to be on an 
unrestricted diet, having attempted the elimination diet with no symptom improvement. 
Dietary analysis of this participant’s diet is not reported.  
The demographic characteristics of the N=29 patients completing a WFR over the RPAH EoE 
dietary protocol is presented in Table 5.15. Participants were more likely to be male (59%), 
with an average age of 34±11 years and BMI just outside the healthy weight range (26kg/m2). 
At their initial appointment, eleven patients reported to have already restricted their diet, with 
limiting milk/dairy (N=6) and/or wheat/gluten (N=6) the most common dietary modifications. 
Reasons for restricting or limiting foods included concomitant food allergy or coeliac disease, 
advice from specialist or dietitian or self-restriction due to symptoms.  
Table 5.15: Demographic characteristics of eosinophilic oesophagitis patients completing a 










Male N (%) 17 (59) 13 (52) 10 (56) 2 (33) 
Age mean (SD) 34 (11) 33 (10) 31 (10) 36 (15) 
BMI mean (SD) 26 (6) 26 (6) 26 (7) 26 (6) 
Self-restricting diet N (%) - 11 (39) - - 
Supplementing N (%) - 12 (48) 13 (72) 5 (83) 
 
5.17.2 Baseline nutritional adequacy  
At baseline, patients with EoE had low average intakes of calcium and fibre (Figure 5.28). 
Average percentage energy intake from carbohydrates (42%) was just below the lower limit of 
the AMDR, whilst percentage energy from fat (34%) and protein (19%) intake was within the 
AMDR at baseline. On average, patients with EoE consumed greater than 100% of their EAR/AI 





meeting their EAR/AI for macro and micronutrients all participants met their EAR for protein, 
niacin and phosphorus. However, less than half of patients met the NRV for calcium (48%), 
fibre (32%) and potassium (44%) without supplements. Furthermore, on average, females did 
not meet the EAR for calcium (91% of EAR), with median percentage intake of the EAR 
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Figure 5.28: Differences in percentage intake of macronutrients and micronutrients between patients with eosinophilic oesophagitis restricting (N=11) and 
not restricting (N=14) their diets at baseline (excluding supplements). Abbreviations: EAR: Estimated average requirements, *: p<0.05, **: p<0.001. A Mann 
Whitney U tests identified significant differences in the median percentage micronutrient intake of the EAR between patients restricting and those not 
restricting their diets at baseline for: thiamin (U=38, p=0.033), riboflavin (U=29, p=0.008), folate (U=15, p<0.001), calcium (U=34, p=0.018), phosphorus 





Data suggests that patients self-restricting their diets at baseline may be at risk of insufficient 
intake of calcium and fibre. On average, patients self-restricting their diet, did not meet their 
EAR for calcium, potassium and fibre.  In contrast, on average, the unrestricted group was 
identified to meet greater than 100% of their EAR/AI for all nutrients. More specifically, 
median percentage intake of calcium was significantly lower in the restricted group (p=0.018). 
Additionally, percentage intake of thiamin, riboflavin, folate, iodine, iron and phosphorus were 
all significantly lower in the restricted group than the unrestricted group, however, the median 
intake of both groups was still greater than 100% of the EAR (Figure 5.28). 
5.17.3 Baseline dietary quality  
Overall, results suggest that patients with EoE baseline diets do not align with the ADG 
recommendations, consuming an average of four and a half serves of discretionary foods and 
less than the recommended number of serves for all core food groups, except meat/meat 
alternatives. This is exemplified by the median total HEIFA-2013 score of 50 (out of 100). Most 
patients (68%) met the recommended number of serves for meat and meat alternatives, 
consuming an average of three and a half serves. Fruit and grains were the core food groups 
that the smallest proportion of patients met the recommended serves for (16%), consuming an 
average of one and four serves respectively. Males scored significantly higher on the fruit and 
grains sub scores (p=0.014, p=0.007 respectively), whilst females scored significantly higher for 
unsaturated fat (p=0.008). Additionally, those with a BMI in the overweight/obese category 
scored more positively for fruit (p=0.002) and poorly on the sodium sub score (p=0.036). It 
should be noted that fluid intake was poorly reported and could not be properly examined.  
At baseline, patients with EoE were identified to consume more vegetables and meat/meat 
alternatives than the general Australian population.414 Male patients with EoE consumed an 
additional one and a half serves of vegetables and one serve of meat, but one and a half serves 
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Figure 5.29 a): Median intake of core food groups for male patients with eosinophilic 
oesophagitis compared to the Australian male population.414 The dotted line indicates the 
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Figure 5.29 b): Median intake of core food groups for female patients with eosinophilic 
oesophagitis compared to the Australian female population.414 The dotted line indicates the 





Females with EoE also consumed approximately one serve more of meat than the average 
Australian female population, but consumed approximately one serve less of fruit and grains 
(Figure 5.29b).414 
Patients self-restricting their diets at baseline consumed significantly less serves of fruit, 
dairy/dairy alternatives and sodium than non-restrictors (p<0.001, p=0.029, p=0.015 
respectively). Consequently, patients restricting their diet at baseline were identified to score 
significantly lower on the fruit and dairy/dairy alternatives sub scores (p<0.001, p=0.038 
respectively) and higher on the sodium sub score (positively) than non-restrictors (p=0.029).  
5.17.4 Elimination diet: Nutritional adequacy  
Overall, results suggest that patients with EoE can meet their nutrient requirements on the 
strict elimination diet, however, intake of some nutrients, particularly, vitamin A and calcium 
may be low. More specifically, the average percentage energy intake from carbohydrates 
(41%) was just below the lower limit of the AMDR, whilst the average percentage energy from 
fat (35%) and protein (20%) were within the AMDR. There were no differences in mean energy 
intake or macronutrient distribution before and on the strict elimination diet. Furthermore, on 
average, patients with EoE on the strict elimination diet met greater than 100% of the EAR/AI 
for all nutrients except vitamin A (48% of EAR), calcium (73% of EAR) and fibre (87% of AI) 
without supplementation. Only one patient met the EAR for vitamin A and calcium on the strict 
elimination diet (without supplementation) suggesting there is a probability of insufficient 
intake of these nutrients, on the elimination diet. Additionally, less than half of patients met 
folate (50%), magnesium (50%), potassium (39%) or fibre (28%) requirements on the strict 
elimination diet (without supplementation). Thus, these are nutrients that may also have a 
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Figure 5.30: Differences in median percentage intake of Estimated Average Requirements for micronutrients at baseline and on the elimination diet (Paired 
data, N=15). Abbreviations: EAR: Estimated Average Requirements. *: p<0.05, **: p<0.001. Wilcoxon Signed rank tests identified significantly lower 
percentage intakes of riboflavin (Z=-2.78, p=0.005), folate (Z=-2.16, p=0.031), vitamin A (Z=-3.41, p=0.001), calcium (Z=-3.35, p=0.001), phosphorus (Z=-2.90, 





When examining paired data (N=15), a significant decrease in percentage of the EAR/AI being 
met was identified on the elimination diet (from baseline) for vitamin A, riboflavin, folate, 
calcium, vitamin C, phosphorus, iodine, potassium, sodium and fibre (Figure 5.30). However, 
median intake on the elimination diet was still greater than 100% of the EAR/AI for riboflavin, 
vitamin C, phosphorus, iodine and sodium. Overall, there were significant decreases in the 
proportion of patients meeting their EAR for folate (p=0.014), vitamin A (p=0.001), calcium 
(p=0.005) and magnesium (p=0.014) on the strict elimination diet (without supplementation).   
Results from patients including a vitamin and mineral supplement (N=13) on the strict 
elimination diet indicate that supplementing can assist with meeting requirements for at risk 
nutrients. On average, when supplements were included, patients met greater than 100% of 
all their nutrient requirements except potassium (80% of AI) and exceeded the UL level of 
intake for niacin (162% of UL) and magnesium (103% of UL). More specifically, when 
supplements were included, all patients met greater than 100% of their EAR for niacin, vitamin 
C, phosphorus and zinc. Additionally, almost all (92%) met the EAR for thiamin, riboflavin and 
iron. Unsurprisingly, significant increases in the average percentage of EAR/AI being met were 
identified for all nutrients (except phosphorus or potassium) when including supplements in 
the dietary analysis (Table 5.16). Of note, median percentage EAR for vitamin A and calcium 
improved to be greater than 100% of the EAR with inclusion of supplements. Furthermore, 
there was a significant increase in the proportion of patients meeting 100% of EAR for vitamin 
A (p=0.031) and calcium (p=0.031) with the inclusion of supplements, which were previously 





Table 5.16: Differences in percentage intake of micronutrients on the elimination diet when including and excluding supplements (N=13).  
Micronutrient Excluding supplements 
(Mean % EAR) 
Including supplements 
(Mean % EAR) 
P value Including supplements 
(Mean % UL) 
Vitamin A 38.5 120.7 0.008β 20.3 
Thiamin 128.3 1630.6 0.005β NA 
Niacin 353.2 486.9 0.001α 161.9 
Riboflavin 130.3 812.1 0.005β NA 
Folate 108.3 241.1 0.003 α 78.5 
Vitamin C 166.3 554.2 0.003β NA 
Calcium 64.2 107.4 0.004 α 36.8 
Iodine 117.9 188.4 0.002 α 17.4 
Iron 183.8 259.7 0.006 β 44.9 
Magnesium 97.7 108.7 0.023 β 103.1 
Phosphorus 209.3 209.3 0.708 α 31.3 
Zinc 126.4 143.1 0.002 β 40.3 





5.17.5 Elimination diet: Dietary quality 
Overall, results indicate that dietary quality improves on the strict elimination diet, 
predominantly due to decreased consumption of non-core discretionary foods. Total median 
HEIFA-2013 score significantly increased on the strict elimination diet from baseline (p=0.001) 
(Table 5.17). More specifically, there was a significant increase in median intake of unsaturated 
fat (serves) on the strict elimination diet. A notable decrease in median sodium intake, 
percentage energy from sugar and saturated fat, alcohol serves, and non-core food serves on 
the strict elimination diet was also identified (Table 5.17). Overall, there was a significant 
increase in median HEIFA-2013 sub scores for wholegrains, unsaturated fat, non-core foods, 
saturated fat and sodium (Table 5.17). Unsurprisingly, results indicate that consumption of 
fruit, dairy products and grains is impacted on the strict elimination diet as pears are the only 
allowed fruit, and dairy and gluten containing products are routinely excluded. More 
specifically, the proportion of patients meeting the recommended serves of fruit was low 
(17%), with an average intake of one serve per day. Additionally, dairy/dairy alternatives and 
grain serves were only met by one individual on the strict elimination diet, with average daily 
dairy/dairy alternative intake identified to be 0.75 serves per day. Furthermore, there was a 
significant decrease in dairy/dairy alternatives serves consumed on the strict elimination diet, 
from baseline (p=0.001). There was also a significant decrease in median HEIFA sub scores for 
fruit serves score and dairy/dairy alternatives score (Table 5.17). There was no significant 
difference in the proportion of patients meeting the recommended number of serves of any of 
the core food groups before and on the strict elimination diet, though the decrease in 





Table 5.17: Median daily intake of food and nutrient components assessed in the HEIFA-2013, composite sub score and total median HEIFA-2013 score for 
eosinophilic oesophagitis patients at baseline and on the elimination diet (N=15).αDependent t-test, βWilcoxon signed rank test 
 ADG Recommended serves/day 
(Males) 





Vegetable (serves/day) 6 - 3 (4) 3 (2) 0.865β 
Vegetable (serve score) - 5 3 (4) 3 (2) 0.525β 
Vegetable (variety) - 5 1 (3) 2 (2) 0.147β 
Fruit (serves/day) 2 - 1 (3) 1 (1) 0.156β 
Fruit (serve score) - 5 3 (4) 1 (3) 0.030β 
Fruit (variety score) - 5 0 (0) 0 (0) 0.157β 
Grains and cereals (serves/day) 6 - 4 (4) 4 (2) 0.964α 
Total grains (score) - 5 3 (3) 3 (2) 0.972β 
Total whole grains (score) - 5 0 (3) 2 (5) 0.036β 
Meat and meat alternatives (serves/day) 3 - 3 (7) 4 (2) 0.233α 
Meat and meat alternatives (score) - 10 10 (2) 10 (0) 0.059β 
Dairy and dairy alternatives (serves/day) 2.5 - 2 (3) 1 (4) 0.001β 
Dairy and dairy alternatives (score) - 10 6 (8) 2 (4) 0.002β 
Unsaturated fats (serves/day) 4 - 1 (1) 2 (2) 0.039β 
Unsaturated fats (serve score) - 5 1 (3) 4 (4) 0.038β 
Fluids (score) - 5 1 (1) 0 (2) 0.959β 
Non-core foods (serves/day) ≤ 3 - 5 (5) 2 (2) 0.015β 
Non-core foods (score) - 10 3 (3) 8 (5) 0.007β 
Alcohol (serves/day) < 2 - 0 (6) 0 (1) 0.034β 
Alcohol (score) - 5 5 (0) 5 (0) 0.157β 
Sodium (mg/day) < 920-1600 - 2728 (1587) 1385 (801) 0.004α 
Sodium (score) - 10 0 (5) 10 (5) 0.006β 
Added sugar (% energy/day) < 15 % energy intake - 8 (10) 4 (4) 0.036β 
Added sugar (score) - 10 10 (0) 10 (0) 0.705β 
Saturated fat (% energy/day) < 10 % energy intake - 12 (5) 7 (2) 0.003β 
Saturated fat (score) - 5 3 (5) 5 (0) 0.007β 





5.17.6 Personalised/liberalised diet: Nutritional adequacy  
Personalised diets varied between the six individuals who completed a WFR (Table 5.18). Soy, 
gluten, dairy and amines were the most commonly limited whole food/ food chemical groups. 
Four patients were identified to be liberalising at the time of completing the WFR (Table 5.18).  
Table 5.18: Personalised/liberalised diets of eosinophilic oesophagitis patients completing a 


































1 X L L L L L ✔ 
2 X X X L X ✔ ✔ 
3 X X X ✔ X ✔ ✔ 
4 X X X L X X ✔ 
5 L ✔ X X ✔ ✔ ✔ 
6 ✔ ✔ X X ✔ X X 
    ✔: allowed, L: liberalising, X: avoiding 
 
Results suggest that patients with EoE can meet their nutrient requirements on their 
personalised diet, however, calcium and fibre intake may be insufficient. More specifically, 
average percentage energy intake from carbohydrates (38%) was just below the lower limit of 
the AMDR, whilst the average percentage energy from fat (40%) and protein (19%) were 
within the AMDR. On average, patients with EoE on their personalised diets met greater than 
100% of the EAR/AI for all nutrients except calcium (73% of EAR), potassium (88% of AI) and 
fibre (93% of AI) without supplementation, similar to intake at baseline and on the elimination 
diet. More specifically, all patients met their EAR for protein, riboflavin, niacin, iron, zinc and 
phosphorus on their personalised diet. However, no patients (N=3 including dairy, N=3 
excluding dairy) met the EAR for calcium on their personalised diets (without 
supplementation). Further exploration of the relationship between the restriction of specific 





size. Nor could differences in nutritional adequacy between baseline, the strict elimination diet 
and personalised diets.  
Results from patients including a vitamin and mineral supplement on their personalised diet 
indicate that supplementation can assist with meeting requirements especially for nutrients 
where intake may be low. On average, when supplements were included, patients met greater 
than 100% of all their nutrient requirements except potassium (93% of AI) and exceeded the 
UL level of intake for niacin (192% of UL) and magnesium (147% of UL).  
5.17.7 Personalised/liberalised diet: Dietary quality  
Overall, results indicate that consumption of fruit, dairy and grains is impacted on the 
personalised diet, due to restriction of salicylates (fruit), dairy products and gluten containing 
grains. None of the patients completing a WFR on their personalised diet met the 
recommended number of serves for fruit, dairy/dairy alternatives or grains, consuming an 
average of one serve of fruit, one serve of dairy/dairy alternative and four serves of grains per 
day. Small improvements in overall dietary quality appeared to be maintained on the 
personalised diet with a median HEIFA-2013 score of 54 (out of 100). Differences in dietary 
quality between baseline, the elimination diet and personalised diets could not be examined 
due to small numbers.   
5.17.8 Nutritional adequacy on an elemental diet: Case C 
Patients with adverse food reactions may self-restrict intake without appropriate food 
substitutions or supplementation.415 Case C provides an example of the potential risks of 
dietary self-restriction without dietetic input.  Case C is a 52-year-old female who presented on 
a self-restricted, liquid diet consisting of blended rice milk and brown rice. The patient 
reported increasingly self-restricting her diet over the past year due to increasing symptoms 
(dysphagia, nausea, abdominal pain, diarrhoea and headaches/migraines). The patient also 





18kg/m2). Previous trial of the 6-FED had no impact on symptoms and resulted in weight loss. 
At baseline, the patient’s intake was identified to be nutritionally inadequate. More 
specifically, energy intake was identified to be insufficient (79% of EER). Energy contributions 
from protein (12%) and fat (15%) were below the lower limit of the AMDRs, whilst percentage 
energy intake from carbohydrate (72%) exceeded the upper limit. Additionally, intake of 
vitamin A, riboflavin, folate, vitamin C, iodine, potassium, zinc and fibre (28% of AI) was 
inadequate (Figure 5.31).  
From assessment and discussion with the patient, the decision was made to trial an exclusive 
elemental diet. The patient was started on an elemental formula (Neocate Advanced),416 taken 
orally, which relieved her symptoms and a repeat oesophageal biopsy showed histological 
remission. Overall, on the elemental formula nutritional adequacy improved. Notably, the 
patient was identified to meet the EAR for all micronutrients except potassium (Figure 5.31). 
Energy intake (77% of EER) was insufficient at the time of the WFR completion due to the 
patient slowly increasing the amount of elemental formula consumed over time, as her 
symptoms settled, and she could tolerate a greater strength formulation. Furthermore, on the 
elemental formula percentage energy from protein (14%) remained slightly below the lower 
limit of the AMDR, whilst energy from carbohydrate (45%) aligned with the AMDR. Energy 
from fat (41%) exceeded the upper limit. This is due to nutritional profile of the elemental 
formula reflecting the higher energy needs of children for growth.412 Fibre intake was also 
identified to be inadequate on the elemental diet due to the elemental formula not containing 
fibre. Clinically, Case C was reassessed once she had increased her elemental formula intake to 
meet 100% of her energy requirements and a fibre supplement was introduced. Overall, this 
case provides an example of the importance of a personalised dietetic intervention to improve 
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5.18 DISCUSSION: NUTRITIONAL ADEQUACY AND DIETARY QUALITY 
The present study examined the nutrient intake and dietary quality of patients with EoE over 
the RPAH EoE dietary protocol. Calcium and fibre intake was identified to be inadequate at 
baseline, on the strict low chemical elimination diet and on the personalised diet. In line with 
these findings, dairy/dairy alternatives and grain intake was identified to be below the 
recommended number of serves at these time points, as was fruit. Vitamin A intake was 
identified to be inadequate on the strict low chemical elimination diet, but improved with 
supplementation. Overall dietary quality improved on the strict low chemical elimination diet. 
5.18.1 Nutritional adequacy 
Nutrient intake in the EoE population at baseline appears to be similar to the Australian 
general population, with low calcium and fibre intakes. Half the Australian population aged 
two years or older has been found to have inadequate usual intakes of calcium, with the 
prevalence of inadequate calcium intake higher amongst females.413 Likewise, we identified 
females were more likely to have inadequate calcium intake at baseline. Inadequate calcium 
and fibre consumption was also identified in patients with EoE who were restricting their diets 
at baseline. Dairy and gluten were the most common restrictions at baseline, similar to the 
Australian general population reporting dietary restriction due to food allergy/intolerances.413 
The restriction of these food groups also accounts for the lower carbohydrate, calcium and 
fibre intakes seen in this study. Overall, this suggests that dietitians should consider nutrients 
where intake is likely to be low and dietary restrictions at baseline in the nutritional 
assessment of patients with EoE. This is essential to the provision of tailored nutritional advice, 
ensuring nutritional adequacy, particularly if further dietary restriction is required for 
management.  
Calcium intake was also identified to be at risk of inadequacy on the strict elimination diet and 





per day decreased on the strict elimination diet, from baseline, with many patients already 
having inadequate intakes of calcium at baseline. Adequate calcium intake is difficult on the 
strict elimination diet due to the restriction of dairy and soy products, with fortified rice milk 
the main calcium source. Similarly, lower calcium intake has also been described in individuals 
restricting dairy products as part of milk allergen avoidance,266 low Fermentable 
Oligosaccharides, Disaccharides, Monosaccharides and Polyols (FODMAPs)219 and vegan 
diets.417 This exemplifies the difficulty of improving dietary nutrient intake when implementing 
further dietary restrictions and thus needs to be considered as part of nutrition assessment 
and intervention planning.  
Calcium is an essential mineral required for maintenance of bones, and neuromuscular and 
cardiac function.220 Calcium homeostasis is tightly regulated by the body, at the expense of the 
bones. Thus, prolonged inadequate intake of calcium has been associated with reduced bone 
mineral density and conditions such as osteoporosis.220,418 Calcium absorption is limited if 
vitamin D levels are inadequate.418 Increased fracture risk has been described in children with 
a history of dairy exclusion due to cow’s milk allergy.419 Monitoring bone mineral density and 
vitamin D may therefore be important in this population, particularly when dairy and soy 
products are restricted long term. Further research monitoring urinary calcium, bone mineral 
density and vitamin D status in patients with EoE would be beneficial to guide dietary and 
supplementation advice.  
The present study identified vitamin A to be at risk of inadequacy on the strict elimination diet. 
Consuming adequate vitamin A on the strict elimination diet is challenging due to restriction of 
carotenoid rich fruits and vegetables, dairy and soy products. Vitamin A is an essential fat-
soluble vitamin that has a role in various physiological and metabolic processes including 
vision, reproduction, growth and immunity. Subsequently, vitamin A deficiency can result in 





deficiency mainly affects children in developing nations where intake is chronically low and/or 
there is a high prevalence of infectious disease so rarely occurs in Western populations.220,421 
Case reports of children in Western countries on highly restricted diets (due to food aversions 
related to autism) resulting in vitamin A deficiency have been described.422 Vitamin A can be 
stored in high quantities in the liver and kidneys and mobilised depending on the body’s 
demand, thus maintaining homeostasis.420 Hence, it is unlikely that short term intake of 
vitamin A below the EAR, such as in the diagnostic phase of the elimination diet and challenge 
protocol will result in deficiency, in adults, assuming adequate stores are available prior to 
commencing the strict elimination diet. However, further research using biomarkers, such as 
urinary retinol is required to confirm this. Interestingly, one patient was identified to be 
meeting their vitamin A requirements on the elimination diet. This was due to regular 
consumption of eggs and the use of vitamin A fortified margarine in cooking. Thus, 
encouraging the consumption of vitamin A rich foods, fortified products and/or supplements 
will allow patients with EoE following a strict low chemical elimination diet to meet their 
vitamin A requirements.  
Folate, magnesium, potassium and fibre were also identified to be nutrients at potential risk of 
low intake on the strict elimination diet. Additionally, percentage energy intake from 
carbohydrate was just below the AMDR. Lower carbohydrate, fibre, folate, thiamin, iron, 
calcium and magnesium intake has also been described in patients following a low FODMAPs 
diet219 and gluten free diets.266,364,423,424 It has been suggested that lower intake of nutrients 
seen on a gluten free diet is dependent on two factors: diet specific limitations, and the 
individuals food choices.424 For example, intake of folate may be low on the strict elimination 
diet due to the lack of fortification of gluten free grains and cereals with folate, compared to 
the mandatory practice of fortification of wheat based flour in Australia (diet specific 





requirements commonly consumed fortified gluten free breakfast cereals. Thus, encouraging 
regular consumption of fortified gluten free grains and cereals in patients following a strict low 
chemical elimination diet or gluten free personalised diet will help ensure adequate folate 
intake.  
Alternatively, low intakes of fibre, percentage energy from carbohydrate and grain serves seen 
in our sample at baseline continued on the strict elimination diet suggesting that the low 
intake of these nutrients on the elimination diet is partially reflective of patient food choices. 
Though it is noted that consuming adequate fibre on the strict elimination diet can be difficult 
due to limiting gluten-containing grains and peeling fruits and vegetables. A study comparing a 
‘standard’ gluten free diet pattern and one encouraging consumption of ‘alternative’ gluten 
free grains identified patients following a ‘standard’ gluten free diet generally chose white 
rice/rice based products or omitted grains at meals. In contrast, when consumption of 
‘alternative’ gluten free grains was encouraged, higher consumption of grain serves, and fibre 
intake was identified.425 Thus, encouraging regular consumption of a variety of gluten free 
grains and cereals, including education on how to use and incorporate ‘alternative’ gluten free 
grains into the strict elimination diet or gluten free personalised diet will likely help ensure 
adequate carbohydrate and fibre intake. Similarly, magnesium is distributed widely in the food 
supply,220 thus, whilst the strict elimination diet reduces the variety of magnesium containing 
foods available (diet specific limitation), encouraging appropriate choices of low chemical 
options will allow patients to meet their magnesium requirements.  
Supplementation was identified to be a useful way to increase intake of at risk nutrients on the 
strict elimination diet. Dietary supplementation has been shown to be effective in improving 
vitamin A status in children who have low dietary intake.421 Supplementation with calcium, in 
combination with vitamin D, has been previously shown to have a small, positive affect on 





identified to increase intake of some nutrients (niacin and magnesium) into the UL of intake in 
this study, similar to studies in the general population,426,427 and in those on a restricted diet 
taking a multivitamin supplementation.428 The effect of excess intake remains unclear, as data 
addressing adverse effects from multivitamin and mineral supplementation is limited.427 For 
example, the UL for niacin is based on reports that excess intake of nicotinic acid can cause 
flushing reactions, whilst magnesium may cause diarrhoea when consumed as a 
supplement.220 Short term gastrointestinal symptoms, rashes and headaches have been 
described in small numbers taking multivitamin and mineral supplements as part of RCTs. 
Whilst, long term use of single, high dose vitamin supplements (but not multivitamin and 
mineral supplements) has been associated with increased mortality. Currently, multivitamin 
and mineral supplementation is considered safe at physiological doses in the short and long 
term and is recommended in groups at risk of inadequate nutrient intake.427 Thus, 
recommendation of a multivitamin and mineral supplement on the strict low chemical 
elimination diet and/or personalised diet can assist patients with EoE to meet their nutrient 
requirements in the short term (such as Vitamin A). Long term, supplementation will likely 
need to be individualised based on the level of dietary restriction maintained. For example, 
calcium supplementation is likely warranted in EoE populations were calcium intake from food 
is inadequate, both in the short and long term. However, further research examining long term 
dietary intake of patients with EoE is required to establish long term multivitamin 
supplementation recommendations.  
5.18.2 Dietary quality 
Dietary quality in our EoE population appears to be similar to the Australian general 
population, at baseline, with high discretionary food and poor grain, dairy/dairy alternative 
and fruit intake. Similarly, an Australian university student population had a mean HEIFA-2013 





discretionary foods.222 Additionally, a recent survey of Australians using the Commonwealth 
Scientific and Industrial Research Organisation healthy diet score (based on the ADG) identified 
an average score of 59 (out of 100), with high intake of discretionary foods identified to be 
significantly contributing to poor diet quality.429  
Dietary quality significantly improved on the strict elimination diet due to increases in 
wholegrain and unsaturated fat consumption and decreases in non-core food consumption. 
Higher diet quality has been described in other populations on restricted diets. For example, 
children with ASD following a gluten and casein free diet, had lower intakes of sodium, positive 
polyunsaturated to saturated fat ratio430 and higher Healthy Eating Index scores, compared to 
children with ASD on an unrestricted diet.431 Whilst, children with coeliac disease following a 
gluten free diet have also been identified to score positively on the Canadian Healthy Eating 
Index, consuming a greater number of fruit and vegetable serves than controls.364 Additionally, 
a study comparing vegan, vegetarian, semi-vegetarian, pesco-vegetarian and omnivore diets 
identified significantly higher Healthy Eating Index 2010 and Mediterranean Diet Scores for the 
vegan diet.417 Suggested reasons for higher dietary quality on restricted diets include reduced 
discretionary choices417 and individuals following a restricted diet may be more health 
conscious.417,430 These are likely true of our EoE study population as a strict low chemical 
elimination diet has reduced discretionary choices and patients were identified to be health-
oriented and conscientious (Part C). Furthermore, nutrition education has been shown to 
increase dietary quality432–435 which would also account for the improvements seen in our 
study.  
It is interesting to note that patients following the elimination diet cannot achieve a diet 
quality score of 100 (maximum possible score 95), as they cannot score for fruit variety due to 
the restriction of fruit to pears only. Despite this limitation, diet quality improved on the 





indices for other restricted diets. For example, the Mediterranean Diet Score includes a score 
for traditional meat and fish consumption, constituting a drawback for diets restricting 
these.417 Thus, it has been suggested that adaption of specific components or development of 
a specific tool may be required to better explore diet quality of specific restricted diets.223,417  
5.18.3 Exclusive elemental diets 
Case C provided a unique example of the risks of self-imposed dietary restriction and secondly 
highlighted the benefits of an exclusive elemental diet in such cases. Overall nutritional 
adequacy improved on the elemental diet, though macronutrient distribution was not aligned 
completely with the AMDR. Groetch et al.103 suggests that macronutrient and micronutrient 
intake should be monitored due to differences in the elemental formulas available on the 
market. The authors also advocate to leave one to two foods in the elemental diet to help 
preserve or develop oral feeding skills in children. Elemental formula use in adults has been 
shown to be effective in improving symptoms and achieving histological remission, however, 
adherence has been reported to be poor. One study reported three participants dropped out 
of an exclusive elemental diet trial after one day due to poor palatability and a further eight 
participants dropped out within the next two weeks or consumed other foods during the trial 
period.134 The use of enteral feeding has also been reported in children with EoE to increase 
adherence to an elemental diet.103 Cost has been highlighted as a key consideration on an 
elemental diet1 and is particularly notable for Australian adult patients with EoE, as elemental 
formula is currently only subsidised by the Australian government for patients under 18 years 
of age.  
In summary, an elemental diet can improve nutritional adequacy in adult patients at high 
nutritional risk, in those who cannot complete an elimination diet and/or after failure of 
medical treatment or dietary elimination.1 However, consideration of cost, adherence, 





supplement intake on an elimination diet.103 Further research into food reintroduction and 
long term outcomes of patients following an elemental diet is required.  
5.18.4 Conclusion 
At baseline, patients with EoE were identified to have low calcium and fibre intake. On the 
strict low chemical elimination diet calcium, vitamin A and fibre intake was identified to be 
inadequate, but improved with supplementation. Overall dietary quality improved on the strict 
low chemical elimination diet from baseline, due to decreased consumption of discretionary 
food choices. Dietary quality appears to be maintained on the personalised diet, however, 
calcium and fibre intake may still be low without supplementation. Further research exploring 
nutritional adequacy and dietary quality on the personalised diet and long term is required. 
Overall, with proper nutritional assessment, intervention planning and monitoring, patients 
with EoE can meet their nutrient requirements and improve dietary quality when following a 
low chemical elimination diet or their personalised diet. Nutrition education should include the 
promotion of calcium fortified dairy alternatives, vitamin A rich foods and fortified gluten free 
wholegrains. Calcium and multivitamin and mineral supplements may be required. Monitoring 





SUMMARY AND INSIGHTS FROM THE CASE STUDY OF THE 
ROYAL PRINCE ALFRED HOSPITAL ALLERGY UNIT  
This chapter presents a case study of dietary investigation and management of patients with 
EoE in a clinical context. Case study methodology allowed an in-depth exploration of a group of 
patients with EoE undergoing a dietary management protocol. Characteristics of a case series 
of patients with EoE were described including symptoms, concomitant conditions, atopic and 
endoscopic features, allergen test results, as well as their response to a low chemical 
elimination diet and challenges, to develop a personalised diet. QOL and nutrient intake were 
also examined. Evidence from this case study suggested that approaching EoE as part of a 
broader clinical spectrum of interrelated conditions provides a framework for holistic 
assessment and highlights the need for multidisciplinary assessment and management. More 
broadly, management should also consider the impact of the disease, symptoms and 
management strategies on QOL, psychosocial and physical health. These findings also 
informed insights into potential aetiological mechanisms. 
5.19 CLINICAL MANAGEMENT OF PATIENTS WITH EOSINOPHILIC 
OESOPHAGITIS 
 At the RPAH Allergy Unit, patients with EoE present with a variety of different symptoms, 
concomitant conditions, atopic and endoscopic features. Thus, a variety of factors need to be 
considered in the clinical assessment, nutritional intervention and monitoring and evaluation 
of these patients (Table 5.19). These findings are explored and expanded further in Chapter 7 






Table 5.19: Considerations for nutrition assessment, intervention and monitoring/evaluation of patients with eosinophilic oesophagitis. 
Nutrition assessment Nutrition Intervention 
 (Part 1: Dietary elimination) 
Nutrition Intervention/Management 
(Part 2: Challenges and personalised diet) 
Monitoring 







• Concomitant conditions 
• Coeliac disease screen 
• Food allergy 
• Oral allergy syndrome 
• SPT 
• Endoscopic features 
• Histological features 
• Patient-reported food triggers 
• Texture related 
• Food allergy 
• Food intolerance 
• Eating behaviour 
• Quality of Life 
• Psychosocial characteristics 
• Nutrient intake and dietary 
quality 
• Dietary elimination 
• Food allergens 
• Food chemicals 
• Food texture modification 
• Dietary adherence 
• Nutrient intake (including 
supplements) and dietary 
quality 
• Symptom response 
• Histological response 
• Quality of Life 
• Other 
• Specialist referral required 
• Food challenges 
• Check SPT results 
• Whole foods 
• Food chemicals 
• Symptom response 
• Personalised diet 
• Food allergens 
• Food chemicals 
• Food texture modification 
• Dietary adherence 
• Concomitant conditions 
• Nutrient intake (including 
supplements) and dietary 
quality 
• Symptom control 
• Histological response 
• Quality of Life 
 
• SPT 
• Dietary adherence 
• Symptom response 
• Histological response 
• Quality of Life 
• Psychosocial 
characteristics 




• Specialist referral 
required 





This case study highlighted that patients with EoE presentations are idiosyncratic in nature and 
thus a personalised approach to management is required. Symptoms provide an excellent 
example of how the variety of considerations identified in this case study (Table 5.17) may be 
used to inform the nutrition assessment, intervention and monitoring/evaluation of a patient 
with EoE, to personalise their dietary management approach. Firstly, several types of 
symptoms may be considered as part of assessment (oesophageal, non-oesophageal and non-
gastrointestinal). Secondly, symptoms could direct referral within the multidisciplinary team, 
such as to an allergist for food allergy testing, if symptoms and/or patient-reported food 
triggers are suggestive of an IgE-mediated food allergy. In addition, symptoms may identify 
food related textural issues, which may direct dietary education on food texture modification 
or indicate structural or motility disorders requiring assessment and management (e.g. 
dilatation). Recognition that patients may self-restrict foods due to symptoms and/or 
perceived food triggers is also important to ensure adequate nutrient intake. Symptoms may 
also inform the choice of dietary and/or medical management approach. For example, with 
patients in the case series, dietary elimination and challenges was used to identify if symptoms 
were related to food intolerances. However, depending on patient circumstances, a step down 
approach or medication may be used. Managing symptoms of allergic rhinitis and reflux may 
also be required for effective control of oesophageal symptoms and inflammation. 
Additionally, management of concomitant conditions (e.g. asthma) through patient education 
or appropriate referral should be considered. Furthermore, recognition that symptoms and 
concomitant conditions may have a profound impact on QOL and mental health, for example 
behavioural problems have been associated with poorer mental health,329 so may influence 
intervention choice or be considered in monitoring and evaluation. Lastly, monitoring and 
evaluation of symptoms and histology is essential to the effective management of patients 





This case study focused on a variety of clinical factors that need to be addressed in the dietary 
management of patients with EoE. However, it is also recognised that a person centred 
approach to care should be individualised based on the patient’s situation, needs and 
preferences rather than focusing exclusively on the disease.158 Dietary adherence is possibly 
the largest barrier to effective dietary management of EoE. Adherence to the RPAH EoE dietary 
protocol in those returning to the Allergy Unit was high, however, the large proportion of 
patients that did not return highlights that modifications to the current protocol may be 
required. Current recommendations highlight that the less restrictive 4-FED and step-down 
approaches can be efficacious and possibly increase dietary adherence and that PPI therapy 
and swallowed corticosteroids are also effective treatments.1 To ensure a patient centred and 
personalised approach to management, patients should be provided with information on the 
variety of management options, including risks and benefits. Patient information gathered 
from the nutrition assessment can be used by the health professional to help guide the patient 
to choose the most appropriate option for them, tailoring the approach to their circumstances 
and with the understanding that the approach may need to be fluid based on any changes in 
the future.  
5.20 STRENGTHS AND LIMITATIONS OF THE CASE STUDY OF THE ROYAL 
PRINCE ALFRED ALLERGY UNIT 
The use of case study methodology was useful in providing an in depth and contextual 
exploration of the dietary management of patients with EoE, in situ. The use of multiple 
methods including analysis of a case series, and questionnaires and nutritional analysis 
conducted prospectively, provided rich descriptive detail specific to the NCP, in a real life 
setting. However, it is recognised that this case study is restricted to the single clinic context 





Strengths of the case series analysis applied to this clinic context included the ability to provide 
descriptive information on symptoms, associated conditions, allergen testing results and 
patient-reported triggers, classification of atopy according to pre-defined guidelines, and the 
use of DBPC challenges. However, several limitations of this analysis need to be acknowledged. 
Firstly, the case series presents characteristics of patients referred to a metropolitan allergy 
unit and thus may not be reflective of the broader EoE population. It is also possible that those 
who perceived that their symptoms were food related/interested in food would be more likely 
to attend an allergy clinic. Additionally, patients who were more diet conscious or found that 
the low chemical elimination diet helped their symptoms would also be more likely to return.   
Secondly, the retrospective nature of the data collected in the case series, which may have 
resulted in inconsistencies in recording between physicians/dietitians/gastroenterologists and 
the emergence of missing data, presents as a limitation. Just under a third of the patients did 
not have endoscopies or did not have endoscopy results, which could be classified under 
missing data bias. However, Sterne et al.436 suggest that when missing data occurs only in an 
outcome variable that is measured once in an individual, that such analyses will not be biased. 
This assumes that the data is missing at random, which is true of this study. Additionally, the 
lack of a control group receiving standard treatment such as an alternative dietary 
intervention, the large proportion of loss to follow up, the small subgroup analysis sample 
sizes, and small numbers of non-responders make it difficult to draw conclusions about 
reasons for responding. The case series sample also had a greater proportion of males and 
adults which could have led to Type II error. Furthermore, apart from challenge analysis, the 
significance level was not adjusted for multiple comparisons, thus it is acknowledged that Type 
I error could have occurred.437  
Strengths of the prospective study included the prospective nature, follow up at multiple time 





included the small sample size, particularly for the personalised diet and the high volume of 
questionnaires, which may have resulted in questionnaire fatigue or discouraged patients from 
participating in the study. The greatest limitation of this study was the small numbers of 
patients completing the full battery of questionnaires and large loss to follow up, which may 
mean conclusions of this study are skewed towards patients that are more likely to return for 
clinical follow up and/or had symptomatic improvement.  
The attempt to follow up all patients at the clinic using a follow up survey was a strength 
however was limited by the low response rate. Reasons for the low response rate likely 
included the high volume of questionnaires, out of date email addresses and the time required 
to complete the survey. Overall, the significant numbers lost to follow up in the case series and 
prospective studies requires further exploration. Difficulties adhering to the diet due to other 
life factors were also noted clinically, for example pregnancy, death of a close relative, 
travelling for work, holidays or moving house. 
QOL and psychosocial assessment was strengthened by the use of validated questionnaires 
and combined use of generic and specific QOL tools. However, as previously described in 
Chapter 2 the FRQOL has not been validated and thus conclusions drawn from this tool are 
limited.  
A limitation of the SDQ was the patient reported rating of frequency and severity on a Likert 
scale, as it decreased the ability to correlate with QOL and psychosocial assessment scores and 
dietary adherence. Future studies using a validated symptom scoring tool may allow for 
greater exploration of the relationship between symptoms and dietary adherence. Improving 
dietary adherence measures through the development of a validated scoring tool, such as 





Dietary data collection and analysis using four day WFR methodology was beneficial in its 
ability to identify nutrients at potential risk of inadequacy in patients with EoE following the 
RPAH EoE dietary protocol, with strategies to promote adequate intake of nutrients at risk on 
the strict elimination diet identified. WFRs are an advantageous dietary data collection method 
due to the ability to collect quantitative information on an individual’s food intake over a set 
time period. However, limitations of the methodology must be acknowledged including: 
measurement of current intake (not usual intake), potential changes in dietary behaviours by 
respondents, conversion of portion sizes and matching of foods recorded to food composition 
databases.226 Additionally, whilst every effort was made to obtain detailed dietary information, 
the self-reported nature of the dietary data including poor reporting of fluid intake and 
inclusion of under and over-reporters may have resulted in error. The use of a FFQ over WFR 
methodology may encourage greater participation in the future due to the decreased 
participant burden.225 Measuring nutritional biomarkers throughout the dietary elimination 
and challenge process and long term could help reduce these inconsistencies and is important 
to identify the impact of inadequate intake of key nutrients at each of these stages. Finally, the 
inherent limitations of food composition data should be acknowledged. The AUSNUT 2011-
2013 database is the most up to date database available, however, many new food products 
were not included in the database.229  
The use of a validated diet quality index was also a strength of the dietary data analysis in Part 
D. However, analysis was limited by the small sample size, particularly for the personalised diet 
and lack of follow up data obtained.  
The elimination diet described here (RPAH elimination diet and challenge protocol) was 
beneficial in its exclusion and challenge of all possible whole food, natural food chemical and 
additives to identify food chemical sensitivities. However, it is recognised that the RPAH 





beyond this setting. Additionally, robust research assessing the efficacy of diets low in natural 
food chemicals and additives is not available elsewhere.31,123 This presents a limitation and 
needs to be considered as part of the findings of this research.  
5.21 CONCLUSION 
This case study of dietary investigation and management at the RPAH Allergy Unit identified a 
variety of areas for consideration and further research for the clinical management of patients 
with EoE. Firstly, assessment of oesophageal, non-oesophageal GIT, non-GIT symptoms and 
atopic conditions as well as QOL, psychological functioning and nutrient intake was found to be 
important considerations in patients with EoE. Secondly, patients with EoE report a variety of 
foods to be symptom triggers which were found to be related to allergy test results and food 
texture, and thus may be useful in directing assessment and education. However, patient-
reported symptom triggers were not related to final challenge outcomes, thus dietary 
elimination and challenges are required to determine an appropriate personalised diet.  
The strict low chemical elimination diet and challenge protocol provided patients with 
symptomatic and histological improvement on the diagnostic diet and identified various 
symptom triggers, this enabled a personalised diet to be devised for each patient, on which 
they can maintain symptomatic and histological improvement. Additionally, this process could 
potentially be completed in a shorter time frame and with a reduced number of endoscopies 
compared to other dietary elimination strategies. However, it is initially more restrictive in the 
diagnostic phase than four and six food elimination diets, may result in a more restrictive diet 
long term, and impact QOL and nutrient intake. Overall, the strict low chemical elimination 
diet and challenge protocol is beneficial in allowing a personalised approach to managing 
symptoms, histological outcomes and identifying food triggers. However, further research is 





Overall, this case study provided a variety of considerations, specific to the clinical setting and 
the NCP, that can assist dietitians in providing personalised care to patients with EoE. In order 
to determine how these considerations can be implemented to provide personalised dietary 
care, the next chapter (Chapter 6) explores Australian dietitians’ knowledge and perceived 







CHAPTER 6: KNOWLEDGE AND SKILLS OF AUSTRALIAN 
DIETITIANS IN THE DIETARY MANAGEMENT OF EOSINOPHILIC 
OESOPHAGITIS 
6.1 INTRODUCTION 
This thesis has identified a range of considerations and barriers for the implementation of 
dietary investigation and management of EoE. The survey reported in Chapter 3 highlighted 
the current inconsistencies in dietary management. Qualitative research in Chapter 4, 
suggested that patients with EoE felt that dietitians did not provide individualised dietary 
advice, information on food challenge/reintroduction or adequate information to ensure a 
nutritionally adequate diet. Chapter 5 examined patient characteristics and a dietary 
management protocol, and identified potential impacts on QOL and nutritional adequacy 
providing a number of considerations for dietitians using the NCP. However, in order to 
consider how dietetic management can be implemented to provide the best available care and 
manage some of the concerns described in Chapters 3 and 4, it is important to investigate 
dietitians’ perceived knowledge and skills in managing EoE and investigate the resources 
currently available. Therefore, this chapter considers dietetic knowledge and skills key to the 
NCP.  
 
It has been suggested that, to achieve success with dietary therapy for patients with EoE, a 
collaborative and multidisciplinary approach including gastroenterologists, immunologists and 
dietitians, is essential.164,438 Dietitians have been promoted as an essential participant in 
successful dietary therapy, to assure proper patient education, nutritional assessment, 
appropriate nutritional planning and avoidance of cross-contaminants.164 Dietitians have also 





patients with EoE, especially in children.105 However, a survey conducted by Maslin et al.311 
indicated that Australian dietitians had a low to moderate competency in educating patients 
on food avoidance, managing multiple food allergies and developing food challenge protocols. 
Current information on dietitian’s knowledge and skills, specifically in the management of EoE, 
is unknown. Understanding existing knowledge and competency of dietitians providing dietary 
advice to patients with EoE, as well as currently available resources, is essential for developing 
appropriate targeted resources and training for dietitians to use when working in this area. 
Therefore, this study aimed to explore current knowledge, skills and training needs of 
Australian dietitians in the dietary management of EoE. 
The objectives of this study were: 
1) To report on the knowledge and skills of Australian dietitians in the dietary 
management of EoE. 
2) To examine currently used and available dietary resources, as well as to explore 
resource and training needs of dietitians for the future.  
6.2 METHODS 
6.2.1 Overview of study design 
This work was part of a larger surveya exploring the knowledge and skills of Australian 
dietitians in the management of adverse food reactions. The study involved two parts: firstly; a 
survey of Australian dietitians to explore their self-reported knowledge and resources and 
training needs including queries specific to their care of patients with EoE. For the purpose of 
the present study, only the results related to EoE are presented. Secondly, desktop analysis 
was performed to identify currently available resources and education materials. This study 
                                                          
aThe PhD candidate designed all questions related to EoE, collated and analysed the survey responses as 





was approved by the Sydney Local Health District Human Research Ethics Committee (#X15-
0169 & LNR).  
6.2.2 Survey methods 
The survey was adapted from a questionnaire conducted four years’ prior.311 The survey 
(Appendix T) was designed to explore and assess dietitian’s knowledge, understanding and 
skills in the dietary management of adverse food reactions including food allergy, food 
intolerance, coeliac disease, EoE and other conditions, such as Food Protein-Induced 
Enterocolitis Syndrome. Additionally, questions asked about current and past training and 
education, the use of resources and preferences for developing training and resources. 
Questions were updated to reflect new knowledge and new technologies and resources, such 
as phone applications. The questionnaires were constructed and distributed using the online 
survey tool 'Survey Monkey' (Survey Monkey Inc. California, USA).230 
Purposive sampling was conducted through the DAA, the peak body for accreditation of 
dietetic professionals in Australia.439 An advertisement was placed in the DAA national weekly 
newsletter and an email was sent to members of DAA who are part of the food allergy and 
intolerance interest group (approximately 1000 members). A follow up email was distributed 
at two and three weeks to increase participation rates. Consent was implied by completion of 
the survey. 
Results were de-identified and collated in Survey Monkey. Further analysis, using descriptive 
statistics was conducted using SPSS statistical analysis software (IBM Australia Ltd., Sydney, 
Australia).231 Percentage responses were calculated per question based on the number of 
respondents answering the question. Chi Square cross tabulations were calculated to 
determine if any factors were associated with higher levels of reported proficiency. Statistical 





6.2.3 Desktop analysis 
Desktop analysis was utilised to identify and examine training tools and resources specific to 
dietetic practice. The NCP2 was used as a framework to identify tools relevant to each of the 
broad steps of dietetic management of EoE.  Specifically, the formal websites of established 
Australian and international adverse food reaction organisations for example the Australasian 
Society of Clinical Immunology and Allergy,440 major hospitals with speciality in EoE, for 
example Cincinnati Children’s Hospital,441 food education websites such as Food Standards 
Australia and New Zealand,442 support organisations, for example ausEE443 and dietitian 
resource hubs such as Practice-Based Evidence Nutrition. These websites were searched to 
identify relevant training and self-study tools, and patient resources related to each step of the 
NCP with EoE between August and October 2016. These websites were chosen as they are the 
peak medical and/or dietetic professional bodies or organisations in adverse food reaction or 
dietetic management. General food allergy or background information on EoE, unrelated to 
the implementation of the NCP, were considered to be beyond the scope of this project. 
Where necessary the organisations were contacted directly to identify resources not publicly 
available or currently under development.  The relevant materials from each website were 
identified and tabulated under each NCP heading.  
6.3 RESULTS 
6.3.1 Characteristics of the study sample 
A total of 274 participants completed the questionnaire, providing an approximate 
participation rate of 27% who subscribed to the mailing list. Most participants identified as 
working in private practice, had been working as a dietitian for less than ten years and 





Table 6.1: Demographic characteristics of all participants. 
Characteristic Response 
N (%) 
Years in practice (N=274) 
Less than 10 years 




Practice setting* (N=238) 





























*Participants could choose more than one practice area 
6.3.2 Self-reported knowledge and skills 
Participants were asked to rate their knowledge and skills in all aspects of EoE management 
(Table 6.2). Overall knowledge and skills was identified to be low. Notably, a third of the 
participants reported that they were ‘not at all proficient’ in conducting food 
challenges/reintroduction with patients with EoE. Dietitians who had been practising for less 
than ten years reported their proficiency in all areas of EoE dietary management to be ‘low to 
not at all proficient’ compared to dietitians who had been practising for greater than 10 years 
(moderate to low). Unsurprisingly, there was a significant association between a higher 
proficiency in the dietary management of EoE and implementing challenges in EoE, and the 





Table 6.2: Self-reported knowledge and proficiency of dietitians in eosinophilic oesophagitis (N=227). 






Not at all 
N (%) 
Understand EoE 26 (11) 62 (27) 68 (30) 48 (21) 
Identify symptoms 18 (8) 56 (25) 70 (31) 57 (25) 
Understand appropriate diagnosis pathway 17 (7) 45 (20) 74 (33) 65 (27) 
Conduct food challenges 14 (6) 36 (16) 73 (32) 74 (33) 
Dietary management 14 (6) 47 (21) 74 (33) 66 (29) 
Educate on food avoidance* 53 (24) 121 (54) 40 (18) 8 (4) 
*N=225 
 
Table 6.3: Self-reported knowledge and proficiency of dietitians in restricted diets for adverse food reactions in adults and children (N=225). 






Not at all 
N (%) 
Children Adults Children Adults Children Adults Children Adults 
Implement nutritionally adequate avoidance diets 33 (15) 47 (21) 65 (29) 101 (45) 58 (26) 51 (23) 35 (16) 15 (7) 
Monitor nutritional adequacy* 51 (23) 57 (26) 67 (30) 100 (45) 45 (20) 38 (17) 20 (9) 13 (6) 
Manage multiple adverse food reactions 18 (8) 24 (11) 66 (29) 90 (40) 68 (30) 72 (32) 43 (19) 26 (12) 






Participants were also asked to report on their knowledge and skills in working with patients 
with adverse food reactions, on restricted diets, for example implementing a nutritionally 
adequate, restricted diet (Table 6.3). Dietitians reported that they were moderately proficient 
in managing adults with adverse food reactions on restricted diets, compared to the 
management of infants and children, where a moderate to low proficiency was reported. 
Higher proficiency in implementing nutritionally adequate avoidance diets, for adverse food 
reaction management, in adults (p=0.002) was significantly positively associated with length of 
practice. Furthermore, there was a significant association between a greater proficiency in 
implementing a nutritionally adequate diet in children with adverse food reactions, and 
managing feeding problems and the percentage caseload composed of children with EoE 
(p=0.005, p<0.001 respectively).   
6.3.3 Training  
A small proportion (17%) of participants reported receiving training in the dietary 
management of EoE during their university dietetic training. Commonly, respondents reported 
being self-taught (36%) in the dietary management of EoE. Journals, conferences, webinars 
and mentoring from experienced dietitians were the most common resources utilised in 
learning. 
Dietitians were asked about the specific areas of adverse food reaction management they felt 
they needed further training. Perhaps unsurprisingly, EoE was the area most dietitians (73%) 
identified as requiring further training. Other areas of training included implementation of an 
elimination diet and challenges, dietary liberalisation post challenges and monitoring 
nutritional adequacy on a restricted diet. Online learning, for example webinars, was the 





6.3.4 Resources  
Most dietitians reported using diet sheets (89%) for patient education on food avoidance, 
followed by information on label reading (72%), recipes (58%), smartphone applications (53%) 
and shopping information (42%) in their current management of patients with adverse food 
reactions. In identifying further needs, development of similar resources was preferred 
including diet sheets (76%), other information sheets (60%), audio visual materials (47%) and 
smart phone applications (44%). 
Within the NCP area of nutrition intervention, implementation of elimination diets, challenges 
and dietary liberalisation post challenges were identified from the survey as important areas 
requiring resources and/or training materials for dietitians. Similarly, within monitoring and 
evaluation, nutritional adequacy on a restricted diet was identified as an important area 
requiring resources and further training. Desktop analysis identified a total of 37 
resources164,443,452–461,444,462–471,445,472–478,446–451 (Table 6.4). Many of the resources identified were 
diet sheets or recipe and meal ideas. No resources were identified in relation to nutrition 
assessment and diagnosis. Nine resources were identified to provide information on food 
challenge/reintroduction, however, none of these identified the amount of the food to 






Table 6.4: Training and resource materials currently available to dietitians identified by desktop analysis. 
Nutrition Care 
Process area 
Resource name Author Year Purpose Description 
Intervention 
(Elemental diet) 
Efficacy of Amino Acid-
Based Diet on Histologic 
Remission & Restoring 
Esophageal Mucosal 





2016 Dietitian self-study Webinar: elemental diet in adults 
Intervention 
(Elemental diet) 
Elemental diet445 CHOCa Children’s 2015 Patient education Tips and resources for elemental 
diet and food reintroduction 
Intervention 
(Elemental diet) 
Elemental diets: what do 
you need to know446 
APFEDc 2013 Patient education Goals of the elemental diet 
Intervention 
(Elemental diet) 
Recipes25 APFEDc 2016 Patient education Single food recipes for food 




Baking alternatives for six 
food elimination diet448 
CHOCa Children’s 2015 Patient education Baking substitutions for the six 
food elimination diet 
Intervention 
(Empirical diet) 
Cow’s milk, egg, wheat 
and nut free recipes449 
Women’s & Children’s 
Hospital Adelaide 




Cow's milk, soy, egg, 
wheat and nut free 
diet450 
Women’s & Children’s 
Hospital Adelaide 




Elimination diet 101451 APFEDc 2013 Patient education Tips for elimination diet, 




Elimination diet and Food 
Trial Tips443 




Elimination diet meal 
planning guide by age 
guide452 
CHOCa Children’s 2015 Patient education Food choices and serve sizes 








EoE tracker453 I-Gastro.net 2011 Patient education Phone application for tracking 6 
food elimination diet 
Intervention 
(Empirical diet) 
Food elimination454 CHOCa Children’s 2015 Patient education Food substitutes, cross-




Meal and snack ideas for 
the six food elimination 
diet455 
CHOCa Children’s 2015 Patient education Meal and snack ideas for the six 
food elimination diet 
Intervention 
(Empirical diet) 
Recipes456 CHOCa Children’s 2015 Patient education Six food elimination diet recipes 
Intervention 
(Empirical diet) 
Six food elimination diet: 
foods to eat and avoid457 




Six Food elimination diet 
Overview458 






CHOCa Children’s 2015 Patient education Wheat free substitutions 
Intervention 
(Empirical diet) 
6 Food Exclusion Diet for 





2016 Patient education List of allowed foods, meal and 
snack ideas, nutrition and growth 
considerations 
Intervention Allergy School on 
Eosinophilic 
Esophagitis461 
EAACId 2017 Dietitian self-study 
and training 
Conference lectures and 
workshops: background and 
practical identification of culprit 
food 
Intervention  Are alcoholic drinks safe 
for EoE adults on an 
elimination diet462 
APFEDc 2014 Dietitian self-study Video on alcohol and EoE 
Intervention  Dietary changes resolve 
EoE in most kids463 
Mayo Clinic 2016 Dietitian self-study Summary of diet restriction and 










2012 Dietitian self-study Webinar slides discussing dietary 
implementation and nutrition 
substitutions 
Intervention  Dietary management of 
eosinophilic esophagitis 
in children Seth Marcus 
MD, MSc465 
Dr. Seth Marcus  2015 Dietitian self-study Lecture: overview of 3 main 
diets, implementation and 
nutritional adequacy 
Intervention  Dietary management of 
eosinophilic 
oesophagitis466 
Education in Nutrition 2015 Dietitian self-study Webinar: choosing appropriate 
diet options 
Intervention  Dietary management of 
eosinophilic 
oesophagitis: When, 




2014 Dietitian self-study Webinar slides: choosing an 
appropriate diet options and 
addressing feeding difficulties 
Intervention Eosinophilic esophagitis 
(EoE) and food by Dr. 
Alan Baldridge467 
Dr. Alan Baldridge 2015 Dietitian self-study Lecture: Overview of 3 main 
diets, nutritional adequacy, food 
reintroduction 





2016 Dietitian self-study Decision tree for nutrition 
intervention 
Intervention Eosinophilic esophagitis 
nutrition guidelines469 
UW health 2014 Patient education Overview of 3 main diets, foods 













2010 Dietitian self-study Webinar: Identification of feeding 
difficulties and appropriate 
referral and management 




CHOCa Children’s 2015 Patient education Frequently asked diet questions  
Intervention Nuts and Bolts of Dietary 
management of EOE 




2015 Dietitian self- study Webinar slides: appropriate diet 
choice, nutritional adequacy, 
strategies for implementation, 
food reintroduction and feeding 
difficulties 
Intervention Practical approach to 
implementing dietary 




Doerfler et al.  2014 Dietitian self-study Journal article: Six food 
elimination diet implementation 
and nutritional adequacy 




CHOCa Children’s 2015 Dietitian training Education program aimed at 
improving dietitian management 
of EoE 
Intervention Reintroduction of food 
after elimination diet474 




Alternate sources of 
Nutrients475 
APFEDc 2013 Patient education List of alternate food sources of 









Replacing lost nutrients 
due to food allergies476 
Kids with food 
allergies 
2016 Patient education List of alternate food sources of 





intake and calcium rich 
foods477 
CHOCa Children’s 2015 Patient education Food and supplement 




Transitioning care from 
teens into adulthood: 






2015 Dietitian self-study Dietary management in children 
and teenagers including 
discussion of unique nutrition 
requirements 
aChildren’s Hospital of Orange County, bAustralian Eosinophilic Support Network, cAmerican Partnership for Eosinophilic Diseases, d European Academy of Allergy and 





The survey found that in a sample of Australian dietitians (27%), who are members of the DAA 
food allergy and intolerance interest group, proficiency in the dietary management of patients 
with EoE, particularly in food challenge/reintroduction was reported to be low.  Additionally, 
Australian dietitians reported poor knowledge in implementing and monitoring nutritionally 
adequate restricted diets for adverse food reactions. This is likely due to most dietitians only 
seeing patients with EoE occasionally, limited guidelines for dietary management of patients 
with EoE and insufficient training received in this area, with over a third of respondents 
reporting that they were self-taught. There are a number of resources available to support 
dietitians in their management of patients with EoE. However, resources providing detailed 
nutrition assessment and food challenge/reintroduction information were notably variable in 
instruction.  
6.4.1 Dietitian knowledge in the nutrition care process for patients with eosinophilic 
oesophagitis 
Proper nutritional assessment and planning is essential for patients with EoE as many of the 
foods removed in the dietary management of EoE (e.g. milk) are staples in the modern 
western diet and hence provide a large proportion of essential daily nutrients.103,164 
Elimination of these staple foods, in children with adverse food reactions, without adequate 
supplementation has been linked to inadequate intake of essential nutrients. For example, 
children on milk free diets had significantly lower intake of energy, protein, fat, calcium, 
riboflavin and niacin than children including milk.479 In addition, even if nutritional goals are 
met, children with adverse food reactions often have lower weights and heights than age 
matched controls.480 Though, overall, evidence suggests that if appropriate supplementation is 
made, nutrition requirements can be met in patients with adverse food reactions,481 with 




nutritional adequacy on restricted diets for adverse food reactions, particularly in children, 
was identified to be an area of low proficiency for dietitians in this study. Doerfler et al.164 and 
Groetch et al.103 provide practical advice on proper nutritional assessment and planning for 
managing nutritional limitations on elimination diets (empirical and elemental) specifically for 
EoE. The authors address the use of food substitutions, nutritional supplements and elemental 
formula, with examples, to ensure adequate nutrient intake as well as providing consideration 
of the use of elemental formula for supplementation, and prioritising highly nutritious foods 
into food challenge/reintroduction.103,164 Information on nutrients, particularly micronutrients 
likely to be at risk and appropriate food substitutions and supplements was also well covered 
in resources identified in the desktop analysis. However, given this group of dietitians believe 
they are ill prepared to ensure nutritional adequacy on elimination diets in EoE, perhaps 
training and education in the practical implementation of these resources is required. 
Additionally, currently, there is no information available on whether the advice on dietary 
substitutions and supplementation improves nutritional adequacy specifically in children with 
EoE, highlighting an important area for future research. 
Maladaptive feeding behaviours such a food refusal, food aversion and anxiety may contribute 
to malnutrition and growth disturbance in children with adverse food reactions,479,481 with 
feeding difficulties and poor growth common symptoms among children with EoE.1 There is 
limited information about ensuring nutritional adequacy in children with EoE and concomitant 
poor growth and/or feeding difficulties, and dietitians in this study did not feel confident in 
intervening. One resource specific to this area was identified,470 thus the use of this resource 
and further research into nutritional adequacy, growth and development and feeding 
behaviours in children with EoE is required. Overall, use of the available resources and further 
training are important to ensure dietitians provide nutritionally adequate restricted diets, at 




Food challenge/reintroduction was an area that the dietitians surveyed identified as having 
very low proficiency. Information on food challenge/reintroduction in the literature and 
consequently available resources, lacks consistency and clear guidelines. For example, the 
frequency at which a new food should be introduced varies with a new food introduced every 
three days,130 every week,105 every two weeks,143 and every six weeks.145 The order in which 
foods are introduced also varies and has been directed by patient preference and skin test 
results,143,145 or on their allergenicity, such that the least allergenic foods are introduced first, 
and most allergenic are introduced last.105 Additionally, the amount of a particular food that 
should be introduced is not addressed in resources, as this has not been clearly outlined in any 
studies to date. These inconsistencies make it very difficult for dietitians to implement food 
challenge/reintroduction, and subsequently provide a patient with a personalised diet, 
emphasised by the survey and focus group results in Chapters 3 and 4. The inconsistencies and 
lack of resources also limit their ability to increase their skills in this area. Chapter 5 provided 
evidence for a potential food challenge/reintroduction protocol for use with patients with EoE. 
Chapter 7 also provides a summary of the food challenge/reintroduction recommendations for 
clinical practice from this thesis. Future research and resource development should focus on 
providing a protocol for food challenge/reintroduction with types and amounts of foods to be 
introduced for each age group, including decision points such as IgE mediated food allergy.  
6.4.2 Training and resources  
Most dietitians who completed this survey indicated that they would like more training in the 
dietary management of EoE. In this survey, only a small proportion of dietitians reported 
receiving training in EoE during their dietetic degrees. In other emerging areas of nutrition (e.g. 
nutrition genomics), evidence suggests that dietitians who completed undergraduate training 
or professional development were more likely to achieve better knowledge scores.482 Hence, 




knowledge and may also improve broader proficiency in the workplace. However, this would 
depend on curriculum capacity, and the time and availability of an experienced dietitian in the 
area to provide the curricula. Additionally, it is recognised that only a small proportion of 
dietitians will see patients with EoE in their practice, thus it may not be a priority area for 
inclusion in core nutrition subjects. Hence, alongside university programs, there should also be 
professional development programs or post graduate courses. One specialised training course 
in the dietary management of EoE (paediatrics) by the Children’s Hospital of Orange County, 
California, who have a specialised multidisciplinary clinic dedicated to the management of EoE, 
was identified,473 but this is not accessible to Australian dietitians. Online learning was 
preferred by dietitians, however, the ability to ask questions is often lost in this format.483,484 
Web lectures,484 case-based learning and an internet modules approach to learning has 
previously received high ratings from students and professionals, and improved 
knowledge.482,485 It has also been suggested that content should focus on knowledge and 
practical skills.484 Development of an online training course in EoE with a focus on dietary 
implementation, food challenge/reintroduction and nutritional adequacy would benefit 
dietitians currently practising in this area and in the future. However, overall it is recognised 
that the lack of standard guidelines for the dietary management of EoE makes design and 
implementation of training difficult. Thus, consideration also needs to be given to more 
research so that there can be development of standard practice guidelines.  
6.4.3 Study strengths and limitations  
The survey was a useful tool to facilitate data collection from a large group of Australian 
dietitians, from the adverse food reactions interest group, most likely to be managing patients 
with EoE and using elimination diets more generally. A limitation of this study was its self-
reported nature and the low response rate (27%). Additionally, data was not collected on the 




of the Australian dietitian population. Desktop analysis was a useful method to identify 
currently available resources and the content areas missing to dietitians in practice. However, 
whilst every effort was made to identify available resources, the resources provided may not 
be a complete compilation. 
6.5 CONCLUSION 
In summary, this group of Australian dietitians report low proficiency in the management of 
EoE, particularly food challenge/reintroduction and nutritional adequacy. A variety of 
resources specific to each stage of the NCP are available to assist dietitians, however, 
development of specific food reintroduction resources would be beneficial. Furthermore, 
implementation of university training and a national training course, suitable for online 
learning, would assist dietitians to develop skills in this area. This research highlights that in 
emerging or speciality practice areas, dietitians should identify strategies for continuing 
professional development. In particular, focus on core dietetic practice skills such as dietary 
manipulation (elimination and challenge/reintroduction) and review of nutritional adequacy in 




CHAPTER 7: THE NUTRITION CARE PROCESS FOR EOSINOPHILIC 
OESOPHGITIS: CONCLUSIONS AND RECOMMENDATIONS 
7.1 SUMMARY OF THIS RESEARCH 
This research aimed to inform the dietary management of EoE, from assessment through to 
monitoring and evaluation, within the constructs of personalised medicine and the nutrition 
care process. This included four key aims: 
1) exploring patient characteristics and current management; 
A broad descriptive survey was initially used to gather information on patient characteristics 
and current management practices in Australia, from a support group (Chapter 3). This 
national survey provided insight into the variability in patient presentation and range of 
dietary management practices. 
2) exploring patient experiences and needs; 
A qualitative approach was used to gather information on the experiences and perspective of 
patients with EoE on the optimisation of the management process (Chapter 4) and highlighted 
the following themes: 
• desire for a clear and direct treatment pathway and holistic management; 
• difficulties with dietary therapy and food challenge/reintroduction, expectations of 
the role of the dietitian and concerns about nutritional adequacy and growth; and 
• a desire for greater professional awareness, knowledge, support and understanding. 
3) examining the use of a low chemical elimination diet to develop a personalised dietary 




Themes were explored in further detail in a case study of the management of EoE at the RPAH 
Allergy Unit. Firstly, patient characteristics documented in Chapter 3 were referenced in the 
analysis of the case series (Chapter 5) providing insight into considerations for nutrition 
assessment, intervention and monitoring to better provide holistic care, a key expectation of 
patients identified in Chapter 4 and the NCP. In particular, unique lower GIT and non-GIT 
symptoms were identified to be impacting patients with EoE, in conjunction with their 
oesophageal symptoms and concomitant conditions. Additionally, a more thorough 
understanding of biopsychosocial factors influencing patients with EoE were examined 
(Chapter 5, Part C) including impacts on QOL due to symptoms and dietary restriction at 
baseline, as well as symptoms of anxiety and depression.  
Secondly, the case series and prospective study from RPAH Allergy Unit case study (Chapter 5) 
provided further in depth exploration of dietary therapy considerations. Outcomes of a 
personalised dietary management approach were presented (Chapter 5, Part B) and was the 
first study to provide evidence that a low chemical elimination diet followed by challenges may 
be effective in the dietary investigation and management of patients with EoE. Notably, the 
dietary protocol can induce symptomatic and histological remission, and a personalised diet 
was provided based on challenges. Symptoms, challenge results and personalised diets were 
identified to be idiosyncratic, emphasising the need to individualise the dietary approach to 
the patient. QOL considerations when on dietary restriction, and important information on 
nutritional adequacy and dietary quality was also exposed in Chapter 5. Overall, key issues 
related to nutrition assessment, intervention and monitoring/evaluation were identified in line 
with the third aim of this thesis:  
• Assessment of symptoms: oesophageal, GIT and non-GIT 
• Review of atopic conditions including allergy testing 




• Review of endoscopic and histological features 
• Introduction of dietary elimination, food challenge/reintroduction and 
personalised diets 
• Consideration and monitoring of quality of life 
• Assessment of psychological characteristics  
• Assessment and monitoring of dietary intake (nutrients and quality) and 
evaluation of use of supplementation 
• Consideration of dietary habits, food texture and adherence 
4) exploring dietitian knowledge.  
The importance of a dietitian in the implementation and monitoring of diet restriction was 
emphasised (Chapters 3-5), therefore the final study of this thesis examined dietitian 
knowledge and skills in the management of EoE as well as currently available resources 
(Chapter 6). This highlighted the need for training in adverse food reaction management as 
part of dietitians’ university studies and ongoing training opportunities in the dietary 
management of EoE, as well as food challenge/reintroduction resource development to 
facilitate clinical management.  
The fact that patients and dietitians identified several common barriers to the dietary 
management of EoE, including food challenge/reintroduction and nutritional adequacy, is a 
relevant finding and further supports the clinical recommendations from this research.  
7.2 CLINICAL PRACTICE RECOMMENDATIONS FROM THIS RESEARCH 
The extensive literature review and studies outlined in this thesis resulted in several clinical 
practice recommendations. These recommendations are specific to dietetic practice, in line 
with the aims of this thesis. Many of the considerations for the NCP are core to general 




dietitians do not feel proficient in applying these core skills to the dietary management of EoE, 
they are discussed here for completeness. In addition, due to the multidisciplinary context of 
the management of these patients, it is first prudent to discuss broad management 
considerations highlighted in this research which may impact the dietetic consult. The 
recommendations for dietetic practice are then outlined in line with the NCP framework.  
7.2.1 Broad investigation and management considerations for patients with 
eosinophilic oesophagitis 
Prior to the initial dietetic consult there is an expectation that the patient has undergone 
accurate diagnostic procedures and been provided with education on the disease, treatment 
options, long term outcomes and consequences of going untreated. However, evidence from 
the national survey and focus groups (Chapters 3 and 4) suggested that patients often do not 
receive disease information or treatment choices. Subsequently, the dietitian needs to assess 
the patient’s knowledge, preferences for treatment and reason for referral. Additionally, to 
support a patient centred approach to care, the dietitian may need to provide general disease 
education, an overview of treatment options, information on the benefits and limitations of 
these options and long term outcomes and consequences. This also reiterates the importance 
of communication within the multidisciplinary team to ensure consistency of information 
provision.  
The importance of the multidisciplinary team in the effective management of patients with 
EoE was a consistent theme identified throughout this thesis. Apart from the dietitian, 
members of the multidisciplinary team identified included the primary care physician (GP or 
paediatrician), gastroenterologist, immunologist and possibly a psychologist. Additionally, 
depending on their concomitant conditions, patients with EoE may also see a respiratory 
specialist, ENT specialist, dermatologist, rheumatologist and social worker. Importantly, the 




influence symptoms and pathology, such as reflux and rhinitis, in patients with EoE. It is 
evident that the multidisciplinary team must not only be skilled in disease management but 
also acknowledge and manage the impacts of the disease, concomitant conditions and 
treatments on broader aspects of health, such as QOL. Subsequently, communication, 
collaboration and co-ordination of care is vital to holistic care in this patient group. The 
dietitian is well placed to liaise between the patient, carers and other members of the 
multidisciplinary team and will need to focus on sound communication and advocacy 
strategies to assist others to realise the complexities of dietary management in these patients. 
In particular, the dietitian can emphasise the need to conduct nutrition assessment and 
monitoring, individualise the dietary approach and complete food challenge/reintroduction. 
Communication within the multidisciplinary team will also support other factors highlighted as 
important to patients in this research including patient support, follow up, a clear and direct 
treatment pathway, and holistic management of EoE and concomitant conditions.  Overall, the 
themes identified in this thesis are consistent with the consensus recommendations1 with the 
advantage of providing specific guidelines for dietitians. 
7.2.2 Nutrition assessment of patients with eosinophilic oesophagitis 
A variety of considerations for nutrition assessment were highlighted in this research. Many of 
these are core to the nutrition assessment of any patient such as anthropometric measures, 
personal, social, family and medical histories, medications, dietary intake and the use of 
supplements. Unique assessment criteria for patients with EoE identified in this research 
included endoscopic and histological features, allergy test results, a broad array of symptoms 
and concomitant conditions, current dietary restrictions including the impact on nutrient 
intake, suspected food triggers and food habits/compensatory strategies, and QOL and 
psychological impacts (Table 7.1). Comprehensive assessment accounting for these factors will 




monitoring and collaboration with the multidisciplinary team including referral to additional 
services when required. Importantly, the assessment criteria outlined here will help support 





Table 7.1: Nutrition assessment considerations for the dietary management of eosinophilic oesophagitis.  





• Head circumference 
• BMI 
• Weight change 




• WHO growth charts486 
• CDC growth charts487 
Biochemical data, medical 
tests and procedures 
• Endoscopic features 
• Histology 
• Allergy test results 
• Coeliac serology/HLA genotype 
• Nutritional biomarkers 
• Endoscopy and oesophageal biopsy 
o Endoscopic Reference Score (EREFS)488 
o 15 eosinophils/HPF1 
o Eosinophilic Esophagitis Activity Index (EEsAI PRO)489 
• SPT and/or RAST 
Client history • Personal history 
• Social history 
• Quality of life 
• Psychological characteristics 
• Family history 













• Concomitant conditions 
• Atopic conditions 
Adult: 
• Dysphagia symptom questionnaire491 
Children: 






• Food and nutrient intake 
o Macronutrient 
o Micronutrient 
o Food allergens 
o Food chemicals 
o Types and patterns 
o Supplements 
• Current dietary restrictions/ food 
avoidance 
• Patient-reported food triggers 
• Food texture/ eating behaviours 
• Food and nutrition knowledge/skill 
• Barriers to dietary adherence 
• Nutrient Reference Values220  
• Australian Dietary Guidelines114 
Abbreviations: BMI: Body Mass Index, WHO: World Health Organisation, CDC: Centre for Disease Control and Prevention, HLA: Human Leukocyte Antigen, EREFS: 




7.2.3 Nutrition diagnosis of patients with eosinophilic oesophagitis 
The nutrition diagnosis component of the NCP can be used by dietitians to identify and 
describe the most important nutritional considerations impacting on the health of the patient.2 
The nutrition diagnosis step is informed by the assessment phase and this research highlighted 
that assessment of patients with EoE requires consideration of a variety of symptoms, 
conditions, nutrition and psychosocial factors. Thus, it is reasonable to conclude that there is 
no single nutrition diagnosis for patients with EoE. The nutrition diagnosis should be individual 
and based on factors identified in the assessment process that can be improved by nutrition 
intervention. Example nutrition diagnoses have been provided in Table 7.2 and likely 
intervention and monitoring/evaluation options are described below. However, importantly, 
these diagnoses will most likely relate to the potential for inadequate nutrient intake 
depending on the phase of dietary intervention.  
Table 7.2: Example nutrition diagnosis statements for patients with eosinophilic oesophagitis. 
Example nutrition diagnosis statements 
Inadequate micronutrient intake (calcium) related to food and nutrition knowledge deficit 
regarding appropriate calcium fortified dairy alternatives as evidenced by diet history with 
avoidance of dairy products and insufficient intake of dairy alternatives. 
Excessive bioactive substance intake related to idiosyncratic sensitivity to amines as 
evidenced by reflux, abdominal pain and headache which resolves on elimination of amines 
from the diet and re-occurs on blinded and unblinded provocation with amines. 
 
7.2.4 Nutrition intervention of patients with eosinophilic oesophagitis 
Nutrition intervention can include food and/or nutrient delivery, nutrition education, nutrition 
counselling and/or coordination of care. This research highlighted that the dietary 
investigation and management of EoE is an ongoing process, with two main phases of nutrition 
intervention: a diagnostic elimination diet, and food challenge/reintroduction to provide a 
personalised diet, which must be individualised to the patients symptoms, tolerance and 




Table 7.3: Nutrition intervention and management considerations for the dietary management of patients with eosinophilic oesophagitis.  
Nutrition Intervention/Management Phase 1- Diagnostic elimination diet Phase 2- Food challenges and personalised diet 
Food and/or nutrient delivery • Choice of dietary elimination 
• Symptoms 
• Food allergens 
• Food chemicals 
• Nutrient intake 
• Food texture/ eating behaviour  
• Quality of life 
• Psychosocial 
• Monitoring/evaluation - symptoms and 
histology 
 
• Choice of food challenges 
• Check SPT results 
• Whole foods 
• Food chemicals 
• Monitoring/evaluation – symptoms 
and/or histology  
• Personalised diet 
• Food allergens 
• Food chemicals 
• Concomitant conditions 
• Food texture/eating behaviour 
• Dietary adherence 
• Nutritional adequacy and dietary quality 
• Quality of life 
• Psychosocial 
• Monitoring/evaluation - symptoms and 
histology 
Nutrition education and counselling 
 
• Types of adverse food reactions 
• Diet/disease relationship 
• Recommended dietary modifications 
• Food texture modification 
• Nutrition label reading 
• At risk nutrients and increasing intake 
• Barriers to dietary adherence 
• Food reintroduction  
• Symptom expectations on food reintroduction 
• Recommended dietary modifications 
• Food texture modification 
• Nutrition label reading 
• At risk nutrients and increasing intake 




Coordination of nutrition care 
 
• Coordinate follow up endoscopy and oesophageal 
biopsy on the elimination diet with 
gastroenterologist 
• Specialist referral required 
• Coordinate follow up endoscopy and 
oesophageal biopsy on the personalised diet 
with gastroenterologist 
• Coordinate follow up allergy testing with 
immunologist 
• Specialist referral required 




The initial dietary intervention decision should be made in conjunction with the 
multidisciplinary team and the patient. The initial choice of elimination diet and foods to 
exclude will be dependent on several factors. Firstly, symptoms for example, if a patient has 
symptoms suggestive of food chemical intolerance then broader dietary food chemical 
elimination will likely be beneficial. Secondly, other adverse food reactions, such as IgE-
mediated food allergy or coeliac disease, patient’s perceived food triggers and current dietary 
restrictions will influence foods excluded in this phase. Food allergy test results may also be 
used to guide dietary elimination. Finally, the patient’s personal and social history, 
circumstances, preferences, QOL and psychological characteristics will determine the 
feasibility and level of dietary restriction required. In some cases a 4-FED or step down 
approach may be more appropriate. Patients assessed as high nutritional risk may also need to 
be prescribed an elemental formula to supplement intake. A plan for follow up is imperative.  
Nutrition education in the initial diagnostic elimination phase should include explanation of 
types of adverse food reactions, diet/disease relationship, and an outline of the plan for food 
reintroduction and follow up. The dietitian will also need to acknowledge that diet may not be 
the only contributing factor to symptomology or inflammation (e.g. reflux and rhinitis). 
Nutrition counselling should focus on foods, food products, meals and snacks the patient can 
include on their elimination diet. Patients should be encouraged to consume foods high in 
nutrients likely to be at risk of inadequate intake and/or provided with recommendations for 
supplementation with a multivitamin/mineral supplement or elemental formula. Advice should 
be individualised based on the patient’s current diet and address barriers to dietary 
adherence. Food texture modification education and nutrition label reading information may 
also need to be provided.   
Food challenge/reintroduction to establish a personalised diet is critical. Discussion with the 




frequency of repeat endoscopies is required. The food challenge/reintroduction protocol 
presented in this research was effective in identifying symptom triggers and a personalised 
diet in clinical practice so may be a useful guide for dietitians. Overall, evidence from the 
literature and this thesis suggests that food challenge/reintroduction should be specific and 
involve: the inclusion of the purest/least processed form of the food (e.g. milk); daily, in line 
with amounts recommended in the dietary guidelines appropriate to the patient’s age and 
gender. Additionally, allergy testing/monitoring should be considered to avoid the risk of 
challenge with foods likely to cause severe IgE-mediated allergic reactions.354 Patient 
preferences and nutritional quality can also guide the choice of food to challenge/re-introduce. 
When providing nutrition education on food challenge/reintroduction, dietitians should focus 
on the type and amount of food to challenge/reintroduce and how to practically include the 
food into the daily diet. Dietary counselling about possible expected symptoms may assist in 
relieving anxiety around food challenge/reintroduction.  
Once food triggers have been established, dietary prescription of a personalised diet can 
occur. Nutrition counselling should focus on foods, food products, meals and snacks the 
patient can include on their personalised diet. Additionally, education should focus on 
encouraging patient consumption of foods high in nutrients likely to be at risk of inadequate 
intake and/or recommendation of supplementation with a multivitamin/mineral supplement 
or elemental formula. Advice should be individualised based on the patient’s dietary 
preferences and may also need to address social factors such as eating out, celebrations and 
holidays. 
7.2.5 Monitoring and evaluation of patients with eosinophilic oesophagitis 
The nutrition assessment, diagnosis, intervention and monitoring components of the NCP are 
interconnected and dependent on each other. As such, the monitoring/evaluation component 




nutrition diagnosis can assist with determining outcomes to monitor. Importantly, changes in 
symptoms and histology must be monitored to establish if the intervention goals have been 
met, but are not the only outcomes to be considered. Monitoring nutrient intake is essential to 
prevent deficiencies and may be supported by monitoring anthropometry and biochemistry.  
Establishing dietary adherence is also a key step in the evaluation process and monitoring QOL 
should also be considered.  
Overall, a concerted effort is required to consider each patient’s individual needs and 
expectations in the dietary management process within the context of the hospital system and 
multidisciplinary team. Use of the NCP framework, consensus recommendations1 with 
acknowledgement of the considerations highlighted in this research and collaboration with 
multidisciplinary team will assist dietitians to provide personalised and patient centred care to 
individuals with EoE, aligning with the thesis hypotheses. Further dissemination of the results 
of this thesis through peer reviewed publications and presentations, development of resources 







Table 7.4: Nutrition monitoring and evaluation considerations for the dietary management of 
eosinophilic oesophagitis.  
Nutrition monitoring and evaluation 
Anthropometric measurements • Weight 
• Height/length 
• Head circumference 
• BMI 
• Weight change 
• Growth pattern 
Biochemical data, medical tests and 
procedures 
• Endoscopic features 
• Histology 
• Allergy test results 
• Nutritional biomarkers 
Client history • Personal history 
• Social history 
• Quality of life 
• Psychological characteristics 
• Family history 
• Medication history 






• Concomitant conditions 
• Atopic conditions 
Food/nutrition related history • Food and nutrient intake 
o Macronutrient 
o Micronutrient 
o Food allergens 
o Food chemicals 
o Types and patterns 
o Supplements 
• Dietary restrictions/food avoidance 
• Patient-reported food triggers 
• Food texture/eating behaviour 
• Food and nutrition knowledge/skill 
• Barriers to dietary adherence 
Abbreviations: BMI: Body Mass Index 
7.3 STRENGTHS, LIMITATIONS AND FUTURE DIRECTIONS 
Overall, the combined use of qualitative and quantitative research methods was beneficial in 
allowing a comprehensive assessment of the complexity of dietary investigation and 




A dietetic focus through the constructs of personalised medicine and the NCP was applied 
allowing recommendations for clinical practice to be provided, supporting and enhancing 
current guidelines1. However, this meant that the research does not cover all related topics or 
stakeholders.  Firstly, much of the research was conducted with adults, thus, some paediatric 
specific considerations require greater clarification. Additionally, the case study, was 
conducted in the specific context of the RPAH Allergy Unit in the Sydney region of NSW. 
Therefore, the generalisability of this research requires consideration. A significant number of 
patients did not return for follow up after initial education on dietary intervention and 
therefore it is likely that some individuals are not responsive to dietary therapy. Similarly, the 
lack of a control group means that it is not possible to infer if patients may have improved 
without the interventions used here. However, evidence from patients completing food 
chemical challenges suggests this is unlikely. The response rates for the follow up survey study 
were also lower than expected, limiting the conclusions about long term impacts of EoE 
related to dietary therapy outcomes, QOL, psychological symptoms and nutritional adequacy. 
As such, the following recommendations are made for future research in order to enhance 
clinical practice recommendations and better understand food chemical intolerance in the 
aetiology of EoE.  
7.3.1 Dietary therapy in eosinophilic oesophagitis 
• This research was unique in its identification of patient-reported food triggers and 
examination of their relationship to allergen tests and food chemical challenge results. 
Possible relationships to food allergen test results but not food chemical challenge 
results were identified. Further research with larger numbers, in multicentre studies is 
required to confirm these findings and better understand their importance in assessment 




• This research identified that patients with EoE often have minor food sensitisations on 
allergen tests, which fluctuate overtime and may influence response to dietary therapy. 
Further research to establish the clinical relevance and emphasis that should be placed 
on these food sensitisations is required, as well as exploration into their significance in 
disease pathology. Examination of local oesophageal IgE antibodies may be beneficial. 
• The present research attempted to explore factors that influence symptomatic and 
histological response to dietary therapy, and identified food sensitisations and dietary 
adherence to influence histological response. However, conclusions were limited by 
small numbers. Future research in larger multicentre populations could examine 
predictors of dietary response, possibly using regression analysis, to provide information 
to support clinicians and patients in care planning.  
• A gap in current knowledge identified in this research was whether there is a dose 
related threshold for dietary triggers in patients with EoE. This would be beneficial to the 
understanding and development of food challenge/reintroduction protocols and long 
term dietary avoidance requirements. Case evidence from this thesis suggests a dose 
related response. Further exploration of dose response in patients with EoE through 
systematic, graded introduction of a specific amount of a known food trigger for a period 
of time, followed by multiple, repeated symptom and histological assessment could 
provide this information but requires ethical and feasibility considerations.  
• This research attempted to provide information on long term follow up of patients with 
EoE who had undergone dietary elimination and challenges, however, due to low 
questionnaire participation rates, conclusions were limited. Greater understanding of 
long term outcomes of patients undergoing dietary therapy is essential to better 
understand the benefits and limitations of dietary therapy, particularly regarding QOL 
and nutritional adequacy. This will ensure patients and health professionals can make 




• The research in this thesis was unique in its exploration of psychological characteristics in 
adult patients with EoE. Thus, further research in other EoE populations is required to 
support the findings, specifically investigating greater numbers of patients undergoing 
different treatment modalities may be relevant. The validated psychological assessment 
tools used in this study could also be used in future trials. The use of both general and 
specific QOL tools was also identified to be an advantage of this study and should also be 
considered in future studies. 
• A variety of factors influencing dietary adherence were examined in this research but 
were not found to be significant in our population. More research examining these 
factors and others, such as symptom severity (Chapter 5, Part C) is important to assist 
with identifying specific factors influencing dietary adherence,407 support care planning 
and intervening before patients with EoE become non-adherent.199 Qualitative research 
may be beneficial in this regard. Future studies should also consider development of 
dietary adherence scoring tools to allow consistent assessment of dietary adherence. 
• The research in this thesis was also unique in its examination of nutritional adequacy and 
dietary quality in patients with EoE completing an elimination diet and challenges. 
Further research examining nutritional adequacy and dietary quality in adults and 
children with EoE undergoing dietary therapy is required to support clinical 
recommendations across the NCP. Future trials should consider the use of nutritional 
biomarkers, anthropometry and development of specific dietary quality measures to 
enhance knowledge and guide dietary and supplementation advice. WFR were an 
effective measure for nutritional adequacy in this study and could be used in future trials, 
however, may not be feasible in larger scale trials. Multi-pass 24hr recall or FFQ 
methodology could be considered but would likely need adaption to ensure less 




7.3.2 Low chemical elimination diets and food chemical intolerances in eosinophilic 
oesophagitis 
• The research in this thesis identified a variety of symptoms suggestive of food chemical 
intolerance to be experienced by patients with EoE that have not previously been well 
reported.  Future work could use the protocols developed here in multicentre research 
globally to corroborate these findings. Additionally, exploration of the relationship 
between oesophageal and non-oesophageal symptoms and eosinophilic inflammation 
may be important to understanding the significance of these symptoms.  
• The case series methodology used in Chapter 5 was beneficial in allowing description of 
outcomes of the low chemical elimination diet in patients with EoE. However, case series 
studies are not designed to provide cause and effect, thus further prospective research 
using stronger research designs are required to determine the efficacy of the use of a low 
chemical elimination diet in patients with EoE. For example, prospective studies 
comparing a low chemical elimination diet or possibly avoidance of food chemicals alone 
to less restrictive diets such as the 6-FED would be of great value. 
7.3.3 Resources and training  
• The development of clear and specific food challenge/reintroduction guidelines is 
essential for effective practice implementation. This research provided an example of 
food challenge/reintroduction guidelines that can be used in patients following a low 
chemical elimination diet as well as identifying decision points that may be important 
as part of this protocol (e.g. allergy test results and age). Future research could assess 
the efficacy of this low chemical elimination diet and challenge protocol in other EoE 
populations.  
• The development of an online training module or course covering areas of nutrition 




identified as a key requirement for dietitians in Chapter 6. Measurement of 
effectiveness of training implementation should also be included in the development of 
any such education modules. Furthermore, a review of current Australian university 
dietetic training in adverse food reaction management would be useful to better 
understand current training and identify priority areas and needs for implementing 
university training, as well as how this could be supported by further training as part of 
continuous professional development.  
• Patients participating in the focus groups identified that they desired resources that 
provided an overview of diagnostic, treatment/management and long term outcomes.  
The 2017 consensus management guidelines1 provide an overview of the management 
pathway options for health professionals. However, development of a patient specific 
resource providing an overview of treatment options and considerations could further 
support patient-provider decision making and subsequently a patient centred 
approach to care. 
• Patients participating in the focus groups identified that they desired resources on 
nutritional adequacy and food substitutions when on an elimination diet. Many 
resources were subsequently identified in Chapter 6, however, were not necessarily 
EoE specific or contextually appropriate to the Australian diet. Thus, development of 
Australian specific resources may be beneficial to both patients and dietitians.  
• The focus groups in Chapter 4 highlighted that awareness, knowledge, understanding 
and support from all health professionals in the multidisciplinary team were desired by 
patients with EoE. The dietitians’ survey specifically assessed knowledge and skills of 
dietitians in relation to EoE. However, assessing awareness, skills and knowledge of 
gastroenterologists, immunologists, paediatricians and GPs may be useful in 
identifying areas for training and resource development or identify possibilities for 




managing patients with EoE were not obtained in the focus groups. Further research, 
through surveys, focus groups or interviews, is needed to understand the perceptions 
and potential barriers to implementing personalised care, in different practice settings, 
by health care professionals working in this area to facilitate improved service 
provision and development of training and resources. 
This thesis has explored the dietary investigation and management of EoE in the Australian 
context from the perspective of the NCP and personalised medicine. The dietary investigation 
and management of EoE is complex but there are many opportunities for improving patient 
outcomes including increasing disease awareness, care coordination within the 
multidisciplinary team, thorough nutrition assessment, personalised dietary intervention and 
monitoring and evaluation, as well as improving training and resources for dietitians. Thus, 
work in this thesis not only provides an outline of considerations for dietitians following the 
NCP, but importantly, highlights patient experiences and the need to both advocate for 
patients as well as provide them with education, to ensure they feel empowered to work with 
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APPENDIX A: BACKGROUND TO THE ROYAL PRINCE ALFRED HOPSITAL 
ELIMINATION DIET AND CHALLENGE PROTOCOL IN PATIENTS WITH 
EOSINOPHILIC OESOPHAGITIS 
A.1 Background to the development of the Royal Prince Alfred Hospital elimination 
diet and challenge protocol 
In 1977 the attending immunologist and dietitian at the RPAH Allergy Unit became interested 
in the role of dietary substances in recurrent urticaria and angioedema due to recent reports 
in the 1960’s and 1970’s of salicylates, preservatives and colourings provoking urticarial 
reactions. An Australian exclusion diet was developed from a review of the available literature. 
The diet was based mainly on work by Rowe, Shelley, Feingold and Warin and excluded 
common food allergens, salicylates, preservatives and azo-dyes.493 The exclusion diet was used 
to produce an asymptomatic baseline, to allow for medication cessation and reducing 
background symptoms (confounding symptoms), before challenging with the chemicals and 
preservatives. However, when compiling and implementing this diet, it was identified that 
food composition data on the salicylate content of many common foods was incomplete and 
thus extensive analysis of salicylates in foods was undertaken and the original elimination diet 
modified accordingly.67 
In the 1980s, it became evident both in clinical practice and the literature that patients with 
urticaria reported other symptoms including abdominal pain, diarrhoea, headaches, migraines, 
behaviour and mood changes (such as hyperactivity), rhinitis and asthma. These patients also 
reported that dietary elimination improved these symptoms. Further research indicated that 
dairy, gluten, natural amines, MSG and other food additives such as artificial antioxidants, may 
also be implicated in provoking symptoms. Thus, a more stringent elimination diet was 




challenge substances was extended, and challenges were updated to be DBPC capsule 
challenges with sucrose and starch placebos. 
A.2 Royal Prince Alfred Hospital low chemical elimination diet and challenge 
protocol 
The standard dietary intervention (Figure A1) excludes foods containing natural salicylates, 
biogenic amines and glutamate, as well as additives: preservatives including propionates, 
artificial antioxidants, benzoates, sorbates, sulphites and nitrates, and colourings. Gluten, dairy 
and soy are excluded on the RPAH elimination diet when the patient reports gastrointestinal 
symptoms, implicates the food in symptoms or has a family history of dairy, gluten or soy 
sensitivity.355 At their initial appointment patients were provided with standard dietary 
education by the attending dietitian on starting the low chemical elimination diet. This 
included an overview of types of adverse food reactions and dietary management. Detailed 
instructions and explanation of the foods to include and avoid, alongside information for the 
reasons for the inclusion and exclusion of foods, practical shopping, cooking and management 
of restrictions to lifestyle. The importance of adherence to the diet was emphasised. Patients 
were provided with a handbook355 with lists of foods to include and avoid, products and easy 
recipes. The dietitian also provided education on nutritional adequacy and appropriate vitamin 
and mineral supplementation.  
Withdrawal reactions; a temporary flare up in symptoms during the first one to two weeks of 
the elimination can occur, after which symptoms settle.355 Challenges are commenced after at 
least two weeks on the elimination diet, once there has been five consecutive days in a row 
free of symptoms. Challenge testing is DBPC, using capsules containing the purified food 
chemicals. Individuals with a history of asthma undergo respiratory assessment before taking 
challenges with salicylates, MSG and sulphites, which are administered under appropriate 




deemed more appropriate (for example in children), some patients’ complete food challenges, 
with foods containing the specific food chemical.  Additional food challenge testing is also 
conducted with whole foods to test reactivity to dairy, gluten and soy. Each food chemical is 
systematically challenged, one at a time, and a positive challenge result is identified based on 
the patients reported symptoms. Challenges are spaced at least three days apart, to allow for 
delayed reactions and any response to a challenge is followed by at least three days’ symptom 
free (refractory response). Food additive food and capsule challenges are conducted over a 
three day period, whilst whole food and natural food chemical challenges are conducted over 
a seven day period, with instructions to consume foods daily in quantities similar to ‘usual 
intake’.356  
Challenge doses are based on typical daily consumption and are listed in Appendix A.4. For 
whole foods, usual intake is based on average amounts consumed in a typical daily diet and 
the number of serves recommended to be consumed per day in the ADG, for example three 
serves of dairy/dairy alternatives per day.356 For additives, usual intake is based on average 
amounts that could be consumed in a typical daily diet according to Australian food standards 
upper limits.496 Patients need to eat at least the recommended amounts to ensure they can 
tolerate the food, food chemical or additive. Challenge doses are adjusted for children to be 
age appropriate.  
Patients excluding gluten, dairy and soy are encouraged to challenge with these food groups 
first and reintroduce if tolerated, for the remainder of the challenges. If a response to any 
challenge is uncertain it is followed by a repeat capsule or open food challenge. Once patients 
have completed all challenge testing, their results are decoded, and their diet modified 
(‘personalised diet’), based on their results. Food chemicals and additives that did not provoke 
symptoms are reintroduced and symptoms monitored. Once stable on their personalised diet 




and food chemicals they reacted to, one by one, to find their threshold; the point at which 
symptoms reoccur. Thus, a patients liberalised diet will include whole foods and natural food 
chemicals they are sensitive to, however; the amount will depend on the patients’ individual 
threshold. Additives are not liberalised due to the variability in amounts added to food 
products.356  
A.3 Adaptation of the Royal Prince Alfred Hospital elimination diet and challenges in 
the development of a dietary management protocol for eosinophilic oesophagitis 
As with the previous reviews and adaptations of the RPAH elimination diet for newly 
recognised symptoms, a variety of considerations and adjustments were made to account for 
the unique presentation of EoE. These various considerations were founded over time from 
clinical experience and evolving evidence from the literature. Discussion of these 
considerations is presented below. The final protocol is presented in Chapter 5 as part of the 
prospective study initiated in July 2015.  
Exclusion of gluten, dairy and soy 
In general, gluten, dairy and soy are excluded on the RPAH elimination diet when the patient 
reports gastrointestinal symptoms. Thus, when the elimination diet was first used at the 
Allergy Unit for EoE, not all patients had dairy, gluten and soy mandatorily eliminated from 
their diet. However, a large proportion of these patients did report gastrointestinal symptoms 
and so had these foods excluded (Chapter 5). 
Evidence from the literature repeatedly identifies milk, wheat and soy as common triggers of 
EoE.497 Additionally, evidence suggests that the NPV for SPT with milk in patients with EoE is 
low and thus milk elimination is suggested regardless of SPT results.139 Uncertainty exists as to 
whether wheat elimination or exclusion of all gluten containing grains is required. Practices 




Hence, elimination of dairy, gluten and soy from the diagnostic elimination diet is mandatorily 
excluded as part of the RPAH EoE dietary protocol.  
Exclusion of egg, fish and nuts 
The RPAH elimination diet allows eggs, fresh white fish and shellfish and cashews (10/day) as 
clinical experience and early adaptations of the RPAH elimination diet suggested that these 
were not common triggers in patients with food chemical intolerance.357 However, a typical 
empirical elimination diet for EoE excludes these, as they are common food allergens in 
children and had been associated with EoE from early work with directed diets.41,133 More 
recent evidence from food reintroduction in patients with EoE in the literature suggests that 
fish and nuts are uncommon triggers,41,129,141 hence the more recent adaptation of the 
empirical 6-FED to the 4-FED. Evidence for egg as a trigger of EoE is largely variable with 
prevalence ranging from 5-54%. PPV, NPV and sensitivity of SPT for egg have been shown to be 
high for patients with EoE.139 Thus, all EoE patients routinely undergo SPT for egg, fish and 
nuts. If SPT are positive, then these foods are excluded, and this protocol was followed in this 
thesis.  
Skin prick testing and monitoring 
It has long been recognised that many patients with EoE have IgE food sensitisations.16 
Evidence suggests that food allergens can contribute to symptoms and oesophageal 
inflammation in patients with EoE.138 However, the low efficacy of the directed elimination 
diet highlights the apparent lack of consistency between allergy testing results and 
identification of EoE triggers. This highlights that for some patients, food allergens may not be 
the only contributing factor and further elimination may be required.139 Thus, SPT with a 




and food allergen elimination completed in conjunction with the low chemical diet after 
individual assessment.  
Repeat endoscopy on the diagnostic elimination diet 
Response to the RPAH elimination diet in patients with suspected food intolerance is usually 
assessed through symptom improvement. Initially, patients with EoE did not routinely undergo 
an endoscopy on the elimination diet. However, it was soon realised that a more systematic 
means of evaluation was needed and that monitoring histological changes as well as 
improvement in symptoms was required. An endoscopy before and on an elimination diet is 
routinely conducted in the literature to assess for macroscopic and histological changes in 
patients with EoE.1 Thus, a repeat endoscopy is now routinely completed as part of the RPAH 
EoE dietary management protocol. 
Duration of diagnostic elimination diet 
Patients are required to have been on the RPAH elimination diet for two weeks, with at least 
five symptom free days in a row before challenges can be commenced.356 In clinical practice, 
this typically means patients are on the diet for an average of four weeks (but up to eight 
weeks) before commencing challenges. A similar protocol was originally implemented in 
patients with EoE. However, it was observed that whilst patients may experience symptom 
improvement within those first four weeks, histological remission took longer to occur. A 
review of the duration of elimination diets used elsewhere for patients with EoE identified an 
average duration of eight weeks (median six weeks)29,35,113,115–117,119,121,212,230,297,499–502 and this is 
reflected in clinical practice. Thus, the protocol was adapted to six to eight weeks on the low 
chemical elimination diet to allow patients sufficient time to settle symptomatically and 




patients to book in for an endoscopy with their gastroenterologist, who often have significant 
wait periods.  
Capsule challenge considerations 
No literature exists on the use of DBPC capsule challenges in EoE. As such, the RPAH 
elimination diet protocol for DBPC capsule challenges was not changed, and is examined as 
part of this thesis.  
Food challenge considerations 
Evidence from the literature suggests a variability in the length of time of food challenges in 
patients with EoE with food reintroduction periods ranging from every three days130 to every 
six weeks.145 Kelly et al.130 reported symptoms occurred within 0.5-8hrs of food reintroduction, 
whilst others reported longer time frames of three days143 with most patients symptomatic 
within five days of adding the trigger food.164 This is consistent with clinical experience in 
patients with food intolerance at the RPAH Allergy Unit, thus one week is used here as it was 
considered sufficient for symptom induction from whole foods.  
The amount and type of each food/food group introduced is not well quantified in the 
literature. Two studies suggest that the food should be consumed daily,144,145 consistent with 
practices at the Cincinnati Centre for Eosinophilic Disorders at Cincinnati Children’s Hospital (A. 
Cassin, personal communication, March 2017), whilst two other studies suggest consuming 
one serve twice daily.130,232 Considering the limited evidence and that it was somewhat 
consistent with the current food challenges used on the RPAH elimination diet,356 this was not 
altered and rather considered a pertinent factor to be explored in the current research.  
In the EoE literature, the order and choice of foods to reintroduce varies and has been directed 
by patient preference, SPT results and allergenicity.105 SPT results also influence whether a 




remain on the elimination diet and not to reintroduce any tolerated foods until all challenges 
have been completed.  
Assessing challenge response 
Challenge response can be assessed in two ways; symptom response and histological 
response. Traditionally the RPAH elimination diet and challenge protocol uses symptoms to 
identify positive challenge responses.356 However, repeat endoscopies are frequently 
completed after reintroduction of each food in patients with EoE, with the purpose to identify 
causative foods based on histological changes.103 The frequency of these follow-up biopsies 
varies, generally ranging from every four to six weeks after the introduction of each new 
food.69 The frequency of endoscopies presents a concern in relation to feasibility, cost, 
associated risks and invasiveness. Furthermore, as described above symptom onset occurs 
within the first week,502,143,141 however endoscopies are not completed until four to six weeks 
post reintroduction, thus prolonging the time patients are symptomatic and on a restricted 
diet. Interestingly, many studies reported that food reintroduction was stopped if symptoms 
reoccurred before the end of the reintroduction period and an endoscopy may or may not 
have been completed.500 Additionally, a dissociation between eosinophilia and symptoms in 
patients with EoE has been identified, with symptoms having a modest accuracy in identifying 
histological remission.270,272,362 Overall, the use of symptoms to identify triggers is 
inconsistently used and has not been well evaluated.   
An endoscopy after the introduction of each food and food chemical was considered 
impractical due to the number of foods and food chemicals challenged as part of the RPAH 
elimination diet and challenge protocol.  Additionally, clinical observations identified that on 
challenging and liberalising their diet patients often experienced a progression of symptoms 
developing overtime, starting as non-oesophageal symptoms before oesophageal symptoms 




inflammation. Thus, to make the protocol clinically practical in relation to feasibility, cost and 
invasiveness, an endoscopy is not conducted after each challenge, but after the patient has 
been on their personalised diet for four to eight weeks. However, it is acknowledged that this 
could result in potential error either by overly restricting the diet or missing potential triggers 
of inflammation that do not result in symptoms. Thus, part of this thesis examines the second 
nutrition intervention step; symptom responses to challenges and the outcomes of the 
personalised diet results.  
Reflux and rhinitis assessment and management 
Evidence suggests that there is likely a relationship between EoE pathology and reflux1 and 
rhinitis.61 Subsequently patients are assessed for reflux symptoms and prescribed treatment; 
medication or dietary modification. Evaluation of rhinitis, including possible allergic rhinitis 
and treatment with avoidance measures and intranasal steroids are also considered for 
patients with EoE within this thesis.  
Other medications 
Patients on swallowed corticosteroids are advised to wean off their medication to allow for 




A.4 Capsule challenge compounds and doses used in the Royal Prince Alfred Hospital 
elimination diet and challenge protocol 
Table A1: Capsule challenge compounds and doses.  
Challenge type Capsule Compound Capsule (mg) 




Salicylates Aspirin 600 



































APPENDIX B: LITERATURE REVIEW OF QUALITY OF LIFE TOOLS USED IN ASSESSMENT OF PATIENTS WITH EOSINOPHILIC 
OESOPHAGITIS 
Table B1: Summary of studies and reported quality of life outcomes. 
Author Date Respondents Population % 
Male 





Treatment Overall QOL 
Outcomes 






2013 53 Adults 75 ≥18yrs at time of study, 
diagnosed with EOE in 
childhood (criteria 
>20eos/HPF, after 
2months on PPI) 
Eosinophilic 
gastrointestinal 
disease other than 
the oesophagus, 














Normal QOL QOL of patients following 
dietary restriction was 
significantly impaired 











50 Confirmed diagnosis of 




coeliac disease, IBD 
Qualitative Moderate Not 
recorded 
Dietary restriction 
or topical steroids 
QOL tool 
development 



















2011 31 Adults 74 Newly diagnosed with EoE 
and dysphagia 











2012 50 Adults 50 >18yrs, diagnosed EoE 
(oesophageal symptoms, 
>15eos/HPF after 8weeks 























Mental component scores, 
role emotion and social 








2014 97 Children 
and 
parents 


















No treatment: 9% 
Impaired QOL QOL improved from 
baseline to 6 months. 
Lower symptom severity at 





2011 54 Children 
and 
parents 
64 Children aged 2-18yrs, EoE 
diagnosis or indeterminate 
esophagitis 
Not specified Cross-sectional Low Not 
specified 
Not specified No difference in 




for children with 
symptoms of 





2011 42 Adult 69 Paediatric diagnosed 
(≥15eos/HPF) EoE 





PPI: 41% Impaired QOL 
 
Patients with 
paediatric EoE are 
likely to have 






2011a 24 Adult 70 Adults (18-70yrs), EoE 
diagnosed (>15eos/HPF 
after PPI therapy 6-8 
weeks) 










2013 7 Children 57 Not specified Not specified Cross-sectional Low Not 
specified 
Not specified Normal QOL scores 
when assessed with 
a generic tool. 
Impaired QOL 
scores when 



































2011b 201 Adult 44 
 
Adults (18-70yrs), 
diagnosed with EoE 
(presence of oesophageal 
symptoms, >15eos/HPF, 
whilst on PPI for 6-8weeks) 





Diet therapy: 72% 
QOL tool validation 
 
Impaired QOL 
scores were related 
to symptom 
severity. 
QOL tool validation 
Lucendo et 
al.359 














QOL tool validation QOL tool validation 
 
Impaired QOL for patients 
following a diet restriction 
compared to those 





Table B2: Summary of QOL tools used to assess QOL in patients with EoE. 
QOL Tool QOL Domains Adult/Paediatric Specific/Generic Target population 
PAGI-QOL: Patient assessment of upper 




Diet and food habits 
Relationships 
Psychological wellbeing and distress 
Adult Specific Patients with dyspepsia, GERD, gastroparesis 




Role limitations due to physical health problems 




General health perceptions 
Adult Generic General population 
PedsQL: Paediatric QOL inventory (Includes 





Paediatric Generic General population 
EORTC QLQ-OES18: European Organisation 
for Research and Treatment of Cancer 
Quality of Life-Oesophageal module 
Symptoms 
Eating/Food 
Adult Specific Patients with oesophageal cancer 
PedsQL EoE module184 Symptoms 
Treatment 
Worry 
Food and eating 
Food feelings 
Paediatric Specific Patients with EoE 









SF-12 QOL: Short Form Health survey for 
QOL290,378 
Physical functioning 
Role limitations due to physical health problems 
Bodily pain 
General health perceptions 
Vitality (energy/fatigue) 
Social functioning 
Role limitations due to emotional problems 
General mental health (psychological distress and well-being) 
Adult Generic General population 
PedsQL-GI: Paediatric QOL Inventory 
Gastrointestinal Symptoms Module (includes 
child self-report and parent proxy report)502 
Stomach pain 
Stomach discomfort when eating 
Food and drink limits 
Trouble swallowing 
Heartburn and reflux 
Nausea and vomiting 
Gas and bloating 
Constipation 
Blood in faeces 
Diarrhoea 
Paediatric Specific Patients with acute and chronic health conditions, as 
well as healthy school and community populations 




Social and dietary limitations 
Paediatric (adult version also 
available) 
Specific Patients with food allergy 








Paediatric Specific Families with children suffering from acute and 




APPENDIX C: FOOD RELATED QUALITY OF LIFE QUESTIONNAIRE 
The following questions concern the influence your food problem has on your quality of life. 
 
 
Do you find that you... Never Sometimes Often Always 
1 
must always be alert to what you are eating?     
2 
are limited as to the foods/products you can consume?     
3 
must read food labels?     
4 
have less control of what you eat when eating away from home?     
5 
must refuse many things during social activities?     
6 
are reluctant to accept an invitation to stay for a meal?     
7 
are reluctant to try various products when eating away from home?     
8 
are reluctant to eat out?     
9 must check whether you can eat something when eating away from 
home? 
    
10 
hesitate eating a food/meal/product when you have doubts about it?     
11 
are troubled that people underestimate your food reactions?     
12 
are unclear as to which foods (if any) you are reacting?     
13 are often frustrated by having to explain to those around you that you 
have food reactions? 
    
14 sometimes frustrate people when they are making an effort to 
accommodate your food requirements? 
    
 
     
 
How troublesome is it... 
Not at 
all 






that the ingredients of a product change?     
16 
that some foods are not labelled e.g. takeaway, bakery etc.?     
17 
that the lettering on food labels is too hard to read?     
18 
that a food label states: ‘May contain (traces of)...’?     
 
     
 
Are you worried... 
Not at 
all 











that your reactions will become increasingly severe?     
 
     
 
Are you concerned about... 
Not at 
all 






having a severe reaction to food?     
22 
accidentally eating a food that you know you may react to?     
23 



















































































































































APPENDIX F: HEALTH PROFESSIONALS RECOMMENDING DIETARY INVESTIGATION AND PROVIDING DIETARY ADVICE 
Table F1: Health professional who recommended dietary investigation (N=82). 






Gastroenterologist 61 (74) 17 (71) 44 (76) 
Immunologist/ allergist 48 (59) 11 (49) 37 (64) 
GP 4 (5) 3 (13) 1 (2) 
No medical recommendation 5 (6) 3 (13) 2 (3) 
Other 8 (10) 2 (8) 6 (10) 
 
Table F2: Health professional who provided dietary advice (N=82). 






Dietitian 62 (76) 15 (63) 47 (81) 
Doctor/specialist  43 (52) 14 (58) 29 (50) 
Naturopath 3 (4) 2 (8) 1 (2) 
Own research 16 (20) 4 (17) 12 (21) 





APPENDIX G: THEMES IDENTIFIED FROM THEMATIC ANALYSIS 
Table G1: 34 dominant themes identified from thematic analysis. 
Theme Subtheme Definition Exemplary quote 
Alternative method 
to endoscopy 
 Method to test disease activity 
other than an endoscopy 
“it would be great if we had another method for testing for EoE rather 
than an endoscopy”  
Participant 6, Focus group 2 
Associated or 
contributing 
conditions and their 
relationship to EoE 
 Conditions that may contribute, be 
associated or be a consequence of 
EoE and the effect of their 
management on EoE 
“the next specialist we found was an asthma specialist and once we 
could deal with that, then that also paid off in terms of his EoE, that 
once he was not having admissions for pneumonia and asthma his EoE 
stabilised as well”  
Participant 2, Focus group 2 
Role of environment Environmental factors may 
contribute to EoE 
“we really don’t know what’s causing it, I do believe its environment 
because he gets hives to dust and moulds and pollens”  
Participant 2, Focus group 1 
Awareness and 
education in the 
community 
 Desire for general understanding of 
EoE in the general public especially 
in schools, friends and family. 
 “if we can inform the circle of people around us; GPs, grandparents, 
whoever it is, from the moment the kids get diagnosed then that’s going 
to help from the start” 
Participant 1, Focus group 2 
Education and 
awareness in schools 
and care facilities 
Desire for general understanding of 
how EoE affects children wellness 
and the role of food 
“I’m constantly fighting them [schools] trying to do things that are more 
inclusive for all kids with food allergies. Sometimes it’s like hitting my 
head against a brick wall with them…. They don’t really understand what 
it is or what it can do”  
Participant 6, Focus group 2 
Education and 
awareness of families 
and friends 
Desire for general understanding of 
EoE among family and friends, 
particularly the role of food 
“I think family members they understand but at the same time they 
probably don’t understand the significance of food”  
Participant 2, Focus group 1 
Clear and direct 
treatment pathway 
 A protocol of the treatment 
procedure to allow progress 
“All these things need to be compiled into something that can be 




problem (EoE) or may be in the beginning stages; what’s my next step; 
what do I do next; how do I proceed?”  
Participant 3, Focus group 4 
Control vs. lack of 
control 
 Ability to “control” the disease is 
desired. 
“it made me realise…. that something that I felt like was so out of 
control could be in control “  
Participant 3, Focus group 3 
Cure  Desire for a disease cure “a cure would be wonderful”  
Participant 5, Focus group 2 
Time and emotion 
associated with 
diagnosis 
 The diagnostic journey including 
time to diagnosis and emotional 
aspects. 
“Well, I probably had EoE most of my life.  It's just that in October 2014 I 
got diagnosed with the condition after I had a few episodes where I had 
rice that got lodged in my throat”  
Participant 1, Focus group 4 
Relief at diagnosis Identification of cause is a relief “[getting] a diagnosis of EoE … it was like a big load off my shoulder”  
Participant 5, Focus group 2 
Length to diagnosis Time from symptom onset to 
diagnosis is delayed 
“I’ve only just been recently diagnosed in September last year but prior 
to that [I had] symptoms pretty much my whole life”  
Participant 9, Focus group 3,  
Referral pathway Pathway of specialists, tests and 
alternative diagnoses taken by 
patients to reach diagnosis 
“I went to my GP in 2011, I had a burning pain in my chest that I couldn’t 
explain. I saw neurologists, ENTs, and lots of specialists … and then my 
GP … he wanted an endoscope. That was in January 2014”  
Participant 8, Focus group 3 
Diet therapy  Aspects of dietary management 
including type, positive and 
negative facets. 
“If they [food] gave me a reaction … I then learned to steer clear of 
them”  
Participant 2, Focus group 4 
Length of time on 
restricted diet 
Length of the dietary elimination 
and reintroduction process 
“we’re 18 months into the diet” Participant 2, Focus group 1 
 
Difficulty and 
motivation of dietary 
change and 
maintenance.  
Overwhelming struggle of changing 
dietary habits and motivation to 
maintain a restricted diet. 
“I found it [elimination diet] was very hard because it was such a big 
lifestyle change”  






effort and skill 
Diet requires proficiency, time and 
effort in food planning and 
preparation 
“I’ve got used to taking everything with me and always planning ahead … 
It’s constantly on your mind; what am I going to eat later?”  
Participant 3, focus group 3 
Restricted diet types  Dietary elimination strategy used 
e.g. 6 food elimination diet 
“she’s [daughter with EoE] off the Top 8 plus sesame, corn, barley, rye, 
lentils” Participant 3, focus group 1 
Self-directed Patient or parent directs dietary 
changes with limited professional 
input 
“You’re sailing the ship on your own when it comes to diet and 
eliminating foods with your child”  
Participant 6, Focus group 2 
Elemental formula is 
positive 
Elemental formula provides an 
optimal nutrition source and 
symptom improvement 
“It was just fabulous being solely on Elecare [elemental formula] … it was 
only for a short period of time, but it was such a relief to our family”  
Participant 2, Focus group 2. 
Difficulty of food 
reintroduction and 
trigger identification 
Trigger identification through food 
reintroduction is difficult 
“I felt that every time I tried to introduce food it would be that much 
worse”  
Participant 8, Focus group 2 
Disease mechanism Physiology of cause What caused it/ Why did I get the 
disease/Possible to diagnose from 
birth 
“What’s the chicken, what’s the egg? Why’re they (eosinophils) there in 
the first place? Why are they (eosinophils) grouping there? Why does 
that cause symptoms?”  
Participant 3, Focus group 4 
Role of family history 
or genetics  
What is the relationship of family 
history 
“There’s an adult (participant 5) who went undiagnosed with it for 
27years and then there’s my son…Why aren’t you interested in my 
story? It might help him” Participant 5. Focus group 2. 
Role of food and food 
components  
What is the role of food and food 
components in the disease process 
“wheat and dairy, that’s too broad for me, it has to be something 
specific in there, whether it’s the gluten, whether it’s the protein”  
Participant 7, Focus group 3 
Easy, quick and 
reliable dietary 
testing method 
 Test used to identify dietary 
triggers 
“Something that allows you to be less blunt with diet … so that we can 
move quickly”  







 Treatment of patient as whole not 
per each condition 
“My sons got a respiratory specialist, a dietitian, a gastroenterologist, an 
immunologist, a paediatrician and a GP. And they all want to … focus on 
one particular thing not him as a whole”  
Participant 2, Focus group 1 
Case manager Medical advocate to assist 
professional communication and 
treatment plan 
“I felt that there needed to be a case manager, someone that was in 
charge of what was going on”  




Communication between multiple 
medical specialists is important and 
desired 
 
“People with [a] chronic disease I think are chopped up by the 
profession in terms of their particular symptoms”  
 Participant 2, Focus group 2 
Information in a 
clear and plain 
language 
 Simple information on the disease, 
current research and known 
resources 
“I’d like to have much more information that I can understand, in plain 
English, so that I can really understand what this illness is”  




disease and disease 
treatment 
 Future implications of the chronic 
disease and disease treatment 
“the compounding impacts of high levels of medication versus significant 
and dangerous symptoms”  
Participant 2, Focus group 2 




Future implications of medication 
use 
“I worry about the long term effects of things like medication”  
Participant 1, Focus group 2 
Medication therapy  Aspects of medical management 
including adverse reactions, 
administration and desire for 
alternatives 
“I want to know how we can improve the treatment of it [EoE]” 
Participant 1, Focus group 2 
Adverse reactions to 
medications 
Symptoms experienced from 
medications 
“The steroids actually made the behaviour that much worse. It was like 
living with a two year old on ‘roid rage”  







Alternatives to corticosteroids and 
enhanced administration options 
“Non-steroidal medications to treat EoE would be my top two”  




 Difficulty of maintaining nutrition 
and growth in children and adults 
with EoE 
“He was literally fading away in front of our eyes, there’s not much [of] 
him as I think with all EoE kids, they’re really skinny because they’re not 
getting any nutrients from what they do eat”  




how others view 
them 
 Mothers and adults feel that others 
view them as extreme and have a 
“desire to be normal” 
“Being diagnosed it gave that reason for being a nutcase all these years” 
Participant 9, Focus group 3 
Experiences with 
endoscopy 
 Experiences with endoscopy 
including positive and negative 
experiences 
“My little one had his tonsil ruptured on the way out and he was in 
hospital for five days”  
Participant 1, Focus group 1 
Potential disease 
trajectory 
 Knowledge of disease path and 
possible barriers and conditions 
“when you get told [that] you're going to have a baby they say, ‘Don't go 
in having too much of a plan about your birth plan because it could 
change’ … I guess EoE is a bit like that; you need to go in with an open 
mind”  






 Knowledge or lack of knowledge of 
all health professionals 
surrounding EoE 
“We were under a general paediatrician, a GP, the allergy clinic and no 
one at any time mentioned EoE until we saw the sleep specialist. He 
referred us to a paediatric gastro”  
Participant 2, Focus group 1 
Awareness in primary 
care setting 
Greater disease recognition is 
desired by patients among primary 
care physicians e.g. General 
Practitioners (GPs) 
“As the others have said it’s the whole education and awareness being 
at the GP level and the hospital level”  




Lack of belief or 
support from 
professionals 
Lack of validation of symptoms by 
health care professionals and 
appropriate referral/management 
“I had a really hard time finding a doctor who believed me until they 
actually saw it. I actually called my doctor and said, “My son’s reacting 
now I’m coming to bring him in’”  
Participant 9, Focus group 2 
Impact on physical 
functioning 
 Impacts of EoE on daily tasks “I started getting progressively worse … that hugely impacted my day to 
day life, performing every day, dancing from 830-330, hugely impacted 
… going from normal stuff [food] to pretty much nothing, my energy 
levels went down” Participant 2, Focus group 3 
Emotional Impact  Thoughts and feelings associated 
with the patient journey 
“I think for me personally I felt guilt that I didn’t pick it up sooner”  
Participant2, Focus group 1 
Frustration Anger or annoyance by lack of 
progress 
“It’s frustrating that we could never really find a diagnosis”  
Participant 4, Focus group 1 
Fear Distress experienced from 
symptoms 
“He had a very bad choking episode at my neighbour’s house and when 
she bought him in to me she was quite frazzled, and she explained how 
horrific it was” Participant 6, Focus group 2 
Worry Anxiety or stress about the disease 
management 
“One worry replaces another worry and I think that’s how it’s going to 
be always” Participant 7, Focus group 2 
Despondency Low spirits from disease symptoms 
and diet restrictions 
“[It’s a] very depressing time for a mother who just wants to feed their 
child and is just hitting brick wall after brick wall. So, lots of crying. Lots 
of crying in the super market aisles”  
Participant 6, Focus group 2 
Eating enjoyment Pleasure derived from food and 
eating occasions 
“There's no point going out to eat for him.  It's so terrifying and 
unpleasant for everyone” 
Participant 2, Focus group 2 
Financial impact  Burden of healthcare costs “If you want to get your child well and scoped and all that fast you have 
to pay for it”  
Participant 1, Focus group 2 
Impact on 
relationships 
 Disease effects on the relationships 
with family, friends and partners. 
“It was a lot of hard years; a lot of sad years watching your child not 





Participant 7, Focus group 2 
Family impact, support 
and understanding 
Impact of the disease on family 
members especially: mothers, 
partners and siblings 
“I think it does take a toll on everybody, my daughter who’s 17 has 
always said… his [Brother] illness affects everybody… that’s really hard 
for siblings”  
Participant 4, Focus group 1 
Impact on friendships 
and support and 
understanding of 
friends 
Impact of the disease on 
friendships 
“my friends are pretty good, they know what I can and can’t do, they 
always ask me before they do something, but they don’t get it either 
because they don’t live with it”  
Participant 3, Focus group 1 
School or care 
impact 
 Impact of disease and food 
restrictions on school attendance 
and performance 
“It’s just turned into this rollercoaster of him missing enormous amounts 
of school and he loves school” 
Participant 4, Focus group 1 
Social impact  Disease changes involvement with 
other people and activities 
“I found socially it’s hard because I’d just end up saying no to pretty 
much everything”  
Participant 3, Focus group 3 
Difficulty of special 
occasions/celebrations 
Difficulty managing diet with 
celebrations  
“Birthday parties are just hell. My little fellow is really social; loves 
everyone and gets invited to every birthday party. It’s a total nightmare, 
he loves it; we just hate it”  
Participant 2, Focus group 2 
Difficulty eating out Difficulty managing symptoms and 
diet when eating out 
“the first time I did go to a restaurant it was just embarrassing, I had two 
people standing there in front of me going we told you we cater for 
allergies and coeliac, we do gluten free and I said well actually I’m not 
coeliac I’ve got lots of other food allergies and they go well what’s your 
problem? We can give you salad, it was a big nightmare, I mean it was 
just totally humiliating”  
Participant 8, Focus group 3 
Self-conscious Feeling uncomfortable or aware of 
symptoms or diet restrictions in 
front of others 
“he is very self-conscious about it, especially at school. We’ve missed a 
lot of school activities that revolve around food because he just doesn’t 





Participant 5, Focus group 2 
Work impact  Impact of disease and food 
restrictions on work attendance 
and performance 
“I have had to change my employment. He has missed so much school 
that I needed a job where I could work from home, where I could 
disappear at a moment’s notice”  
Participant 2, Focus group 2 
Role of dietitian  What do patients view as the most 
important aspects of nutrition 
assessment and management by a 
dietitian  
“The fear and the anxiety that comes with eating food, you need support 
to be able to even trial those foods” 
Participant 9, Focus group 3 
Food reintroduction 
guidance 
Instructions on how to introduce 
food 
“This year I’m going to try and introduce some more foods. So, if I didn’t 
have the dietitian that would be something that I wouldn’t be able to 
figure out on my own” Participant 1, Focus group 4 
Individualised dietary 
advice and support is 
lacking 
Tailored dietary advice and support 
is desired 
“just a little bit more than a booklet thrown at me, saying, ‘here try 
these recipes’, which still have stuff that my kids allergic to, I would just 
like a little bit more support”  
Participant 6, Focus group 1 
Information on how to 
meet nutrient 
requirements and 
increase intake on 
restricted diet 
Specific strategies to meet macro 
and micronutrient requirements on 
a restricted diet. 
“I think the toughest thing has been working out how to get enough 
nutrition with such a narrow number of foods … I think that really 
specialist advice, nutritional advice around how you get enough calcium, 
how you get enough protein”  
Participant 2, Focus group 2 
Recipes and food 
product knowledge 
Provision of reliable recipes, foods 
and products.  
“the recipe book, that was a really big help to me”  




 Participants desire provision of 
information, support, and regular 
follow up and are contactable  
“It’s very overwhelming, so somebody that could actually explain it to 
you, this is what it is, this person had recommended this plan of attack”  
Participant 6, Focus group 1 
Self or parent as 
advocate and 
researcher 
 Patient or parent has to advocate 
for specialist referrals and 
treatment and research the 
disease. 
“he was sent to a paediatrician because I asked to be sent to a 
paediatrician not because they felt it was necessary”  







 Mothers/adults express that 
“something was not right” with 
their child 
“we first realised something wasn’t quite right when he was about 5 
months old we started introducing solids and couldn’t get past the puree 
stage” 
Participant 1, Focus group 2 
Support  Support or lack of support from 
family, friends, health 
professionals, schools and 
community. 
“The friendship we’ve got [friend with EoE] has probably been the best 
thing”  




 Support of others with experience 
in EoE is beneficial 
“[I’m] on Facebook … I’ve never met with anyone and I don’t often 
comment but it’s just nice to know there’s other people with this [EoE]” 
Participant 2, Focus group 4 
Symptoms  Symptom type and severity and 
their relationship with food and 
disease activity 
“Having a little boy that just doesn't choose to eat and never has.  It's 
not like you're holding things back for him.  He's quite happy to not 
touch anything.  He just doesn't care to eat” 
Participant 3, Focus group 2 
Unpredictable 
reactions 
Reactions can be lengthy, delayed 
or unclear 
“it’s how long it takes to start having a reaction and then having to go 
back to nothing [elimination diet food]” 
Participant 5, Focus group 3 
Type and severity Types and frequency of symptoms 
experienced by participants and 
the perceived severity 
“I had a burning pain in my chest that I couldn’t explain”  
Participant 6, Focus group 3 
Variability in symptoms 
between cases 
Symptoms experienced among EoE 
patients is varied 
“A lot of people tonight are saying the gagging and the vomiting, and the 
stomach upset, we didn’t get any of that. The only thing we got for my 
son, especially as he got older, was extreme behavioural issues” 
Participant 8, focus group 2 
Treatment  Broadly describes the treatment of 
EoE including the time taken to 
commence treatment, treatment 
effectiveness and treatment 
choice. 
“The gastroenterologist didn’t really give us a choice with treatment, she 
just said, “He needs to go on medication. He needs to go on it now” 






Response to treatment including 
positive or negative responses and 
monitoring effectiveness.  
“We did flixotide, and that worked for a long time. Then it stopped 
working. They increased the dose. It worked for a little while and then it 
stopped working” Participant 3, Focus group 2 
Treatment options or 
choice 
Patients desire treatment choice “We were never given the option of medication. We were only given the 
option of diet. When I did say to the gastro, ‘well, what about some 
medicine?’ he kind of just shook his head.” Participant 7, Focus group 2 
 
 
APPENDIX H: SKIN PRICK TEST PANELS FOR ADULTS AND CHILDREN 
 







Figure H2: Skin prick test standard panel for adults 2013-2014. 
 
 













Figure H5: Skin prick test standard panel for children 2013-2014. 
 
 
Figure 10.6: Skin prick test standard panel for children 2014-2017. 
 
 
APPENDIX I: SYMPTOM/DIET QUESTIONNAIRES 
I.1 Baseline Symptom/Diet Questionnaire 
 
Today’s date         /        /         Height (without shoes)   cm Weight  kg 
 Measured by RPAH staff  Reported by parent/carer/patient 
____________________________________________________________________________ 
 
PLEASE ANSWER ALL QUESTIONS 
 








2a.  Please indicate the symptoms you have AT PRESENT (in the last 6 months)? 
 
 
SYMPTOM FREQUENCY SEVERITY 
 Never Occas. Monthly Weekly Daily Mild  Mod.  Severe 
EXAMPLE SYMPTOM           
Eczema           
Hives            
Swelling (e.g. face/hand)           
Rashes (other ____________)           
Hayfever (seasonal)           
Sneezing           
Runny nose           
Blocked nose           
Post nasal drip (swallowing 
mucus) 
          
Asthma           
Mouth ulcers           
Nausea           




Reflux (acid)           
Heartburn           
Indigestion           
Wind/Gas           
Bloating/Discomfort           
Stomach pain/Cramps           
Diarrhoea           
Constipation           
Headache/Migraine           
Fatigue           
Muscle/Joint aches           




2b. Please indicate the symptoms you have AT PRESENT (in the last 6 months)? 
 
SYMPTOM FREQUENCY SEVERITY 
 Never Occas. Monthly Weekly Daily Mild  Mod.  Severe 
EXAMPLE SYMPTOM           
Difficulty getting food to go 
down 
          
Sensation of food sticking           
Food impaction (food stuck in 
the oesophagus) 
          
Choking on food           
Regurgitation of food           
Discomfort or pain on 
swallowing 
          
Chest pain during/after eating           
Chest pain unrelated to eating           
           




Other (specify)           
           
           








3. Have you had any of the following? 
 
 
4. Have you been screened for Coeliac disease?   Yes  No  Don’t know 
 
If YES,  When? __________________________ 
 
Was it by:  blood test?   endoscopy + biopsy? 
 
Were you avoiding gluten when the tests were done?  
 
 Yes  No  Don’t know/can’t remember 
 
Did you do a gluten challenge before having the test?   
 














 Current Past Never Details 
Anxiety     
Depression     
Eating disorder  
(specify, e.g. anorexia nervosa, 
bulimia, other) 
…………………….…………………………. 










6. Over the last year, has your weight been    
 
 Details 
 Stable?  
 Increasing?  




7a. Have you modified or restricted your diet?    Yes   No 






Source of the advice 
e.g. doctor, naturopath, 
dietitian, friend/family, 
internet/magazine/books 




















 Vegetarian/Vegan         
 Belief based diet  
(Kosher, Halal, Hindu 
etc.) 
   
     
 Mediterranean diet         
 Low cholesterol/low fat         
 Low calorie         
 Diabetic diet         
 Gluten-free diet         
 Wheat-free         
 Milk-free         
 Lactose-free         
 Low-FODMAP diet         
 An “Elimination” diet         
 Detox         




         
         
         




7b. Have you sought other advice from any of the following regarding your diet?  Yes 
  No 
If yes, please explain: 
 What advice were you given? 
Doctor  
 GP  
 Specialist  
Alternative health practitioner  




 Dietitian  
 Nurse  
 Pharmacist  
 Friend/ family member  









8a. Which of the following fruits do you eat?  





      
Banana 
      
Berries 
      
Strawberries 





      
Raspberries 
      
Citrus fruit 
      
Oranges 
      
Mandarin 
      
Lemon 
      
Dates 
      
Dried fruit 
      
Figs 
      
Fruit juice 
      
Grapes 
      
Kiwi fruit 
      
Mango 
      
Melons 
      
Watermelon 
      
Rockmelon 
      
Honeydew melon 
      
Passionfruit 
      
Paw paw, papaya 
      
Pear 
      
Pineapple 
      
Rhubarb 
      
Stone Fruit 
      
Apricot 
      
Cherry 
      
Peach 
      
Nectarine 
      
Plum 
      
Other (specify below) 
  
      
 
      
 












8b. Which of the following vegetables do you eat? 





      
Beetroot 
      
Bok choy/pak choy/choy sum 
      
Broccoli 
      
Brussels Sprouts 
      
Cabbage 
      
Capsicum 
      
Carrot 
      
Cauliflower 
      
Celery 
      
Corn 
      
Cucumber 
      
Eggplant 
      
Herbs and spices 
      
Leek 
      
Lentils/legumes (e.g. kidney beans, 3/4 bean mix etc.) 
      
Lettuce - Iceberg 
      
Lettuce – Other (e.g. cos, coral, rocket, etc.) 
      
Mushrooms 
      
Onion 
      
Green beans 
      
Green peas 
      
Garlic 
      
Potato 
      
Pumpkin 
      
Seaweed/Nori (Sushi rolls, nori chips) 
      
Shallot 
      
Spinach 
      
Swede 
      
Sweet potato/Kumera 
      




Fresh       
Tomato sauce       
Pasta sauces (e.g. bolognaise, lasagne)       
Vegetable juice/vegetable stock 
      
Zucchini 
      
Other (specify below) 
  
      
 
      
 






9a. Have you had any reactions to particular foods or drinks?    Yes   No 
 










9b. Do you avoid any particular foods?    Yes   No 
 
If yes, please list 













9c. What is your response to eating the following foods?  (choose as many as apply) 
 




Apple      
Brussels Sprouts      
Cabbage      
Garlic      
Green Beans      
Leek      
Legumes/Lentils      
Onion      
Parsnip      
Pear      
Potato      
Shallot      
Tomato      
 
 




Shared (who?) Other (who?) N/A 
Grocery shopping        
Cooking        
Baking  
(e.g. cakes, biscuits, bread) 
       
 
10b. How would you describe your/their cooking and baking skills?  
 Poor Basic Good Excellent 
Cooking     
Baking (e.g. cakes, biscuits, bread)     
 
10c. How much do you agree with the following? 
 Not at all Just a little Pretty much Very much 
The less physical energy I need to prepare a meal, the better.     
The ideal meal can be prepared with little effort.     
Preferably, I spend as little time as possible on meal preparation.     




At home I preferably eat meals that can be prepared quickly.     
It’s a waste of time to spend a long time in the kitchen preparing a meal.     
I enjoy cooking.     
I enjoy making new dishes.     
I like to experiment with recipes.     
Preferably I prepare meals according to new recipes.     
I enjoy thinking up new meals.     
Preferably I prepare meals which I know how to prepare.     
 
10d. How much do the following factors determine your food shopping choices? 
 Not at all Just a little Pretty much Very much 
Price     
Convenience     
Health claim on label     
Glycaemic index (GI)     
Sugar content     
Gluten-free     
Omega 3 content     
Low cholesterol     
Low fat     
Trans-fats     
Low salt     
Additives     
Organic produce     
Genetically modified (GM) foods     
Pesticides     
Other _____________________________     












Daily Weekly Monthly Occas. Never 
Type  
e.g. favourite dish, cuisine, name of restaurant 
Restaurant        
Café       
Fast food       
Home cooked        
Other (specify below) 
       
       









12. Do any of the following smells, fumes or environmental chemicals make you feel unwell?   
 










    
 
Deodorants 
    
 
Scented toiletries 
    
 
Cleaning agents 
    
 
Insecticide sprays 
    
 
Cigarette smoke 
    
 
Petrol 
    
 
Car fumes 


















13. Are you currently taking any medication? 
 Yes   No 
 
If yes, please list 
 Brand Daily Weekly Monthly Occas. 
Medications – prescribed     
      
      
      
      
Medications – over the counter     
      
      
      
      
Supplements (vitamins and minerals)     
      
      
      
      
Herbal medicines     
      
      
      
      
Other (e.g. fish oils, probiotics)     
      
      









 Yes -->  Full-time  Part-time What work do you do? 
______________________________ 
 
 No -->  Unemployed   Retired  Pensioner   Home duties
   
 Other _________________ 
   
14b. What is the highest level of education you have completed? 
 







15. How much do you agree with the following statements?  
 Not at all Just a little Pretty much Very much 
I am a healthy eater     
I am a fussy eater     
I eat fast food on a regular basis     
Taste is more important to me than nutrients     
I eat low-fat food on a regular basis     
I rarely think about the long term effects of diet on my health     
Enjoying food is one of the most important pleasures in my life     
I have fond memories of family food occasions     
Money spent on food is well spent     
I think about food in a positive way     
I think natural, organic foods are better for you than 
commercially grown/processed foods 
    
I think natural, organic foods taste better than commercially 
grown/processed foods 
    
 
 
16. How well do the following statements describe your personality?  
I see myself as someone who… 
 
Not at all Just a little Pretty much Very much 
… is reserved 
    
… is generally trusting 
    
… tends to be lazy 




… is relaxed, handles stress well 
    
… has few artistic interests 
    
… is outgoing, sociable 
    
… tends to find fault with others 
    
… does a thorough job 
    
… gets nervous easily 
    
… has an active imagination 
    
… is considerate and kind to almost everyone 
    
 
 
17. AT PRESENT, how much do your symptoms impact on your quality of life?  
Not at all Just a little Pretty much Very much 
    
 





I.2 Elimination diet symptom/diet questionnaire 
 
Today’s date         /        /         Height (without shoes)   cm Weight  kg 
 Measured by RPAH staff  Reported by parent/carer/patient 
 
PLEASE ANSWER ALL QUESTIONS 
1. Did you start the Elimination Diet after coming to the Allergy Clinic?   
 Yes →  go to question 4    No  →  go to question 2  
 
2. Please explain the reasons you didn’t start the Elimination Diet  






3. Did you modify your diet at all based on the information you were given at the Allergy Clinic? 
 Yes    No  →  go to question 12b 
      ↓ 





Go to question 5 
 
4. When did you start the Elimination Diet? _____/_____ (month/year) 
 
5. Did you notice any improvement in symptoms on the modified diet?  
 Yes   No  →  go to question 7 
 ↓ 
6. How long were you on the modified diet before you noticed any improvement? _____________  
 
7. Was there a “withdrawal” effect (flare-up of symptoms)?    Yes   No   
If YES,  When?  ____________________ (days after modifying your diet) 
What symptoms did you get?  _____________________________________ 
How long did it last?   ___________________ (days) 
 
 
If Question 1 = YES & Question 5 = NO → Question 8 
If Question 1 = YES & Question 5 = YES → Question 11a 
If Question 1 = NO → Question 11b 
 
 
8. How long did you persist with the Elimination Diet before deciding it wasn’t helping? 





9. Did you go back to your normal diet?   Yes   No 





→  go to question 11b 
 
11a. Please indicate the symptoms you had before your initial appointment at the clinic  
and when you were at your best* ON THE ELIMINATION DIET?  
SYMPTOM  FREQUENCY SEVERITY  













to go down 
Before              
On Elim 
diet* 





Before              
On Elim 
diet* 







Before              
On Elim 
diet* 




Before              
On Elim 
diet* 





Before              
On Elim 
diet* 








Before              
On Elim 
diet* 





Before              
On Elim 
diet* 
          
  






SYMPTOM  FREQUENCY SEVERITY  




          
  
On Elim diet*             
Eczema 
Before              
On Elim diet*             
Hives  
Before              
On Elim diet*             
Swelling 
(e.g. face/hand) 
Before              
On Elim diet*             
Rashes  
(other ____________) 
Before              
On Elim diet*             
Hayfever (seasonal) 
Before              
On Elim diet*             
Sneezing 
Before              
On Elim diet*             
Runny nose 
Before              
On Elim diet*             
Blocked nose 
Before              
On Elim diet*             
Post nasal drip 
(swallowing mucus) 
Before              
On Elim diet*             
Asthma 
Before              
On Elim diet*             
Mouth ulcers 
Before              
On Elim diet*             
Nausea 
Before              
On Elim diet*             
Vomiting 
Before              
On Elim diet*             
Indigestion 
Before              
On Elim diet*             





On Elim diet*             
Heartburn 
Before             
On Elim diet*             
Wind/Gas 
Before              
On Elim diet*             
Bloating/Discomfort 
Before              
On Elim diet*             
Stomach pain/Cramps 
Before              
On Elim diet*             
Diarrhoea 
Before              
On Elim diet*             
Constipation 
Before              
On Elim diet*             
Headache/Migraine 
Before              
On Elim diet*             
Fatigue 
Before              
On Elim diet*             
Behavioural problems 
Before              
On Elim diet*             
Muscle/Joint aches 
Before              
On Elim diet*             
Bladder/Vaginal 
irritation 
Before              
On Elim diet*             
              
Other (specify) 
Before              
On Elim diet*             
 
Before              
On Elim diet*             
 
Before              




11b. Please indicate the symptoms you had before your initial appointment at the clinic and now?  
 
SYMPTOM  FREQUENCY SEVERITY  
  NEVER OCCAS. MONTHLY WEEKLY DAILY MILD  MOD.  SEVERE COMMENTS 
SYMPTOM  FREQUENCY SEVERITY  





          
  
Now             
Difficulty 
getting food 
to go down 
Before              





Before              







Before              




Before              




Before              





Before              





Before              









          
  
Now             
Eczema 
Before              
Now             
Hives  
Before              
Now             
Swelling 
(e.g. face/hand) 
Before              




Before              
Now           
  
Hayfever (seasonal) 
Before              
Now             
Sneezing 
Before              
Now             
Runny nose 
Before              
Now             
Blocked nose 
Before              
Now             
Post nasal drip 
(swallowing 
mucus) 
Before              
Now 
 
         
  
Asthma 
Before              
Now             
Mouth ulcers 
Before              
Now             
Nausea 
Before              
Now             
Vomiting 
Before              





Before              
Now             
Reflux (acid) 
Before              
Now             
Heartburn 
Before              
Now             
Wind/Gas 
Before              
Now             
Bloating/Discomfort 
Before              
Now             
Stomach 
pain/Cramps 
Before              
Now             
Diarrhoea 
Before              
Now             
Constipation 
Before              
Now             
Headache/Migraine 
Before              
Now             
Fatigue 
Before              
Now             
Behavioural 
problems 
Before              
Now             
Muscle/Joint aches 
Before              
Now             
Bladder/Vaginal 
irritation 
Before              
Now             
 Before              
Other (specify) 
Now             
Before              




Before              
 
Now             
Before              
 
12.  Have you developed any new conditions/problems since your last visit?    Yes 
  No  
If Yes, please explain, 
 
13a. Which of the following fruits are you eating now?  
 Daily Weekly Monthly Occas. Never 
Apple 
     
Banana 
     
Berries 
     
Strawberries 
     
Blueberries 
     
Raspberries 
     
Citrus fruit 
     
Oranges 
     
Mandarin 
     
Lemon 
     
Dates 
     
Dried fruit 
     
Figs 
     
Fruit juice 
     
Grapes 
     
Kiwi fruit 
     
Mango 
     
Melons 
     
Watermelon 
     
Rockmelon 
     
Honeydew melon 
     
Passionfruit 
     
Paw paw, papaya 
     
Pear 
     
Pineapple 





     
Stone Fruit 
     
Apricot 
     
Cherry 
     
Peach 
     
Nectarine 
     
Plum 
     
  
     
 
     
 










13b. Which of the following vegetables are you eating 
now?  
Daily Weekly Monthly Occas. Never 
Avocado 
     
Beetroot 
     
Bok choy/pak choy/choy sum 
     
Broccoli 
     
Brussels Sprouts 
     
Cabbage 
     
Capsicum 
     
Carrot 
     
Cauliflower 
     
Celery 
     
Corn 
     
Cucumber 
     
Eggplant 
     
Herbs and spices 
     
Leek 
     
Lentils/legumes (e.g. kidney beans, 3/4 bean mix etc.) 
     
Lettuce - Iceberg 
     
Lettuce – Other (e.g. cos, coral, rocket, etc.) 
     
Mushrooms 
     
Onion 
     
Green beans 
     
Green peas 
     
Garlic 
     
Potato 
     
Pumpkin 
     
Seaweed/Nori (Sushi rolls, nori chips) 
     
Shallot 
     
Spinach 
     
Swede 
     
Sweet potato/Kumera 
     
Tomato      
Fresh      




Pasta sauces (e.g. bolognaise, lasagne)      
Vegetable juice/vegetable stock 
     
Zucchini 
     
  
     
 
     
 










14. Since your last appointment at the Allergy Unit, have you had any reactions to particular foods or 
drinks? 
    Yes   No 
 











15. Since your last appointment at the Allergy Unit, do any of the following smells, fumes or 
environmental chemicals made you feel unwell?   
 










    
 
Deodorants 
    
 
Scented toiletries 
    
 
Cleaning agents 
    
 
Insecticide sprays 
    
 
Cigarette smoke 






    
 
Car fumes 








16. Are you currently taking any medication? 
 Yes   No 
 
If yes, please list 
 
 Brand Daily Weekly Monthly Occas. 
Medications – prescribed     
      
      
      
      
Medications – over the counter     
      
      
      
      
Supplements (vitamins and minerals)     
      
      
      
      
Herbal medicines     
      
      
      
      




      
      
      
      
 
If question 11a used → Go to question 17a  
If question 11b used → Go to question 17b  
 
17a. Indicate the extent to which you feel your symptoms impact on your quality of life,  
 Not at all Just a little Pretty much Very much 
Before your first appointment     
On the Elimination Diet, at their best     
 
 
17b. Indicate the extent to which you feel your symptoms impact on your quality of life,  
 Not at all Just a little Pretty much Very much 
Before your first appointment     




I.3 Personalised diet Symptom/diet questionnaire 
 
Today’s date         /        /         Height (without shoes)   cm Weight  kg 
 Measured by RPAH staff  Reported by parent/carer/patient 
_____________________________________________________________________________ 
PLEASE ANSWER ALL QUESTIONS 
1a. Please indicate the symptoms you had before your initial appointment at the clinic  
and when you were at your best* ON THE ELIMINATION DIET and now 
SYMPTOM  FREQUENCY SEVERITY  









          
  
Now             
Eczema 
Before              
On Elim 
diet* 
          
  
Now             
Hives  
Before              
On Elim 
diet* 
          
  
Now             
Swelling 
 (e.g. face/hand) 
Before              
On Elim 
diet* 
          
  




Before              
On Elim 
diet* 
          
  





Before              
On Elim 
diet* 
          
  
Now             
Sneezing 
Before              
On Elim 
diet* 
          
  
Now             
Runny nose 
Before              
On Elim 
diet* 
          
  
Now             
Blocked nose 
Before              
On Elim 
diet* 
          
  
Now             
Post nasal drip 
(swallowing 
mucus) 
Before              
On Elim 
diet* 
          
  
Now             
Asthma 
Before              
On Elim 
diet* 
          
  
Now             
Mouth Ulcers  
Before              
On Elim 
diet* 
          
  
Now             
Nausea  
Before              
On Elim 
diet* 





Now             
Vomiting  
Before              
On Elim 
diet* 
          
  
Now             
Reflux (acid) 
Before              
On Elim 
diet* 
          
  
Now             
Heartburn 
Before              
On Elim 
diet* 
          
  
Now             
Indigestion 
Before              
On Elim 
diet* 
          
  
Now             
Wind/Gas 
Before              
On Elim 
diet* 
          
  
Now             
Bloating/Discomfort  
Before              
On Elim 
diet* 
          
  
Now             
Stomach 
pain/Cramps  
Before              
On Elim 
diet* 
          
  
Now             






          
  
Now             
Constipation 
Before              
On Elim 
diet* 
          
  
Now             
Headache/Migraine 
Before              
On Elim 
diet* 
          
  
Now             
Fatigue 
Before              
On Elim 
diet* 
          
  
Now             
Behavioural 
problems 
Before              
On Elim 
diet* 
          
  
Now             
Muscle/Joint aches 
Before              
On Elim 
diet* 
          
  
Now             
Bladder/Vaginal 
irritation 
Before              
On Elim 
diet* 
          
  
Now             
              
              






          
  
Now             
 
Before              
On Elim 
diet* 
          
  
Now             
 
Before              
On Elim 
diet* 
          
  
Now             
 
Before              
On Elim 
diet* 
          
  
Now             




SYMPTOM  FREQUENCY SEVERITY  
  NEVER OCCAS. MONTHLY WEEKLY DAILY MILD  MOD.  SEVERE COMMENTS 
EXAMPLE 
SYMPTOM 




          
  
Now             
Difficulty 
getting food 
to go down 




          
  








          
  










          
  
Now             
Choking on 
food 




          
  








          
  
Now             





*When you were at your best on the Elimination Diet 
2. Are you continuing to maintain a modified diet? 
 Yes   No  →  go to question 21 
 ↓ 
 
3. Please indicate how much your intake is restricted for each class of foods or chemicals.  









Milk / dairy     
Wheat     
Salicylates     
Amines     
MSG     
Additives     
Other ________________________     
Other ________________________     
 Any amount 
tolerated 
3 or more 
“moderate” 
serves / day 
Tolerate 1-3 
“moderate” 
serves / day 
Less than 1 
“moderate” 











          
  








          
  




4. Which of the following fruits do you eat?  





      
Banana 
      
Berries 
      
Strawberries 
      
Blueberries 
      
Raspberries 
      
Citrus fruit 
      
Oranges 
      
Mandarin 
      
Lemon 
      
Dates 
      
Dried fruit 
      
Figs 
      
Fruit juice 
      
Grapes 
      
Kiwi fruit 
      
Mango 
      
Melons 
      
Watermelon 
      
Rockmelon 
      
Honeydew melon 
      
Passionfruit 
      
Paw paw, papaya 
      
Pear 
      
Pineapple 
      
Rhubarb 
      
Stone Fruit 
      
Apricot 
      
Cherry 
      
Peach 
      
Nectarine 
      
Plum 




Other (specify below) 
  
      
 
      
 




5. Which of the following vegetables do you eat? 





      
Beetroot 
      
Bok choy/pak choy/choy sum 
      
Broccoli 
      
Brussels Sprouts 
      
Cabbage 
      
Capsicum 
      
Carrot 
      
Cauliflower 
      
Celery 
      
Corn 
      
Cucumber 
      
Eggplant 
      
Herbs and spices 
      
Leek 
      
Lentils/legumes (e.g. kidney beans, 3/4 bean mix etc.) 
      
Lettuce - Iceberg 
      
Lettuce – Other (e.g. cos, coral, rocket, etc.) 
      
Mushrooms 
      
Onion 
      
Green beans 
      
Green peas 
      
Garlic 
      
Potato 
      
Pumpkin 
      
Seaweed/Nori (Sushi rolls, nori chips) 
      
Shallot 





      
Swede 
      
Sweet potato/Kumera 
      
Tomato       
Fresh       
Tomato sauce       
Pasta sauces (e.g. bolognaise, lasagne)       
Vegetable juice/vegetable stock 
      
Zucchini 
      
Other (specify below) 
  
      
 
      
 




6. How often do you experience food reactions now? 
 Never Occasionally Fairly often Frequently 
  
Less than once 
a month 
1-3 times per 
month 
Once a week or 
more 
Accidentally 
    
Knowingly 
    
 




8. Since your last appointment at the Allergy Unit, are there any smells, fumes or environmental 
chemicals which can make you feel unwell?   
 
How sensitive are you to the following?  










    
 
Deodorants 
    
 
Scented toiletries 
    
 
Cleaning agents 
    
 
Worse The same A little better Much better Completely well 





    
 
Cigarette smoke 
    
 
Petrol 
    
 
Car fumes 









9. Are you currently taking any medication? 
 Yes   No 
 
If yes, please list 
 Brand Daily Weekly Monthly Occas. 
Medications – prescribed     
      
      
      
      
Medications – over the counter     
      
      
      
      
Supplements (vitamins and minerals)     
      
      
      
      
Herbal medicines     




      
      
      
Other (e.g. fish oils, probiotics)     
      
      
      
 
10. Indicate the extent to which you feel your symptoms impact on your quality of life,  
 Not at all Just a little Pretty much Very much 
Before your first appointment     
On the Elimination Diet, at their best     
Now     
 






























































APPENDIX K: CLASSIFICATION OF PATIENT REPORTED SYMPTOM TRIGGERS 
Table K1: Classification of patient reported food triggers into food groups. 
Food Group  Food trigger 







Dried fruit (any) 
Dried Sultanas/Raisins 
Fig 
Fruit fresh (any) 




















































Other Legumes / Dried beans (specify) 
Soy Soy (any) 
Soy drink 
Soy based formula 
Eggs Egg 
Egg - fried 
Egg - hard boiled 




Meat Barbecue Meat, chicken 
Beef 
Chicken 














Fish and chips 
Mussels 
Octopus, Squid, Calamari 





Tuna - fresh 
Tuna canned 






Other nut (specify) 
Peanut butter 
Peanuts 











Rice & Rice products GF Rice cakes/crackers 
Rice 
Rice milk 
Gluten containing Bread Bread 
Croissant 
Other bread (specify) 
White bread 
Wholemeal/wholegrain bread 










Gluten containing bakery Banana bread/cake 
Cake (any) 
Chocolate cake/muffin/dessert 
Other cake or pastry (specify) 
Pancakes 
Pastries, apple pie etc 
Biscuits (any) 
Muesli bar 
GF breads GF breads 
GF grains and cereals Other GF cereal (specify) 
Other GF grain or flour (specify) 
Other GF pasta or noodle (specify) 
GF bakery GF Chocolate cake/muffin/dessert 
Fats & Oils Nuttelex 
Oil (any) 
Olive oil 
Drinks (non-alcoholic) Coffee 
Tea, herbal, peppermint 
Coke, Pepsi 
Cordial lemon/orange 
Mineral water/Soda water/Tonic water 
Soft drink (any) 
Soft drink lemon 
Soft drink lemonade 








Sweets Artificial sweeteners 
Chocolate 
Honey 
Jelly lollies, babies, beans, snakes, sweets, jube, 












Mixed Meal Chicken /nuggets & chips e.g. McDonald’s, 
Takeaway 
Curry meal/ Indian meals 
Fatty food/Fried food 
Food (any) 
Hamburgers e.g. McDonalds /burgers/meals 
Italian Pasta meals e.g. Bolognese/Lasagne 
Mixed meals (specify) e.g. steak + ice-cream + 
wine 
Other fast food/take-away (specify) 






South East Asian, Indian, Chinese, Malaysian, 




Meat & salad sandwich 














Other flavour (specify) 
Weaning (specify food/formula) 
Caffeine 
Formula not milk-derived (specify) 
Other food (specify) 
Milk Milk 
Goats milk 
Cow's milk formula 




Milkshake/Smoothie Chocolate flavoured 
Milkshake/Smoothie (any) 
Chocolate - milk 
Other dairy Cheese (any) 
Cheese Camembert/ Blue vein cheese/Parmesan 
Cheese Cheddar, tasty 
Cheese Ricotta 







Sauces/Spreads/Dressings/Seasonings Vegemite, Marmite 
BBQ sauce 
Fish sauce/oyster sauce 
Gravy e.g. Gravox 
Pesto 
Soy sauce/Blackbean sauce 
Tomato sauce/paste 
Vinegar 
MSG, flavour enhancers e.g. 635, chicken salt 
Stock cubes/powder/seasoning 
 
Table K2: Classification of patient reported food triggers into allergen groups.  
Allergen Group Food trigger 







Tomato Tomato (any) 
Tomatoes (canned) 
Pea Peas green 
Corn Corn 
Celery Celery 
Egg white Egg 
Egg - fried 
Egg - hard boiled 












Any Seafood Crustacea e.g. Crayfish, Crab, Clam 
Fish 
Fish and chips 
Mussels 
Octopus, Squid, Calamari 





Tuna - fresh 
Tuna canned 






Other nut (specify) 
Peanut butter 
Peanuts 



























Pastries, apple pie etc 
Biscuits (any) 
Oat Oats 
Barley Pearl barley/barley 
Milk Milk 
Goats milk 
Cow's milk formula 
Formula milk-based (specify) 
Milkshake/Smoothie Chocolate flavoured 
Milkshake/Smoothie (any) 
Chocolate - milk 
Cheese (any) 
Cheese Camembert/ Blue vein 
cheese/Parmesan 
Cheese Cheddar, tasty 
Cheese Ricotta 







Soy Soy (any) 
Soy drink 
Soy based formula 
 
Table K3: Classification of patient reported food triggers into food chemical groups.  
Food Chemical Group Food trigger 
Dairy Milk 
Goats milk 
Cow's milk formula 





















Soy Soy (any) 
Soy drink 
Soy based formula 








































Tuna - fresh 
Tuna canned 
Antioxidants Fatty food/Fried food 
Fish and chips 
Potato hot chips 





APPENDIX L: NUMBER OF PATIENTS WITH EOSINOPHILIC OESOPHAGITIS 




































































Figure L1: Number of patients with eosinophilic oesophagitis presenting to the Royal Prince 
Alfred Hospital Allergy Unit per year between August 1997 and February 2017 (N=169). 
 
APPENDIX M: EXAMPLE OF FOOD ALLERGEN SENSITISATION PATTERNS OF 





















































































































































a ) d )c )b )
 
Figure M1: Example of food allergen sensitisation patterns of patients with eosinophilic oesophagitis at baseline (N=56). Each row represents an individual 
patient. Darker colour indicates a larger skin prick wheal size (mm). Skin prick test wheal size is displayed per patient for egg white, cow’s milk, nuts, soy and 
wheat. Figure a) Patients with skin prick test wheal size to food < 3 mm, Figure b) Patients with a single food allergen sensitisation ≥ 3mm, Figure c) Patients 




APPENDIX N: RELATIONSHIP BETWEEN PATIENT REPORTED SYMPTOM 
TRIGGERS AND SKIN PRICK TESTS 
Table N1: Chi square analysis of patient reported symptom triggers and food allergens 
identified on skin prick test.  
Food N P 
Chicken 131 Expected cell count < 5 
Egg 160 Expected cell count < 5 
Milk 161 Expected cell count < 5 
Soy 160 Expected cell count < 5 
Tomato 127 Expected cell count < 5 
Rice 35 Expected cell count < 5 
Kiwifruit 95 Expected cell count < 5 
Banana 126 Expected cell count < 5 
Apple 82 Expected cell count < 5 
Wheat 161 0.666 
Seafood ANY 157 0.050 
Beef 133 Expected cell count < 5 
Pork 133 Expected cell count < 5 
Lamb 83 Expected cell count < 5 
Nuts ANY  160 0.039 
Potato 134 Expected cell count < 5 
Pea 129 Expected cell count < 5 
Corn 132 Expected cell count < 5 
Oat 52 No SPT ≥ 3 
Barley 52 No reported triggers 
Mango 38 Expected cell count < 5 
Strawberry 91 Expected cell count < 5 
Peach 81 No reported triggers 





Table N2: List of pollens and grasses known to cross react with foods.315 
Inhalant allergen Food trigger 



































APPENDIX O: CHANGES TO CAPSULE CHALLENGE SETS OVER TIME 
Table O1: Capsule challenge sets between 1997 and 2017. 
June 1997-Decemeber 2000 January 2001-November 2004 December 2004-Present 
Aspirin  Aspirin  Aspirin  
Amine Tyramine HCL & B 
phenylethylamine  
Amine Tyramine HCL & B 
phenylethylamine  
Amine Tyramine HCL & B 
phenylethylamine  
MSG  MSG  MSG  
Sodium nitrate & sodium 
nitrite  
Sodium nitrate & sodium 
nitrite  
Sodium nitrate & sodium 
nitrite  
Lactose  Lactose  Lactose  
Sucrose  Sucrose  Sucrose  
Starch (potato)  Sucrose Sucrose 
Gluten  Gluten  Gluten  
Preservatives: sodium 
benzoate, 4OH Benzoate, 
sorbic acid & sodium 
metabisulphite  
Preservatives: sodium 
benzoate, 4OH Benzoate, 
sorbic acid & sodium 
metabisulphite  
Preservatives: sodium 
benzoate, 4OH Benzoate, 
sorbic acid & sodium 
metabisulphite  
BHA & BHT BHA & BHT BHA & BHT 
Sodium Propionate Sodium Propionate Calcium Propionate  




APPENDIX P: SELF REPORTED SYMPTOM FREQUENCY BEFORE, ON THE 











D y s p h a g ia
S e n s a t io n  o f  fo o d  s t ic k in g
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Figure P1: Self-reported symptom frequency before, on the elimination diet and at follow up 




APPENDIX Q: BASELINE WHO-QOL-BREF DOMAIN SCORES FOR PATIENTS WITH 






































A u s tr a l ia n  P o p u la t io n
D o m a in
 
Figure Q1: Baseline WHO-QOL-bref domain scores for patients with Eosinophilic 
Oesophagitis comparison to Australian population norms386 (N=19). A higher score 
indicates a better QOL.  Mean physical QOL score for EoE patients is one standard 
deviation below the mean Australian norm (73.3±14.1 vs. 87.0±13.5). Overall patients 
perceived their QOL to be high (4 out of 5) and were moderately satisfied with their 




APPENDIX R: BASELINE GENDER DIFFERENCES IN PYSCHOLOGICAL 
CHARACTERISTICS  
Table R1: Baseline gender differences in psychological characteristics in patients with 
eosinophilic oesophagitis.  







































^ Mann Whitney U test 
 
APPENDIX S: RELATIONSHIP BETWEEN BASELINE SYMPTOMS AND 
PYSCHOLOGICAL CHARACTERISTICS 

























Dysphagia 7.5 7.0 0.596 34.5 39.0 0.518 34.5 37.0 0.236 
Sensation of food 
sticking 
4.0 10.5 0.103 30.5 44.5 0.016 32.0 49.0 0.012 
Impaction 7.0 8.0 0.832 36.5 39.0 0.553 35.0 47.0 0.377 
Regurgitation 5.5 8.0 0.348 34.5 44.0 0.113 35.0 50.0 0.181 
Pain on swallowing 7.5 7.0 0.613 34.5 39.0 0.698 36.0 35.0 0.826 
Throat irritation 11.0 7.0 0.567 35.0 41.0 0.187 35.0 36.0 0.670 
Chest pain with eating 5.5 15.0 0.134 32.5 44.0 0.103 34.5 47.0 0.306 
Gastrointestinal 
Nausea 7.0 9.0 0.590 34.0 42.5 0.074 35.0 37.5 0.869 
Reflux 5.5 14.5 0.151 30.0 44.5 0.063 30.5 50.5 0.008 
Heartburn 4.0 16.0 0.034 30.0 47.0 0.009 34.0 51.0 0.035 
Indigestion 5.5 11.0 0.233 30.0 44.5 0.005 31.5 50.5 0.024 
Abdominal pain 4.0 15.0 0.033 30.0 44.0 0.001 33.0 50.0 0.018 
Diarrhoea 4.0 21.0 0.001 30.5 51.5 0.010 33.5 51.0 0.005 
Constipation 4.0 11.0 0.036 31.0 44.0 0.003 34.0 50.0 0.066 
CNS 
Headache 4.0 13.0 0.080 36.0 41.5 0.131 35.0 48.5 0.434 
Fatigue 2.5 14.5 0.006 30.5 46.0 0.000 32.0 51.0 0.001 
Joint aches and pains 4.0 19.5 0.034 33.0 44.5 0.043 34.5 50.5 0.090 
Respiratory 





APPENDIX T: DIETITIANS SURVEY  
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